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Summary
Papaver somniferum (opium poppy) plants have been known to mankind for 
thousands of years, and used for food, oil, relief of pain, and recreation; it has 
also been misused with much social harm. The major active ingredient for pain 
relief is the alkaloid, morphine. The morphinan alkaloids are nitrogenous 
compounds that are complex in structure and synthesis. The complex reactions 
that are involved in the plant are difficult to replicate in vitro. Advancing our 
understanding of the process involved in the in vivo synthesis of morphine can 
eventually lead to an insight of where these complex molecules are made and 
give an insight into the types of enzymes required. Ultimately this work can lead 
to the future understanding as to how and why plants invest so much energy into 
these molecules.
This research investigates poppy germplasm (natural genotypes, mutants and 
transgenics) that have varying profiles of benzylisoquinoline alkaloids. First it 
was necessary to characterise several new Papaver somniferum morphinan 
alkaloid mutants by end product analysis. Second, in order to enable a global 
analysis of the transcriptome of these various genotypes, I have developed a 
cDNA Papaver somniferum library and produced a low-redundancy 17 000 
cDNA microarray.
By looking at the molecular phenotype of a number of different morphinan 
alkaloid accumulating germplasm and comparing these to the wildtype or control 
morphinan alkaloid accumulation any gene changes can be attributed either 
directly or indirectly to morphine biosynthesis.
Microarray analysis of the transcriptomes of the characterised germplasm, with 
particular emphasis on the thebaine and oripavine accumulating mutant topi, has 
shown a set of ten genes to be consistently differentially expressed in several of 
the alkaloid variants compared to wildtype poppy. Further analysis has revealed 
that this set of ten genes can be reduced to just three different genes, which are
vii
associated with morphinan alkaloid accumulation in the opium poppy. Using 
database searches these genes have homology closest to: cDNA 116D7, light-
harvesting chlorophyll a/b binding protein Lhca2.1; cDNA 221C9, an 
aminotransferase cDNA which is differentially spliced in the mutant; and cDNA 
151H8, which has no homology in the database. This work has opened up new 
insights and new avenues for further research into the levels of control and 
regulation on the morphinan pathway in the unique species P. somniferum.
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Chapter 1
Literature Review
1.1 Introduction
The study of secondary metabolites in plants has improved in recent times due to 
the increasing development and availability of sensitive methods of analysis, 
permitting the discovery of products that are generally produced in small 
quantities, and were previously difficult to study. Secondary metabolites were 
initially considered to be debris or plant metabolic waste products until the 1960s 
when it became clear they had functional characteristics variously contributing to 
plant survival (Wink, 1998). Many secondary metabolites represent a significant 
investment of energy and resources by the plant and often include the valuable 
plant resource nitrogen. Nitrogen is essential for primary metabolism and is 
often of limited availability to plants, suggesting that the plant must gain some 
selective advantage in continuing to produce these supposedly ‘redundant’ 
molecules.
Secondary metabolites include molecules responsible for flower colour, scent and 
nectar to ensure pollination and continuance of the species. They also contribute 
to plant protection from damaging UV light; some of the genes responsible for 
the synthesis of phenolics and terpenoids are induced by UV light (Wingender et 
al., 1989; reviewed in Ensminger, 1993). The main purpose of plant secondary 
metabolites appears to be plant protection, since many are found to accumulate in 
response to treatment with pathogens. A well-studied example is the induction of 
phcnylpropanoids in soybean (reviewed in Hahlbrock and Grisebaeh, 1979). It is 
now becoming evident that secondary metabolites function in a variety of plant 
functions beyond plant protection. Some secondary metabolites interact with 
symbionts to enhance plant growth; the flavone luteolin is expressed and exuded 
from the roots of alfalfa to activate rhizobial nodulation genes thus playing an 
important role in root colonisation (Peters et al., 1986; Hartwig et al., 1991).
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Another secondary metabolite, jasmonic acid, is actually part of a signal 
transduction chain that ultimately ends in the activation of defence genes and 
plant senescence (Gundlach et al., 1992; Reinbothe et al., 1994; reviewed in 
Kutchan 2001).
The most diverse group of secondary metabolites are the alkaloids with as many 
as 12,000 alkaloids having been documented in plants (Wink, 2004). Some 
alkaloids are extremely toxic to animals; ouabain is used in arrow poisons 
(Neuwinger, 1998) and coniine is the active ingredient of hemlock (Wink, 1998). 
Many alkaloids are the active ingredients of folk medicines and stimulants in the 
human diet: caffeine in tea from the shrub Camellia sinensis, and in coffee from 
Coffea arabica; theobromine, the active ingredient of chocolate from the cacao 
plant Theobroma cacao; the antibacterial sanguinarine from Sanguinaria 
canadensis; atropine from Atropa belladonna was used as a medieval anaesthetic 
and is still used today in ophthalmology and as an antispasmodic; hemlock 
(Conium maculatum) which contains the piperidine alkaloid coniine used for 
murder; the powerfully addictive cocaine which comes from the coca plant 
(Eiythroxylum coca); mescalin which has activities similar to LSD is produced in 
the peyote cactus, Lophphora williamsii (Wink, 1998); nicotine from Nicotiana 
tabacum is useful as an insecticide as well as the main active stimulant in 
tobacco; and the medicinally important morphinan alkaloids from Papaver 
somniferum, such as morphine and codeine, used as painkillers and to suppress 
coughing. The medicinal properties of secondary metabolites may be the indirect 
result of their role as defence compounds; the same effects they have on a 
predator’s fitness through binding to various receptors or interfering with 
biochemical pathways, allows them to be recruited for human use (Wink, 1998).
The benzylisoquinoline alkaloids contain some of the most pharmacologically 
active compounds known to man, including morphine. This class of alkaloids 
can be found primarily in plants that belong to five families: the Berberidaceae, 
Fumariaceae, Menispermaceae, Ranunculaceae and the morphinan containing 
Papaveraceae (Facchini et al., 1997). Many of these pharmacologically active 
compounds are still harvested from plants due to the complexity of their chemical 
structures. Approximately 25% of all available modem drugs that play a major
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role in the treatment of human disease are derived from or were first discovered 
in higher plants (Kutchan, 1995: Farnsworth and Bingel, 1997: reviewed De 
Smet, 1997).
Due to their medicinal importance and the difficulty of in vivo synthesis, the 
elucidation of plant alkaloid fonnation has been of great interest, however 
progress has been limited due to the low concentrations of these molecules.
More recently progress has improved due to a number of advancements in the 
fields of radiochemistry, in vitro plant cell growth and in molecular biological 
techniques.
With the introduction of radiolabelled precursors in the 1950s, chemical 
elucidation of alkaloid biosynthetic pathways became possible. Plant cell 
cultures provided the next step in providing a renewable and abundant source of 
secondary metabolic enzymes. The introduction of molecular techniques, in 
particular the polymerase chain reaction (PCR), have now allowed for many of 
these genes to be cloned. In the last few years it has been estimated that at least 
30 genes (Hashimoto and Yamada, 2003) and up to 80 genes (Kutchan, 1995) 
have been cloned which are involved in the biosynthesis of various classes of 
alkaloids. Of the 20,000 to 60,000 genes thought to occur in various plant 
genomes, 15-25% are estimated to encode enzymes for secondary metabolism 
(Bevan et al., 1998: Somerville and Somerville, 1999). The latest wave of mass 
screening technologies includes proteomics, metabolomics (Fiehn and 
Weckwerth, 2003) and DNA microarrays for transcript analysis, sometimes 
tenned transcriptomics (Schena et al., 1995). With these technologies researchers 
are well placed to expand the understanding of genes of secondary metabolism 
and their coordination.
Morphinan alkaloids are one such class of medically important alkaloids that are 
still widely used today and the synthesis of these alkaloids, while possible (Gates 
and Tsundi, 1952; Ginsburg and Elad 1954;), is not commercially viable (Rice, 
1985). Papaver somniferum L. and P. setigerum are the only plant species known 
to accumulate useful quantities of morphine (Meijerink et al., 1999). The aim of 
this project is to further the characterisation of several P. somniferum mutants
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that are altered in their ability to synthesize alkaloids. It is hoped this study will 
further enhance our understanding of alkaloid biosynthesis and in particular that 
of the morphinan alkaloids. Specifically one mutant, topi, will be characterised 
using classical techniques such as alkaloid profiles and feeding studies together, 
with molecular techniques using transcriptomics.
1.2 Alkaloids
The term alkaloid is derived from the Arabic word “al-qali” meaning from the 
ashes and referring to the ashes of the saltwort plant from which soda was first 
obtained (Kutchan, 1995). Alkaloids often exhibit physiological activities (and 
have been exploited by man for their medicinal and toxic properties (reviewed in 
Roberts and Wink 1998). These molecules have been predominantly found in 
about 20% of Angiospermae plant species (De Luca and Laflamme, 2001; 
Facchini, 2001). Over 12,000 alkaloids have been isolated from plants for which 
many structures have been ascribed function in plant defence against herbivores, 
pathogens and insects (Carporale, 1995; Wink 1999; De Luca and St Pierre,
2000; Samanani et al., 2002).
The pharmacological activities of these metabolites that make them useful as 
pharmaceuticals often provides an insight into the biological role they may 
perform in the plant (Carporale, 1995). However many alkaloids still have no 
real assigned function in the plant; and the fact that they generally give a bitter 
taste to the plant is often simplistically used to attribute to them the plant function 
of a feeding deterrent. However bitterness to human taste is not really very 
informative and studies have shown that some animals will still consume the 
plants regardless of the alkaloids (Wink et al., 1993). The most widely used 
plant-derived alkaloids include: stimulants such as caffeine and nicotine; 
anticancer chemotherapeutics including vincristine, vinblastine, camptothecin 
derivatives and paclitaxel; and of course the strong analgesics, morphine and 
codeine (See Figure 1.1 for some examples of important alkaloids).
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The diverse range of structures and activities of alkaloids has made it difficult to 
classify them easily. Alkaloids are generally defined as low molecular weight, 
cyclic and structurally diverse secondary metabolites that contain nitrogen (De 
Luca and St Pierre, 2000). Most alkaloids are derived from amino acids such as 
lysine, histidine, phenylalanine, tyrosine, tryptophan, ornithine, and arginine, 
although some are derived from other substrates such as anthranilic acid, 
nicotinic acid (a non-protein amino acid), and purines (Southton and 
Buckingham, 1989; Dewick, 1998). Most classification systems of alkaloids are 
based on their biochemical origins (Southton and Buckingham, 1989; Dewick, 
1998; Roberts and Wink, 1998) as the nitrogen atom and carbon skeleton 
originating from the amino acid are often retained in the final alkaloid. A large 
group of alkaloids, often termed pseudoalkaloids, acquire their nitrogen atom via 
transamination reactions and the rest of the molecule may be from acetate, 
shikimate, terpenoid or steroid molecules (Dewick, 1998).
Some of the more well known alkaloids are the indole alkaloids derived from 
tryptophan and these include the antimalarial quinine from Cinchona ledgeriana 
and the anti-cancer compound camptothecin, from Camptotheca accuminata,
This class of alkaloid also includes strychnine, ajmalicine, vindoline, tabersonine, 
catharanthine, and the antileukaemia compounds vincristine and vinblastine. The 
indole alkaloids number in excess of 1800 different compounds (Kutchan, 1995). 
The tropane alkaloids, another large group of alkaloids, include the 
anticholinergic drugs atropine, hyoscyamine and scopolamine. The strong 
narcotic cocaine is also classified in this group. Nicotine, a pyridine alkaloid, is 
not classified in the tropane class of alkaloids but has a common intermediate 
found in both the tropane and nicotinic alkaloid pathways. Tropane alkaloids are 
derived from ornithine or arginine. Lysine is the precursor of the quinolizidine 
alkaloids said to constitute about 2 % of all the known plant alkaloids (Wink, 
1987). This group contains the anti arrhythmic sparteine and plant quinolizidine 
alkaloid biosynthesis occurs in the stroma of chloroplasts, the site of lysine 
synthesis (Wink et al., 1980; Wink and Hartman, 1982). The purine alkaloids
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Figure 1.1: Examples of some of the medicinally important alkaloids and the 
plant species from which they are predominantly found. (Adapted from Kutchan, 
1995; Schmeller and Wink, 1998; Verpoorte et al., 2000; and Facchini et al., 
2004).
include: caffeine; the active stimulant of chocolate, theobromine; and the 
bronchodilator, theophylline.
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Tyrosine is the precursor for a very large family of alkaloids consisting of the 
phenylethylamines and the benzylisoquinolines. The phenylethylamines include: 
noradrenaline; adrenaline; and mescaline an alkaloid with psychoactive and 
hallucinogenic properties. The benzylisoquinolines include such compounds as: 
papaverine, a vasodilator; noscapine, a cough suppressant; codeine, a cough 
suppressant and analgesic; berberine, a potent antimicrobial; sanguinarine, an 
antiplaque agent; and morphine, used in the treatment of severe pain and 
diarrhoea. The benzylisoquinoline morphinan alkaloids (Figure 1.2) constitute 
some of the most medically important of all the alkaloids. Man has used 
morphinan alkaloids in the form of opium, which contains over 40 alkaloids, for 
thousands of years both as a source of medicinal relief of many ailments and for 
recreational use. Unfortunately the recreational use of opium and derivatives also 
results in addiction and associated social problems.
1.3 The History of Opium
Mankind has cultivated opium poppy, Papaver somniferum L., for thousands of 
years for use as a source of food, medicinal and recreational use. Remains of 
cave-dwellers living in Neolithic times (4-5 thousand years BC) in the territories 
of what is now Spain, France, Germany and Flungary, contained evidence for the 
use and knowledge of poppies (Tetenyi, 1997). Clay tablets of the Sumerians 
refer to the poppy as ‘hul giF or plant of joy and its collection as far back as 3 
thousand years BC (Brownstein, 1993). There is evidence in the Egyptian Ebers 
papyrus (1500 BC) of its use; flowers and pieces of poppies were found in tombs 
from the XVIIIth Dynasty. There are also many instances through classic 
literature of the mention of poppy and its use even in Homer’s Odyssey and Iliad. 
The word opium is probably of Greek origin, opos juice, opion poppy juice 
(Schiff, 2002). Hippocrates (460- 377BC) knew of the use of poppy as a 
hypnotic, narcotic, styptic and cathartic agent as well as the nutritive value of the 
seeds. It is thought that the poppy was introduced to India when the Persians 
under Alexander the Great (4th Century BC) invaded and used the plant for the 
needs of their army. Herakleides (340 BC) reported that women on the Greek 
Islands used poppy extracts for euthanasia. The Arabs formerly called the opium
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Figure 1.2: A simplified pathway illustrating the major branchpoints and 
compounds of the benzylisoquinoline morphinan pathway. (Adapted from 
Dewick, 1998; Facchini et al., 2000; and Ounaroon et al., 2003).
poppy “Abou-el-noum”, father of sleep and it was widespread throughout the 
Arab Empire (Schiff, 2002).
The spread of opium poppy as a source of medicine and food is thought to have 
coincided with the spread of the Roman Empire with evidence of its use 
throughout Europe and Asia. However the uses of the opium poppy plant became 
differentiated between the East and West. The East concentrated more on 
poppies for opium production and the West for the food value of the seed and oil. 
On their return to Western Europe, the Crusaders (between 1095 and 1270)
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Figure 1.3 (Previous Page): The benzylisoquinoline pathway from tyrosine to 
morphine. The morphinan alkaloids are in the irregular shaped box. 1: Tyrosine 
decarboxylase, 2: Phenol oxidase, 3: Transaminase, 4: Decarboxylase, 5: 
Tyrosine aminotransferase, 6: Phenol oxidase 7: Tyrosine decarboxylase, 8: (S)- 
Norcoclaurine synthase 9: Norcoclaurine 6’-0-Methyl-transferase 10: (5)- 
Coclaurine A-Methyltransferase 11: (^-A-Methylcoclaurine 3’-hydroxylase 
(Cyp80Bl) 12: 3’-Hydroxy-AMVIethylcoclaurine 4'-0-m ethyl transferase 13: (S)- 
Reticuline oxidase 14: 1,2 Dehydroreticulinium ion reductase 15: Salutaridine 
synthase 16: Salutaridine reductase 17: Salutaridinol acetyl-transferase 18: 
Thebaine synthase 19: Thebaine demethylase 20: Codeinone reductase 21: 
Codeine demethylase. Figure adapted from Kutchan 1998; Facchini et al., 1997 
and Facchini et al., 2000).
reintroduced the use of poppy as a drug. Later it is the alchemist, Paracelsus 
(1493-1541), trained in Basle but widely travelled through Europe, Russia, China 
and Turkey, who is generally credited with the introduction of laudanum, an 
alcoholic extract of opium, which remained popular for social and medicinal use 
well into the 20th century. After making his first fortune as a buccaneer on the 
Spanish Main, Thomas Dover (1660-1742) returned to Bristol and made his 
second fortune from his concoctions called Dovers Powders, which had opium 
and ipecacuanha as active ingredients. The latter is a mixture of isoquinoline 
alkaloids from Psychotria ipecacuanha, a small shrub found in Brazil and 
Columbia and its root powders were used as an emetic, digestive aid and 
expectorant. Dover included such large amounts of opium that many apothecaries 
were said to suggest that their patients settle their affairs and write their wills 
before using it; a high incidence of mortality obviously resulted from its use.
Addiction from the prolonged misuse of opium was noted as early as the 10th 
century in Arab literature and manuscripts have been found describing opium 
abuse in Turkey, Egypt, Germany and England from the 16th century. With the 
outlawing of tobacco in China, the smoking of opium became prolific, resulting 
in much addiction. The Chinese passed imperial laws, including capital 
punishments for the sellers and even confiscated and destroyed opium from
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American and British ships importing opium into Canton as an exchange for tea. 
This angered the British who started the first of the Opium Wars with China 
(1839-1842), and led to the concession of Hong Kong Island to the British as a 
reimbursement for the lost opium. The second Opium War in the next decade 
included American and British fleets taking even more concessions from the 
Chinese. Each time the concessions included the free trade of opium into China 
from the British-controlled Bengal. The Boxer rebellion at the turn of the 20th 
century was another uprising in China to evict the foreigners and with it the 
opium they brought with them. Again the Chinese lost further economic and 
territorial concessions. Not until the communists took control of China after 
World War II could the large rate of addiction be curtailed.
The principal active ingredient of opium poppy, a weak base, was first isolated 
by Sertürner in 1806 and was named morphine after Morpheus the Greek god of 
dreams. The purification of morphine gave a 10-fold increase in analgesic effect 
over opium and provided 19th century physicians with a unique tool for treating 
both postoperative and chronic pain, and as an adjunct to general anaesthetics. In 
1853 this was further enhanced with the invention of the hypodermic syringe 
allowing a more effective method of delivery. This revolutionised the treatment 
of the wounded in the Crimean and American Civil wars with soldiers able to 
self-administer the drug during conflict.
By the time of the 1870s a new phenomenon had arisen with American upper 
class women hosting morphine parties where the hostess would inject morphine 
into the arms of the guests. It was widely believed that injection of the drug 
avoided the addictive qualities of opium smoking and injection of morphine was 
often prescribed as a cure for this addiction. This resulted in a surge of addiction 
which coincided with the return home of thousands of Civil War soldiers who 
were also dependent on the drug from its liberal use. A new search was 
undertaken to develop an alternative non-addicting opiate.
Heroin (diacetylmorphine) (Figure 1.4) was synthesised in 1874 by Alder Wright 
and thought to be more effective than morphine and less addictive. In fact heroin 
was even more addictive than morphine due to its increased lipophilicity and
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consequent ability to cross the blood-brain barrier. Heroin was originally 
marketed by Bayer in 1898 as a cough suppressant in syrup form and quite often 
given to children as an aid to quieten them. Shortly after this, various 
governments realised its highly addictive potential and passed legislation to ban 
its use.
Heroin has been shown to be no more effective as an analgesic and antitussive 
than hydromorphine (introduced in 1926 by catalytic reduction of morphine to 
dihydromorphine followed by oxidation), and the drug is now rarely used for this 
purpose (O’Brien, 2001) (Figure 1.4). Unfortunately it is still available on the 
illicit market and is a major problem in world illicit drug use and addiction today.
1.4 Importance, Uses and Analogues of Morphinan Alkaloids
Research into the mechanism of opium addiction led to the discovery of highly 
specific opiate receptors found in brain membranes (Pert et al., 1973; Simon et 
al., 1973; Terenius 1973). Further studies have revealed three classes of 
receptors: mu (p), kappa (k ), and delta (8), present in nerve cells of the brain, 
medulla, gastrointestinal regions, and the urogenital regions. These receptors are 
conserved across species, however their concentration and distribution is not 
uniform across species (Meijerink et al, 1999). The finding of these specific 
receptors led to the search for endogenous compounds similar to the opiates as it 
was thought at the time that these receptors were highly unlikely to have co-
evolved as a result of using plant opiates or poppy cultivation; these receptors 
also occur widely in vertebrates. The search for endogenous opioid compounds 
that also bind the opioid receptors, led to the discovery of three distinct peptide 
families coded by three separate genes: enkephalins (Hughes et al., 1975), 
endorphins (Cox et al., 1976), and dynorphins (Goldstein, 1981) (reviewed in 
Akil et al., 1984). Each of the three families are commonly termed endorphins 
(from endogenous and morphine) and like the receptors are variously distributed 
across vertebrate species.
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The endorphins and opiates work by altering K and Ca~ flux in and out of nerve 
cells, inhibiting the release of excitatory neurotransmitters and in synaptic 
activity (Schiff, 2002). The search for endogenous opioids eventually led to 
morphine itself being isolated from toad skin (Oka et al., 1985). Subsequently 
several opiates, other than morphine, have been isolated from various mammalian 
tissues (Goldstein et al., 1985; Donnerer et al., 1986; Weitz, et al., 1986; 
Donnerer et al., 1986; Kodaira et al., 1989), and recently reticuline has been 
found in rat brain (Zhu et al., 2003).
Liver homogenates were used to show that transformation of racemic reticuline 
to saiutaridine was possible (Weitz et al., 1987). A cytochrome P450 has been 
purified and characterised from pig liver and shown to catalyse the phenol 
oxidative coupling of (7?)-reticuline to saiutaridine (Amann et al., 1995). Cells of 
rat liver, kidney and brain microsomes were able to transform thebaine to 
morphine via the same intermediates that occur in plant biosynthesis, namely 
oripavine and codeine (Kodaira and Spector 1988). These studies illustrate that 
several of the required enzymes are present in mammalian cells to produce 
morphine, in particular the critical step from reticuline to saiutaridine. There is 
also some evidence that endogenous morphine and/or codeine levels are elevated 
in rats after surgery or in humans after fasting (references in Meijerink et al., 
1999). While not conclusive these data support current views that morphine is 
endogenous in mammals.
An aromatic ring and a piperadine ring maintain the stereochemistry at the chiral 
centre of morphine necessary for its centrally active analgesic activity. By 
altering the composition of various groups and side groups around the basic 
molecule, it is possible to alter the effects of morphine to make new drugs with 
different qualities to morphine such as having fewer side effects, longer lasting 
analgesia, or having activity as an antagonist of opiates to help against drug 
addiction.
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1.5 Opium and Poppies
Lancing the unripe capsule of P. somniferum L. and air-drying the resulting 
milky exudate, latex, results in the production of opium. The latex is found in a 
system of specialised cells called laticifers. The laticifers are a series of non- 
articulated fused cells (anastomising) that form by the gradual thinning of the 
walls between adjacent laticifer cells (Nessler and Mahlberg 1979). It is within 
the vacuoles of the laticifers that the opiates accumulate (Homeyer and Roberts 
1984). The opium, now an oxidised and hardened product, becomes more dense 
and tough on storage. This traditional method of harvest of the opium poppy is 
still practiced today in the major opium producing regions in India. However 
most of the world’s licit poppies are now harvested by taking the dried upper 
stalk of the plant, including the capsule, which is called the poppy straw, and 
crushing it for solvent extraction of the alkaloids. The seed does not contain any 
significant quantities of alkaloids and is generally removed before extraction of 
the alkaloids (Bemath, 1998)
Poppy seed is still used today in Austria, Czech Republic, Estonia, Germany, 
Netherlands, Poland, Slovakia, Ukraine and the United Kingdom (International 
Narcotics Control Board, 1993) for culinary purposes as a source of: oils for 
human consumption (having similar properties to sunflower and olive oil (Beare 
et al., 1979)); for baking in breads and cakes; and as a replacement for soybean 
meal in animal feed stocks. The seed oil is also used for industrial products such 
as paints and varnishes (Balbi, 1960). The world licit and illicit drug trade far 
exceeds the value and importance of the poppy seed trade.
The illicit production of opium poppies has traditionally been found in remote 
border areas of the Golden Triangle (including Laos, Thailand, and Myanmar), 
the Golden Crescent (Afghanistan, Iran and Pakistan), India, Lebanon and 
Mexico. Estimates of world illicit opium production have remained relatively 
unchanged since the 1990s of between 4000 to 5000 metric tonnes per annum 
(United Nations World Drug Report 2004). Recently opium production in the 
Golden Triangle is on the decline and production has shifted more to
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Figure 1.4: The various alkaloids chemically synthesised from morphine. 
(Adapted from Dewick 1998 and Gagliardi et al., 2003)
Afghanistan, which now accounts for about three quarters of the world’s illicit 
opiate supplies (United Nations World Drug Report 2004).
The licit production of opium poppies for the production of medicinal alkaloids 
such as the analgesics codeine and morphine, rather than for seed, is the more
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important aspect of the cultivation of opium poppy. The cultivation of poppies 
for medicinal use is increasing with the demand for raw materials to make new 
semi-synthetic pharmaceuticals including: etorphine, oxycodone, buprenorphine, 
(Figure 1.5), normorphine, nalorphine, hydromorphine, hydrocodone and 
dihydrocodone (Figure 1.4). Some countries still produce opium for the home 
market and for export, including China, India, and the Democratic People’s 
Republic of Korea. Australia, China, Czech Republic, France, Hungary, Slovakia, 
Spain, Macedonia, Turkey, Yugoslavia all grow P.somniferum for the production 
and sale of alkaloids.
The Australian island state of Tasmania produces approximately half of the 
world’s licit crop with approximately 17,500 hectares planted out in the 2002/3 
season (Fist, pers. commun.). Figures collated by the International Narcotics 
Control Board (2003) reveal 18,477 hectares were planted in 2002 for the 
production of licit opium, with an expected opium yield of 720 tonnes. In the 
same year 117,000 hectares were planted worldwide for the production of refined 
opiates, including purified thebaine, and morphine. The combined production of 
these two pharmaceuticals is in excess of 62.000 tonnes (International Narcotics 
Control Board 2003). Worldwide sales of alkaloid-containing drugs were 
believed to exceed US$4 billion for 2002 (Raskin et al., 2002).
Opium poppy is known to produce over 40 different alkaloids with the 
morphinan alkaloids, the benzylisoquinoline papaverine (Figure 1.2 and 1.3) and 
the phthalideisoquinoline noscapine (Figure 1.6) accounting for most of the 
alkaloid content of opium.
1.6 The Benzylisoquinoline Alkaloid Pathway
The alkaloid pathway (Figure 1.2 and 1.3) in P. somniferum can be broken down 
into two separate parts. The first part of the pathway, central to the production of 
all benzylisoquinoline alkaloids, entails the differentiation of primary metabolism 
to secondary metabolism with the concomitant production of 4- 
hydroxyphenylacetyl-aldehyde and dopamine via decarboxylation, ortho-
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hydroxylation, and deamination of L-tyrosine (Rueffer and Zenk, 1987; Stadler et 
al., 1988)).
The enzyme responsible for the initial decarboxylation step of L-tyrosine, tyrosine 
decarboxylase, (TYDC) is the only enzyme purified of this part of the pathway, 
from P. somniferum (Facchini and De Luca 1994), Eschscholzia californica and 
Thalictrum mgosum (Marques and Brodelius, 1988). TYDC has been cloned 
from P. somniferum (Facchini and DeLuca, 1994; Maldonado-Mendoza et al.,
1996) and this aromatic L-amino acid decarboxylase accepts both and 
exclusively, L-tyrosine and L-dopa as substrates in vitro. Expression of two 
TYDC genes as fusion proteins in bacteria identified the enzyme as accepting 
DOPA and tyrosine as substrates (Facchini and De Luca 1995a; 1995b).
The TYDCs found in opium poppy are encoded by a minimum 14 genes divided 
into three different classes (Facchini and De Luca, 1994; Maldonado-Mendoza et 
al., 1996; Facchini et al., 1998) with different spatial and temporal expression 
patterns (Facchini and De Luca 1995; Park et al., 1999; El-Ahmady and Nessler 
2001)). Rueffer and Zenk (1987) used precursor-feeding studies, isolation of 
intermediates and in vivo NMR techniques to find evidence suggesting the 
existence of more than one biosynthetic route from L-tyrosine to dopamine, via 
conversion of tyrsoine to either tyramine or L-Dopa (3,4- 
dihydroxyphenylalanine).
The other intermediate involved in the norcoclaurine synthase reaction, 4- 
hydroxyphenylacetylaldehyde could also have two alternate precursors, both 
direct products of tyrosine, tyramine or 4-hydroxyphenyl-pyruvic acid.
The stereospecific enzyme norcoclaurine synthase (NS) uses a Mannich-like 
reaction to condense dopamine and 4-hydroxyphenylacetylaldehyde to yield (Y)- 
norcoclaurine, the precursor to all benzylisoquinoline alkaloids in plants (Stadler 
et al., 1987; 1989, Samanani and Facchini 2001; 2002). Norcoclaurine synthase 
fails to discriminate between 4-hydroxyphenylacetylaldehyde and 3,4- 
dihydroxyphenylacetalaldehyde (Loeffler et al., 1987) and it was originally
17
Thebaine
Etorphine
Oxycodone
Buprenorphine
4 NCH3
Oxvmorphone
Naloxene Nalbuphine
Naltrexone
Figure 1.5: Molecules chemically synthesised from thebaine. (Adapted from 
Dewick 1998)
believed that the tetrahydroxybenzylisoquinoline alkaloid (5)-norlaudanosoline 
was the precursor to benzylisoquinoline alkaloids (Rueffer et al., 1981; 1983), 
however, only (^-norcoclaurine is found in plants. (5)-norcoclaurine undergoes 
three methylation steps and one hydroxylation step to form (5)-reticuline, a key
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Figure 1.6: The different alkaloids derived from the central benzylisoquinoline 
intermediate (S)-reticuline. (Adapted from Fachini et al., 1997 and Facchini et 
al., 2000).
branchpoint in the manufacture of tetrahydroberberine, protopine, 
benzophenanthridine and morphinan alkaloids.
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(^-coclaurine is produced from the first of the methylations of (5)-norcoclaurine 
to its 6-carbon moiety and occurs by the transfer of the S-methyl group of S- 
adenosyl-L-methionine (SAM). The cytosolic enzyme catalysing this reaction is 
norcoclaurine 6-O-methyltransferase (6-OMT) (Reuffer et al., 1983; Frenzel and 
Zenk, 1990; Hara, et. al., 1994; Sato et al., 1994). The gene for this enzyme has 
been cloned from Thalictrum tuberosum (Frick and Kutchan, 1999), Coptis 
japonica (Morishige, et al., 2000) and more recently from P. somniferum 
(Ounaroon, et al., 2003).
The next catalytic step in the pathway to (.S)-reticuline is the methylation of the N  
moiety of (Sj-coclaurine by coclaurine A-methyltransferase (CNMT) (Frenzel 
and Zenk, 1990; Wat et al., 1986; Choi et al., 2001). CNMT catalyses the 
transfer of a methyl group from SAM to (6)-coclaurine to form (S)-N- 
methylcoclaurine (Table 1.1) and the gene has been cloned from cultured cells of 
Coptis japonica (Choi et al., 2002) and more recently from P. somniferum 
(Ounaroon, et al., 2003). (S^-coclaurine can also be converted to another major 
alkaloid, papaverine, via A-nor-reticuline (Uprety et al., 1975).
(^-A-methylcoclaurine was previously thought to be hydroxylated by a 
phenolase (Kametani et al., 1970,1973), but studies since have revealed that this 
reaction is catalysed by CYP80bl (Table 1.1), a methyl jasmonate inducible 
cytochrome P450-dependent mono-oxygenase also called (S)-N- 
methylcoclaurine 3’-hydroxylase (Pauli and Kutchan, 1998).
Subsequent to this hydroxylation reaction is the final methylation to produce (S)- 
reticuline undertaken by S'-adenosyl-L-methionine: 3’-hydroxy-A- 
methylcoclaurine 4’-<9-methyltransferase (4’-OMT). This enzyme was co- 
purified with 6-OMT from Coptis japonica (Morishige et al., 2000); the two 
enzymes showed high substrate specificity for their respective substrates.
Cloning and expression of the genes encoding different OMTs from Thalictrum 
tuberosum (Frick and Kutchan 1999) showed that these OMTs acted 
enzymatically as heterodimers. Expressing different monomer combinations of 
these heterodimers in baculoviruses, led to different substrates being
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preferentially O-methylated (Frick et al., 2001). This suggested that different 
plant species have evolved different methods of O-methylation. 7-OMT is 
responsible for the methylation of reticuline to form laudanine (Figures 1.2 and 
1.7). Recent cloning of the 6-OMT and 7-OMT (Table 1.1) genes from/5. 
somniferum has shown that these genes most closely resemble the OMT genes 
isolated from C.japonica rather than the T. tuberosum genes (Ounaroon, et al., 
2003).
(Y)-reticuline itself is a key intermediate in the biosynthesis of a number of 
structurally diverse isoquinoline alkaloids (Figure 1.6). These include the 
morphinan alkaloids and benzophenanthridine alkaloids, the latter including 
berbamunine, (+)-tubocurarine, sanguinarine and approximately 270 other 
dimeric bisbenzylisoquinoline alkaloids (Facchini, 2001). The 
phthaiideisoquinoline group of alkaloids, including narcotine, narcotiline and 
narceine are formed from (^-reticuline via scoulerine and noscapine (Nyman and 
Hanson, 1978). Not all of these pathways appear in P. somniferum, however the 
antitussive agent noscapine (Ye et. al., 1998) and the antimicrobial sanguinarine 
do accumulate in opium poppy.
The P. somniferum benzylisoquinoline alkaloid papaverine (Figure 1.1 and 1.3) is 
derived from the hydroxylation and methylation of (Y)-coclaurine to A-nor- 
reticuline and subsequent methylations and dehydrogenations (Dewick, 1998). To 
date no radioactive precursor studies of possible intermediates, or enzyme 
activity studies have been instigated into the synthesis of the muscle relaxant 
papaverine, leaving the author (Dewick, 1998) to postulate this route of synthesis.
A number of other alkaloids have been found in P. somniferum whose exact 
biochemical origin is yet to be determined. These alkaloids include (S)- 
norreticuline, (Y)-norlaudanine, (5)-norcodamine, (A)-codamine, (S)- 
norlaudanosine, (A)-laudanosine and (6)-laudanosiline (Uprety et al., 1975; 
Ayyangar and Bhide, 1988). These products have been difficult to study due to 
their infrequent occurrence and low levels of accumulation.
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1.7 Morphinan Alkaloids
Morphine and codeine are present in considerable quantities in the opium poppy 
with morphine being the dominant alkaloid present in commercial crops. 
Thebaine, the methyl enol ether of codeinone, is also found in opium poppy and 
while not used medicinally itself, is important in the manufacture of codeine and 
several other important semi-synthetic compounds. Thebaine is not readily 
converted into heroin making it more attractive as an alternative morphinan 
alkaloid source. Other synthetic morphinan alkaloids include the 14- 
hydroxymorphinans, such as oxycodone, naloxene, naltrexone, nalbuphine and 
nalmefene (Figures 1.4 and 1.5), which are important due to their activities as 
potent analgesics and/or narcotic antagonists and are manufactured from thebaine 
as a starting material.
Other important opiate derivatives such as the ring-C bridged compounds 
buprenorphine and etorphine, are also most practically prepared from thebaine. 
Due to the relatively small amounts of thebaine found in P. somniferum most of 
the material prescribed was previously produced by synthesis from morphine. To 
better serve this growing market many attempts have been made to find P. 
somniferum or alternative plant species, which accumulate thebaine.
Conversion of (5)-reticuline to its (7?)-epimer is the first committed step in the 
production of morphinans (Figure 1.3), although it is only with thebaine that the 
pentacyclic morphinan structure is formed. The epimerisation to (/ü)-reticuline is 
achieved in two steps, first by an oxidation-reduction process forming the 
intermediate 1,2-dehydroreticulinium ion (De-Eknamkul and Zenk, 1990; Hirata 
et al., 2004). The NADPFl-dependent enzyme, 1,2-dehydroreticuline reductase, 
which has been purified from opium poppy seedlings, stereospecifically reduces 
1,2-dehydroreticuline to (^)-reticuline (De-Eknamkul and Zenk, 1992). This 
cytosolic enzyme is only found in plants that synthesise morphinan alkaloids.
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NH CoclaurineNorcoclaurine
N-m ethylt ra nsf e rase6-O-Methyltransferase
(S)-Norcoclaurine (S)-Coclaurine
(S)-N-M ethylcoclaurine
(S)-N-M ethylcoclaurine
3'-Hydroxylase
(S)-3'-Hydroxy-N-
methyl-coclaurine
4‘-0-M ethyltransferase
(S)-ReticulineThebaine (S)-3'-Hydroxy-N-
m ethyl-coclaurine
LaudanineDehydroreticulinium ion
(R)-Reticuline
Figure 1.7: Schematic biosynthetic pathway leading from (5)-norcoclaurine to 
(S^-reticuline and thebaine. (R, ^-reticuline 7-O-methyltransferase can act on the 
R or S enantomer of reticuline to form laudanine (Adapted from Ounaroon et al., 
2003).
The R enantiomer of reticuline undergoes a C-C phenol-coupling reaction of C12 
to C13 forming the phenanthrene ring system of salutaridine. Previously this 
class of reaction was attributed to laccases, phenolases and peroxidases 
(Kametani et al., 1970, 1973) because of the relative abundance and broad 
substrate specificities of these plant enzymes. However in vitro analysis of 
purified extracts revealed catalysis to be performed by a highly substrate specific 
membrane bound cytochrome P450 enzyme known as salutaridine synthase 
(Gerardy and Zenk, 1993a).
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Salutaridine, found as a minor alkaloid constituent in the opium poppy, 
undergoes a stereospecific reduction of the carbonyl group by the cytosolic 
enzyme salutaridine: NADPH 7-oxidoreductase (Gerardy and Zenk, 1993b) to 
produce 7(S)-salutaridinol. Treatment of the phenanthrene salutaridinol with acid 
in vitro can demonstrate the next step in the pathway creating the ether linkage 
ring closure of C-4 and C-5 by nucleophilic attack of the phenol group on to the 
dienol system and subsequent displacement of the hydroxyl group. However in 
the plant an esterification reaction is undertaken to provide a better leaving group 
by the enzyme acetyl coenzyme A: salutardinol-7-O-acetyltransferase (SAT) to 
produce salutaridinol-7-O-acetate. The ring closure then occurs readily but 
dependent on pH 6-7 and possibly without any enzyme participation (Lenz and 
Zenk, 1994) to form the pentacyclic morphinan skeleton. SAT has been purified 
from P. somniferum cell cultures (Lenz and Zenk, 1995a) and molecular 
characterisation of the gene has shown the gene is expressed in root, stem, leaf 
and capsule (Grothe et al., 2001).
Parker et al., (1972) first proposed the pathway to morphine from thebaine via 
neopinone, codeinone and codeine. Thebaine undergoes an enol ether cleavage 
to neopinone then subsequent non-enzymatic isomerization to codeinone 
(Gollwitzer et al., 1993). Reduction of the enol ether codeinone is catalysed by 
the NADPH-dependent codeinone reductase purified from both P. somniferum 
cell suspensions and plants. Enzyme activity, from highest to lowest, could be 
detected in capsule, shoot, root, leaf and cell cultures (Lenz and Zenk, 1995b; 
Lenz and Zenk, 1995c). Cloning of the gene and the analysis of its expression 
levels showed that the highest level of expression could be found in roots with 
decreasing levels of activity found in stem, capsule, leaf and cell suspensions 
(Unterlinner et al., 1999).
Brochmann-Hanssen (1984) used radioactive feeding studies to show an alternate 
pathway to morphine in Tasmanian P. somniferum cultivars via the 
demethylation of thebaine at carbon atom 3 to yield oripavine. Oripavine is 
thought to be demethylated via hydroxylation at carbon atom 6 to produce 
morphinone with a carbonyl group at carbon atom 6. This in turn undergoes 
stereospecific reduction of the carbonyl group at carbon atom 6 to morphine.
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Codeinone reductase has also been shown to reduce morphinone to morphine 
(Hodges & Rapoport, 1980; Lenz and Zenk 1995c) suggesting that this enzyme 
may act in both pathways from thebaine to morphine (Figure 1.3).
1.8 Compartmentalisation of Alkaloids
It is now well established that some alkaloids are produced in one part of the 
plant and transported to other parts of the plant. For example the tropane 
alkaloids (reviewed in De Luca and St-Pierre, 2000) and nicotine are mainly 
synthesised in the root and transported to aerial parts where they accumulate. 
Sanguinarine and morphine share the common intermediate reticuline yet 
sanguinarine accumulates in the roots and morphine in the aerial part of the plant 
(Facchini and De Luca, 1995). Due to the general toxicity of alkaloids especially 
in large concentrations most of them are sequestered into various compartments 
in the plant and usually into the plant vacuole.
Several sequential enzymatic steps in alkaloid biosynthesis have been shown to 
occur in distinct cell types suggesting that intercellular transport of intermediates 
and specific enzyme localisation occurs (Bird et al., 2003). Measurements of the 
alkaloids morphine, codeine, thebaine, papaverine, and noscapine in latex 
showed that more than 90% of the alkaloid content was found in two different 
types of vacuole (Fairbairn et al., 1974; Fairbaim and Steele, 1981; Homeyer and 
Roberts, 1984; Roberts et al., 1983; Roberts, 1987). One vacuole type was 
designated 900xg and the other 11 OOxg due to their sedimentation properties at 
these respective centrifugal forces. The 900x g variety seemed to contain the 
higher proportion of alkaloids of the two types of vacuoles and seemed to 
accumulate all of the aforementioned alkaloids except thebaine (Figure 1.8) in the 
three weeks after petal opening (Pham and Roberts, 1991). Dopamine (Homeyer 
and Roberts 1984; Roberts 1987) and (5)-reticuline (Deus-Neumann and Zenk 
1986) have also been shown to accumulate in the latex vacuoles.
The study of the morphine pathway is limited by several factors. Firstly 
morphinan alkaloids are only found in appreciable amounts in the Papaver
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me conic acid 
codeine
dopamine
papaverine
morphine
VS-reticuline
dopamine
morphine
noscapine 
mcconic acid 
codeine
S-reticuline
Latex
dopamine 
meconic acid 
codeine
S-reti culine 
papaverine
Figure 1.8: Diagram illustrating where the alkaloids have been found to 
concentrate in the vesicles of the latex. Thebaine accumulates in the smaller 
(oval shapes) 11 OOx g vesicle fraction and the other morphinan alkaloids 
accumulate in the larger (rectangles) 900x g vesicle fraction along with 
noscapine, papaverine, reticuline and tyrosine (Adapted from Pham and Roberts
1991).
species such as P. orientale, P. somniferum, P. somniferum subspecies setigerum 
and P. bracteatum. Secondly very few mutants have been reported in the 
literature. Thirdly, although a transformation system is now available for opium 
poppy few genes have been characterised or cloned in order to retransform them 
into the plant. A further reason is that P. somniferum cell suspensions fail to 
reliably accumulate appreciable quantities of morphinan alkaloids.
Thebaine, a precursor of morphine synthesis, is useful as a starting compound for 
several important pharamaceuticals including; naltrexone and buprenorphine. 
Thebaine is the major alkaloid found to accumulate in P. bracteatum Lind, and 
can constitute up to 3.5% of the dry weight material in the mature capsule
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(Vincent et. al., 1977). Several studies have tested this species as a potential crop 
plant (Aynehchi and Jaffarian, 1973; Vincent et al., 1977; Corrigan and Martyn, 
1981; Seddigh et al., 1982) and high yields of thebaine are possible from this 
species, however its biennial growth habit has made it uneconomical to use as a 
replacement for the annual P. somniferum, which is a much more reliable source. 
P. bracieatum yields decrease with overcrowding (Bare, et al., 1987), and the 
self-incompatibility system of this species makes it impossible to breed pure lines 
through selfing. P.bracteatum has been successfully regenerated in tissue culture 
(Day et al., 1986) making micropropagation of selected elite genotypes a 
theoretical possibility, however this would make pure lines for commercial 
production too expensive. Further to the problems of utilisation of P. bracteatum 
as an alternative source of thebaine, are the socio-political problems associated 
with countries, such as Turkey and India. These countries have become reliant 
on the incomes derived from P. somniferum crops and the loss of these crops 
would be problematic if there was increased competition from industrialised 
western countries growing the non-narcotic P.bracteatum (Theuns et al., 1986).
Attempts to use in vitro cell cultures of P. bracteatum (Kamo and Mahlberg, 
1988) as an alternative source of thebaine have proved unsuccessful, as cultures 
failed to accumulate appreciable levels (Kutchan et. al. 1983). Kamimura et al. 
(1976) indicated that morphogenetic differentiation from cultured cells of P. 
bracteatum was needed before higher levels of thebaine could be produced. 
Various researchers have confirmed the need for some vascular differentiation in 
P. bracteatum cultures before any thebaine is detectable (Staba et al., 1982; 
Kutchan et. al., 1983). Similarly P. somniferum cell suspensions were attempted 
to provide an alternative source of morphinan alkaloids with the same result.
The need to induce morphogenesis in cell cultures dramatically increases the 
technical difficulties and reduces the economic feasibility of using them as a 
production system. Reports have been published suggesting that morphinan 
alkaloids can accumulate in cell suspensions (Kamimura et al., 1976; Tam et al., 
1980; Hodges and Rapoport 1982; Kamo et. al., 1982; Staba et al., 1982; 
Lockwood 1983; Hsu and Pack, 1984; Yoshikawa and Furuya, 1984; Griffing et. 
al., 1989; Siah and Dorian, 1991; Facchini and Bird, 1998), but these reports
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were all of very small quantities and were not reproducible. One cell suspension 
of P. somniferum was shown to reliably produce small quantities of thebaine as 
the only morphinan alkaloid (Gerardy and Zenk, 1993a). This is despite the fact 
that enzymes from this part of the pathway could be purified from suspension 
cultures (Wilhelm and Zenk 1997). This problem is not limited to the morphinan 
alkaloids; other alkaloids such as vinblastine, hyoscyamine, scopolamine, and 
vincristine have also proved difficult to accumulate in cell suspensions of their 
respective source species (Verpoorte et. al., 2000).
Many isoquinoline alkaloids can be produced in de-differentiated cell cultures of 
the Berberis species and this has led to the advancement of the study of many of 
the alkaloids leading to (Y)-reticuline (reviewed in Zenk, 1995). The failure to 
reliably accumulate the morphinan alkaloids in poppy cultures suggests that there 
is some developmental, compartmental or transport control operating which 
prevents these compounds being synthesised in the absence of differentiated 
laticifer cells (Kutchan et. al., 1983; Yoshikawa and Furuya, 1984; Hsu and Pack, 
1984; Galewsky and Nessler, 1986; Griffing et al., 1989; Siah and Doran, 1991). 
As a consequence cell cultures are no longer considered a viable alternative to 
cultivated poppy crops in the production of morphinan alkaloids. They are also 
not a viable system to study the final steps in morphine biosynthesis.
1.9 Alkaloid Transport
Some form of alkaloid transport mechanism must exist for morphinan alkaloids 
as many of the intermediates are known to accumulate in specialised cells in the 
vacuoles and the enzymes necessary for several of the steps of morphinan 
biosynthesis are not found in the latex. The cytochrome P-450 enzyme 
salutaridine synthase has been shown to be active in roots, shoots, capsule and 
leaf vein but not in the latex (Gerardy and Zenk, 1993b).
Two hypothetical possibilities for alkaloid transport in P. somniferum have been 
suggested: passive diffusion with an “ion trap” mechanism and specific carrier 
mediated transport.
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The “ion trap” hypothesis proposes that the lipophilic alkaloids can passively diffuse 
from the cytoplasm across the vacuolar membranes where they are trapped in the 
acidic vacuolar compartment by protonation and salt formation (Neumann et al., 
1983; Matile 1984; reviewed in Roberts et al., 1991). It has been shown in 
Chelidonium majus that chelidonic acid readily complexes with alkaloids (Hauser 
and Wink, 1990) and thereby provides the acidic properties required to allow the 
accumulation against a concentration gradient; this mechanism has gained support 
from studies of the uptake of sanguinarine and various other lipophilic alkaloids into 
latex vacuoles (Matile, 1976; Hauser and Wink, 1990). In P. somniferum meconic 
acid is the major complexing agent found to accumulate in the latex in high 
concentrations (Fairbaim and Williamson, 1978). High levels of sulphate and 
chloride were also found in latex suggesting that there may be some form of ion trap 
mechanism for the major alkaloids of opium poppies (Pham and Roberts, 1991).
There is no direct evidence to suggest an “ion trap” is responsible for the 
accumulation of morphinan alkaloids in latex. Evidence against the ion trap 
mechanism of transport comes from the observation that morphine accumulates in 
opium poppy in preference to several more basic alkaloids. An addition of ATP 
caused morphine uptake into the vacuoles to increase, suggestive of a specific 
transporter. Despite this, the addition of ATP inhibitors did not reduce morphine 
uptake into the vacuoles, suggesting that there may be a specific alkaloid channel as 
well as a specific morphine transporter (Roberts et al., 1991). It is thought that the 
vacuoles of P. somniferum latex may be specialist vacuoles due to their size, 
resistance to external measures designed to reduce the A pH, and capacity to 
sequester millimolar quantities of alkaloids (Roberts et al., 1991). Further to this the 
rapid and specific uptake of the major opium alkaloids has no absolute requirement 
for MgATP, is independent of temperature and does not show saturation kinetics 
(Homeyer and Roberts, 1984).
The second hypothetical method of alkaloid accumulation in the vacuole involves 
specific carrier mechanisms. This is evident for (5j-reticuline, a charged species
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under cytosolic pH, and this mechanism appears to be stereoselective for the S- 
rather than the ^-configured compound (Deus-Neumann and Zenk, 1986). This 
discrimination for the naturally occurring (Y)-enantomiers has also been shown for 
the alkaloid (Y)-scoulerine (Deus-Neumann and Zenk, 1986). Transport is thought to 
occur by a H+ antiport mechanism for alkaloids such as lupanine (Mende and Wink, 
1987), (S)-reticuline, (^-scoulerine (Deus-Neumann and Zenk, 1986), and 1- 
(malonylamino)-cyclopropane-l-carboxylic acid (Bouzayen et al., 1989). H+- 
ATPase is a major vacuolar protein (Leigh and Walker, 1980; Sze, 1985; Bremberger 
et al., 1988) and along with pyrophosphatase (Leigh and Walker, 1980; Rea and 
Sanders, 1987; Bremberger et al., 1988) is responsible for tonoplast H+ concentration 
being greater than in the cytoplasm (Thom and Komor, 1984; Sze, 1985; Rea and 
Sanders, 1987; Heidrich et al., 1989; Taiz, 1992). The proton gradient is important 
for substrate-proton antiport transport (Liittge et al., 1981; Hager and Hermsdorf, 
1981; Thom and Komor, 1984, 1985; Briskin et al., 1985; Blumwald and Poole,
1985 a,b; Blumwald, 1987; Blackford et al., 1990; Getz, 1991).
Increasing interest in the transport mechanisms in plants, in particular for secondary 
metabolites, has led to a number of new classes of transporters being isolated and 
characterised. These include the multidrug resistance (MDR) class of proteins that 
have now been found in large numbers in plants (Rea et al., 1998, Theodoulou,
2000), including one recently found in Coptis japonica and possibly involved in 
alkaloid transport (Yazaki, et al., 2001). The glutathione (5)-transferase class of 
transporters may also be involved in alkaloid transport. The maize Bronze-2 gene, 
which encodes a protein thought to be responsible for the deposition of anthocyanins 
in the vacuole, has been shown to be a glutathione (^-transferase (Marrs et al.,
1995). There is still some conjecture as to how the glutathione (Sj-transferase 
transports the anthocyanins into the tonoplast. A type III glutathione (Sj-transferase 
has been cloned from fungal elicited P. somniferum cell suspensions (Yu and 
Facchini, 2000) using degenerate primers to other plant GSTs in the database, 
however it still remains to be shown if it has any role in alkaloid trafficking.
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Figure 1.9: The different developmental stages of the opium poppy P. somniferum. 
The six to eight leaf prehook-stage (b) prior to the hook stage (c) is where the 
maximum production of morphinan alkaloids occurs in the plant. The final 
accumulation of morphinan alkaloids occurs in the capsule at the final stage (f). 
(Diagram not to scale).
1.10 Regulation of the Morphinan Alkaloid Pathway
Early studies have shown that alkaloids are regulated in such a way as to allow 
accumulation of particular alkaloids in certain parts of the P. somniferum plant. 
Morphine is the dominant alkaloid in the aerial part of the plant (Facchini and De 
Luca 1995) and accumulates in the laticifer system of the mature capsule. The 
developing poppy plant also accumulates morphinan alkaloids at varying rates as the 
plant matures (Williams and Ellis, 1989). See Figure 1.9 for the different 
developmental stages of P. somniferum.
Several genes from the alkaloid pathway have been cloned from P. somniferum or 
other alkaloid producing species (summarised in Table 1.1) and have been shown to 
be inducible and regulated developmentally (Facchini and Park 2003). Gene 
transcripts of cyp80bl, tydc and bbe are all upregulated with the addition of methyl
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jasmonate to cell suspensions. However no corresponding increase in morphinan 
yields occurred, suggesting that there are still transcripts involved in morphine 
biosynthesis that are not regulated by methyl jasmonate. Cyp80bl and bbe were 
differentially expressed in developing plants, across mature plants and in cell 
suspensions (Huang and Kutchan 1999), while codeinone reductase isoform 1 was 
not. Cor 1 expression remained unchanged with the addition of methyl jasmonate. 
Cor 1 gene transcript was also much higher in the stem than root or bud, while bbe 
transcript was not detected in the bud or capsule of the mature plant. Both tydc and 
bbe transcript are induced by the addition of methyl jasmonate and both promoters 
have been isolated, although no common promoter elements have yet been found 
(Park et al., 1999). More recent work with newly cloned genes V-methyl transferase, 
4’-OMT, 6'-OMT and salutaridine acetyl transferase, showed these gene transcripts 
were also upregulated in cell suspensions with the addition of methyl jasmonate 
elicitor or wounding (Facchini and Park, 2003).
In cultured cells of E. californica the addition of 2mM butyric or pivalic acid led to 
the acidification of the cytoplasm that subsequently led to the induction of alkaloid 
biosynthesis (Roos et al., 1998). This mimicked the response to known fungal 
elicitors such as Botrytus spp. The reverse was also true that by depleting the 
vacuolar proton pool the elicitor-triggered pH shifts and subsequent alkaloid 
induction were prevented. It is possible that a common regulator is responsible for 
the coordinated increases in alkaloid biosynthesis.
Common trans- regulators, ORCA2 and ORCA3, have been found to co-ordinately 
regulate monoterpenoid indole alkaloid biosynthetic genes in C. roseus (Van Der Fits 
and Memelink, 2000). The ORCAs (Octadecanoid-Responsive Catharanthus 
AP2/ERF-domain) are members of the AP2/ERF-domain family of transcriptional 
regulators unique to plants. They are characterised by the APETALA2 (AP2) and 
the Ethylene Responsive Factor (ERF) domains. They were discovered (Menke et 
al., 1999a) using a yeast one-hybrid screening method and using the terpenoid indole 
alkaloid gene strictosidine synthases' promoter element, involved in jasmonate -and
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elicitor-responsive gene expression (JERE), as bait (Menke et al., 1999b). It has 
been suggested that these plant regulators could be used to alter secondary metabolic 
pathways that are responsive to the addition of Methyl Jasmonate including 
benzylisoquinoline biosynthesis (Memelink et al., 2001).
Overexpression of ORCA2 in C. roseus increased transcription of an Str promoter: 
reporter gene fusion (Menke et al., 1999b). A further ORCA gene, ORCA3, was 
characterised by its overexpression in C. roseus, which led to an increase in gene 
transcript of Str, Tdc and the downstream products of these genes (van der Fits and 
Memelink, 2000; 2001). ORCA2 and 3 are both transcriptionally induced by 
jasmonate (Menke et al., 1999b; van der Fits and Memelink, 2001) and it is thought 
that the ORCA proteins are activated by methyl jasmonate to increase their own 
transcription and consequently increase the relevant alkaloid genes (vom Endt et al., 
2002).
Transcription factors have been isolated involved in strictosidine synthesis, a critical 
early enzyme in tryptophan derived monoterpenoid indole alkaloids (Hashimoto and 
Yamada, 1994) including vinblastine and vincristine in C. roseus ((Kutchan et al., 
1988; De Luca et al., 1989). Such studies confirm that there are regulatory genes, 
and possibly signal transduction pathways, controlling alkaloid synthesis. To date 
there have been no reports of transcriptional regulators interacting with the morphine 
or general benzylisoquinoline pathway of any species.
Further levels of control have been shown to exist on the pathway. The failure of 
poppy cell suspensions to reliably produce morphinans, even though codeinone 
reductase and several other cloned genes from the pathway are present, suggests that 
differentiation of the cells into laticifers is necessary for morphinan alkaloid 
accumulation (Roberts et al., 1993).
Expression studies using northern blotting techniques have shown that cyp80bl, 
coclaurine A-methyl transferase, 6’ O-methyl transferase, 4’-0  methyl transferase,
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berberine bridge enzyme, salutaridine acetyl transferase, and tyrosine decarboxylase 
are all induced upon wounding or upon addition of elicitor (Facchini and De Luca 
1994; Facchini et al., 1996; Park et al., 1999; Facchini and Park, 2003). Several 
other genes are developmentally controlled such as berberine bridge enzyme and 
cyp80bl (Huang and Kutchan, 2000).
Tyrosine decarboxylase message was shown to be most abundant in metaphloem 
cells of the stem and roots and at low levels in the developing capsules (Facchini and 
De Luca, 1995). Metaphloem cells are closely associated with laticifers (Nessler et 
al., 1985). Further to this is the evidence that several key enzymes, salutaridine 
synthase and salutaridine: NADPH 7-oxidoreductase, show greater activity in stems 
and roots than in capsules (Gerardy and Zenk 1993a; 1993b). This evidence suggests 
that the alkaloids are produced in the roots and stem and accumulate in the capsule. 
Codeinone reductase is relatively unchanged developmentally or with the addition of 
elicitors to cell suspensions (Huang and Kutchan 2000; Facchini and Park, 2003), 
however there are spatial distribution differences across plant tissue types (Huang 
and Kutchan, 2000). Codeinone reductase message levels are highest in the stem 
leaf and capsule (Huang and Kutchan 2000) suggesting the first part of the 
morphinan pathway is produced in the stem and roots while the latter synthesis takes 
place in the stem and capsule.
1.11 The General Study of Alkaloids (A review of methods used)
Many of the modem day drugs were originally isolated from plants producing large 
enough quantities of the relevant alkaloid to give their pharmacological effect. 
Several of the less complex alkaloids can be efficiently and cost effectively 
chemically synthesised for modem use, however many of the more complex 
alkaloids are difficult or expensive to chemically synthesise. It was hoped plant cell 
suspensions would enable large-scale factory production of useful alkaloids and 
other secondary metabolites, however these efforts have been met with limited
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success. Very few successful cases have been reported where the yield of the 
required secondary metabolite was sufficient to offset the costs of maintaining large 
batch cultures of aseptic plant cell suspensions. Two examples of moderate success 
were in the production of the antitumour compound paclitaxel, and the antiviral and 
anti-inflammatory shikonin (Verpoorte et al., 2000). Yields of the alkaloids are often 
much lower in cell suspensions than in the native plant which also have their 
limitations subject to seasonal variation and environmental factors. Political pressure 
can also affect the supply of raw materials for use in the pharmaceuticals industry 
because of the raw materials being diverted for illicit purposes.
This has led to research targeted at better understanding the pathways involved in 
alkaloid production. There are several factors that hamper the understanding of 
many alkaloid pathways and consequently make alkaloid production in cell 
suspensions difficult to achieve. Most alkaloids have complex pathways with a large 
number of enzymatic steps. For example the benzylisoquinoline macarpine has 20 
enzymatic steps from its precursor tyrosine (Kutchan and Zenk, 1993; Kämmerer et 
al., 1994). This creates a daunting prospect to upregulate all the genes, or find, those 
genes whose modification will have the greatest effect, for improved alkaloid yield. 
Even more daunting would be attempting to produce these alkaloids in transgenic 
microbial cell systems.
One of the first attempts at over expression of a gene in a medicinally important 
alkaloid pathway was of the gene coding for hyoscyamine-6ß-hydroxylase. In one 
primary transformed plant of Atropa belladonna L. increases were found of the end 
product scopolamine (Yun et al., 1992). This effect was inherited by the progeny to 
the extent that when mature these plants contained scopolamine as almost the only 
tropane alkaloid.
Another problem facing efforts to increase alkaloid yields in cell suspensions is that 
many alkaloids are stored in vacuoles or specialised storage compartments such as 
the specialised vacuoles in P. somniferum latex (Pham and Roberts 1991); the
37
efficient transportation of these molecules in and out of storage compartments may 
be a limiting factor.
Many alkaloids are produced in one part of the plant and transported or stored in 
another part making it difficult to simulate in cell suspensions. Nicotine is possibly 
the most widely studied of the alkaloids and its role in the plant best defined. It is 
already well established that nicotine is synthesised in the roots and transported to 
the leaves (Dawson, 1941; 1942; Wink and Roberts, 1998). Systemic alkaloid 
induction in Nicotiana attenuata has been shown to occur in response to simulated 
herbivore attack (Baldwin and Ohnmeiss, 1993).
Sanguinarine is produced in the aerial part of the plant and transported to the roots 
(Facchini and De Luca, 1995) and quinolizidine alkaloids are made in the chloroplast 
of green cells (Wink et al., 1980; Wink and Hartman, 1982) and yields are increased 
in the presence of light (Wink et al., 1981; Wink and Hartman, 1980). Further to 
these problems of alkaloid production in cell suspensions is that many of the desired 
alkaloids are not always the end product but rather pathway intennediates which do 
not normally accumulate. For example the indole alkaloid ajmalicine, was shown to 
be continually synthesised but rapidly degraded in cell cultures of C. roseus (Dos 
Santos et al., 1994).
Gene silencing has been successfully utilised to knock out individual structural genes 
and their encoded enzymes and eliminate various alkaloid products in the plant. An 
example is the recent development of caffeine-free coffee plants by targeting the 
gene for theobromine synthase (Ogita et. al., 2003). There have been several reports 
of the use of antisense techniques to alter benzophenanthridine alkaloid content. 
Transformation of Eschscholzia californica cell suspensions transformed with the 
gene encoding either the antisense construct for the berberine bridge enzyme (BBE) 
or N-methylcoclaurine 3’ hydroxylase (CYP80B1) and cell suspensions were found 
with lowered levels of the respective transcripts. This decreased message led to a
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reduced accumulation of benzophenanthridine alkaloids compared to the control cell 
suspension lines (Park, et al., 2002).
Recently the direct transformation of opium poppy with an antisense construct to the 
gene encoding the BBE 1 enzyme showed perturbation in the alkaloid content of 
latex but not in the roots. There was an increase in upstream and side branch 
alkaloids but no concomitant reduction in the root accumulating sanguinarine, the 
end product of the BBE branch point enzyme (Frick et al., 2004). These latter results 
were obtained from only one transgenic event and will need to be repeated and 
extended. Hairpin RNA induced gene silencing of the penultimate step in morphine 
synthesis, codeinone reductase, has resulted in the accumulation of (5)-reticuline, 
some seven enzymatic steps back from codeinone reductase (Allen et al., 2004). (S)- 
reticuline is the major benzylisoquinoline branchpoint intermediate. This surprising 
result illustrates how difficult it is to predict the outcome (alkaloid phenotype) when 
individual gene activities are enhanced or eliminated.
The inverted repeat knockout systems (or DNA-directed hairpin RNA gene 
silencing) could also be quite useful in eliminating negative regulators responsible 
for inhibiting alkaloid biosynthesis. Conversely it may be possible to knock down 
the expression of genes responsible for controlling the regulators.
Tryptophan decarboxylase (TDC) decarboxylates tryptophan to produce tryptamine 
and is condensed with secologinin by the enzyme strictosidine synthase (Str) to 
produce strictosidine. Both genes have been shown to increase biosynthesis (Aerts et 
al., 1994) via an increase in message levels in response to a fungal infection (Menke 
et al., 1999a). This process was shown to occur via a signal cascade involving 
methyl jasmonaie and this cascade is widespread in plants (Sembuner and Earthier, 
1993; Wastemack and Parthier, 1997) suggesting that an understanding of the 
regulation of strictosidine accumulation will be of value in other alkaloid pathways 
(vom Endt et al., 2002).
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Master transcription factors responsible for the regulation of secondary metabolic 
pathways have been found associated with flavonoid synthesis (Weiss, 2000), 
suggesting that co-ordinated transcription could also be occurring in alkaloid 
synthesis. This may not be the only level of control, however, as it is likely there are 
post-transcriptional controls in place to regulate these pathways (vom Endt et al., 
2002) .
1.12 The Study of Morphinan Alkaloids
One way to look at the morphinan pathway is to use mutants that are deficient in one 
or more aspects of the pathway. One advantage of using mutants in secondary 
metabolism is that, unlike mutants in primary metabolism, they are rarely lethal. 
Mutants deficient in aspects of a biosynthetic pathway have been very powerful tools 
in dissecting and characterising secondary metabolism. The proanthocyanidin 
pathway is one of the most well studied pathways in plant secondary metabolism. 
Initially mutations from petunia, tobacco, maize and barley have helped to isolate 
several of the genes in the biosynthetic pathway and to reveal several levels of 
control.
Arabidopsis mutants are now helping to examine the latter stages of the 
proanthocyanidin pathway, its regulation and transport of the intermediates and end 
products. By using the transparent testa (tt) mutants (Shirley et al., 1995), named for 
their transparent or proanthocyanidin free seed coats or the tannin-deficient seeds 
(tds) (Abrahams et al., 2003a) it has been possible to find a number of new genes 
involved in proanthocyanidin pathway. Arabidopsis has become the species of 
choice in which to study proanthocyanidin synthesis, as it appears all but one of the 
genes involved in the pathway for flavanoid synthesis are encoded by a single gene 
copy (reviewed in Winkle-Shirley, 2001). Arabidopsis’ small genome, fast life 
cycle, ease of transformation, and a low level of gene duplication has helped with the
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discovery of several new genes involved in proanthocyanidin biosynthesis that have 
been difficult to discover in other species such as maize and barley.
The Arabidopsis mutants have helped to isolate several proanthocyanidin structural 
genes encoding for example: flavanol 3’hydroxylase with t t l ; flavonoid 
3’hydroxyase with tt6\ dihydro flavanol reductase with tt 3 (Shirley et al., 1995) and 
leucoanthocyanidin dioxygenase (LDOX) (Abrahams et al., 2003b). Several genes 
encoding different classes of transcriptional regulators of the proanthocyanidin 
pathway have been isolated using tt mutants such as: the ttl mutant which encodes 
an R2R3 MYB regulator, a key determinant in the latter genes of proanthocyanidin 
accumulation in developing seed (Nesi et al., 2001); a MADS-homeobox containing 
gene from tt\6 (Nesi et al., 2002) and WIP from ttl, a zinc-finger class of protein 
different enough to be put into its own subclass. Other examples include: the ref2 
and ref8 mutants of Arabidopsis that have helped to provide a better understanding 
of the phenylpropanoid pathway and lignin deposition (Hemm et al., 2003; Franke et 
al, 2002).
A proanthocyanidin specific transporter has also been discovered using t t l l  that is 
specific for the vacuolar membrane (Debeaujon et al., 2002). These are several 
examples of the many genes cloned that are involved in the proanthocyanidin 
pathway giving new insights into the complexity of this secondary metabolic 
pathway.
Using the flavanoid mutants of Arabidopsis tt4, tt5, and tt3 it was shown that 
insertion and expression of the maize orthologs could rescue the Arabidopsis mutant 
(Dong et al., 2001) illustrating that secondary metabolic enzymes may not be 
subjected to such rapid divergence as previously thought.
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Figure 1.10: An abbreviated alkaloid pathway showing where some of the
morphinan mutants, produced by Dr Fist at Tasmanian Alkaloids Pty Ltd., disrupt
the pathway. A broken line across the arrow representing the enzymatic step/s 
represents that the mutant still progresses past this point but the yields are very much 
reduced. None of these mutants have been characterised and the figure is based on 
several morphinan alkaloid yields that have been measured on these plants. See
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Table 4.1 for a detailed explanation of the mutants’ new alkaloid phenotype. 
(Adapted from Kutchan, 1998).
While there is still much to learn about the proanthocyanidin pathway, the 
proanthocyanidin mutants in Arabidopsis have illustrated how rapidly a complex 
secondary metabolic pathway can be determined. The morphinan alkaloid pathway 
has several disadvantages to the proanthocyanidin biosynthetic pathway. Firstly, 
benzylisoquinoline alkaloids appear not to be synthesised in Arabidopsis or any other 
prospective model species. Secondly, few of the genes isolated from opium poppy 
have been found in Arabidopsis except for possible analogues to the berberine bridge 
enzyme (The Arabidopsis Genome Initiative, 2000). Thirdly, although a robust 
transformation system is now available for the opium poppy (Park and Facchini, 
2000; Chitty et al., 2003) its life cycle is much longer than that of Arabidopsis. 
Fourthly, there have been few mutants characterised in the benzylisoquinoline 
alkaloid pathway, in particular the morphinan branch.
Papaver somniferum is a predominately self-pollinating species and has 2n=22 
chromosomes. Levy and Milo (1998) studied 8 of the 11 chromosomes of P. 
somniferum and found mainly sub-terminal chromosomes, 2 pair very long, 4 pair of 
medium length, and 3 pair of short chromosomes. Hybrids between P. somniferum 
(2n=22) and P. setigerum (2n=44) suggested that P. setigerum had three genomes: A 
with 11 pair; B with 3 pair; and C with 8 pair. There is still much conjecture as to the 
relationship of P. setigerum and P. somniferum however importantly all 11 
somniferum chromosomes in the P. somniferum x P. setigerum hybrid paired with 11 
setigerum chromosomes (presumably the "A" genome). By contrast no somniferum 
chromosomes paired with those of P. orientale (2n=28) or P. bracteatum (2n=14) 
when crossed. This is consistent with somniferum being a true diploid (x=l 1). 
Kadereit and Sytsma (1992) claim evidence from chloroplast DNA supporting the 
view that P. setigerum is just a tetraploid version of P. somniferum. P.setigerum 
behaves as a diploid and crosses readily with P.somniferum in breeding studies (Fist 
pers. communication.). Several recessive spontaneous mutants with altered flower
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qualities have been identified (Sharma and Singh, 1983). Khanna and Singh (1975) 
have used gamma rays on opium poppy seeds and found several M1 mutants with 
different characteristics such as: male sterility, opium less plants, high morphine and 
increased capsule number. Nigam et al., (1990) also used gamma rays to find dwarf 
and early flowering varieties. Using a combination of EMS and gamma ray 
treatment seemed to enhance the mutation frequency (Patra and Chauhan, 1990; 
Chauhan and Patra, 1993).
Very few of these mutations have been utilised to further the understanding of the 
alkaloid pathway, and at least some of them appear to have been unstable. Polyploid 
P. somniferum plants have been reported to have higher morphine content and 
capsule number than the parent from which they were obtained (Levy and Milo, 
1998), however late seed setting and poor seed yield were major shortcomings for 
potential commercial production.
Nyman and Hall (1976) described a spontaneous mutant in poppy accumulating 
thebaine as the major alkaloid instead of morphine, however this phenotype was 
unstable and true-breeding lines of the mutant could not be obtained (Nyman, 1978; 
1980). A non-narcotic variety of opium poppy named Sujata has been obtained 
using EMS (Sharma et al., 1999a,b). This mutant is intended for cultivation for 
poppy seed oil and culinary seed, not for alkaloid production. Little genetic or 
biochemical characterisation of this mutant has been reported. An Indian landrace 
mutant, aco, has been reported which form androcarpels in place of inner whorl 
stamens in their flowers (Prajapati et al., 2001). Limited analysis suggested that this 
mutant accumulated more morphinan alkaloids in the capsule due to the increase in 
androcarpel wall mass, which accumulates alkaloids.
A series of stable mutations in the morphine pathway have now been identified by 
Dr. Fist at Tasmanian Alkaloids, which hold great promise as tools to explore the 
regulation of the pathway (Figure 1.10). The present study employs traditional
44
characterisation techniques of metabolite analysis to analyse these morphinan 
alkaloid mutants.
In this thesis, particular attention is given to topi, a mutation in which morphine and 
codeine are entirely replaced by thebaine and oripavine (Fist et al., 2000; Millgate et 
al., 2004). Oripavine and thebaine have no real value directly as pharmaceuticals 
since their adverse affects outweigh any analgesic properties. Indeed thebaine 
induces vomiting and oripavine causes convulsions and death when fed to mice 
(Gomez-Serranillos et al., 1998). The topi mutant was found to have the same high 
yielding alkaloid characteristics, as the progenitor parent genotype and alkaloid 
yields have subsequently been further enhanced through breeding. The topi 
mutation in homozygous condition has been utilised in commercial production in 
Tasmania in a number of released cultivars with the harvested thebaine and oripavine 
being used as feedstocks for many of the newer pharmaceuticals. This plant 
constituted almost 50 % of the total P. somniferum crop grown in Tasmania in 2002 
(International Narcotics Control Board 2003).
It is anticipated that the transcription of various genes associated with morphine 
accumulation will be affected in these mutants. It is further anticipated that the 
identity of the genes differentially expressed in one or more mutants, will provide a 
better understanding of the control of morphine biosynthesis and accumulation.
This study will take advantage of these previously unstudied P. somniferum 
morphinan mutants. All the mutants and topi in particular will have their 
transcriptional changes logged and compared. The genes responsible will be assessed 
for whether they play a role in the regulatory or transport processes controlling 
morphine biosynthesis. Using homology to known sequences from other species in 
the database roles can be inferred. This is dependent upon there being some 
functional characterisation of these genes, which have been annotated in other 
species. However it still doesn’t rule out the possibility that these genes may have 
more than one function which is yet to be described or discovered or that these genes
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may be different enough from the genes described in the database as to have a 
entirely unrelated function.
Many questions remain regarding the synthesis and accumulation of morphinan 
alkaloids. It is still not known where the morphinan alkaloids are synthesised. The 
morphinan alkaloids accumulate in specialised latex vacuoles but how do they get 
there and what form of transport mechanisms moves them to the appropriate 
compartment for the next catalytic step to take place. For example thebaine is 
known to accumulate in the specialised vacuoles but the next catalytic step is a 
demethylation, which most likely involves a cytochrome P450 enzyme, which is 
most likely closely associated with the endoplasmic reticulum; the products of the 
demethylation again are known to accumulate in the vacuole as codeinone or 
oripavine.
1.13 Methods of Transcriptional Profiling
There are several traditional ways to map the transcriptional profile of a pathway, 
such as Northern blotting, differential display-PCR (DD-PCR), serial analysis of 
gene expression (SAGE) and cDNA amplified fragment length polymorphisms 
(cDNA-AFLPs). There are positives and negatives for each type of the techniques. 
Northerns are still considered the benchmark of transcription profiling as they are 
still used to authenticate real time PCR and microarray results, however they are 
laborious and time consuming making it impractical to screen large numbers of 
unknown genes for differences in transcriptional profiles.
cDNA-AFLPs use the power of PCR-based markers for the rapid screening of 
genetic diversity (Vos et al., 1995) and have been used successfully to isolate a 
number of genes in non-model organisms. The use of PCR allows this technique to 
be highly sensitive. This method has been used with some success to analyse the 
nicotine biosynthesis pathway in tobacco (Goossens et al., 2003). Their limitation
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however is that a large number of PCR reactions need to be followed by restriction 
enzyme analyses which need to be run on agarose gels. This is time consuming. 
Retrieval and identification of the correct DNA band can also be difficult and time 
consuming. If the mutation is one that is in the promoter region of a gene or affects 
the subsequent processing of the expressed gene, then cDNA-AFLPs will be 
uninformative of the possible gene lesion. cDNA-AFLPs also have the added 
difficulty in identifying homologous markers (alleles) hindering heterozygosity 
analyses (Mueller and Wolfenbarger 1999) and fail to give quantitative data.
DD-PCR enables the researcher to identify differentially expressed genes without 
prior knowledge of sequence and availability of cDNA clones by arbitrary 
amplification, labelling with radioactive probes and comparison of different mRNA 
sources. Modifications to this system have enabled researchers to amplify and clone 
products over 2 kb in size (Diachenko et al., 1996). Again being a PCR based 
approach it can also be highly sensitive. The inability of the system to quantify the 
expression differences is DD-PCRs major shortcoming as well as similar issues to 
cDNA-AFLP analysis of running gels of many reactions and identifying the correct 
band.
SAGE involves the use of very short cDNA sequence tags, generally 9-14 bps in 
length. Using these sequence tags as a unique identifier for transcripts can give a 
quantitative estimate of the expression level of many transcripts. The identity of the 
gene corresponding to the gene tag can only be inferred if the gene is already 
annotated revealing a major limitation of this method of analysis especially for a 
non-model species such as poppy. Not many of the genes responsible for alkaloid 
synthesis are available in the database at the present time and regulatory sequences 
of morphinan alkaloid synthesis are yet to be cloned limiting the transcriptional study 
of the control of the pathway using these methods.
The use of cDNA microarrays has become an important tool in the understanding of 
global gene expression. The advantages of this system are its ability to spot several
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thousand cDNAs from a particular tissue type and to quantitatively compare 
transcript expression levels of a test and reference sample over them. This technique 
uses fluorescently labelled reverse transcribed cDNAs rather than radioactive 
labelled probes. The DNA sequence is not needed to produce primer combinations 
or DNA probes. The cDNAs that are differentially expressed between the test and 
reference samples can be sequenced and further annotated.
There are several problems associated with using cDNA microarrays as a tool for 
gene discovery. Firstly, using cDNA microarray analysis to analyse mutants is 
reliant upon the mutation causing a change in transcript levels. The mutation could 
be in a structural enzyme, which affects the enzyme catalytic activity or translational 
process, but not the gene’s expression, making it unlikely that the mutation will be 
seen using cDNA microarray analysis. Secondly the mutation may affect the post- 
transcriptional modification, for example causing alternative splicing, which unless 
specific parts of an expressed clone are placed on the array would not be detected, as 
similar amounts of transcript would still be present to bind to the array. Thirdly, it is 
possible that the RNA transcript has a different half-life in a particular tissue and 
unless material is used from the correct stage and tissue the mutant will not be 
detected using cDNA microarrays. Microarray technology is also less sensitive than 
the more specific PCR based approaches and can have cross-hybridisation issues 
with competition between analogues clones or sequences. The other major drawback 
with microarrays, especially with ones that do not contain the whole genome, is that 
not all of the genes/clones of interest are represented on the array.
Microarrays have been shown to be powerful tools in the mass analysis of genome 
wide transcript profiling and have been widely utilized in model systems such as 
Arabidopsis and rice to help understand plant stress responses such as: cold (Seki et 
al., 2001; Breton et al., 2003); wounding (Strassner et al., 2002); and pathogen 
attack (Schenk et al., 2000). The sequencing of the Arabidopsis genome has brought 
with it rapid developments in the use of microarrays as gene analysis on sequenced 
EST clones is much more informative than if undertaken on unknown clones. Each
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subsequent microarray analysis adds more information about the ‘unknown’, but 
sequenced gene, allowing possible mode/s of function to be ascertained. Interesting 
genes can be further analysed through the use of reverse genetics and either partially 
or totally knocking out the candidate gene to create a phenotype lacking the genes’ 
function/s.
Study of a mutant’s phenotype can often be limited using classical characterisation 
techniques due to the complex nature of the mutation, pleiotropic effects or no 
obvious phenotype. Study of the transcriptome of mutants enables the researcher to 
analyse what genes are being affected by the mutation. Already several mutants 
have been studied using microarrays in Arabidopsis allowing the investigators to 
postulate the gene’s role in the plant and relation to several metabolic pathways. In 
particular microarrays give the sensitivity and a broad net to contribute to the 
understanding of the mutated function. By using mutants in Arabidopsis it was 
possible to illustrate the knotted1 -like homeobox encoded protein, 
BREVIPEDICELLUS (BP), was responsible for the regulation of lignin biosynthesis 
(Mele et al., 2003) giving a new insight into this genes’ function that was previously 
unknown, as the phenotypic effects were too varied to classify a direct function.
This enabled the authors to concentrate their efforts to show that the BP protein binds 
promoters of several genes involved in the lignin pathway.
It has also been shown that many genes regulated in parallel can share common ex-
acting regulatory elements for transcription (Harmer et al., 2000; Gross et al., 2000). 
Even if the gene or genes directly responsible for the mutant phenotypes in P. 
somniferum used in this study are not revealed through microarray analysis it should 
reveal a class of genes associated with the mutation and possibly co-regulated with 
the morpninan pathway.
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1.14 Aims of the Present Study
Understanding the morphinan alkaloid pathway is important in a commercial aspect, 
it’s biochemical and scientific aspects are equally if not more so important. Several 
questions arise when considering the alkaloid pathway. Why does the plant invest 
resources from primary metabolism to these secondary metabolic pathways? Why 
does the plant invest even more resources and have many levels of control on the 
production of these secondary metabolites? For example the opium poppy and many 
other plants have a laticifer system to store these compounds requiring even greater 
investment of the plants resources. By studying the morphinan pathway this will 
help further our understanding of the complexities of secondary metabolic pathways 
and possibly further our understanding the benefits that these pathways confer upon 
the plant. While this study does not hope to answer such large and involved 
questions in full it is hoped that some small steps can be made in determining some 
of the genes that are associated with the morphinan pathway, leading to further 
avenues of study of the morphinan pathway, its control and regulation.
This thesis is a study of the morphinan alkaloid pathway in opium poppy and 
involves the production of a 17,000 cDNA clone micrarray and global analyses of 
transcriptional differences between the normal poppy and various mutations and 
other genotypes in which the morphine pathway is disturbed. Germplasm to be 
utilised includes: the mutants deficient in alkaloid synthesis produced at Tasmanian 
Alkaloids Pty Ltd. (See Figure 1.10 for where the mutations occur); a genetically 
transformed P. somniferum containing an RNAi knockout construct to the codeinone 
reductase gene; a low alkaloid cultivar P. somniferum cv. Marianne; and a different 
Papaveraceae species E. californica. The different germplasms can be separated 
into three groups: 1) those that accumulate at the major branchpoint of (S)- reticuline 
including one mutant (E40/41), the hairpin RNA codeinone reductase transgenic 
(hpCOR) and E. californica; 2) those that accumulate at the next major branchpoint, 
thebaine, in the morphinan pathway, (including the mutants F075 and topl)\ and 3)
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those that have reduced morphinan alkaloid yields (including D120 and the P. 
somniferum cv. Marianne).
Not all of the genes for morphinan alkaloid biosynthesis have been cloned, making it 
difficult to determine the position of mutations in the pathway. Little is known of 
many of the morphinan genes’ level of expression and where the morphinan 
alkaloids are produced or transported in the plant. It is often difficult to predict 
whether the mutation is in: a regulatory pathway; transport process; structural 
changes in cells or particular cell types; or in the gene coding for the enzyme 
immediately after the blockage itself. By looking at the phenotype at the molecular 
level rather than just the classical mutant characterisation it is hoped to create a 
greater understanding of the morphinan alkaloid pathway.
It is hoped that a global analysis of differential gene expression in P. somniferum 
mutants, with altered morphinan phenotypes, will deliver a short list of candidate 
genes for having roles in regulation, metabolism and transport of alkaloid 
intermediates. The shortlisted genes will then qualify for further characterisation 
both within this present study and beyond. It is anticipated that the mutated genes 
themselves may not be transcriptionally affected; this would be the case if the 
mutation encoded a non-functional protein but the transcript level was unchanged. 
However the lack of a functional protein will have other transcriptional 
consequences in the pathway, including through feedback controls. It is also possible 
that the gene corresponding to the mutation is not even printed on the slide, but again 
the secondary transcriptional affects of the mutation should be evident. It is these 
secondary transcriptional changes, which are anticipated to provide some new 
insights into the alkaloid pathway.
The steps involved in attaining these goals can be stated as a series of aims:
1. To establish a P. somniferum cDNA library and use this to develop 
microarray slides.
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2. To characterise several different genotypes with disturbed morphine 
alkaloid biosynthesis characteristics.
3. To undertake a global transcriptional analysis of this germplasm using the 
cDNA microarrays.
4. To compare differentially expressed clones between the different 
genotypes, sequence them and use BLAST analysis to determine potential 
functions.
5. To reduce the number of genes to a short-list of candidates most likely to 
be involved in or interact with the morphine pathway; a short-list 
warranting further study.
Chapter 2 contains the methods used in this thesis. Chapter 3 concerns the classical 
characterisation (where it is original work) of each of the different genotypes being 
presented. Chapter 4 examines the development of the microarrays and the results of 
the microarray analyses. A set of differential genes is characterised further in 
Chapter 5 and a short-list of genes established warranting further investigation 
beyond the scope of this thesis.
If successful, this work will be the first cDNA microarray study of P. somniferum 
and the first molecular study of mutations affecting morphine biosynthesis. It is 
hoped that new genes will be uncovered which will expand our understanding of the 
pathway, especially into areas of regulation and transport, which currently are very 
poorly understood.
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Chapter 2
Methods
2.1 Cultivation of Plants
Tasmanian Alkaloids Pty Ltd isolated the morphinan alkaloid mutant lines used 
in this thesis. The M2 of EMS treated seed of the Tasmanian cultivar C052 were 
grown to between the 10-leaf stage and the "running up" stage (Figure 1.7) prior 
to flowering.
minutes
Figure 2.1: a) HPLC trace file of P. somniferum at the 6-8 leaf running up stage 
of development compared to the HPLC trace file b) of the immature (2-4 leaf) P. 
somniferum.
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This stage is prior to morphinan accumulation in the capsule as can be seen by 
Figure 2.1, which shows the HPLC trace files of the difference in the levels of 
accumulation of the morphinan alkaloids of young plants (from 2-4 leaf stage) 
compared to the older 10 leaf stage. Screening of the EMS generated M2 mutant 
population was undertaken by solvent extraction of latex collected from leaf, and 
HPLC analysis.
The elite P. somniferum line used for the production of the cDNA library is the 
parent line C052 provided by Tasmanian Alkaloids Pty Ltd. The control plant 
was used rather than the mutant to produce the cDNA library for slide printing 
due to the likelihood that the mutation has caused a down regulation in the 
pathway. It was preferable that the down-regulated genes be represented on the 
microarray.
Plant material was germinated and grown under glasshouse conditions of 16 hr 
days at 25 °C and 8 hr nights at 18 °C. The potting mix contained Scott’s 
Osmocote® Plus controlled release fertilizer at the company’s recommended 
dose.
Plant material for the microarrays was grown in the glasshouse under the same 
conditions as the C052 elite cultivar used for the production of the Papaver 
somniferum cDNA library. Leaf material was harvested at the running up or 
prehook stage (See Figure 1.7) just before flowering and RNA prepared as 
Chapter 2.3.
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Latex from 
excised capsule
RNA taken from 
whole plant for 
cDNA synthesis
RNA from 
deveined leaf
RNA from 
lateral root
Figure 2.2: Diagramatic representation of a P.somniferutn and the regions RNA 
was taken for RNA analysis
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Figure 2.3: Picture showing the quality of P. somniferum total RNA run on a 
formaldehyde gel and used for Poly A+ mRNA extraction.
2.2 RNA Extraction
RNA was isolated from plant material grown to the running up or prehook stage, 
just prior to flowering and capsule formation of the poppy (Figure 2.2), using the 
scaled up method of NTES buffer, phenol/chloroform extraction and LiCl 
precipitation (Higgins et. al., 1976).
The prehook stage was chosen because this is when the alkaloid production and 
accumulation is maximal in the poppy plant (Williams and Ellis, 1989). 8 gm of 
whole plant (excluding roots) from six separate plants was harvested and 
immediately placed in liquid Nitrogen and ground with a mortar and pestle 
yielding good quality RNA. The P. somniferum Poly A+ RNA (100 pg at a 
concentration of 20 pg/mL with an A260/280 of 1.9) was isolated using the
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Promega PolyATtract mRNA isolation System (Catalogue #Z5210). To check the 
quality of the RNA and Poly A+ mRNA they were electrophoresed on gels 
consisting of 0.66 M formaldehyde mixed with 1 x MOPS buffer (0.1 M 3-(JV- 
morphilino) propane sulphonic acid (pH 7.0), 40 mM sodium acetate and 5mM 
EDTA (pH 8.0)) and 1.32 % agarose as described in Sambrook et. al., (1989). 10 
pg of total RNA was incubated for 5 minutes at 65 °C in a total volume of 20 pL 
containing 40 % formamide (deionized), 15 % formaldehyde, 1 X MOPS buffer 
(Sambrook et. al., 1989) andl mg/mL Ethidium Bromide. Gels were visualised 
using a Gel Documentation 2000 system from Bio-Rad (Figure 2.3).
2.3 cDNA Synthesis
The Papaver somniferum plasmid cDNA library was provided in the 
pCMV*Sport6 vector (Figure 2.4) transformed into EMDH10B cells by Life 
Technologies Catalogue No. 11138-013. The library yielded 2.63 x 10s cfu with 
an average insert size of 1.82 kb and 96% of the colonies having an insert >200 
bp. To minimize representational biases from occurring during the expansion of 
plasmid cDNA libraries (Kriegler 1990) semi-solid amplification of the primary 
cDNA transformants was undertaken. The Life Technologies modified protocol 
was used to amplify the cDNA transformants at 30°C to help stabilise any 
unstable clones (Hanahan et. al., 1991). The cDNA library redundancy was 
calculated by sequencing 1056 clones at AGRF (see section 2.8) and aligning 
each sequenced cDNA clone to the other 1055 sequenced clones. Thus the 
percentage of singletons was very high at 98.5%. This gave 16 redundant clones 
of which there were eleven groups (Appendix 1). Using these figures an 
approximate percentage of the redundancy of the library could be ascertained 
(Huang and Weir 2001).
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% Redundancy = Total number of clones - (Singletons + redundant groups)
Total number of clones
% Redundancy = 1054-( 1038 + 11) = 0.005%
_____________ x 100
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2.4 Microarray Printing
The PCR amplification of a total of 17,000 P. somniferum cDNAs (AB Gene 
Catalogue #AB-0600) was undertaken in 96 well PCR plates by adding 47 pL of 
a PCR cocktail to each well and adding the 3 pL of the overnight LB culture (see 
above). The PCR cocktail contained PCR Buffer (500 mM Tris/HCL pH 9.2,
160 mM (NH^SCL, 22.5 mM MgCL), 25 ng of each primer (SP6 and T7 (Figure 
2.5) each at 100 ng/pL made by Sigma), 0.2 mmoles of dNTPs (Promega 
Catalogue #U1240) and 1 unit of Taq DNA Polymerase in a final volume of 50 
pL. The PCR plates were sealed (AB Gene Clear PCR Plate seals Catalogue 
#AB-0580) then placed into a Corbett PCR thermocycler (PC-960C) under the 
following conditions: 5 minutes at 94 °C, 35 cycles of 30 seconds at 94 °C, 30 
seconds at 48 °C and 1 minute 30 seconds at 68 °C, then 1 cycle of 94 °C for 30 
seconds, 48 °C for 30 seconds, 72 °C for 10 minutes before a final step at 20 °C. 
lpL of loading dye (from a 6 X stock: 15% FicollK 400, 0.03% bromophenol 
blue, 0.03% xylene cyanol FF, 10 mM Tris-HCl (pH 7.5) and 50 mM EDTA) 
was added to 5 pL of the PCR reaction and run on a 1% agarose and 0.5 X TBE 
gel in 0.5 X TBE buffer at 120 mV and 0.8 Amps to check for insert size and 
amplification. This quality control was undertaken on all of the 96 samples of 
each 96 well plate. Any plates where there were greater than 5 PCR reactions
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SP6- 5 TATTTAGGTGACACTATAG 3 ’ 
T7- 5 TAATACGACTCACTATAGGG 3’
Figure 2.5: PCR primers used for the amplification of the P. somniferum cDNA 
inserts contained within the pCMV'Sport 6 vector.
combined, which either did not amplify or gave more than one band were either 
repeated or replaced with clones that did give one strong band from a new PCR 
reaction. This was undertaken so that the degree of multiple bands 
(contamination by more than one cDNA clone) on the array was minimised. This 
gave confidence that the spots defined as being statistically differentially 
expressed in the experiment would be single clones and easier to analyse later.
Once plates were confinned as having amplified products (Figure 2.6) the 
contents of each well was precipitated with 2.2 volumes of 95% drum EtOH (not 
100 % as it contains fluorescent impurities) and 0.1 volumes of 3M sodium 
acetate, pH 5.2 mixed well by pippeting up and down. The resealed plates were 
placed at -20 °C for at least an hour before spinning in a Sorvall RC-5B 
refrigerated bench top centrifuge with a SH-3000 rotor at 4000g for 1 hour then 
decanting the ethanol acetate solution. The precipitates were washed with 80 % 
ethanol (also made from 95 % drum ethanol) and centrifuged at 4000g for 45 
minutes before carefully decanting the ethanol wash. The precipitates were dried 
of residual ethanol by spinning the plates at 100 rpm for 1 minute upside down in 
the Sorvall centrifuge with paper towel cut to size underneath. The plates were 
allowed to air dry before adding 8 pL of 50% DMSO (giving a DNA 
concentration of 0.15 to 0.20 pg/'pL), resealing and storing at 4 °C overnight to 
allow resuspension of the DNA into the DMSO solution. Again, quality control 
was undertaken by checking the first row of each precipitated 96 well plate, this 
was done by running 0.5 pL of each of the resuspended DNA samples on a 1% 
TBE agarose gel containing Ethidium bromide as above (Figure 2.6).
To facilitate slide printing the samples were then transferred to 384 well plates 
(Whatman
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Figure 2.6: 1% Agarose gel run on 0.5X TBE showing amplification of cDNA 
clones and the range of sizes of the clones
384 well 80 pL polypropylene v-bottom Uniplate Catalogue # 7701-5101) using 
a multi-channel pipette and the order of the 96 well plates recorded.
The 384 well plates were then sealed using the adhesive plate seal and stored at 4 
°C until printing onto glass microarray slides (Corning CMT-GAP2 coated slides 
Catalogue #40004, non-bar coded) with the microarrayer (Bio-Rad VersArray 
Chip Writer Pro.) at CSIRO Plant Industry with reservoir pins 100-120 pm in 
size. After the slides had been printed they were baked at 80 °C for 4 hours to 
crosslink them and stored dry and in the dark at room temperature.
2.5 RNA Labelling and Hybridisation of Arrays
RNA was extracted from plant material at the same developmental stage (unless 
otherwise stated in the appropriate chapter) using the same RNA extraction 
procedure as per Chapter 2.3. RNA quality was checked by running on a MOPs 
formaldehyde gel as per the methods described in Chapter 2.3. (For a 
diagrammatic representation of the RNA labelling, hybridisation and analysis see 
Figure 2.7). 100 pg of test (different morphinan accumulating germplasm) and 
reference P. somniferum (C052) RNA was labelled, ethanol precipitated and 
taken up in 10 pL. 4 pL of this was then used for each slide hybridisation.
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Figure 2.7: Diagrammatic representation of the RNA labelling, hybridisation and 
analysis used for the P. somniferum experiments. (Adapted from Brown and 
Botstein 1999).
Probes for the microarray slides were labelled using a two-step method in the 
incorporation of Cy3/Cy5 (Amersham Pharmacia FluoroLink™Cy3/Cy5-dUTP 
Catalogue #PA 53022 and 55022) dyes by random priming (Schenk et. al., 2000). 
The first strand synthesis reaction was initially heated at 70 °C to anneal 100 pg 
of either the test or reference RNA and oligo dT (23 mer dT with C/G/A at 3’ end 
made by Sigma) at a final concentration of 2.5 pg/pL before transferring to ice. 
The reaction was then continued at 42 °C for 1 hour after adding 2 x 10̂  Units of 
Superscript II Reverse transcriptase (200 U/mL) (Gibco BRL catalogue # 18064- 
014), l sl strand synthesis buffer (lx supplied with Superscript), 0.01M DTT, and 
0.5mM of dNTP (final concentration at 0.5 mM of each dNTP) mix. RNase H (1 
unit Promega Catalogue # M4281) was added and the cDNA-RNA mix incubated 
at 37 °C for 30 minutes. The reaction was purified using Amicon Microcon 
YM30 filters (Catalogue # 42410) and eluted to a final volume of 8 pL with TE 
(pH 8.2) buffer. 1 pL of the elution of unlabelled cDNA was taken and diluted
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1/20 with TE (pH 8.2). 1 pL was used in a PCR reaction to check the quality of 
the cDNA synthesis reaction. Primers were used to the 5’ and middle region of 
the codeinone reductase gene for amplification of the expected band size. This 
would enable an mRNA and cDNA synthesis quality control point that the 3’ to 
5’ directional synthesis was working efficiently.
The Cy3 or Cy5 labelling reaction of the cDNA involved the annealing of 
random primers to the cDNA. The 40 pL reaction initially contained 4 pL of the 
cDNA reaction, 6 pg of Random Primers (hexanucleotides Gibco Catalogue # 
48190) and IX Fill in Buffer (10X provided with Klenow Polymerase) heated to 
95 °C for 2 minutes then let cool at room temperature. A dNTP mix was added 
(to a final concentration of 0.025 mM each except dTTP which was at 0.009 mM 
(Promega)), then 10 Units of Klenow polymerase (USB Catalogue # 70057Z) and 
25 nmol of either Cy3 dUTP or Cy5 dUTP (to either test or reference sample 
cDNA) and the reaction carried out in darkness at 37 °C for 3 hours. The 
reaction was again purified using Amicon filters and dried down in a SpeedVac. 
The probe was taken up in 10 pL of TE (pH 8.2) buffer and the total reaction 
used for the following hybridisation procedure.
For the hybridisation, 25 % formamide, 5 X SSC, 0.1 % SDS, and 30 pg of 
Salmon Sperm DNA were added to the probe to a final volume of 45 pL. The 
probe solution was heated to 95 °C for 5 minutes and spun to cool before adding 
to a prehybridised slide. Slides were prehybridised by incubating at 42 °C for 45 
minutes in 25 % formamide, 5 X SSC, 0.1 % SDS and 0.1 mg/mL Bovine Serine 
Albumin (BSA) as per the CMT-GAPS Coated slides protocol for DMSO 
printings. Slides were rinsed with distilled water and dried by spinning in a slide 
spinner. Once the probe was added to the slide, a coverslip (Sigma Hybri-slips 
22X 40mm) was added and the slide placed into a hybridisation chamber and 
incubated at 42 °C for 16 hours. The slide chamber was disassembled and the 
coverslip removed by washing the slide at 42 °C in 2 X SSC and 0.1 % SDS 
before the placing the slide in fresh 2 X SSC and 0.1 % SDS at 42 °C for 5 
minutes. This was followed by a 10 minute room temperature wash of 0.1 X 
SSC/ 0.1 % SDS and 4 room temperature washes of 0.1 X SSC each for 1
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Figure 2.8 (Previous Page): A typical microarray slide from the experiments
performed on the 17,000 P. somniferum cDNA library.
minute.
Slides were then rinsed for 10 seconds in distilled water and rinsed with EtOH 
(95 % drum ethanol) before spinning upside down in a centrifuge to dry.
Slides were scanned (Figure 2.8) with a GenePix 4000A microarray scanner 
(Axon Instruments, Union, CA), and spots were analysed using GenePix Pro 3 
software. Manual adjustment of any spots that were poorly read by the software 
was undertaken to ensure only high quality microarray data was used. This 
involved manually checking the circled areas that the software had calculated as 
being a fluorescent spot. Cy3 and Cy5 labels were interchanged between sample 
and control cDNA in complementary experiments to reduce any of the effects 
from differential photobleaching of the two fluorescent dyes and cDNA 
incorporation inequalities and any inequalities in the incorporation of the two 
dyes into cDNA.
2.6 Microarray Analysis
Statistical functions written in R code, (Ihaka and Gentleman, 1996; for review 
see Ellner, 2001) freely available at http://www.r-project.org/, were used in a new 
statistical microarray analysis package, tRMA (tools for R Microarray Analysis; 
Wilson et. al., 2003). Details and a manual of tRMA are available online 
(http://www.pi.csiro.gena.trma.au). Normalisation was undertaken to eliminate 
possible biases in fluorescence due to a difference in label incorporation during 
cDNA synthesis and differences in the stability of the dyes. A spatial 
normalisation algorithm in tRMA helps to remove possible spatial fluorescence- 
based biases. The data were normalised using spatial-normalisation protocol 
from the tRMA package (Yang et. al., 2001). Median values were calculated for 
each gene from the total number of biological and technical replicate slides for 
each experiment. Biological replicates consisted of repeat experiments of groups
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of six plants grown under the same conditions and material harvested from each 
of the plants at the same time and RNA pooled from each individual within each 
group. This level of replication was repeated for both the control C052 and each 
test sample line.
The biological replicates are necessary to try to avoid random gene expression 
due to variations in conditions and genetic material. While plant genetic material 
was matched as closely as possible, plants still vary in expression patterns of 
particular genes. As well as biological replicates, technical replicates were 
employed of each biological replicate to remove inconsistencies between the 
labelling and fluorescing efficiencies of each of the dyes.
Using the relevant function in tRMA, differentially expressed genes were 
extracted from the complete list o f-17000 clones’ median values. Firstly the 
data is normalised and then rescaled with a mean of 0 and SD of 1 so that 
differentially expressed genes can be found statistically using standard Gaussian 
distribution. As the statistically defined genes always have a cut-off of less than 
2-fold we applied a more stringent cut-off of 2 to select the differentially 
expressed genes.
2.7 Sequencing of Differentially Expressed Genes
Differentially expressed clones were taken from -80 °C storage and grown 
overnight in LB with 200 pg/mL Ampicillin and the next day plasmids were 
purified using the Qiagen QIAprep Spin Miniprep Kit (Catalogue # 27104).
Primers to the vector at the 5’ and 3’ regions of the inserted cDNA were used to 
get sequence data of the differentially expressed genes. The standard Big Dye 
Version 3.1 sequencing method was used and the precipitated product sent to the 
Australian Genome Resource Facility (AGRF) (University of Queensland St 
Lucia, QLD. Australia) and run on an ABI Prism Model 377 sequencer. 
Sequences were BLASTed against the NCBI database for both BLAST x and 
BLAST n results. For those clones that needed internal sequencing runs, internal
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specific primers were designed which had an annealing temperature >65 °C and 
made by Sigma.
Sequencing was analysed on BioManager by ANGIS (University Of Sydney 
NSW, Australia), (http://www.anuis.onz.au/) first by running CodonCode 
BaseCaller (http://www.codoncode.com/oem/basecaHer) version 0.000918 
(Ewing et al., 1998; Ewing and Green 1998) by CodonCode Corporation to 
determine correct coding of bases. Vector trimming was undertaken using 
CodonCode Matcher with vector (http://www.codoncode.com/oem/matcher) 
version 0.000918 by CodonCode Corporation. The resulting sequence was 
assembled using Contig Express supplied with Vector NTI 8 (Frederick,
Maryland U.S.A.). Resulting sequence data was then screened for homology to 
database sequences using Biomanager by ANGIS for tBLAST x, BLAST x, 
BLAST n (Altschul, et al., 1997). A cut off of an E value to power -60 was used 
to assign function or similarity to known genes in the database. tBLAST x values 
were used to help assign probable function rather than BLAST n values as there 
are few poppy genes sequenced in the database. It was generally found that the 
sequence similarities between: rice and poppy and Arabidopsis and poppy, were 
not close enough to give reliable BLAST n results and assign function. 
Chromatogram data was checked for poor sequence data and any that was found 
to be unreliable was discarded and repeated. The cDNAs were also screened for 
redundancy by alignment on Biomanager by ANGIS using ClustallW (accurate) 
(Thompson et al., 1994).
2.8 HPLC Analysis of Alkaloids
Latex from the plants was harvested by lancing the unripe capsules and adding 
approximately 0.5 pL of the exuding latex immediately to 250 pL of buffer (0.2 
M ammonium phosphate, 0.25% SDS, 20% ethanol, pH 4.5). The sample was 
vortexed then centrifuged. 200 pL of the supernatant was decanted into a 40 x 8 
mm auto analyser tube and an additional 250 pL of buffer was added to allow the 
sampling needle to reach the solution. The samples were run on a 96-tube 
carousel Waters HPLC system with a standard sample containing morphine, 
codeine, oripavine and thebaine. The HPLC phase was aqueous methanol
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(approximately 30%) containing ammonium acetate buffer (0.08-0.12 M), pH 4- 
5. The flow rate of the mobile phase was 0.8-1.5 mL/minute. A Whatman 
Partisphere SCX column (4.6 x 125 mm) was used at a temperature of 40 °C. A 
Waters 440 UV detector was used to detect the peaks at 254 nm. The data was 
interpreted and collated on a Waters Millenium Data Station.
2.9 HPLC Analysis of Carotenoids
Approximately 100 pL of latex was isolated from each of the mutant topi and the 
control C052 after lancing the unripe capsule at 4 days post petal drop for 
possible carotenoid extraction and determination by HPLC (a detailed description 
of the HPLC procedure can be found in Norris et al., 1995). 500 pL of 
acetone/ethyl acetate (60:40) was added and the solution vortexed. 400 pL of 
H2O was added and the solution mixed again and spun fro 5 minutes at 13,000x 
rpm. The top layer containing the ethyl acetate (and colour from the topi latex) 
was transferred to a new tube (taking care not to get any of the water) and this 
was spun for 3 minutes. The samples were run on a standard C l8 reverse phase 
column HPLC with ACN (Acetonitrile)/H20/TEA (triethylamine) background 
and an ethyl acetate gradient and run for 15 mins.
Saponification of samples was undertaken using a method based on Granado et 
al. (2001), the latex was extracted in ethanol (equal volume) and KOH added to a 
final concentration of 6% (v/v). The samples were left overnight under nitrogen 
in the dark and the next day diethyl ether was (approximately 100 pL) added to 
the sample. The carotenoid pigments partition into the ether phase. The sample 
was washed several times with distilled water to remove the KOH. The ethyl 
layer was removed and evaporated under oxygen-free nitrogen. The sample was 
reconstituted in ethyl acetate and injected onto the HPLC.
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2.10 TLC Analysis of Alkaloids
Thin Layer Chromatography (TLC) was used to analyse alkaloids. Latex was 
collected from the mid vein of a torn leaf and adding to 200 pL of latex 
extraction buffer (20 % EtOH, 0.25 % SDS and 0.2M NH4H2P04). The latex- 
buffer solution was vortexed and allowed to sit for 30 minutes then spun and 5 
pL taken for loading onto a TLC plate (Merck Silca gel 60). The plates were run 
according to Wagner (1984) using a chromatography solvent of toluene: acetone: 
ethanol: concentrated ammonia (40:40:6:2).
Standards used for the TLC were dissolved in 50 % EtOH/ 50 % NH4OH in the 
following concentrations 2.5 mg/mL oripavine, 1.25 mg/mL thebaine, and 5 
mg/mL codeine base, 5 mg/mL and morphine base. All alkaloids were kindly 
provided by Tasmanian Alkaloids Pty Ltd.
2.11 Radioactive Feeding Studies
[NB. This section (Section 2.12) describes experiments conducted by a 
collaborator in Germany. They are included here, rather than the introduction, as 
there has been no other publication of the method for this data for the mutant 
topi].
Plants used in the feeding studies were germinated in pots (30-50 cm in diameter) 
and allowed to grow for 5-6 weeks (10-12 cm total length) in the greenhouse 
before cutting the plant just above the root and placing in a 1.5 mL 
microcentrifuge tube filled with 300 pL of feeding solution. These plants were 
then placed in a transparent plastic lidded box containing enough Millipore water 
to obtain a relative humidity of 80-90% to stop the plants from wilting.
Feeding solutions consisted of: 200 000 cpm 14C-oripavine and 9 nmol of 
oripavine; 215 000 cpm 14C-thebaine and 15 nmol of thebaine; 500 000 cpm 3H- 
codeine and 10 nmol codeine; 500 000 cpm H-salutaridinol and 16 nmol 
salutaridinol; 260 000 cpm H-/?-reticuline and 6 nmol /^-reticuline; each made
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up to a total volume of 300 pL with Millipore water. The duration of each of the 
feeding studies was 24 hours for oripavine, thebaine, salutaridinol and R- 
reticuline. The codeine solution was fed for a period of 72 hours. To prevent 
plants from running dry Millipore water was used to top up the microcentrifuge 
tube.
After the feeding assay the plants were cut into small pieces and extracted in 80% 
Ethanol for 15-20 minutes. The crude extract was lyophilised and dissolved in a 
small quantity of methanol and run on TLC. A two dimensional TLC was used 
with Dimension 1 solvent system consisting of chloroform: acetone: 
diethylamine (5:4:1) and dimension 2 consisting o f toluene: acetone: ethanol: 
ammonia (45:45:7:3).
2.12 Semi Quantitative Real time PCR
For analysis of the differentially expressed cDNA clones gene-specific 
oligonucleotides were made by Sigma. RNA was extracted using the Qiagen 
RNeasy Plant kit (Catalogue # 74903) as per the method supplied. Primer sets 
were designed using the Primer3 software package (http://www- 
genome.wi.mit.edu/cui-bin/primer/primer3 www.cgi) (Table 2.1). These primers 
were designed to have a Tm of 59-63 °C (with the optimal being =60 °C), yield a 
PCR product around 225-275 bp (optimal being 250 bp), GC content from 40- 
60% (with the optimal being 50 %), a Max self-complementarity equal to 4 and a 
Max 3’ self-complementarity equal to 3. Qiagen Quantitect™ SYBRK Green Real 
Time PCR kit (Catalogue # 204243) was used in half reactions as per the 
manufacturer’s instructions, for authentication of differentially expressed genes.
A typical reaction contained 10 pL Quantitect7 M SYBR Green RT-PCR Master 
Mix, 0.5 pM each of forward and reverse primers, 0.2 pL of Quantitect™ RT mix, 
10 ng of RNA and RNase-free water to 20 pL. The reactions were carried out on 
a RotorGene 2000 (Corbett Research), and data was analysed by ‘Relative 
quantitation’, a comparison of two or more genes to each other and the result 
calculated as a ratio. (For further information see
http://does.appliedbiosvstems.com/pebiodocs/04303859.pdtT See Appendix 2
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Table 2.1: List of primers and the respective sequence used for the qRT- 
PCR, RT-PCR reactions and for further analysis._____________________
Primer
Name
cDNA
and
Primer
direction
Size
(bp)
Sequence of Oligonucleotide
AGM261 * 221C9 5’ 24 ACGGTCCTGAAAGATAGAGACTTG
AGM262* 221C9 3’ 24 TCCAGAGAAAAGGAAAAACAAAAC
AGM263* 221C9 3’ 24 ACCAGTGAAAGTAAACATCCCAAT
AGM264* 221C9 3’ 24 GAT AGGTTT CCTCC AGG AT CT AC A
AGM265* 221C9 5’ 24 GTTT AC TTTC ACT GGTTT G A AT A A
AGM180 221C9 5’ 21 GCTCAGGATCAATATGGGCTA
AGM181 221C9 3’ 20 TTAATAGCATCCGCAAGGTG
AGM249 27D12 5’ 21 GGCT G A AG AGGT GAT ATTT GG
AGM250 27D12 3’ 20 TATGCCTTGTCCACCAACTC
AGM256 116D7 5’ 20 AAAAATACCGACGCCTGATG
AGM257 116D7 3’ 20 AT GCAAAAGCCGAGAAAATG
AGM188 157C4 5’ 20 ATGTCGCCCTCTTGGTTTAT
AGM189 157C4 3’ 20 GTAGTCCACCTCTCGGGTGT
AGM182 91G3 5’ 20 CCTTGTTCGCATTTTGACTC
AGM183 91G3 3’ 20 AGGAATCTGGAGCCTACGAG
AGM64 SAT 5’# 20 ACAACAACAAATGCGGTCAA
AGM65 SAT 3 ’# 20 ATAATCCCATCCTGCACCAG
AGM196 111C7 5’ 20 GCCATAACATTTGAGGGTGA
AGM197 111C73’ 20 TTCCATTCCTCTCCAGGTTT
AGM259 91B6 5’ 20 ATC AA AAAT GCCC AC AT GGT
AGM260 91B6 3’ 20 TT C AGC AACG AC AC AT C AC A
AGM137 54F9 3’ 28 AGAATAAGCAAGGCGGCTCTAAGT
TCAA
AGM138 54F9 5’ 28 CTTACGCGTACCCAGCTTTCTTGTA
CAA
AGM210 151H8 5’ 20 TCCACCAGAAAAGAGGGTTT
AGM211 151H8 3’ 20 TTTGTCTCGCCCAGGAGTAT
* these primers were extra primers designed to the cDNA 221C9 for further 
RT-PCR analysis see Chapter 5. # is the Salutaridine acetyl transferase 
(SAT) gene used as a control for the qRT-PCR analysis._________________
for the detailed qRT-PCR data.
2.13 Reverse transcriptase PCR
Several attempts were required to detect the appropriate number of cycles to 
show a difference in expression levels between the control and mutant topi RNA 
samples. Each reaction sample was repeated in triplicate to authenticate the 
results. RNA was run on a gel (See Chapter 2.3) to authenticate accurate spectral
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quantification, as well as using an internal control of primers to the salutaridine 
acetyl transferase gene. The primers for this gene were also picked using the 
same program as the one used for the selection of qRT-PCR primers. Resulting 
reverse transcriptase-PCRs (RT-PCRs) were run on 0.5 X TBE agarose gel in 0.5 
X TBE buffer at 120 mV and 0.8 Amps and visualised using the Biorad Gel 
Documentation System.
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Chapter 3
Characterisation and Definition of the Different Germplasm Used
in this Thesis
3.1 Introduction
To further the aims of this thesis a range of germplasm have been assembled. 
These include: several mutants of P. somniferum with altered morphinan alkaloid 
phenotypes (morphinan alkaloid yields of each of the mutants and their respective 
parental phenotypes are presented in Table 3.1); a low morphine cultivar of P. 
somniferum, Marianne; Eschscholzia californica, a distant member of the 
Papaveraceae family; and a transgenic P. somniferum with altered morphinan 
phenotype.
This chapter, where applicable, will extend the classical characterisation of the 
different genotypes, including HPLC and TLC analysis of the alkaloids and, in 
the case of the mutant topi, an investigation of the altered latex colour in order to 
determine if the colour change is related to the altered alkaloid phenotype. 
Further, feeding studies of the mutant topi will be presented to establish the 
blockage in the morphinan pathway and preliminary proteomic analysis will be 
presented to illustrate the extent of differences in protein expression in topi. A 
focus will be given to the alkaloid mutant topi due to its economic significance, 
its relevance to studying the last steps of morphine biosynthesis, and its genetic 
stability.
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3.2 Reticuline Accumulating Germplasm
The first grouping of genotypes with altered alkaloid phenotypes is defined here 
as the reticuline accumulating germplasm. This class includes: Eschscholzia 
califomica which, contains the alkaloid pathway to the reticuline branchpoint 
before continuing on to sanguinarine (Figure 3.1); the reticuline accumulating 
mutant P. somniferum (E40/41) (Figure 3.1); and the reticuline accumulating 
hairpin RNAi silenced transgenic P. somniferum (Figure 3.1).
3.2.1 Eschscholzia califovnica
Eschscholzia californica is a member of the Papaveraceae family and is 
commonly known as the California poppy. A native to North America it was 
named after Johann Friedrich von Eschscholtz a famous botanist, physician and 
naturalist. The plant grows as a perennial, regenerating from the roots in spring in 
colder climes, and flowers annually with a gold coloured flower. The American 
Indians, who ate the boiled leaves and sometimes smoked the leaves and petals, 
used E. californica in traditional medicine.
Recent advances in E. californica transformation techniques (Park and Facchini, 
1999; 2000a; 2000b; 2001; Lee and Pederson, 2001) will allow genetic 
manipulation of the benzophenanthridine pathway in this plant species. 
Transformation of plant cell suspensions and root cultures with BBE or 
CYP80B1 (Park et al., 2002 and 2003), illustrate that metabolic engineering of 
benzophenanthridine alkaloid accumulation is achievable. The stable genetic 
transformation of this species will help analysis of the regulation of the 
benzophenanthridine pathway by allowing newly isolated genes to be expressed 
or knocked out in stable cell or whole plant lines.
The main alkaloids found to accumulate in the E. californica plant are the pavine 
type, such as eschscholtzine and califomidine and the benzophenanthridine 
alkaloids sanguinarine (Figure 1.6) and chelerytrine (Tome et al., 1999).
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Figure 3.1: Abbreviated alkaloid pathway illustrating the accumulating products 
for each of the germplasm used in this subchapter of reticuline accumulating 
phenotypes. E. californica contains the benzylisoquinoline alkaloid pathway until 
the major branchpoint intermediate ^-reticuline and from here progresses to 
sanguinarine, the major accumulating alkaloid. The morphinan alkaloids have 
not been found in E. californica. The mutant P. somniferum that accumulates S- 
reticuline also accumulates the intermediates laudanosine and laudanine. The 
hairpin inverted-repeat transgenic P. somniferum has the same alkaloid phenotype 
as the reticuline-accumulating mutant. Adapted from Kutchan 1998.
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Eschscholzia cell suspensions have been used as a model system to study 
benzophenanthridine alkaloid biosynthesis since the accidental discovery that the 
medium changed colour when a penicillium contaminated E. californica callus 
(Schumacher et al., 1987). The use of Eschscholzia cell suspensions has led to the 
elucidation of the entire enzymatic pathways of sanguinarine and macarpine 
synthesis (Reviewed in Kutchan and Zenk, 1993; Zenk, 1994; Kutchan, 1995 and 
1996; Chou and Kutchan, 1998). The ability of this species to produce alkaloids 
in suspensions has made the enzymatic determination of these pathways possible. 
Its use has led to the discovery of some very complex reactions, which take place 
via the action of novel cytochrome P450 enzymes; genes cloned include those 
encoding CYP80B1 (Pauli and Kutchan, 1998) and A-methylcoclaurine 3’- 
hydroxylase. Elicited E. californica cell suspensions also enabled the berberine 
bridge enzyme (BBE) to be analysed and cloned (Dittrich and Kutchan, 1991; 
Kutchan and Dittrich, 1995; Hauscniid et al., 1998).
The morphinan alkaloid pathway has not been detected in either the plant or cell 
suspensions of E. californica. Both Papaver species share the pathway from 
tyrosine to the major branchpoint intermediate fSVreticuline (Figures 1.2 and 1.3) 
and also the branchpoint berberine bridge enzyme leading to the production of the 
benzophenanthridine sanguinarine (reviewed in Kutchan 1996). As mentioned 
above the gene encoding the P450 CYP80B1 was cloned from E. californica 
suspension cultures (Pauli and Kutchan, 1998) and a gene coding for the 
equivalent enzyme in P. somniferum, 76% identical at the amino acid level, has 
since been found (Facchini and Yu, unpublished, NCBI # AF191772). The 
Papaver NADPH-dependent cytochrome P450 reductase was also characterised 
and cloned from E. californica cell suspensions and shows 63% homology to the 
P. somniferum cDNA at the nucleotide level (Rosco et al., 1997).
The cyp80bl transcripts for both P. somniferum (Huang and Kutchan, 2000; 
Facchini and Park, 2003) E. californica (Pauli and Kutchan, 1998) are both 
induced upon addition of methyl jasmonate. Similarly BBE has also been shown 
to accumulate in response to elicitors such as methyl jasmonate in both P. 
somniferum (Huang and Kutchan, 2000; Facchini and Park, 2003) and E. 
californica (Dittrich and Kutchan, 1991; Hauschild et al., 1998) suggesting that
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the benzophenanthridine and benzylisoquinoline pathways are under similar 
transcriptional controls. While there are many similarities between the two 
species, the bbel gene promoter isolated from E. californica and fused to a ß- 
glucuronidase (gus) gene, was not functional in P. somniferum cell suspensions 
(Hauschild et al., 1998). Since E. californica entirely lacks the morphinan branch 
after (S)-reticuline, substantial genetic differences between P. somniferum and E. 
californica are expected and this should be reflected in a microarray comparison 
by a large number of transcriptional differences. The object of including a global 
transcript comparison of E. californica to P. somniferum by microarrays was to 
obtain a broader scope of the transcriptional differences and determine if similar 
reticuline branchpoint accumulating germplasm had similar sets of genes 
differentially expressed. It may be expected that if these genes are specifically 
involved with the morphinan pathway they will also be relatively under-
expressed in E. californica where the morphinan branch is also missing.
3.2.2 P. somniferum Reticuline Accumulating Mutant, E40/41
This is the second of three types of germplasm in the study classified as reticuline 
accumulating. The mutant, E40/41, was created using the EMS mutation process 
and discovered at Tasmanian Alkaloids. This mutant was produced in parental 
cultivar, W52-12-10, rather than cultivar C052. W52-12-10 and C052 are said to 
be relatively close genetically (Dr. Fist, pers. comm.). TLC (Figure 3.2) and 
HPLC (Figure 3.3) analysis of latex alkaloids revealed a mutant that failed to 
accumulate any appreciable morphinan alkaloids and instead yielded high 
quantities of reticuline (See table 3.1). Further analysis showed that it was the S- 
enantiomer of reticuline that accumulated in this mutant and not the R form. The 
mutant also accumulated laudanine, laudanosine and codamine (Figure 3.1) in 
measurable quantities that are not usually seen in these quantities in the parental 
line. These compounds are simple methylated derivatives of (^-reticuline.
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Figure 3.2: Picture of a TLC illustrating the difference in alkaloid accumulation 
between the parental control (3) (P. somniferum cv. W52-12-10) and the EMS 
mutant E40/41 (4). Lane 1 are the standards: morphine (M), codeine (C), 
oripavine (O) and thebaine (T). Lanes 2 and 5 are loadings of reticuline 
standards, which contain (from the bottom of the TLC to the top) reticuline, 
codamine and laudanine. Reticuline, codamine, laudanine and laudanosine are 
the dominant alkaloids found in mutant E40/41. The loading on this TLC was not 
enough to visualise the very low quantities of morphine and codeine, which can 
be seen on the following HPLC (Figure 3.3).
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Figure 3.3: HPLC analysis of the reticuline-accumulating mutant, E40/41 (a) 
compared to the control W52-12-10 (b). The reticuline mutant still accumulates 
codeine and morphine but at much lower concentrations than the control. The 
reticuline mutant also accumulates codamine, laudanine, and laudanosine which 
are normally difficult to detect in the control phenotype.
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3.2.3 Hairpin RNAi Silenced Codeinone Reductase P. somniferum
This is the third of three types of germplasm in the study classified as reticuline 
accumulating. It is a transgenic P. somniferum genotype in which codeinone 
reductase (Cor) has been silenced. Codeinone reductase is the penultimate 
enzyme of the morphine biosynthetic pathway in P. somniferum (Figures 1.2 and 
1.3). The cloning of the codeinone reductase gene (Unterlinner et al., 1999) and 
the development of a robust transformation system (Chitty et al., 2003), have led 
to the first genetically transformed opium poppies with a modified morphinan 
alkaloid pathway (Allen et al., 2004). This was achieved by transforming P. 
somniferum with a chimeric DNA-directed hairpin RNA construct designed to 
silence all members of the codeinone reductase multigene family through an 
RNAi mechanism. I am co-author on the paper describing this dramatic example 
of metabolic engineering (Allen et al., 2004).
The efficacy of gene silencing in plants using inverted-repeat transgene 
constructs that encode a hairpin RNA (hpRNA) has been demonstrated for a 
range of genes (Wesley et al., 2001; Wang and Waterhouse, 2002; Helliwell et 
al., 2002; Waterhouse and Helliwell, 2003). This technology relies on using 
intron-containing constructs, where an intron separates the complementary sense 
and antisense sequences. RNAi silencing constructs have resulted in 90-100% of 
independent transgenic plants showing silencing. The degree of silencing with 
these constructs is much greater than that obtained using either co-suppression or 
anti-sense constructs (Smith et al., 2000). The advantages of this technology are 
the ability to specifically silence one, some or all members of a multigene family 
by targeting unique or shared sequences.
Several isoforms of codeinone reductase were isolated from poppy, which have a 
high degree of sequence homology. The employment of RNAi silencing 
techniques to specifically knock out all members of the codeinone reductase gene 
family offers the potential to increase our understanding of the pathway. The 
codeinone reductase gene family contains at least 6 members {cor 1.1-1.6) 
(Unterlinner et al. 1999). A closely related gene, cor2 was also isolated, and 
although attempts to demonstrate that it encoded functional codeinone reductase
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Figure 3.4: TLC illustrating the difference in the alkaloids accumulated by (l) 
the reticuline standard consisting of reticuline, laudanine and laudanosine from 
the bottom to the top of the TLC plate. (2) The control parental phenotype, (3) 
one of the codeinone reductase RNAi silenced transformed plants, which also has 
codamine (upper band) present on the TLC. Adapted from Allen et al., 2004.
by expression in E. coli were unsuccessful (Unterlinner et al 1999), this gene was 
also silenced in case the Tasmanian cultivar C058-34, used for the 
transformation, did possess functional cor2. In order to silence all possible 
members of the cor family, regions of cDNA from both cor 1.1 and cor2 were 
incorporated into a hpRNA based silencing vector, driven by a strong constitutive 
promoter (Allen et al., 2004). The region chosen from cor 1.1 was identical to all 
the known members of the corl family.
TLC (Figure 3.4), HPLC (Figure 3.5) and mass spectrometry showed that the 
precursor (5)-reticuline accumulates in transgenic silenced lines at the expense of 
morphine, codeine, oripavine and thebaine. (S)-reticuline is 9 enzymatic steps 
upstream of the substrate codeinone (Figure 1.3). Northern analysis and RT-PCR 
of transgenic lines verified loss of codeinone reductase gene transcript. Further 
analysis revealed the presence of 22-mer degradation products in silenced lines, 
and the corresponding enzyme activity was substantially reduced (Allen et al., 
2004). The methylated derivatives of (^-reticuline also accumulated in the
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codeinone reductase RNAi silenced plants, including: codamine, laudanosine and 
laudanine (Figure 3.1).
There was some variability in the degree of expression of the cor RNAi induced 
reticuline phenotype in the transgenic T1 plants analysed. For example lines 220- 
15-2, 215-25-lb, and 220-9-2 accumulated very little morphine, with over 90% of 
total alkaloid comprising reticuline and its methylated derivatives, whilst families 
220-2-1 and 13-2 still accumulated morphine at up to 75% of total alkaloid. Most 
lines produced over 75% reticuline and its derivatives, which is profoundly 
different to the alkaloid profile of the commercial Tasmanian parental line C058- 
34 (Allen et al., 2004). Screening 18 independent primary transgenic lines 
showed that reticuline and its derivatives accumulate in direct proportion to the 
decrease in morphine, codeine, thebaine and oripavine. The transformed plants 
showed stable inheritance of the reticuline phenotype (Allen et al., 2004).
Chiral analysis was undertaken on methylated compounds, isolated by HPLC 
from transgenic latex of reticuline, codamine, laudanine and laudanosine, to 
determine if these compounds were the (R) or (S) enantiomer. Comparison with 
optically pure standards of (R)- and (^-laudanosine, revealed these compounds 
were present in the (S) form. Allen et al., (2004) showed that a reduction in the 
level of morphinan alkaloids in the cor RNAi transgenics also led to a 
concomitant reduction in the level of codeinone reductase activity and codeinone 
reductase message levels.
Silencing of codeinone reductase has led to the accumulation of the general 
intermediate (^-reticuline at the expense of morphine, codeine, thebaine and 
oripavine. The accumulation of (^-reticuline suggests that a negative feedback 
mechanism exists between the unique morphinan specific pathway, and the 
benzylisoquinoline secondary metabolic pathway, of which (*S)-reticuline is a key 
intermediate. Such negative feedback seems the only cogent explanation for how 
the entire 9-enzyme morphinan pathway can be closed down in response to the 
loss of codeinone reductase. By reducing the production of codeinone reductase 
transcript and its corresponding protein product the blockage is somehow relayed 
back to the metabolic junction point at (^-reticuline. This intermediate is shared
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Figure 3.5: HPLC profiles of the cor RNAi transgenics (b) and the parental line 
C058-34 (a) used for the transformation showing differences in the alkaloids 
accumulated. The strongest expressing transgenics no longer accumulate 
morphine, codeine, thebaine, and oripavine, instead accumulating (S)- reticuline, 
laudanosine, laudanine and codamine. From Allen et al., 2004.
with other alkaloid pathways in Papaver and other species, such as those 
responsible for berberine, benzophenanthridines (for example sanguinarine),
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phthalide isoquinolines (for example noscapine) and benzylisoquinolines (for 
example codamine, laudanine and laudanosine) (Figure 3.1).
A number of explanations for the resulting phenotype of the cor RNAi 
transformed plants. These explanations include a slight build up of the substrates 
codeinone, morphinone or neopinone which may act as inhibitors of one of the 
early enzymes of the morphinan branch, such as reticuline oxidase (=1,2- 
dehydroreticuline synthase) (Hirata et al, 2004). The substrate feedback may act 
to inhibit transcription of genes encoding earlier enzymes or inhibit the earlier 
enzymes themselves. Another possibility is that codeinone reductase enzyme 
may form a larger inter-dependent enzyme complex; the loss of codeinone 
reductase may disable the entire complex resulting in a failure of the first steps of 
the morphinan branch (Allen et al., 2004).
There is evidence in flavonoid biosynthesis in Arabidopsis endoplasmic 
reticulum for such a multienzyme complex (Burbulis and Winkel-Shirley, 1999); 
chalcone synthase, chalcone isomerase, and dihydroflavonol 4-reductase interact 
in an orientation-dependent manner. Similar evidence exists for multi-enzyme 
complexes involved in polyamine synthesis (Panicot et al., 2002), where 
metabolites are thought to canalise down a particular pathway as they pass from 
one enzyme to the next in the complex. This multienzyme complex is termed a 
metabolon and has been invoked to explain some features of O-methyltransferase 
associations in isoflavonoid biosynthesis (He and Dixon, 2000). It has been 
suggested metabolons may be associated with morphine biosynthesis (Facchini et 
al., 2003) but without evidence.
Compartmentalisation in alkaloid synthesis and accumulation has been 
demonstrated (St-Pierre et al., 1999, Bird et al., 2003), and it is possible that the 
transgenic codeinone reductase RNAi plants have resulted in changes to the 
normal transport and storage architecture, resulting in the failure of (^-reticuline 
accumulating in the correct compartment for further processing into the 
morphinan alkaloids. (S)-reticuline is transported into vesicles preferentially to 
(R)-reticuline (Deus-Neumann and Zenk, 1986). Perhaps the substrate feedback 
inhibition in cor silenced plants acts on the transport or compartmentalisation
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processes. RNAi silencing of codeinone reductase has revealed an unforseen 
level of control over the morphinan alkaloid branch.
The alkaloid profiles of the E40/41 mutant and codeinone reductase RNAi 
silenced plants are nearly identical, however the molecular mechanisms behind 
the phenotype are presumably quite different. The inclusion of both in the 
microarray experiments and comparison of which genes are differential in both 
cases should be interesting and potentially revealing.
3.3 Thebaine Accumulating Germplasm
The second grouping of genotypes to be considered consists of those that 
accumulate a profile of morphinan alkaloids different to wild type. These 
include a mutant P. somniferum accumulating thebaine (F075) and a P. 
somnifemm mutant accumulating thebaine and oripavine (topi) (Millgate et al., 
2004) (Figure 3.6).
3.3.1 P. somniferum Thebaine Accumulating Mutant F075
The mutant F075 accumulates thebaine (Figure 3.6) as the dominant alkaloid 
without a corresponding accumulation of oripavine that occurs in the mutant, 
topi, (see section 3.3.2). The F075 mutant was similar to a spontaneous mutant 
reported by Nyman (1978, 1980) and like the spontaneous mutant the F075 
mutant is unstable. Both Tasmanian Alkaloids Pty Ltd and I have tried 
unsuccessfully to fix the mutation by selfing mutant phenotypic individuals; each 
time thebaine individuals are selfed very few of the progeny show the thebaine 
phenotype. The phenotype does not follow simple Mendellian genetics nor even 
reproducible non-Mendelian ratios. Seed was planted from one F075 mutant line 
that accumulated thebaine but no detectable morphine, oripavine or codeine. The 
seed was grown as per Chapter 2 and a number of plants were taken through to 
the prehook stage of development before screening for progeny that expressed the 
thebaine phenotype.
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Figure 3.6: Abbreviated pathway illustrating where the two mutants discussed in 
this subchapter. The thebaine-accumulating P. somniferum accumulates only
thebaine suggesting some form of a blockage in the pathway after the production 
of thebaine. The topi mutant accumulates the morphinan alkaloids thebaine and 
oripavine. The blockages are represented by lines through the enzymatic steps. 
Adapted from Kutchan 1998.
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Figure 3.7: TLC showing the morphinan alkaloids accumulating in the latex of 
the F075 thebaine mutant compared to the control phenotype and topi mutant 
(see next subchapter 3.3.2).
Six out of a total of 160 plants tested were found to accumulate thebaine as the 
dominant morphinan alkaloid. The remaining plants were similar to the parental 
alkaloid phenotype. TLC (Figure 3.7) and HPLC (Figure 3.8) data was 
undertaken to authenticate the segregating individuals used for the microarray 
studies in the next chapter. The difficulty in obtaining a stable mutant F075 line 
hindered further work on this mutant and feeding studies, such as was undertaken 
with topi, have not been used to determine the enzymatic blockage in the 
pathway.
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Figure 3.8: F1PLC illustrating the accumulation of thebaine in the mutant F075.
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3.3.2 P.somniferum Thebaine and Oripavine Accumulating Mutant, 
topi
The second mutant of the grouping consisting of an altered morphinan profile is a 
mutant called topi. It was an EMS induced mutant isolated at Tasmanian 
Alkaloids Pty Ltd. and shown to accumulate thebaine and oripavine but neither 
morphine nor codeine (Millgate et al., 2004) (Figure 3.9). This morphinan 
alkaloid difference is further illustrated on the TLC plates (Figure 3.10). The 
mutation was named ‘topV for thebaine and oripavine accumulating poppy. A 
true-breeding homozygous topi line was developed and used for further 
characterisation of the phenotype. Two independent crosses were advanced to F2 
generations. The segregation of 375 individuals was Mendelian and consistent 
with a single gene (Table 3.2). The performance in the field revealed that there 
was no change in the total morphinan alkaloid yield of topi compared to its 
parent line C052. It was difficult to accurately determine the heterozygote 
individuals from the homozygous wildtype or mutant phenotype as morphine was
Table 3.2: Segregation data for the topi phenotype
Cross 1a Cross 2b Total
Morphine Phenotype 189 83 272
Thebaine Phenotype 81 22 103
a,bTwo separate crosses between topi and normal morphine lines 
were made and advanced to F2.
As it was not always possible to distinguish heterozygotes from 
homozygous wild type, these two categories are combined for the 
analysis. Chi squared for equality of segregation ratio in the 2 
crosses was 3.106, P between 5 and 10%, therefore acceptable that 
they represent the same genetic ratio.
Chi squared for the totals against a 3:1 ratio with Yates’ correction, 
was 0.44 (P= 0.5068) and therefore conforms to a 3:1 ratio. 
(Millgate et al., 2004)
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Figure 3.9 HPLC profile of the control phenotype a) accumulation of morphine, 
codeine and some thebaine, compared to the topi phenotype b) accumulating 
oripavine and thebaine only (Millgate et al., 2004).
produced in the heterozygotes, suggesting that the mutation is neither dominant 
nor recessive, but rather semi-dominant (Millgate et al., 2004). Topi developed 
similarly to the control parental type and only two apparent phenotypic 
differences were observed: The first being the altered alkaloid profile of thebaine 
and oripavine accumulation; and the second being the appearance of pigmented 
latex rather than the usual white colour seen in the control.
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Figure 3.10: TLC showing topi accumulating oripavine (O) and thebaine instead 
of the control phenotype of thebaine (T), codeine (C) and morphine (M). The 
standards are run on the left lane (Millgate et al., 2004).
3.3.2.1 Mutant Latex Colour Characterisation of topi
The only visible phenotypic change in the mutant was pigmented latex compared 
to the white coloured latex of P. somniferum (Figure 3.11). The latex colour 
change co-segregates with the thebaine phenotype and has become a reliable 
visual marker for the determination of this plant. HPLC analysis was undertaken 
to determine if the compound/s responsible for the colour change were 
carotenoids, in particular lycopene, a red coloured compound. The pink to 
orange colour of the latex lends itself to the possibility of a carotenoid being 
responsible as the colour absorbs around the same wavelength as the red coloured 
carotenoid lycopene. It is possible that the mutation, or a secondary mutation, 
may be perturbing the carotenoid pathway in some way. If it is a secondary 
mutation then it is tightly genetically linked to the mutation causing the alkaloid 
phenotype. While no strict quantification of this linkage is available, many 
thousands of segregants from crosses between topi and morphine poppies have 
been produced and examined at Tasmanian Alkaloids and during this study, and
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Figure 3.11: Picture of lanced mature capsules from Control (C052) and the topi
mutant illustrating the pigmented latex from the mutant. The orange coloured 
latex of the topi mutant is a reliable indicator of its phenotype (Millgate et al., 
2004).
there has never been observed a dissociation of the thebaine/oripavine phenotype 
and latex colour. If the colour is a result of the defect in morphine production it 
could reveal something about the nature of the mutation.
The coloured compound may itself be an alkaloid derivative of the thebaine or 
oripavine, which are accumulating in topi. It may be a product which is normally 
degraded or utilised but is caused to accumulate due to a direct or indirect effect 
of the topi mutation. Similarly it could be the product of a new coloured 
compound that an altered enzyme can now produce. In any case the 
determination of the coloured compound may be revealing of some aspect of the 
topi mutation or the regulation of the pathway.
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If the compound is a new alkaloid that is not normally produced in Papaver or 
any species for that matter it suggests that it is possible to mutate some of the 
enzymes in the pathway to produce and accumulate new alkaloids in opium 
poppy. There is also the possibility that the mutation has created a change in the 
transport process allowing alkaloids to be in a compartment in which they are not 
normally found allowing an enzyme to create a new coloured alkaloid.
While there is some carotenoid (possibly small amounts of the red coloured 
carotenoid lycopene) present in topi latex, it is in similar amounts in the wild 
type (C052) latex (Figure 3.12). The pigment colour eluting from the HPLC 
column at approximately the 5 minute mark; by comparison lutein eluted at 
around 12 minutes. The topi coloured product had a peak absorption at 440 nm. 
As a carotenoid control, an extract of tomato skin was extracted in the same way 
and at the same time as the latex samples. This was to show a trace for lycopene 
(Figure 3.12). Carotenoids display 3 characteristic absorption peaks at 445 nM, 
471 nM and 503 nM (Cunningham et al., 1996); the topi coloured product did 
not have this triple absorption signature suggesting that the colour is not a 
carotenoid. .
Carotenoids are sometimes found as esters and saponification of the HPLC 
extraction was undertaken to see if it is possible to release esterified xanthophylls 
that may be contributing to the latex colour of the mutant. The resulting HPLC 
trace files of the saponified samples did not reveal any esterified carotenoids in 
either the mutant topi or control C052 latex thus eliminating the possibility that 
the pigmented latex of the mutant is due to a change in carotenoid profile.
The data demonstrates that the pigmentation of the topi mutants’ latex is not 
from a carotenoid but could possibly be from an alkaloid or an alkaloid 
derivative. P. bracteatum accumulates thebaine as the dominant alkaloid and 
dry-weight yields of thebaine in the capsule have been recorded as high as 3.6% 
(Lalezari et al., 1974; Küppers et al., 1976) or even 4.5% (Corrigan and Martyn, 
1981). Triploidy-induced cultivars have reported yields as high as 8.8% thebaine 
accumulation in the whole plant in the first growing season, however this yield
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Figure 3.12: HPLC run of: a) C052 latex; b) topi latex; c) tomato skin run as a 
lycopene standard (Note the carotenoid sample is not on the same scale). 
Lycopene appears at approximately the 12-minute mark in the tomato sample. 
There is an unknown peak at around the 6 minutes mark. These peaks were not 
carotenoids and did not have the carotenoid signature three peaks.
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Figure 3.13: Protopine alkaloids are derived from (SVscoulerine, and feeding 
studies have shown incorporation of labelled protopine into rhoeadine in Papaver 
rhoeas L. (Shamma and Moniot, 1978). Figure adapted from Facchini et al., 1997 
and Facchini et al., 2000.
dropped as the plants entered their second year of growth (Milo et al., 1987). P. 
bracteatum ’s latex is also highly pigmented.
Review of the literature revealed that there are several known alkaloids that occur 
in nature to give coloured compounds. Sanguinaria canadensis L., commonly 
known as the bloodroot plant, is a member of the Papaveraceae family and its 
roots produce an intensely red-pigmented juice, attributed to the accumulation of
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the dominant alkaloids, sanguinarine and berberine. Sanguinarine is known to 
produce an intense red colour (Dostal and Slavik, 2000). Similarly, E. californica 
accumulates sanguinarine with other alkaloids in the roots, which have a 
characteristic yellow colour. There was no detectable increase in sanguinarine by 
TLC or HPLC analysis in the latex of the topi mutant as can be seen in Figures 
3.9 and 3.10 respectively.
Rhoeadine and papaverrubine alkaloids are known to be responsible for the red 
colour developed by opium when treated with strong acids (Montgomery et al., 
1983). The rhoeadine alkaloids are derivatives of the protopine alkaloid structure 
(See figure 3.13) and two separate biosynthetic routes have been proposed 
(Shamma and Töke 1973; 1975). Rhoeadine alkaloids have been found in all 
Papaver species studied to date but the type and quantity of rhoeadine alkaloids 
can vary between taxonomic sections (Montgomery et al., 1983). Table 3.3 lists 
the occurrence of various rhoeadine alkaloids in P. somniferum and P. 
bracteatum.
There are several methods of using colour-based reactions to detect thebaine or to 
differentiate thebaine from other alkaloids. These reactions usually involve 
altering the thebaine structure, require acidification and are not generally stable. 
The determination of the weak base thebaine often involves heating the sample 
with mineral acids to cleave the ether linkage, resulting in a phenolic hydroxyl 
group in position four of the morphinan alkaloid structure. This new phenol is 
amenable to the nitroso colour reaction and with the addition of 1% sodium 
nitrite solution gives a pigmented compound with an absorption peak near 450 
nM (Ikonomovski, 1981). The colour fades after 20 minutes however suggesting 
the reaction is not stable. Frohde’s reagent (0.5 gm of ammonium or sodium 
molybdate in 100 mL of concentrated H2SO4) added to thebaine gives an orange 
colour, however this reagent reacts with all of the morphinan alkaloids to give 
specific colours for the respective alkaloid (Vincent et al., 1976).
Meconic acid (Figure 3.14) is a very strong acid that has long been known to be 
in the latex of P. somniferum and its presence usually signifies the presence of the 
morphinan alkaloids (Fairbaim and Williamson 1978). This strong acid can be
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detected by spotting latex onto ferric chloride solution to yield a red-coloured 
complex. It is possible that this acid may be involved in alkaloid transport in and 
out of the latex vacuoles similar to how chelidonic acid is thought to work 
(Hauser and Wink, 1990) in trapping protoberberine and benzophenanthridine 
alkaloids in Chelidonium majus latex vacuoles. Meconic acid is possibly derived 
from chelidonic acid or synthesised from the same pathway as chelidonic acid. 
Tracer studies have suggested that chelidonic acid is derived from the 
condensation of phosphoenolpyruvate with a pentose phosphate. This in turn 
undergoes dehydration, dehydrogenation, ring closure and decarboxylation (Shen 
et al., 2001).
H O Ü C H O O C C O O H
Figure 3.14: Structures of a) meconic acid and b) chelidonic acid.
Another possible basis for the pigmented latex could be the formation of 
dimeric alkaloids that could be initiated by the high concentration of thebaine. At 
least two dimeric alkaloids have been found in P. somniferum, pseudomorphine 
or 2,2’bimorphine (Bentley and Dyke 1959) and somniferine (Figure 3.15). 
Pseudomorphine is obtained by the oxidation of two morphine molecules and has 
been isolated from latex. It is highly unlikely that this is the compound 
responsible for the pigmented colour in the topi latex as morphine has been 
shown to be absent in the mutant. While this molecule is highly fluorescent 
(Darwin and Cone, 1980) it is unlikely it is responsible for the absorbance at 
around 450 nm. Somniferine contains a thebaine and a 14-hydroxymorphinone
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Figure 3.15: Dimeric morphinan molecules that have been found in P. 
somniferum.
unit, obtained via synthesis from morphine. The linkage is found between the C- 
16 carbon of thebaine and C-7 carbon of 14-hydroxymorphinone. The methyl 
ether has also been found (Dragar and Bick, 1988). This molecule was 
specifically isolated from the Tasmanian P. somniferum cultivars.
It is unlikely that this molecule is responsible for the colour change in the latex, 
as it has been found in the latex of the control plant. Another possibility could be 
that the enzymes responsible for these dimeric morphinan alkaloid molecules 
now have more thebaine substrate available and in the right cellular compartment 
to act on. This in turn could give new dimeric thebaine compounds that are 
coloured. To determine if this is the case further work needs to be undertaken. 
This would involve using HPLC to isolate the coloured fraction from the latex 
and then purifying this to homogeneity using columns. The purified compound 
can then be subjected to GCMS techniques to determine if the compound has the 
desired molecular weight of one or any of these dimer compounds.
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Table 3.3: Rhoeadine alkaloids found in P. bracteatum and P. somniferum.
Rhoeadine
Alkaloid
TV-methyl-14-0-
demethyl-
epiporphyroxine
Papaverrubine D 
(Porphyroxine)
Papaverrubine C 
(Epiporphyroxine)
Papaverrubine E
Papaverrubine B
Glaudine
Alpinigenine
Alpinine
P. somniferum P. bracteatum Structure
+
(a,b,f)
+
(a,b)
+
(a,b)
+
(a,b)
Labels refer to references: (a)-Santavy 1970; (b)-Preininger et al., 1981; (c)-
Santavy 1979; (d)-Lavie et al., 1981; (e)-Meshulam and Lavie 1980; (f)-
Brochmann-Hanssen et al., 1968.
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3.3.2.2 Feeding Studies
[NB. This section describes experiments conducted by a collaborator in Germany. 
They are included here, rather than the introduction, to emphasise the logical and 
sequential characterisation of the mutant topi]
Professor Zenk at the Biozentrum Universität Halle, Halle, Germany, undertook 
feeding studies with the mutant topi (Millgate et al 2004). By feeding 
radiolabelled alkaloid precursors to the control C052 and the mutant topi plants it 
is expected to resolve where the blockage occurs in the pathway. By feeding 
radioactive intermediates prior to the blockage at thebaine and oripavine and 
measuring the resulting labelled end products it is expected to show which 
enzyme or enzymes are affected by the mutation. Using radioactive products fed 
to the plants after the blockage will yield the end products. If labelled 
compounds that occur before the blockage are fed to the plants then labelled 
intermediates between these precursors and the blockage should be found but not 
those occurring after the blockage.
The mutant topi had comparable activity (Table 3.4) of codeinone reductase to 
wild type poppy, C052 (Zenk, unpublished). When it was fed radiolabelled R- 
reticuline, topi accumulated label only in thebaine, whereas control poppy 
(C052) accumulated label in thebaine, codeine, oripavine and morphine. When 
fed radiolabelled thebaine, topi accumulated label only in oripavine, whereas 
control poppy (C052) accumulated label in codeine, oripavine and morphine. 
There was no difference when fed labelled codeine, both accumulating label in 
morphine. While control poppy (C052) could convert labelled oripavine into 
morphine, topi could not convert it at all. Taken together these feeding studies 
suggest a double block in the bifurcated pathway (Figure 3.6) between thebaine 
and neopinone and between oripavine and morphinone. Neopinone is not 
detected as a radiolabelled substrate as the conversion of neopinone to codeinone 
proceeds non-enzymatically (Gollwitzer et al., 1993).
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Table 3.4: Incorporation of isotopes after 
radiolabelled intermediate feeding._____
Treatment
Applied
Compound
Measured
Munich
Line
C052 topi
"H- Thebaine 33 39 23
Reticuline Codeine io 7 0
Oripavine 0 4 0
Morphine 7 19 0
Compound X 0 4 0
3h - Thebaine 35 14 20
Salutaridinol Codeine 9 6 0
Morphine 14 ll 0
l4C- Codeine 64 IO 0
Thebaine: Oripavine 0 2 5
Morphine 5 17 0
l4C-
Oripavine:
Morphine 18 7 0
3h -
Codeine3:
Morphine 21 27 26
Compound X is an unknown labelled compound seen 
on the TLC plates.
a AW treatments were left for 24hr except the 1H- 
codeine treatment which was left for 72 hours. See 
above.
As the topi phenotype is semi-dominant, the topi mutation: may be in the gene 
responsible for the demethylation of thebaine and oripavine in the 6 position; or 
it may be a gene that controls the expression of the 6-O-demethylase; or possibly, 
an altered structural or transport component preventing the substrates, thebaine 
and oripavine, arriving at the appropriate sub-cellular compartment for the 
demethylation reaction. It is possible that the same enzyme performs both 6-0- 
demethylation reactions, since both pathways from thebaine to morphine are 
similar in the reaction process except in a different order. The only enzyme 
cloned from the morphinan pathway (Unterlinner et al., 1999) is codeinone 
reductase and it has been shown to play a role in both pathways by stereo- 
selectively converting codeinone to codeine and morphinone to morphine (Lenz 
and Zenk, 1995b; Lenz and Zenk 1995c).
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3.4 Germplasm with Altered Morphinan Alkaloid Yields
The last grouping of genotypes to be considered consists of those with altered 
morphinan alkaloid yields compared to the high morphine controls. These 
include: the P. somniferum cv Marianne (low morphine); the low alkaloid 
accumulating P. somniferum mutant D205; the high total morphinan mutant P. 
somniferum, D242; and the low morphinan but high papaverine alkaloid 
accumulating, P. somniferum, D l20 (Figure 3.16).
3.4.1 P. somniferum cv. Marianne
P. somniferum cv. Marianne has been used previously in Canada for the study 
and isolation of several genes in the alkaloid pathway including TYDC (Facchini 
and De Luca, 1994), BBE (Facchini et al., 1996), 6’-<9MT, 4’-<9MT, 7VMT 
(Facchini and Park, 2003) and norcoclaurine synthase (Samanini and Facchini; 
2001, 2002). Marianne is a high oil seed and low morphine producing variety, 
with much lower concentrations of morphinan alkaloids than any commercial 
varieties grown for morphine. This characteristic probably assisted in obtaining 
regulatory permission to grow the poppy and consequently much of the early 
work on morphinan alkaloid synthesis was undertaken on this variety. However 
P. somniferum cv. C052, a high morphinan alkaloid yielding cultivar grown 
commercially in Tasmania in recent years, and the P. somniferum cv. Marianne 
can be expected to differ in pathway transcript profiles.
3.4.2 P. somniferum Low Morphine Accumulating Mutant D205
D205 is an EMS generated mutant with low morphinan accumulation. HPLC 
analysis was initially undertaken by Dr Tony Fist at Tasmanian Alkaloids Pty Ltd 
to analyse the morphinan alkaloid yields of this mutant compared to the parental 
phenotype C052 on a capsule dry weight basis. Subsequent quantification of this 
mutant has confirmed that morphine is virtually the only detectable alkaloid, and 
the dry weight yield is half that of the C052 progenitor (Table 3.1).
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Figure 3.16: Abbreviated alkaloid pathway showing the accumulating alkaloids 
in the germplasm with altered morphinan alkaloid yields. The P. somniferum 
cultivar Marianne accumulates morphine and codeine but at much lower 
quantities than does the commercial P. somniferum cultivar used as control for 
this thesis. The low morphine mutant P. somniferum D205 similarly has lower 
levels of morphine and codeine to the wildtype P. somniferum. The mutant D242 
accumulates thebaine and oripavine at higher levels than the wildtype whilst 
accumulating similar quantities of morphine and codeine. The last of the mutants 
in this chapter is that of D120 which has lower yields of morphine and codeine
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but also accumulates papaverine at much higher yields, which are usually at very 
low levels in the parental commercial P. somniferum strain. Adapted from 
Kutchan 1998.
The mutation evidently imposes a rate-limiting constraint on morphine 
biosynthesis. It could be speculated that the mutation reduces the efficiency of an 
enzymatic step or affects the transport of intermediates between cell 
compartments of between different cell types. A positive regulator of the 
pathway could have been down-regulated or knocked out completely.
3.4.3 P. somniferum High Total Alkaloid Accumulating Mutant 
D242
Another mutant to be used in the microarray analysis is D242 that has been 
shown to accumulate larger quantities of thebaine and oripavine while still 
accumulating morphine and codeine. It is difficult to illustrate this yield 
difference using TLC plates due to the difficulties of obtaining accurate quantities 
of latex (Figure 3.17). However this can be shown by using small scale trials and 
measuring the content of the morphinan alkaloids using HPLC analysis and 
comparing this to the dry weight of the capsule. Such analyses have shown D242 
accumulates 5x more thebaine and 15x more oripavine than the parental C052, 
while still accumulating similar quantities of morphine and codeine (see Table 
3.1).
This mutant has not been characterised any further than this preliminary analysis, 
and the cause of the phenotype is unknown. It is possible that a negative 
regulator of the pathway, before thebaine and oripavine accumulation, has been 
turned off or down so that it increases the flux through the pathway. The build up 
at the thebaine and oripavine step could be a compartmentalisation problem such 
that these intermediates can build up in higher concentrations but codeine and 
morphine cannot.
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Figure 3.17: TLC showing the phenotype of the high oripavine and thebaine 
mutant D242. This mutant still accumulates morphine and codeine but not to the 
same extent as the parental control, C052. The overall yield of morphine, 
oripavine, codeine and thebaine is higher for the mutant than in the parent line. 
This is not evident in the TLC however HPLC analysis undertaken by Tasmanian 
Alkaloids Pty Ltd has shown that this mutant reliably accumulates more thebaine 
(about 5x) and oripavine (about 15x) than the parental control phenotype while 
still accumulating similar quantities of morphine and codeine (see Table 3.1).
3.4.4 P. somniferum Low Morphinan Alkaloid Mutant High 
Papaverine Accumulating Mutant D120
The papaverine-accumulating mutant (D120) produced much higher 
concentrations of papaverine than is ordinarily found in the wildtype phenotype 
and there is enough produced in the latex of these mutants to visualise the 
papaverine on a TLC plate (Figure 3.18). The resulting phenotype does however 
produce lower concentrations of morphine and thebaine (Table 3.1) suggesting 
that the mutation redirects metabolites toward papaverine but does not entirely 
block the pathway to morphine. Other than HPLC and TLC analyses, no other 
characterisation has been undertaken on this mutant.
It is possible that the mutation is affecting the enzyme responsible for the
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Figure 3.18: TLC showing the accumulation of the various alkaloids in the 
papaverine-accumulating mutant D120. Papaverine (P) standard (Lane 1) runs 
much higher up the TLC plate than the other alkaloids that accumulate in the 
opium poppy. D120 (Lane 2) still accumulates thebaine, codeine and morphine 
similar to the control plant (Lane 3). Lane 4 shows the morphine (M), codeine 
(C), oripavine (O) and thebaine (T) standards from the bottom to the top of the 
TLC plate.
methylation of the intermediate (^-coclaurine, (-SyCoclaurine N- 
methyltransferase. This could be happening in a number of ways. Firstly, the 
mutation may be structural and affect the catalytic activity of the enzyme leading 
to a greater availability of (^-coclaurine for the production of papaverine and 
less substrate, (^-A^-methylcoclaurine, available for the production of the 
morphinan alkaloids. The mutation could be in a promoter region of the enzyme 
or a transcription factor affecting the amount of message and thus enzyme 
available for the reaction. The mutation could be in a transport process for either 
the enzyme or the substrate.
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3.5 Summary
This chapter has highlighted and described three groups of germplasm, which are 
to be further examined in subsequent chapters by global transcript analysis.
These genotypes differ in some aspect of alkaloid profile and include mutants, 
natural variants, a related species and a transgenic.
By using the mutagen EMS it has been possible to develop several lines of P. 
somniferum that have different morphinan alkaloid profiles. Several of the 
mutants have altered morphinan alkaloid profiles such as the mutant F075, which 
only accumulates the morphinan thebaine and the mutant topi, which only 
accumulates thebaine and oripavine. Three other mutants have been characterised 
using HPLC and TLC analysis in this thesis that include: one that produces 
papaverine in greater quantities than the parent (D120); another that has a higher 
total morphinan alkaloid yield with an increase in thebaine and oripavine 
production (D242); and a low morphinan alkaloid yielding mutant (D205). These 
mutants also include the mutant E40/41 that accumulates the benzylisoquinoline 
alkaloid reticuline and contains a blockage to the morphinan alkaloids. The 
hairpin RNAi silenced codeine reductase transgenic lines were shown to 
accumulate the same benzylisoquinoline alkaloids as the reticuline mutant 
(E40/41) suggesting that there are complicated levels of control upon the pathway 
and that much is still to be learned from studying this pathway.
The characterisation of the different germplasm using HPLC and TLC analysis 
enables us to clearly see where the blockages are occurring in the morphinan 
pathway and where there are alkaloids accumulating at much higher 
concentrations due to blockages further down the pathway.
The three groupings are intended to emphasise at a gross level in which portion of 
the morphine pathway they differ. It was necessary to characterise several of the 
mutants and the hairpin RNAi P. somniferum plants in advance of the transcript 
analysis. This initial characterisation has shown that a number of different 
perturbations can occur in the morphinan alkaloid pathway and suggests, not 
surprisingly, that there could be several layers of control operating. It was hoped 
that differential transcript comparisons across these different groupings, and the
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branchpoints they may represent,might add interpretive power to the transcript 
analyses and help eliminate inconsequential changes and highlight shared 
changes of significance. The next chapter will now follow up on this classical 
characterisation and use cDNA microarrays to determine global gene expression 
changes between the different germplasms and a control P. somniferum plant. 
Those genes showing altered expression levels will then be sequenced and further 
analysis, where possible undertaken to determine gene function.
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Chapter 4
Gene Expression Analysis Using cDNA Microarrays Of 
Germplasm With Different Alkaloid Profiles To P. somniferum
4.1 Introduction
A number of P. somniferum EMS generated mutants have been developed and 
made available by Tasmanian Alkaloids Pty Ltd. HPLC analysis was used to 
screen the M2 population for altered morphinan alkaloid profiles (Table 3.1). As 
mentioned in Chapter 1 only a few morphinan biosynthetic genes have been 
cloned, thereby limiting options for direct molecular analysis of mutants. It is 
difficult to predict whether a mutation is in: a regulatory pathway; transport 
process; structural changes in particular cell types; or in the gene coding for the 
enzyme immediately after the blockage itself. Using the combination of mutants 
and different alkaloid accumulating germplasm described in chapter three, this 
chapter will employ global transcript analyses to explore differences between the 
different germplasm and the control P. somniferum plant.
Initial analysis of the topi phenotype using 2D Gel electrophoresis has shown 
that there are more than eight regions of protein changes in the mutant’s latex 
compared to wildtype P. somniferum. These results give reason to believe that 
there would also be transcriptional changes in the mutant phenotype. It is 
anticipated that a mutational blockage will have a cascade of pleiotropic effects 
on other genes, which may include those encoding transcriptional regulators, 
transporters and enzymes. By looking at the mutant phenotype through global 
transcript analysis, and by looking for differential genes shared between the 
various genotypes, it is hoped to create a greater understanding of the morphinan 
alkaloid pathway.
Microarray analysis using cDNA clones has been selected to study the different 
germplasm. This method has been chosen due to its mass screening capabilities
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to study a large number of transcripts expressed in the poppy genome. There are 
few annotated sequences in the database from opium poppy making it difficult to 
utilise oligo arrays. By printing the cDNAs on a microarray and studying their 
relative expression levels between the topi mutant phenotype and the control 
phenotype a large amount of information can be obtained relatively quickly. 
Another advantage of this method is that the cDNAs are stored and readily 
available for subsequent sequencing and further expression studies.
The only studies of alkaloid gene expression using mutants have been in tobacco 
(Wang et al., 2000). The most recent is that of the gene family encoding arginine 
decarboxylase. Normally these genes show an increase in expression after 
removal of the floral meristem and upper leaves and stem, however the low 
alkaloid-producing mutant did not (Wang et al., 2000). It is possible that the 
mutation can affect the RNA expression of a gene involved in the morphinan 
pathway either directly, with a mutation in the promoter, or indirectly by 
affecting a regulator of the gene. Arabidopsis tt and td (Abrahams et al.,
2003a,b) mutants affecting anthocyanin [and tannins] synthesis have shown that 
the detection in changes of expression levels of one or several of the genes 
involved in anthocyanin synthesis is possible. This is important as the alkaloid 
genes may be at low levels of expression in the plant cell and by screening larger 
numbers of expressed sequences the chances of missing any lowly expressed 
genes or transcription factors can be minimised.
There is no publicly available gene library of any type from P. somniferum. 
Therefore a cDNA library needed to be produced for the microarrays. To do this 
a high yielding morphinan alkaloid inbred commercial cultivar was used for the 
source material in order to create a cDNA library enriched in morphinan alkaloid 
structural and/or regulatory genes. Several studies have shown that alkaloid 
production is highest in the plant just prior to flowering and capsule 
development, so the aerial part of the plant of this stage of development was used 
for the cDNA library synthesis. A non-subtractive library approach was taken.
A subtractive library can be useful in enhancing genes expressed at a medium 
level, but the process risks losing low copy genes. On balance it was judged
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safest to make a high quality non-subtractive library and increasing the number of 
cDNAs on the slides.
See chapter 2 for a detailed description of the development of the microarrays 
and the subsequent analysis. 17, 000 cDNA clones were selected randomly from 
a directionally cloned non-normalised cDNA library prepared from the prehook 
stage of P. somniferum (Figure 1.9). Additionally, the slides included several P. 
somniferum alkaloid gene controls, some with non-intergenic (such as the BBE 
intron) sequences and several non-poppy genes as negative controls (See 
Subchapter 4.2). No study had previously been undertaken to determine if the 
enzymes or transcript encoded by these genes would be differentially regulated in 
the mutant phenotype compared to the parent.
A high degree of rigor was applied to ail aspects of the data collection and 
statistical analysis. First, RNA was extracted from tissue and pooled from six 
plants for each of the biological replicates to ensure consistency of the biological 
material. Second, the microarray hybridisations were repeated, including 
technical replicates for each, which involved a fluorescent dye swap. Third, the 
fluorescence data derived from the microarray images were normalized using 
tRMA software (see Chapter 2.6). Normalisation of the data is used for a number 
of reasons. These include: to remove labelling differences between the two dyes; 
fluorescing differences between the two dyes; spatial biases that occur between 
spots in the middle of the slide compared to those on the outside; hybridisation 
and washing inconsistencies across the slide; and differences in spotting of the 
DNA on the slide.
This chapter will first discuss the controls printed on the array and then describe 
each mutant or treatment used in the microarray experiments. The resulting 
differentially expressed genes will be listed and several of the sets of genes will 
be sequenced and compared to the database. Again these experiments on various 
genotypes will be placed in the same groupings as listed in Chapter 3 for cross- 
referencing and comparisons of the differential genes. Their potential 
involvement in the morphinan pathway will be discussed.
I l l
4.2 Microarray Controls
Various controls were printed on the microarray slides at the same time as the P. 
somniferum cDNA library clones. They were replicated and placed at 
randomised positions. Several different heterologous alkaloid-encoding genes 
were PCR amplified for use as positive specificity controls (Table 4.1 A). These 
included: the BBE and cyp80bl coding genes from E. californica; the 6’ and 4’ 
OMT coding genes from C. japonica; and genes coding for TYDC, BBE 
(genomic and cDNA), cytochrome P450 reductase isoforms 1 and 2, and 
codeinone reductase 1.1 and 2.1 were all from P. somniferum.
These were the only alkaloid gene controls that could be obtained at the time the 
arrays were printed. These control genes are not necessarily positive controls in 
the sense that they may not be differentially expressed in the mutants and 
genotypes relative to wild type poppy, As reviewed in Chapter 1.10: BBE 
(Dittrich and Kutchan; 1991); cyp80bl; TYDC; 6' OMT; and 4’ OMT are all 
inducible upon elicitor treatment in opium poppy cell suspensions (Facchini and 
Park; 2003), while codeinone reductase is not (Huang and Kutchan; 2000). 
However even these inducible genes are not necessarily expected to be 
differential in any of the microarray experiments. Little is known about these 
genes’ expression patterns, other than their varying expression levels in root, 
stem, leaf and flower (Facchini and Park; 2003). The intergenic region of the 
BBE gene and its promoter will be beneficial as negative control in assuring us 
that genomic DNA is not contaminating the RNA used for labelling the arrays. 
The alkaloid gene controls were also used to give reference points for grid 
orientation.
P. somniferum, E. californica and C. japonica alkaloid gene controls were PCR 
amplified for printing from cDNAs cloned using primers designed to Genbank 
sequence data, except for the P. somniferum BBE full-length clone with promoter 
region, kindly provided by Professor Facchini (Facchini et. al., 1996). The 
cDNAs for Coptis japonica S-adenosyl-L-methionine: norcoclaurine 6-0
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T ab le  4.1A: T he list o f  a lkalo id  genes used  on the  m icroarray .
A lk alo id  P ath w ay  G enes A ccessio n  N u m b er R eferen ce
B B E  (E. c a lifo rn ic a ) A F 005655 H au sch ild  et. al., 1998
B B E  {P. s o m n ife ru m )  (w hole  genom ic A F 0 2 5 4 3 0 Facch in i et. al., 1996
clone includ ing  in tron)
B B E  p ro m o ter (P. s o m n ife r u m ) A F 025430 F acch in i et. al., 1996
B B E  (P. s o m n ife ru m ) A F 025430 F acch in i et. al., 1996
T Y D C  (P . s o m n ife ru m ) U 16804 M ald o n ad o -M en d o za
C y tochrom e P450 redu c tase  (C PR ) (E . U 67186
et. al., 1996 
R osco  et. al., 1997
c a li fo rn ic a )
C y tochrom e P450 reductase  Iso fo rm  1 U 67185 R osco  et. al., 1997
(P. s o m n ife ru m )
C ytochrom e P450 red u c tase  (C PR ) .
Iso fo rm  2 (P. so m n ife r u m )
6 ’ O -m ethy l transferase  (C . ja p o n ic a ) D 29811 M o rish ige  et. al., 2000
C y p 8 0 b l (E. c a lifo rn ic a ) A F014801 Pauli and  K utchan ,
4 ’ O -m ethyl tran sferase  (C. ja p o n ic a ) D 29812
1998
M o rish ige  et. ah , 2000
C o d einone  reductase  (co r 2 .1) {P, A F 108438 U n terlin n er et. al.,
s o m n ife r u m ) 1999
C odeinone  reductase  ( c o r l . l )  (P. A F 108432 U n terlin n er et. al.,
s o m n ife r u m ) 1999
T ab le  4.1 B: T he list o f  c lones used as n eg a tiv e  con tro ls on the m icro array  slides.
N egative  C on tro ls A ccession  N u m b er
B acillus T h u rin g ien sis  C ry  1 a B T  p ro te in U 89872
P hosp h in o th ric in  acety l tran sferase X I 7220
G reen  F lu o rescen t P ro te in A F 078810
H em oglob in , be ta  (H B B ) N M _ 0 0 0 5 18
B eta-g lu cu ro n id ase  (u idA ) A 00196
H y grom ycin  p h o sp h o tran sfe rase KOI 193
L uciferase X 65316
K an am y cin  (neom ycin  p h o sp h o tran sfe rase ) V 00618
B -cell recep to r A F 126021
M yosin  H eavy  C hain X 13988
M yosin  reg u la to r L igh t chain  2 M 21812
G row th  F ac to r In su lin -like X 0607868
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methyltransferase (D29811: Sato et. al., 1994) and .S-adenosyl-L-methionine: 3’- 
hydroxy-A-methylcoclaurine 4 '-O methyltransferase (D29812: Morishige et. al., 
2000) were kindly provided by Professor Sato.
Negative controls, other than the BBE promoter and intergenic regions, were 
added several times randomly across the array. These included several reporter 
genes not found in poppy and some human gene sequences (Table 4.IB). The 
inclusion of several non-poppy sequences on the array was intended to give 
confidence in the stringency of the hybridising process; they should demonstrate 
that there was no unspecific cross hybridisation. The neomycin 
phosphotransferase II (nptll) gene placed on the array will served as a non-poppy 
sequence negative control for all of the experiments except for the nptll 
containing transgenic P. somniferum plant. In this instance the nptll served as a 
positive control; it was expected to be differential in the transformed poppy. 
Other negative controls placed on the array randomly where DMSO and water 
controls to also check for blocking efficiency and unspecific hybridisation.
4.3 Reticuline Accumulating Germplasm
4.3.1 Eschscholzia californica
E. californica plants were grown under similar conditions to P. somniferum 
plants and plants were harvested pre-flowering, as close as possible to the 
equivalent stage in P. somniferum. RNA extraction and labelling experiments 
were undertaken as described in Chapter 2. Two microarray slides were used for 
the analysis. This included a technical replicate for the one biological sample. 
After analysis of these two experiments, a large number of genes (approximately 
16% of the array) were differentially expressed between the P. somniferum and 
E. californica plant materials (Figure 4.1) using the cut-off of 2. The entire set 
consisted of 2692 differentially expressed genes. Remembering that only one 
biological replicate was included in the analysis, several of the randomly spotted 
control genes were also found to be differential between the two species (Table 
4.2). These differentially expressed clones included five of the negative controls
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Figure 4.1: Graphical representation of the differentially expressed genes 
between E. californica and P. somniferum. A total of 2692 genes were 
differentially expressed (red circles). Out of this total, 1907 genes were more 
highly expressed in the E. californica plant material compared to the P. 
somniferum plant. In comparison only 785 genes were found to be upregulated in 
the P. somniferum control plant.
placed on the array. Each of these clones were spotted at least 7-8 times across 
the arrays, however only one spot for each of these cDNAs showed up as being 
differential. This was the case for controls encoding: neomycin 
phosphotransferase; Insulin-like Growth Factor; Myosin Heavy Chain, and the 
Green Fluorescent Protein. This result suggests that there must be some labelled 
transcripts with slight similarities to bind to these sequences even at the 
stringency of the hybridisation employed. It may be assumed that an increased 
number of biological replicates would have eliminated these spurious control 
results and also would have reduced the total number of differential genes.
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Table 4.2: Control genes that were found to be differential between E. californica and 
P. somniferum._________________________________________________________
Control Gene Name Accession
Number
Expression
Ratio
More Highly 
Expressed In
Bacillus Thuringiensis Cry la BT U89872 4.8 P. somniferum
protein 4.1 E. californica
3.2 E. californica
Kanamycin (neomycin V00618 3.2 E. californica
phosphotransferase)
Growth Factor Insulin-like X0607868 2.5 E. californica
Myosin Heavy Chain X13988 2.6 P. somniferum
Green Fluorescent Protein AF078810 3.5 E. californica
6’ 0-methyl transferase (C. D29811 2.5 E. californica
japonica) 3.1 P. somniferum
TYDC (P. somniferum) U16804 3.9 P. somniferum
3.3 P. somniferum
Cytochrome P450 reductase 3.0 P. somniferum
Isoform 1 (P. somniferum) U67185 2.9 P. somniferum
2.5 P. somniferum
2.5 P. somniferum
3.2 P. somniferum
BBE promoter (P. somniferum) AF025430 3.0 P. somniferum
2.8 P. somniferum
2.5 P. somniferum
The merged cells of the Table show how many replicate spots of the cDNA proved to 
be differentially expressed in the experiment. Since there were eight replicate spots of 
these controls, not all of the replicate spots were differentially expressed in the 
experiment.____________________________________________________________
Another negative control, the cDNA coding for the Bacillus Thuringiensis Cry la 
BT protein, was differentially expressed between the two species also. In this 
case three of the eight cDNAs randomly spotted on the array were differentially 
expressed. This differential expression was not found to be uniform, as two of 
the spots were more highly expressed in E. californica than in P. somniferum and 
the third cDNA spotted on the array was more highly expressed in P. somniferum 
(Table 4.2). This is further evidence that two slides were insufficient for reliable 
conclusions. One of the positive controls, 6’ 0-methyl transferase (C. japonica), 
also showed this type of differential expression where one cDNA was 
morehighly expressed in P. somniferum and the same cDNA spotted in a 
different region of the slide appeared more highly expressed in E. californica 
(Table 4.2). Another positive control, TYDC (P. somniferum), was also
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differentially expressed in this experiment (Table 4.2), however it was only one 
of the eight randomly spotted cDNAs.
Despite the limitations of the Eschscholzia experiments there are other 
indications of its general validity. Two isoforms of the Cytochrome P450 
reductase have been isolated from P. somniferum (Rosco et. al., 1997) while only 
one has been isolated from E. californica (Rosco et. al., 1997). The Cytochrome 
P450 reductase isoform 1 from P. somniferum seems to be unique in this Papaver 
species and the majority of cDNA spots of this gene (five of eight) placed 
randomly across the array were more highly expressed in P. somniferum than in 
E. californica (Table 4.2). The remaining 3 spots of this control cDNA may have 
been in a region with generally poor hybridisation. This result gives confidence 
in the arrays that detecting differentially expressed transcripts is possible even in 
an experiment where the number of replicates and experiments are fewer than 
desirable.
One anomaly that is difficult to explain is the differential expression of the P. 
somniferum BBE promoter region in half the replicate spots. Four of the eight 
genomic promoter regions spotted on the array were more highly expressed in P. 
somniferum than in E. californica (Table 4.2). This suggests that there was 
possible DNA contamination in the extracted RNA used in the experiment, from 
P. somniferum cv. C052. PCR analysis has been used to check the RNA 
extracted for this experiment using primers designed to the gene codeinone 
reductase and to the BBE promoter and neither set of primers gave a positive 
band in the RNA sample, while P. somniferum genomic DNA was positive as 
expected. Closer inspection of the BBE promoter region confirms it does not 
seem to have an internally transcribed region as there are several stop codons in 
all three frames in both directions suggesting that while an RNA transcript may 
be produced it is unlikely that functional protein is. The remaining potential 
explanation is that there is another poppy coding region with sufficient homology 
to the BBE promoter.
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4.3.2 P. somniferum Reticuline Accumulating Mutant E40/41
Plants were grown and RNA prepared for microarray experiments of the 
reticuline accumulating mutant E40/41 and the parental genotype W52-12-10 
with the same procedures and conditions detailed in Chapter 2. The experiments 
consisted of two biological replicates each with their own technical replicate.
Analysis of the microarray experiments revealed a relatively small subset of 
genes that were differentially expressed between the two cultivars (Figure 4.2). 
Only two genes were significantly under-expressed in the control W52-12-10 line 
compared to E40/41. Only 16 cDNAs were significantly under-expressed in the 
reticuline mutant compared to the parental line. The expression ratios were 
relatively low for all of the clones (Table 4.3). Only one clone, 11F5, was found 
to have a differential expression ratio greater than 2. When sequenced it was 
found to match a gene encoding a chlorophyll a/b binding protein (Light 
harvesting complex a gene 3.1). This gene encodes the LHCI-680 protein of the 
light-harvesting complex I (LHCI) (Wang et al., 1994). Such a gene is very 
unlikely to be responsible for the reticuline accumulating phenotype. It’s 
apparent differential expression is more likely a secondary effect of the mutation 
or due to another mutation in E40/41 unrelated to the reticuline accumulating 
phenotype. The differential expression ratios and resulting BLAST x values are 
listed in Table 4.3.
Several of the differential genes reticuline mutant E40/41 (11F5, 24B2, 11B2, 
153C2, 209F1 and 81A11) were homologous to photosynthetic enzymes. There 
were four differentially expressed cDNAs that (33F5, 91B6, 112B7, 27D12) had 
no substantial homology to any sequences in the NCBI databases. Two 
differentially expressed cDNAs (86B7 and 86B2) had reasonable homology to 
two different Arabidopsis clones from the database, however the Arabidopsis 
clones have no known function.
One cDNA (7E1) was homologous to the Arabidopsis nicastrin precursor which 
has a known function in Caenorhabditis elegans as a transmembrane 
glycoprotein that is part of a multimeric complex responsible for
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Figure 4.2: Graphical representation of the differentially expressed genes (red 
circles) of the high reticuline-accumulating mutant, E40/41 compared to the 
parental control W52-12-10.
intramembraneous proteolysis of proteins such as Notch/GLP-1 and beta amyloid 
precursor protein (Nishimura et al., 2000). However its role in plants is yet to be 
determined. Another interesting cDNA from these experiments is 199E8, which 
was homologous to an Arabidopsis gene with accession number AF410286. The 
Arabidopsis clone is a transporter-related cDNA that has several transmembrane 
domains and is possibly involved in the vesicular pathway of protein sorting. It 
is possible that the poppy cDNA (199E8) may be involved in determining where 
one or more of the enzymes involved in the alkaloid pathway are located. It could 
be speculated that under-expression of 199E8 in the mutant could prevent the 
enzyme 1,2-dehydro reticuline synthase to be sorted to the correct sub-cellular 
compartment and resulting in an accumulation of (5)-reticuline.
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Table 4.3: Clones differentially expressed in the reticuline mutant E40/41 compared to 
the control.
Name Expression
Ratio
Accession
Number
Description E-value
11F5 2.1 AF139465 Vigna radiata LHCII type III 
chlorophyll a/b binding protein 
(CipLhcb3) nuclear gene for 
chloroplast product.
IE-161
7E1 1.9 NP_190832 A. thaliana nicastrin precursor. IE -167
86B7 1.9 BT002529 A. thaliana putative protein 
(At3g53720) mRNA.
3E-56
199E8 1.8 AF410286 A. thaliana
At3g 14410/MLN21_19 mRNA. 
Transmembrane transporter
IE -132
24B2 1.8 AF014052 N. tabacum Mg protoporphyrin 
IX chelatase (Chi H) mRNA.
0
33F5 1.7 - No Significant hits -
11B2 1.7 Z50099 S. tuberosum mRNA for 
transketolase.
0*
86B2 1.5 NP_200634 A. thaliana expressed protein IE-77
91B6 1.1 - No Significant hits -
153C2 1.1 AF196292 Apium graveolens nonreversible 
glyceraldehyde-3 -phosphate 
dehydrogenase mRNA.
0
112B7 1.0 - No Significant Hits -
27D12 1.0 - No Significant hits -
111C7 0.9 AY093119 A. thaliana Apospory-associated 
protein c (hypothetical 35.4 kDa 
protein).
4E-52
108H11 0.8 AY099862 A. thaliana Potential 
phospholipid-transporting ATPase 
9 (ec 3.6.3.1)
0
209F1 -1.3 004687 Mesembryanthemum crystallinum 
chlorophyll a/b-binding protein.
1E -121
81 AI 1 -1.4 004687 Mesembryanthemum crystallinum 
chlorophyll a/b-binding protein.
1E-119
All values are BLAST x values except for the * 11B2 which is a tBLAST x value.
4.3.3 Hairpin RNAi Silenced Codeinone Reductase P. somniferum
Three different transgenic lines (215-1,220-1, 220-2) (Allen et al., 2004) were 
grown and RNA harvested as per Chapter 2. RNA extraction and labelling 
experiments were undertaken as described in Chapter 2. The RNA from the three 
transgenics was used as three biological replicates and for each a technical 
replicate (dye swap) was employed. This gave a total of six slides however one
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Figure 4.3: Graphical representation of the differentially expressed cDNAs in the 
transgenic codeinone reductase RNAi plants compared to the parental phenotype 
C058-34. The arbitrary cut-off of 2 was used to select the differential genes (red 
circles).
slide for the transgenic line (220-2) was lost due to a poor Cy3 labelling reaction 
and this left a total of five slides for the microarray analysis.
Analysis of the five-microarray experiments revealed a number of genes that 
were differentially expressed in the transgenic lines compared to the parental 
phenotype C058-34 (Figure 4.3). A total of 31 clones were under-expressed in 
the transgenic and 15 clones were differentially over-expressed in the mutant 
using the cut-off value of 2 (Table 4.4). All 46 differential clones were 
sequenced from both ends in duplicate and used for the BLAST analyses (Table 
4.4). A good positive control that was used in this experiment was the NPTII 
gene that was used as a selectable marker in the transformation of the RNAi-cor
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Table 4.4: Clones that were differentially expressed between the transgenic 
codeinone reductase RNAi plants and the parental phenotype P. somniferum cv.
C058-34.
Name Expression
Ratio
Accession
Number
Description E-value
12B4 3.2 - No Significant Hits -
40D12 2.9 PSAF_FLA F. trinervia photosystem I reaction 
TR centre subunit iii, chloroplast precursor
2E-59
55A5 2.7 - No Significant Hits -
34F10 2.6 - No Significant Hits -
37E1 2.4 RBS4_MES M. crystallinum ribulose bisphosphate 
CR carboxylase small chain 4, chloroplast
precursor (ec 4.1.1.39)
3E-76
30G3 2.3 - No Significant Hits -
117F9 2.3 - No Significant Hits -
30G3 2.3 - No Significant Hits -
87D1 2.2 08136 Prunus armeniaca sulfite reductase IE-150
52D5 2.2 PSU08599 P. sominiferum clone TYDC3 
tyrosine/dopa decarboxylase mRNA.
0#
218E7 2.2 - No Significant Hits -
178D6 2.2 - No Significant Hits -
90B7 2.2 - No Significant Hits -
36D3 2.1 - No Significant Hits -
98C12 2.1 - No Significant Hits -
144C8 2.1 - No Significant Hits -
132H11 2.1 - No Significant Hits -
198B12 2.1 TBB2_ARA A. thaliana tubulin beta-2/beta-3 chain. 
TH
IE-74
81H6 2.1 PSAD_CUC Cucumis sativus photosystem i reaction 
SA center subunit ii, chloroplast precursor
(photosystem i 20 kda subunit)
8E-83
110C10 2.1 - No Significant Hits -
210D2 2.1 - No Significant Hits -
218C4 2.1 - No Significant Hits -
63E10 2.1 - No Significant Hits -
115E11 2.1 - No Significant Hits -
52H3 2.1 Q9XQB1 Phaseolus aureus (mung bean) lhcii 
type iii chlorophyll a/b binding protein.
IE -124
96B2 2.1 - No Significant Hits -
19C10 2.0 - No Significant Hits -
38A12 2.0 - No Significant Hits -
38D10 2.0 - No Significant Hits -
112E5 2.00 - No Significant Hits -
152H6 2.00 - No Significant Hits -
198C10 -2.0 - No Significant Hits -
88F4 -2.1 Q8S4F6 A. thaliana sulfolipid synthase 
(hypothetical protein at5g01220).
IE-65
77D7 -2.1 CB12_LYC
ES
Lycopersicon esculentum chlorophyll a- 
b binding protein 7, chloroplast 
precursor
1E -119
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CD3 -2.1 V00618 Kanamycin (neomycin 
phosphotransferase)
X
110E3 -2.2 Q40185 Lemna gibba light-harvesting 
chlorophyll a/b protein precursor.
IE -129
161D8 -2.2 Q9SVW8 A. thaliana hypothetical protein. 9E-59
196A10 -2.2 Q9XQB6 P. aureus chlorophyll a/b-binding 
protein cp24.
1E -118
C14 -2.2 V00618 Kanamycin (neomycin 
phosphotransferase)
X
198H12 -2.2 Q9XQB2 P. aureus chlorophyll a/b binding 
protein cp29.
IE-130
198G11 -2.2 - No Significant Hits -
86D12 -2.3 METE_CAT C 5- 1E -110
RO methyltetrahydropteroyltriglutamate— 
homocysteine methyltransferase (ec 
2.1.1.14)
83H3 -2.4 PSBO_LYC L oxygen-evolving enhancer protein 1, IE -102
ES chloroplast precursor (oeel)
198C8 -2.4 AB027001 N. paniculata plastidic aldolase 1. 1E -137
CE12 -2.6 V00618 Kanamycin (neomycin 
phosphotransferase)
X
37E12 -3.5 CB24_TOB N. tabacum chlorophyll a-b binding IE-123
AC protein 40, chloroplast precursor (lhcii 
type i cab-40) (lhcp).
# This is the BLAST n value for this cDNA as it was almost an exact match at the
nucleotide level to the TYDC entry listed beside it. The + and -  represent the 
direction of the differential expression in the experiment. + represents the clone was 
differentially underexpressed in the cor hairpin RNAi plants compared to the non 
transformed wildtype plant C052. -  represents the clone was differentially 
overexpressed in the cor hairpin RNAi plants compared to the non transformed 
wildtype plant C052. X-represents sequence identity of an already known gene.
NB: the entire set of differential genes for this experiment are listed, using a 
differential cut-off of 2. None of the possible homologous clones have been 
removed.
construct. The NPTII gene was differentially expressed between the parental 
phenotype and the transgenic lines with a greater than two fold increase in 
expression. While this is a good positive control it is still lower than one would 
expect possibly due to low expression of the NPTII transgene (kanamycin 
neophosphotransferase II gene, V00618) or the expression of genes in the poppy 
of similar nucleotide sequence.
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There are many differential clones in this set, which have no significant 
homology in the database and deserve further attention beyond this thesis. 
Because the transgenic comparison is virtually isogenic, these differentially 
expressed genes are candidates for being affected directly or indirectly by the 
silencing of codeinone reductase and the accumulation of (Sfreticuline (see 
further discussion in Chapter 5).
4.4 Thebaine Accumulating Germplasm
4.4.1 P. somniferum Thebaine Accumulating Mutant F075
Microarray experiments were undertaken on pooled RNA from three of the six 
plants with the thebaine phenotype for the first biological replicate. The 
remaining three F075 thebaine phenotype plants were then pooled for the second 
biological replicate. In both cases a dye-swapping technical replicate was 
included, giving a total of four microarray experiments for the F075 mutant.
Microarray hybridisation results and analyses revealed a set of 46 genes that were 
differentially expressed between the parental control and the F075 mutant (Figure 
4.4) using the expression ratio cut-off of 2. All of the significantly differentially 
expressed genes were found to be under-expressed in the F075 mutant compared 
to the parent. Several genes were differentially over-expressed in the mutant 
F075 compared to the parental wild-type plant however these cDNAs differential 
expression ratios were substantially lower than the cut-off of 2.
The differentially expressed genes in the F075 were sequenced in the 3’ to 5’ 
direction and BLAST x values are listed in Table 4.5.
One cDNA, 20A7, was a shared differential with cv. Marianne (see section 
4.5.1). This gene had no significant hits in the database and may warrant further 
attention.
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Figure 4.4: Graphical representation of the differentially expressed genes in the 
F075 mutant. A 2-fold expression differential was used as the cut-off. The red 
circles show the genes that were differentially down regulated in the F075 
mutant.
Interestingly six cDNAs (156F9, 33H5, 71G5, 145E11, 46A6, 33F11) had similar 
BLAST x values to a tobacco P450-like enzyme in the database (Figure 4.5).
This set of genes were not found to be differentially expressed in the topi mutant 
(see section 4.4.2) suggesting the possibility that these cDNAs are specifically 
associated with the thebaine accumulating phenotype but not the thebaine plus 
oripavine phenotype. It is thought that the plant enzyme responsible for the 
demethylation reactions of thebaine are P450s since mammalian liver P450 
enzymes have been found which perform the demethylation of thebaine in vivo 
and in vitro (Kodaira and Spector 1988).
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Table 4.5: Genes that were differentially expressed between the F075 thebaine 
accumulating mutant and the control C052. All of the genes were more highly expressed 
in the control than in the mutant. NB the entire set of differential genes is listed here. 
None of the possible homologous clones have been removed.________________________
Name Expression
Ratio
Accession
Number
Description E-value
27D12 10.2 - No Significant Hits -
91G3* 9.0 AY372539 A. thaliana signal recognition particle 
receptor-like protein 
(at4g30600/fl 7i23_60).
1E-153
111C7 8.8 AY093119 A. thaliana apospory-associated protein c 
(hypothetical 35.4 kDa protein).
4E-52
91B6 8.7 - No Significant Hits -
108H11A 8.3 AY099862 A. thaliana potential phospholipid-
transporting ATPase 9 (ec 3.6.3.1)
0
156F91* 7.9 AF389267 Glaucidium palmatum  26S ribosomal 
RNA gene, partial sequence
1E-178
151H8 7.7 - No Significant Hits -
28G4 7.7 AF133291 Rhizoctonia solani virus putative capsid 
protein mRNA, complete cds
6E-77
33H5t 7.6 AF389262 Dicentra eximia 26S ribosomal RNA 
gene, partial sequence.
IE-130
83G7 7.1 AY372539 A. thaliana signal recognition particle 
receptor-like protein 
(at4g30600/fl 7i23_60).
1E-153
71G5t 7.0 AF389267 Glaucidium palmatum 26S ribosomal 
RNA gene, partial sequence.
0
83F5* 6.8 AY372539 A. thaliana signal recognition particle 
receptor-like protein 
(at4g30600/fl 7i23_60).
1E-153
157C4 6.8 AB050471 A. thaliana phosphoenolpyruvate 
carboxykinase [atp] (ec 4.1.1.49) 
(pepck).
IE-164
221C9 6.6 AF419301 Securigera parvißora. Aspartate 
aminotransferase (fragment).
2E-54
52F2A 6.3 AY099862 A. thaliana potential phospholipid-
transporting ATPase 9 (ec 3.6.3.1)
0
91E9* 6.2 AY372539 A. thaliana signal recognition particle 
receptor-like protein 
(at4g30600/fl 7i23_60).
1E-153
54F9 5.8 - No Significant Hits -
116D7 5.1 BT002807 A. thaliana psi type ii chlorophyll a/b- 
binding protein, putative.
6E-95
112B7 4.4 - No Significant Hits -
83E5 4.3 AF258810 Lycopersicon esculentum aldehyde 
oxidase (A03) mRNA, complete cds
1E -157
148A9 3.6 - No Significant Hits -
145E1 I t 3.6 AF389270 Xanthorhiza simplicissima 26S 
ribosomal RNA gene, partial sequence.
0
144F10 3.4 - No Significant Hits -
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153C2 3.1 A F196292 Apium graveolens nonreversible 
glyceraldehyde-3-phosphate 
dehydrogenase mRNA.
0
186F8 2.9 AF419301 Securigera parviflora aspartate 
aminotransferase (CRAAT1) mRNA,
6E-40
147A12# 2.7 ATR506156 Amborella trichopoda chloroplast 
genomic DNA, 23S ribosomal RNA
0
46A6t 2.7 AF274639 Cercidiphyllum japonicum  26S 
ribosomal RNA gene, complete sequence
0
194D4 2.7 NPU87848 Nicotiana plumbaginifolia non- 
phosphorylating glyceraldehyde 
dehydrogenase (GapN) mRNA
0
33 F l i t 2.5 AF293760 Sanguinaria canadensis 18S ribosomal 
RNA gene, partial sequence
0
34D10 2.4 - No Significant Hits -
102D3 2.3 - No Significant Hits -
71H4 2.2 - No Significant Hits -
83H8 2 .2 - No Significant Hits -
24C1 2 .2 - No Significant Hits -
20A7 2.1 - No Significant Hits -
8 8 H8 2.1 Q40185 Lemna gibba light-harvesting 
chlorophyll a/b protein precursor.
6E-70
139A8 2.1 - No Significant Hits -
104G9 2.1 - No Significant Hits -
83H7 2.1 - No Significant Hits -
209B1 2.1 Q8L6A3 Vitis vinifera putative ribosomal protein 
19
7E-80
25D3 2 .0 - No Significant Hits -
133D7 2 .0 ATPA_
TOBAC
Nicotiana tabacum atp synthase alpha 
chain (ec 3.6.3.14).
IE -169
103B4 2 .0 Q8H694 Oiyza sativa osjnba0004i20.3 protein. 
Contains the phosphoglycerate mutase 
family phosphohistidine signature
IE-95
89C4 2 .0 Q9LDY5 A. thaliana tl0f20.17 protein (tl0o22.14) 4E-65
(putative fkbp-type peptidyl-prolyl cis-
________________________________________trans isomerase protein)_________________
* These four clones are homologous and were the same four clones that were 
differentially expressed in the topi mutant microarray analysis.
A These two clones are homologous and were the same two clones that were 
differentially expressed in the topi mutant microarray analysis.
tThe best hits for these clones were taken from the BLAST n results. All of these clones 
align to various regions of the nbosomal DNA sequence.
#This is homologous to a chloroplast 23S ribosomal gene.___________________________
The tobacco P450 clone that the translated sequences of the 6 genes aligned to 
was isolated using a synthetic oligonucleotide to the heme-binding region of the 
avocado CYP71A1 (Sugiura et al., 1996). In this work 2,4-D induced cell
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suspensions of tobacco were used to isolate Poly A" RNA to clone and express 
the coding sequence in both E. coli and Saccharomyces cerevisiae. The authors 
showed that when the microsomal located tobacco P450 was co-expression in E. 
coli and S. cerevisiae with a P450 reductase, the extracts had 7-ethoxycoumarin 
(9-deethylase activity (Sugiura et al., 1996). Without the presence of an N- 
terminal microsomal targeting sequence there was no detectable activity. 
Increased message levels of the P450-like gene could be detected by northern 
analysis when cell suspensions were induced with 2,4-D. Further to this, 
evidence was found that the enzyme was a P450 as it produced an absorbance 
spectrum of 450 nm and the enzyme was inhibited when carbon monoxide was 
introduced, a classic characteristic of a P450. Upon checking the BLAST n 
results for these differentially expressed genes I noted that all of these genes were 
highly homologous to plant ribosomal DNA sequences (Figure 4.6). Several of 
the genes gave better BLAST n hits to ribosomal DNA sequences than they did 
BLAST x values. The cDNA sequences in the 5’-3’ direction were homologous 
to the region of DNA coding for the 26S ribosomal DNA. This was perplexing, 
as the characterisation of the tobacco P450-like gene did not mention its possible 
alignment to a 26S ribosomal DNA sequence in the complementary direction. 
Further analysis of the sequence of the tobacco P450-like gene showed that it did 
indeed align to the 26S ribosomal DNA coding region in the complementary 
direction. However the entire tobacco P450-like gene did not align, as the 3’ end 
of the sequence was different to the 26S ribosomal DNA coding region (Figure 
4.7). The cDNA library was directionally cloned (See Chapter 2) but it is 
possible the genes were cloned in the wrong direction if they had a similar 
sequence at the 5’end to the adaptor or an adenosine nucleotide rich region at the 
5’ end.
Further research of the literature revealed another two genes that also code for 
functional enzymes in one direction but have very close homology to the 26S 
ribosomal DNA sequence in the reverse direction. A nuclear-targeted cDNA 
called ribin was isolated from rat using Southwestern-binding assays and was 
shown to modulate ribosomal transcription (Kermekchiev and Ivanova, 2001). 
The complementary strand of the ribin cDNA was homologous to the 26S
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Figure 4.7: Diagram illustrating the homology between the tobacco P450-like 
gene, 3’-5’ direction, and the 26S ribosomal DNA sequence, 5’-3’ direction. The 
red shaded area shows the region of homology at the 5’ end and the blue coloured 
area shows the non-homologous region. The diagram also shows where the other 
two genes, ribin and Tarlp, lie in comparison to the 26S ribosomal DNA 
sequence. Both of these genes also transcribe in the reverse direction to the 26S 
rDNA gene. The ribin gene also has a different 3’ coding region to the 26S 
rDNA.
ribosomal DNA sequence. However, the 3’UTR of the ribin protein is different 
to the rat 26S ribosomal DNA (Figure 4.7).
The other gene encoded in the 26S ribosomal region was Tarlp, Transcript 
Antisense to rDNA. This cDNA was isolated from yeast cells and its 
overexpression rescued a mitochondrial RNA polymerase mutant (Coelho et al., 
2002). This gene was different to the ribin and tobacco P450-like gene (Figure 
4.7).
This has led to several questions. Firstly is it possible to have two functional 
genes overlapping to this extent? Secondly, is the P450 a real P450 or is it a 26S 
ribosomal DNA? Thirdly, is it possible to have functional transcripts 
complementary to the 26S rDNA sequence? The evidence for the tobacco P450-
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like gene being a P450 appears to be sound, since functionality has been 
demonstrated when the cDNA was co-expression in yeast with a P450-reductase.
One problem with this gene is that, if it is a membrane-bound P450, then why 
didn’t Sugiura et al isolate the membrane-spanning coding region as well? The 
authors had to substitute a membrane anchoring coding region to the cDNA for 
its co-expression with the yeast P450-reductase system. Also, there was no 
mention of complementarity to the 26S rDNA and there have been no further 
follow-up publications. This suggests that either the gene analysed was not a 
P450 and follow up work was unrewarding, or the complementarity of the gene to 
26S ribosomal DNA sequence has made it difficult to clone the genomic version. 
Since there are many copies of the ribosomal genes it may be that only one has 
acquired the enzyme functionality in the complementary strand; the strong 
residual homology to the other ribosomal genes would make it very difficult to 
clone the enzyme-encoding version. The 3’ region of the tobacco P450-like gene 
has a very different coding region and if this was present in the 26S rDNA 
sequence it would more than likely lose ribosomal function.
It is now well established that the chloroplast genome has genes nested within 
genes and that the complementary strand can encode different genes (Rasmussen 
et al., 1984). A recent study in yeast has found that 2% of the yeast genome can 
contain new gene transcripts that are transcribed from genes nested within larger 
open reading frames on either the same or complementarystrands (Kumar et al., 
2002). The occurrence of exons within introns is also now known with several 
‘accidental’ discoveries of these genes. The Tau gene of humans contains a 
regulatory sequence within its intron that Tau exon-10 expression is dependent 
upon (D’Souza and Schellenberg, 2002). A conserved intronless gene, C18orf2, 
has been found nested within the GNAL gene on chromosome 18p 111 in humans 
(Vuoristo et al., 2001).
In plants the nuclear encoded 26S rDNA sequence is part of a larger DNA unit 
that encodes the 18S, 5.8S and 26S rDNAs in that order (Figure 4.8). The larger 
nuclear ribosomal DNA unit is repeated many thousands of times in higher plant 
genomes. This sequence is highly conserved across species. The 26S rDNA
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coding region is the least variable and the 5.8 and 18S rDNAs are more variable. 
Separating each of the rDNA sequences is a more variable region (variable in 
comparison to the rDNA sequences but still highly conserved) called the internal 
transcribed spacer (ITS). Many studies have used this conservation as a means of 
establishing relatedness between closely related taxa (Baldwin 1992). With so 
many copies of this rDNA unit in the plant genome it is possible that mutation 
has occurred in one or a few copies resulting in new or altered functions. It is the 
rRNA that affects translation of protein, not a translated protein of this RNA.
The peptidyl transferase reaction still takes place in E. coli when the 5OS subunits 
were treated with proteinase K and SDS, which cleaves and denature proteins 
respectively (Noller et aL, 1992).
It is likely that there are genes transcribed on the complementary strand of 
particular member of the rDNA cluster such as the Tarlp gene, however the 
poppy cDNAs isolated from the microarray study that have homology to the 26S 
rDNA sequence in the complementary strand, all contain a stop codon 
approximately 22 codons in from the start methionine when aligned with the 
tobacco P450-like gene. It is possible that these cDNAs on the array are true 
ribosomal RNAs
Figure 4.8: Illustration of the nuclear ribosomal DNA sequence. The ETS 
represents the external transcribed spacer that has the highest sequence variation 
in the ribosomal DNA sequence. The internal transcribed spacer regions (ITS1 
and ITS2) are the next most highly variable sequence in the ribosomal DNA 
sequence. The arrow shows the direction of transcription of the ribosomal RNA. 
The order of the rDNA in plants is 18S, 5.8S and 26S. The S is a measure of the 
ribosomal RNAs size.
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33 H5 1353 « 2593
156 F9 1352 « 2567
71 G5 1352 «2593
145E1 1 465 «2792
46 A6 1 « 1861
,2500 bp
Figure 4.9: Alignment of the 5 separate 26S rDNA cDNAs that were 
differentially expressed in the F075 mutant microarray experiments. All of the 
cDNAs except for 145E11 had a Poly A1 tail at the 5’ end of the 26S rDNA 
sequence. The green line indicates the homology between the sequences. The 
narrower the green line the better the homology between the different 26S coding 
DNA sequences. For example at the 500 bp region the differences can be 
attributed to the Poly A' tail that has been left on the genes. Appendix 6 contains 
the actual nucleotide alignments.
that have been reverse transcribed within the cDNA library. The isolation of the 
Poly A mRNA for the cDNA library was undertaken using the Promega Poly A 
mRNA beads purification system from total RNA isolated from P. somniferum 
(Chapter 2.2). Ribosomal RNA does not have a Poly A' tail and the P. 
somniferum cDNA library was reverse transcribed using an oligo dT primer on 
Poly A' mRNA (Chapter 2.2). The P. somniferum 26S rDNA coding cDNAs that 
have been sequenced from the thebaine-accumulating microarray experiment all 
contained, except for 145E11, a Poly A' tail. Further to this the total RNA 
isolated for labelling of the probes for the microarray experiments was treated 
with RNase H to degrade any RNA after the labelling process, which again used 
an oligo dT primer to the Poly A1 tail. This is suggestive that either there was 
aberrant ribosomal RNA labelling with Poly A , which has been reverse 
transcribed, cloned and then printed upon the array or that there are genes that are 
transcribed and possibly functional with homology to the 26S ribosomal DNA. 
The microarray experiments of the thebaine-accumulating mutant are the only 
experiments in which the five 26S rDNA cDNAs are differentially expressed.
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The potential significance of this result is underscored by all four cDNAs being 
consistently under-expressed in the thebaine-accumulating mutant.
The five cDNAs are not to identical regions of the 26S rDNA sequence, however 
they do share one region of homology to the 26S rDNA sequence (Figure 4.9). It 
is possible that there is a gene transcribed from the reverse strand of one copy of 
poppy 26S rDNA and it is contained within this region of homology or that there 
is an alternate gene in the poppy that is expressed that has high homology to this 
region. There still remains the question as to why this expressed gene is 
consistently under-expressed in the thebaine-accumulating mutant.
Transcription of the gene could be authenticated on a Northern blot using single 
stranded RNA probes for the complementary strand of the 26S rDNA-coding 
region. The use of Poly A* mRNA on the Northern could be used to enhance the 
results. However the presence of the cDNA with a Poly A tail and the fact that 
RNA is labelled by the microarray labelling process and presents a differential 
expression between the mutant and the parent cultivar indicates that there is 
transcription of this gene taking place.
Further work needs to be undertaken to isolate this gene and to test its function in 
the plant. One way to do this would be to try transforming P. somniferum with 
part of the sequence in an inverted repeat RNAi silencing construct. However it 
may not be possible to obtain transformed plants as the inverted repeat construct 
would also knock down transcription of the 26S ribosome. This would more than 
likely be deleterious to the plant as the inverted repeat technology is not strand 
specific and the 26S ribosome is essential as part of the transcription machinery.
Another way to find the gene encoding this message is to probe the cDNA library 
with the region of homology between the cDNA clones; the set of hybridising 
clones would be sequenced and screened to find one, which can be translated to a 
functional protein. Using a differential library between the thebaine-accumulating 
mutant and the P. somniferum parent lines could enhance success. The problem 
with these experiments is the large number of 26S ribosomal coding regions 
present in the genome.
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Mutant F075 has considerable potential as a tool for deciphering the complexities 
of the morphinan alkaloid pathway. However the major shortcoming of F075 is 
that pure breeding lines cannot be obtained. Because the frequency of plants with 
the thebaine phenotype are rare in seed populations, it is difficult to acquire 
enough material for molecular analysis. It is possible that it is a chromosome 
rearrangement that is unstable rather than a simple point mutation causing the 
phenotype.
4.4.2 P.somniferum Thebaine and Oripavine Accumulating Mutant,
topi
The differentially expressed genes for the topi microarray experiments are 
presented in Table 4.5. This set of experiments utilised a total of 12 microarray 
slides. This included 6 biological replicates, with each biological replicate 
consisting of RNA extracted from pooled material from 6 plants. Each of the 
biological replicates consisted of one dye swap each to give the total of twelve 
microarray slides. The large number of biological replicates yields a much greater 
statistical significance upon the resulting clones that are found to be differential 
between the mutant topi and the control P. somniferum. All of the 14 clones were 
differentially under expressed in the mutant compared to the control and no genes 
were found to be statistically significantly upregulated in the mutant (Figure 
4.10).
Removal of the redundant clones from the set of 14 cDNAs that were 
differentially expressed in the topi experiments left a subset of 10 different 
cDNAs (Table 4.6).
Six of the ten clones showed very high sequence homology to known genes in the 
database of different species (Table 4.6). The most notable of these were four 
clones (83G7, 91E9, 91G3, and 91C9) that showed very high homology to the 
Arabidopsis thaliana signal recognition particle receptor-like protein (SRPR) 
(atg30600/fl7i23_60) (Figure 4.11). These four clones are not full length to the 
coding region of the SRPRS in the database and are missing the 3’ and 5’ UTR
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8 10 12 
Level Of Expression
Figure 4.10: Graphical representation of the analysis of the 12 microarray slides 
from topi compared with the C052 control. The 14 differentially expressed 
genes are each represented by an x. A positive expression ratio shows the genes 
were differentially downregulated in topi compared to the control plant (Millgate 
et aL, 2004).
regions. The nucleotide alignment for these four clones (Figure 4.12) were the 
same indicating they are cDNAs from the same gene, or members of the same 
multigene family. The srpr protein is part of an oligomeric complex known as the 
signal recognition particle that mediates targeting and insertion of the signal 
sequence of exported proteins into the membrane of the endoplasmic reticulum.
Two clones 52F2 and 108H11 had homology to the A. thaliana potential 
phospholipid-transporting ATPase 9 (EC 3.6.3.1) (Figure 4.13) otherwise known 
as an amino phospholipid flippase 9. These ATP-dependent translocators 
(flippases) control transmembrane lipid asymmetry. The nucleotide alignment of 
these two clones (Figure 4.14), however showed that they are almost identical, 
except for clone 108H11, which contains an extra 130 nucleotides 323 bp from 
the start of the sequenced cDNAs. This may be the result of an unexcised intron
137
T ab le 4.6: Possib le  function  o f  the  14 cD N A  clones found  to be d iffe ren tia lly  
regu la ted  be tw een  C 052 and  to p i  (M illga te  et al., 2004).
C lone
cD N A
Size
N u m b er
o f
cop ies
A rray
E xp ression
R atio
D escrip tion  
B est H it b last X E -va lu e
116D7 1098 1 7.9 A. tha liana  psi type  ii 
ch lo rophy ll a /b -b in d in g  
p ro te in , pu tative .
6E-95
91G 3 2152 4 5.1 A. tha liana  signal 
reco g n itio n  p artic le  recep to r-
like p ro te in
(a t4 g 3 0 6 0 0 /fl 7i23_60).
IE -1 5 3
27D 12 498 1 4.7 N o  sign ifican t hits. -
157C4 2402 1 4 .4 A. tha liana  
ph o sp h o en o lp y ru v a te  
ca rb o xyk inase  [atp] (ec 
4 .1 .1 .4 9 ) (pepck).
IE -1 6 4
91B 6 527 1 4.4 N o  sign ifican t hits. -
54F9 144 1 3.9 N o sign ifican t hits. -
52F2 2015 2 3.6 A. tha liana  P o ten tial 
p h o sp h o lip id -tran sp o rtin g  
A T P ase  9 (ec 3 .6 .3 .1)
0
221C 9 995 1 3.4 S ecu rigera  p a rv iflo ra . 
A sparta te  am in o tran sfe rase  
(fragm ent).
2E -54
151H8 785 1 2.9 N o  sign ifican t hits. -
111 C7 913 1 2.7 A. tha liana  A pospory- 
assoc ia ted  p ro te in  c 
(hypo the tica l 35 .4  kD a 
p ro te in ).
4E -52
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Previous Table 4.6: The complete set of non-redundant differentially expressed genes 
in the topi mutant including identified genes and unidentified genes, the latter based 
on E values greater than E'50. The table lists: clone identification (Clone Id); number 
of redundant genes (Number of Copies); accession number (Accession); gene name 
from BLAST x results (Description) and E values are shown, a. The E-value is the 
score calculated by NCBI BLAST x searches, b. The Microarray Ratio is the 
normalised ratio value (see Chapter 2.6) compared to the control P. somniferum. A 
positive value reveals higher expression in the control (reference sample) than in topi 
(test sample).
or there is more than one copy of the gene present. Several sets of primers were 
tried to differentiate between the two clones, 52F2 and 108H11, however 
multiple bands were obtained when primers to either gene were used. It is 
possible there is a gene family of varying sizes or that post-transcriptional 
modification, for example intron removal, may be taking place giving different 
length transcripts. As it was not possible to design quantitative real time PCR 
primers to distinguish between the two, this clone was not authenticated using 
qRT-PCR. Clone 153C2 was similar to the NADP-dependent glyceraldelayde-3- 
phosphate dehydrogenase (EC 1.2.1.9). Other clones with homology to genes of 
known function were: 157C4 (A. thaliana phosphoenolpyruvate carboxykinase 
(pep carboxykinase EC 3.4.24)); and 221C9 (Securigera parviflora aspartate 
aminotransferase). Several other clones had sequence homology, however these 
were to sequences of unknown function. QRT-PCR analysis was used to further 
authenticate the non-redundant set of 10 genes/alleles.
It is possible that by using an array prepared from RNA of specialised cells, such 
as from the latex, the array may have been enhanced for alkaloid genes. For 
example many photosynthetic genes would have been eliminated. However it 
was judged necessary to use the whole above ground plant for the experiments 
because the evidence suggests cells neighbouring the laticifers are important sites 
for the transcripts and biosynthesis (Bird et al., 2003 and Weid et al., 2004).
Many of the genes involved in alkaloid synthesis are possibly expressed in sieve 
element companion cells or phloem parenchyma. Further the use of the parent
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Oryza
Arabidopsis
Cucumis
Papaver
MLEELLIFTRGGLILWSSCRALGGAALKGSPIDALIRSCLLEERSADASFSQDT---
MLEQLLIFTRGGLILWT-CKEIGN-ALKGSPIDTLIRSCLLEERSGAVSFNYDAPGA
MLEQLLIFTRGGLILWT-CKELGN-ALKGSPIDTLIRSCLLEERSADSSYHYEAPGA
Cons ■
Oryza
Arabidopsis
Cucumis
Papaver
-YALKWTFNNDLGLVFVAVYQRMLHLLYVDDLLAAVRKEFSQIYDPKRTSYDDAFNE 
AYTLKWTFHNDLGLVFVAVYQRILHLLYVDDLLSMVKQSFSEVYDPKRMAYDD-FDE
AYTLKWTFNNDLGLIFVAVYQKILHLLYVDDLLSMVKKQFSDIYDPKRTKYYD-FDD
Cons ■ ■ ■ ■ I M  m
Oryza
Arabidopsis
Cucumis
Papaver
VFRQLHLEAEARSEEMKKNKQVTGSRPTKVTTKTNRGDTQGSGGGRK---KGDSGKD
TFRQLRIEAEARAEELRKTKQVGK-PVTSVKKQGQVSKPGLEGGNKRVSSEGGSKKD
VFRQLRNEVEARAEELKKSKQVGRCAPVGLGK§--KGGHQLNQMESR MGIALAK
Cons
Oryza
Arabidopsis
Cucumis
Papaver
DSDG - DSGKEHTLPNGNSf - JlQENSLKDNSHARSVWKGKENGDPNDGAFDVNKLQK 
DGDGGNKAKVSTLTNGHs|--pNHQMEDDSQETNDLANGKENTSS!f-|AVDLSKLQK
MAG--IVILQKTIRRMETLLFIKTGLKRMLLLIIIIIKRIE---- IL§AFDVNKLLK
Cons
Oryza
Arabidopsis
Cucumis
Papaver
MRNK...... SNKKNEVASNVAKNTSKANTKKf-LKKNRVWDDTPDDKKKLDFTDPA
LRSKGVRGRGGVRKTD- -SIGNKSSKVAEPAKKATKKNRVWDDAAPKQSKLDFTDSI
LRSK------ GAKKQE-- jSVVTKAPPKAEPKKKATKKNRVWDDSPPE-TKLDFADPV
Cons b  w m m m m  mmmmm
Oryza
Arabidopsis
Cucumis
Papaver
DERGDEV - IDQVWKQGESMMDKDDWSSDSDEEEEDijjH f NSGASQKKKGWFSS
DENGNNDHVDIVAADQGESMMDKEEVFSSDSESEDDDEPGS-DEKPAQAKKKGWFSS
------------------------- ------- -------------- ADAKKKGWFSS
DDRGIED-MEWTENHGESMMDREEVFSSDSESEEEEDDVAGKDPKIDEKRKGWFSS
Cons . * ; ***** *
Oryza
Arabidopsis
Cucumis
Papaver
MFKSIAGNNVLEKSDIQPALKALKDRLMTKNVAEEIAEKLCESVAASLEGKKLGSFT
VFQSITGKANLERTDLGPALKALKERLMTKNVAEEIAEKLCESVEASLEGKKLSSFT
MFQSISGKASLDKADLEPALKALKDRLMTKNVAEEIAEKLCESVAASLEGKKLASFT
MFQSIAGKANLEMSDLEPALKALKDRLLTKNVAEEIAEKLCESVAASLVGKKLASFT
Cons .*.**.*. *. .*. *******.**.**************** * * * * * * * * * *
Oryza
Arabidopsis
Cucumis
Papaver
RISSTVQTAMEEALLRILTPRRSIDILRDVHAAKERGKPYVIVFVGVNGVGKSTNLA 
RIS STVQAAMEDALVRILTPRRSIDILRDVHAAKEQRKPYVWFVGVNGVGKSTNLA 
RISSTVQAAMEEALVRILTPRRSIDILRDVHAAKEQKKPYVWFVGVNGVGKSTNLA 
RVSSTVQAAMEDALVRILTPXXSIDVLRDVHAAQEQGRPYVITFVGVNGVGKSTNLA
Cons .★★★. ^**************
Oryza
Arabidopsis
Cucumis
Papaver
KVAYWLLQHNLSVSLAACDTFRSGAVEQLRTHARRLQIPIFEKGYEKDPAWAKEAI
KVAYWLQQHKVSVMMAACDTFRSGAVEQLRTHARRLQIPIFEKGYEKDPAWAKEAI
KVAYWLLQHKVSVMMAACDTFRSGAVEQLRTHARRLQIPIFEKGYEKDPAWAKEAI
KIAYWLQQHNISVMMAACDTFRSGAVEQLRTHARRLQIPIFEKGYEKDPAWAKEAI
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Cons
Oryza
Arabidopsis
Cucumis
Papaver
C o n s  * * * . * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Oryza
Arabidopsis
Cucumis
Papaver
C ons
Oryza
Arabidopsis
Cucumis
Papaver
C ons
TDLKKLNVKSIVKTLLK 
TDLKKLNVKAIVKTLLK 
TDLKKLNVKSIVKTLIK
■
■KFNQKLADLSAVPTTRLIDGILLTKFDTIDDKVGAALSMVYISGAPVMFVGCGQSY
1KFNQKLSDLSTSGNPRLIDGILLTKFDTIDDKVGAALSMVYISGSPVMFVGCGQSY
IKFNQKLADLSTSPEPRLIDGILLTKFDTIDDKVGAALSMVYISGAPVMFVGCGQSY
IKFNQKLADLSNSPSSRVIDGIVLTKFDCIDDKVGAALSMVYISGAPVMFVGCGQSY
QEATRNKSDWLVDTAGRMQDNEPLMRALSKLINLNSPDLVLFVGEALVGNDAVDQL 
QEATRNGSDWLVDTAGRMQDNE P LMRALSKLINLNQPDLVLFVGEALVGNDAVDQL 
QEASRNGSDWLVDTAGRMQDNEPLMRALSKLINLNSPDLVLFVGEALVGNDAVDQL 
QEASRNGSDWLVDTAGRMQDNEPLMRALSKLISLNSPDLVLFVGEALVGNDAVDQL
Figure 4.11: The translated alignment of the poppy clone 83E5 with three signal 
recognition particle receptor proteins from the NCB1 genbank database.
Sequence homology is represented by the colour code- JlAD AVG Go o d  
Oryza: putative signal recognition particle receptor [Oryza sativa (japonica 
cultivar-group)]. Accession number: BAD09759.
Arabidopsis: signal recognition particle receptor alpha subunit family protein 
[Arabidopsis thaliana]. Accession number: NP_194789.
Cucumis: signal recognition particle receptor protein [Cucumis sativus]. 
Accession number: AAQ76042.
Papaver. Clone 83E5 from the topi microarray results.
T-COFFEE, Version_1.41 was used for the amino acid alignments (Notredame et 
al., 2000).
plant C052 to generate the cDNA for printing the microarrays may impose a bias 
in certain circumstances, e.g. if the gene of interest have been upregulated in the 
mutant phenotype and is normally not expressed in the control C052, the gene 
will not be found using the array. Several cloned morphine associated genes; 
TYDC, cyp 80b 1, berberine bridge enzyme and codeinone reductase, did not 
show any differential expression between topi and its parent across the 12 slides 
(data not shown).
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1
8 3 F 5 ( 1 )
8 3 G 7 ( 1 )
9 1 E 9 ( 1 )
91 G3 ( 1 )
8 3 F 5 ( 5 1 )
8 3 G 7 ( 5 0 )
9 1 E 9 ( 5 0 )
91G3 ( 5 0 )
8 3 F 5 ( 1 0 1 )
8 3 G 7 ( 1 0 0 )
9 1 E 9 ( 1 0 0 )
91G3 ( 1 0 0 )
8 3 F 5 ( 1 5 1 )
8 3 G 7 ( 1 5 0 )
9 1 E 9 ( 1 5 0 )
91 G3 ( 1 5 0 )
8 3 F 5 ( 2 0 1 )
8 3 G 7 ( 2 0 0 )
9 1 E 9 ( 2 0 0 )
91 G3 ( 2 0 0 )
8 3 F 5 ( 2 5 1 )
8 3 G 7 ( 2 5 0 )
9 1 E 9 ( 2 5 0 )
91G3 ( 2 5 0 )
8 3 F 5 ( 3 0 1 )
8 3G 7 ( 3 0 0 )
9 1 E 9 ( 3 0 0 )
9 1 G 3 ( 3 0 0 )
8 3 F 5 ( 3 5 1 )
8 3G 7 ( 3 5 0 )
9 1 E 9 ( 3 5 0 )
91G3 ( 3 5 0 )
8 3 F 5 ( 4 0 1 )
8 3 G 7 ( 4 0 0 )
9 1 E 9 ( 4 0 0 )
91G3 ( 4 0 0 )
8 3 F 5 ( 4 5 1 )
8 3 G 7 ( 4 5 0 )
9 1 E 9 ( 4 5 0 )
91 G3 ( 4 5 0 )
8 3 F 5 ( 5 0 1 )
8 3G 7 ( 5 0 0 )
9 1 E 9 ( 5 0 0 )
91 G3 ( 5 0 0 )
8 3 F 5 ( 5 5 1 )
8 3 G 7 ( 5 5 0 )
9 1 E 9 ( 5 5 0 )
91G3 ( 5 5 0 )
8 3 F 5 ( 6 0 1 )
8 3 G 7 ( 6 0 0 )
9 1 E 9 ( 6 0 0 )
91G3 ( 6 0 0 )
GCTTCATTCCATCCTACACCCACCACCACCACCACTAACACGCATATACT 
-CTTCATTCCATCCTACACCCACCACCACCACCACTAACACGCATATACT 
-CTTCATTCCATCCTACACCCACCACCACCACCACTAACACGCATATACT 
-CTTCATTCCATCCTACACCCACCACCACCACCACTAACACGCATATACT 
5 1  1 0 0
ACACCACCCAATTCTCAGGTTAAGGTTTTGGATAATCGAAAATGTTAGAA 
ACACCACCCAATTCTCAGGTTAAGGTTTTGGATAATCGAAAATGTTAGAA 
ACACCACCCAATTCTCAGGTTAAGGTTTTGGATAATCGAAAATGTTAGAA 
ACACCACCCAATTCTCAGGTTAAGGTTTTGGATAATCGAAAATGTTAGAA 
1 0 1  1 5 0
CAATTACTGATTTTTACTAGAGGGGGATTAATTTTATGGACCTGTAAAGA 
CAATTACTGATTTTTACTAGAGGGGGATTAATTTTATGGACCTGTAAAGA 
CAATTACTGATTTTTACTAGAGGGGGATTAATTTTATGGACCTGTAAAGA 
CAATTACTGATTTTTACTAGAGGGGGATTAATTTTATGGACCTGTAAAGA 
1 5 1  2 0 0
ACTTGGGAATGCACTCAAAGGATCTCCCATCGATACTTTGATTAGATCGT 
ACTTGGGAATGCACTCAAAGGATCTCCCATCGATACTTTGATTAGATCGT 
ACTTGGGAATGCACTCAAAGGATCTCCCATCGATACTTTGATTAGATCGT 
ACTTGGGAATGCACTCAAAGGATCTCCCATCGATACTTTGATTAGATCGT 
2 0 1  2 5 0
GTTTGTTAGAAGAAAGATCGGCTGATTCTTCTTATCATTACGAGGCTCCA 
GTTTGTTAGAAGAAAGATCGGCTGATTCTTCTTATCATTACGAGGCTCCA 
GTTTGTTAGAAGAAAGATCGGCTGATTCTTCTTATCATTACGAGGCTCCA 
GTTTGTTAGAAGAAAGATCGGCTGATTCTTCTTATCATTACGAGGCTCCA 
2 5 1  3 0 0
GGTGCAGCTTACACTTTGAAATGGACATTCAACAATGATCTTGGTTTGAT 
GGTGCAGCTTACACTTTGAAATGGACATTCAACAATGATCTTGGTTTGAT 
GGTGCAGCTTACACTTTGAAATGGACATTCAACAATGATCTTGGTTTGAT 
GGTGCAGCTTACACTTTGAAATGGACATTCAACAATGATCTTGGTTTGAT 
3 0 1  3 5 0
TTTTGTTGCTGTGTATCAGAAGATTCTTCATCTTCTTTATGTTGATGATC 
TTTTGTTGCTGTGTATCAGAAGATTCTTCATCTTCTTTATGTTGATGATC 
TTTTGTTGCTGTGTATCAGAAGATTCTTCATCTTCTTTATGTTGATGATC 
TTTTGTTGCTGTGTATCAGAAGATTCTTCATCTTCT'TTATGT'TGATGATC 
3 5 1  4 0 0
TTCTTTCTATGGKGAAGAAACAATTCTCTGATATTTATGATCCTAAGCGG
t t c t t t c t a t g g | g a a g a a a c a a t t c t c t g a t a t t t a t g a t c c t a a g c g g
t t c t t t c t a t g g | g a a g a a a c a a t t c t c t g a t a t t t a t g a t c c t a a g c g g
t t c t t t c t a t g g | g a a g a a a c a a t t c t c t g a t a t t t a t g a t c c t a a g c g g
4 0 1  4 5 0
ACAAAGTATTATGATTTTGATGATGTTTTTCGTCAGTTGAGGAATGAGGT 
ACAAAGTATTATGATTTTGATGATGTTTTTCGTCAGTTGAGGAATGAGGT 
ACAAAGTATTATGATTTTGATGATGTTTTTCGTCAGTTGAGGAATGAGGT 
ACAAAGTATTATGATTTTGATGATGTTTTTCGTCAGTTGAGGAATGAGGT 
4 5 1  5 0 0
TGAAGCTAGGGCAGAGGAGTTGAAGAAATCAAAGCAAGTAGGGAGGTGTG 
TGAAGCTAGGGCAGAGGAGTTGAAGAAATCAAAGCAAGTAGGGAGGTGTG 
TGAAGCTAGGGCAGAGGAGTTGAAGAAATCAAAGCAAGTAGGGAGGTGTG 
TGAAGCTAGGGCAGAGGAGTTGAAGAAATCAAAGCAAGTAGGGAGGTGTG 
5 0 1  5 5 0
CTCCAGTTGGTTTGGGCAAGAAACAAGGGGGGACATCAATTGTGAAATCA 
CTCCAGTTGGTTTGGGCAAGAAACAAGGGGGGACATCAATTGTGAAATCA 
CTCCAGTTGGTTTGGGCAAGAAACAAGGGGGGACATCAATTGTGAAATCA 
CTCCAGTTGGTTTGGGCAAGAAACAAGGGGGGACATCAATTGTGAAATCA 
5 5 1  6 0 0
GATGGAAAGCAGAATGGGAATAGCTCTAGCAAAGATGGCGGGGATAGTGA 
GATGGAAAGCAGAATGGGAATAGCTCTAGCAAAGATGGCGGGGATAGTGA 
GATGGAAAGCAGAATGGGAATAGCTCTAGCAAAGATGGCGGGGATAGTGA 
GATGGAAAGCAGAATGGGAATAGCTCTAGCAAAGATGGCGGGGATAGTGA 
6 0 1  6 5 0
TTCTGCAAAAGACCATAAGGAGAATGGAAACCCTATTGTTCATCAAAACG 
TTCTGCAAAAGACCATAAGGAGAATGGAAACCCTATTGTTCATCAAAACG 
TTCTGCAAAAGACCATAAGGAGAATGGAAACCCTATTGTTCATCAAAACG 
TTCTGCAAAAGACCATAAGGAGAATGGAAACCCTATTGTTCATCAAAACG 
6 5 1  7 0 0
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8 3 F 5 ( 6 5 1 )
8 3 G 7 ( 6 5 0 )
9 1 E 9 ( 6 5 0 )
91 G3 ( 6 5 0 )
8 3 F 5 ( 7 0 1 )
8 3 G 7 ( 7 0 0 )
9 1 E 9 ( 7 0 0 )
91 G3 ( 7 0 0 )
8 3 F 5 ( 7 5 0 )
8 3 G 7 ( 7 4 9 )
9 1 E 9 ( 7 4 9 )
91 G3 ( 7 5 0 )
8 3 F 5 ( 8 0 0 )
8 3 G 7 ( 7 9 9 )
9 1 E 9 ( 7 9 9 )
91G3 ( 8 0 0 )
8 3 F 5 ( 8 4 9 )
8 3 G 7 ( 8 4 9 )
9 1 E 9 ( 8 4 9 )
91 G3 ( 8 5 0 )
8 3 F 5 ( 8 9 9 )
8 3 G 7 ( 8 9 9 )
9 1 E 9 ( 8 9 9 )
91 G3 ( 9 0 0 )
8 3 F 5 ( 9 4 9 )
8 3 G 7 ( 9 4 9 )
9 1 E 9 ( 9 4 9 )
91 G3 ( 9 5 0 )
8 3 F 5 ( 9 9 9 )
8 3 G 7 ( 9 9 9 )
9 1 E 9 ( 9 9 9 )
91G3 ( 1 0 0 0 )
8 3 F 5 ( 1 0 4 8 )
8 3 G 7 ( 1 0 4 8 )
9 1 E 9 ( 1 0 4 9 )
91 G3 ( 1 0 4 9 )
8 3 F 5 ( 1 0 9 8 )
8 3 G 7 ( 1 0 9 8 )
9 1 E 9 ( 1 0 9 7 )
91G3 ( 1 0 9 9 )
8 3 F 5 ( 1 1 4 8 )
8 3 G 7 ( 1 1 4 8 )
9 1 E 9 ( 1 1 4 7 )
91G3 ( 1 1 4 9 )
8 3 F 5 ( 1 1 9 5 )
8 3 G 7 ( 1 1 9 8 )
9 1 E 9 ( 1 1 9 4 )
91 G3 ( 1 1 9 6 )
8 3 F 5 ( 1 2 4 5 )
8 3 G 7 ( 1 2 4 8 )
9 1 E 9 ( 1 2 4 3 )
91 G3 ( 1 2 4 6 )
8 3 F 5 ( 1 2 9 5 )
8 3 G 7 ( 1 2 9 8 )
9 1 E 9 ( 1 2 9 3 )
GGGTTAAAAAGAATGTTGTTGTTAATAATAATAATAATAAAGAGAATAGA 
GGGTTAAAAAGAATGTTGTTGTTAATAATAATAATAATAAAGAGAATAGA 
GGGTTAAAAAGAATGTTGTTGTTAATAATAATAATAATAAAGAGAATAGA 
GGGTTAAAAAGAATGTTGTTGTTAATAATAATAATAATAAAGAGAATAGA 
7 0 1  7 5 0
GATTCTGGGG-CTTTCGATGTAAATAAGCTTCTTAAGCTCAGATCAAAAG 
GATTCTGGGG- CTTTCGATGTAAATAAGCTTCTTAAGCTCAGATCAAAAG 
GATTCTGGGG- CTTTCGATGTAAATAAGCTTCTTAAGCTCAGATCAAAAG 
GATTCTGGGGGCTTTCGATGTAAATAAGCTTCTTAAGCTCAGATCAAAAG 
7 5 1  8 0 0
GTGCAAAGAAACAAGAAAGTGTTGTTACAAAGGCTCCTCCfAAGGCGGAG 
GTGCAAAGAAACAAGAAAGTGTTGTTACAAAGGCTCCTCC§AAGGCGGAG 
GTGCAAAGAAACAAGAAAGTGTTGTTACAAAGGCTCCTCCfAAGGCGGAG 
GTGCAAAGAAACAAGAAAGTGTTGTTACAAAGGCTCCTCCMAAGGCGGAG 
8 0 1  8 5 0
CCAAAGAAAAAAGCAACGAAGAAAA- TAGAGTTTGGGATGATTCACCACC 
CCAAAGAAAAAAGCAACGAAGAAAA§TAGAGTTTGGGATGATTCACCACC
c c a a a g a a a a a a g c a a c g a a g a a a a J t a g a g t t t g g g a t g a t t c a c c a c c
c c a a a g a a a a a a g c a a c g a a g a a a a J t a g a g t t t g g g a t g a t t c a c c a c c
8 5 1  9 0 0
a g a g a c c a a g c t g g a t t t c g c a | a t c c t g t t g a t g a t a g a g g t a t c g a g g
AGAGACCAAGCTGGATTTCGCA§ATCCTGTTGATGATAGAGGTATCGAGG 
AGAGACCAAGCTGGATTTCGCASATCCTGTTGATGATAGAGGTATCGAGG 
AGAGACCAAGCTGGATTTCGCA|ATCCTGTTGATGATAGAGGTATCGAGG 
9 0 1  9 5 0
ACATGGAAGTTGTGACAGAGAATCATGGTGAAAGTATGATGGACAGAGAG 
ACATGGAAGTTGTGACAGAGAATCATGGTGAAAGTATGATGGACAGAGAG 
ACATGGAAGTTGTGACAGAGAATCATGGTGAAAGTATGATGGACAGAGAG 
ACATGGAAGTTGTGACAGAGAATCATGGTGAAAGTATGATGGACAGAGAG 
9 5 1  1 0 0 0
GAAGTTTTTAGTAGTGATAGTGAAAGTGAGGAGGAGGAGGATGACGTAflC 
GAAGTTTTTAGTAGTGATAGTGAAAGTGAGGAGGAGGAGGATGACGTASC 
GAAGTTTTTAGTAGTGATAGTGAAAGTGAGGAGGAGGAGGATGACGTAAC 
GAAGTTTTTAGTAGTGATAGTGAAAGTGAGGAGGAGGAGGATGACGTAfC 
1 0 0 1  1 0 5 0
TGGCAAGGACCCGAAGATCGATGAG- AAAAGGAAAGGATGGTTTTCGTCA 
TGGCAAGGACCCGAAGATCGATGAG- AAAAGGAAAGGATGGTTTTCGTCA 
TGGCAAGGACCCGAAGATCGATGAGKAAAAGGAAAGGATGGTTTTCGTCA 
TGGCAAGGACCCGAAGATCGATGAG- AAAAGGAAAGGATGGTTTTCGTCA 
1 0 5 1  1 1 0 0
|TGTTTCggAGTATTGCAGG|AAA|CAAATCTGGAGATGTCAGACCTGGA
| t g t t t c | r a g t a t t g c a g g § a a a | c a a a t c t g g a g a t g t c a g a c c t g g a
-TGTTTCR-AGTATTGCAGGRAAARCAAATCTGGAGATGTCAGACCTGGA 
|TGTTTC|PAGTATTGCAGGfAAA|CAAATCTGGAGATGTCAGACCTGGA  
1 1 0 1  1 1 5 0
a c c a g c t c t c a a a g c t c t t a a a g a c a g g c t c t t g | c t a a g a a t g t g g c t g
ACCAGCTCTCAAAGCTCTTAAAGACAGGCTCTTGiCTAAGAATGTGGCTG
ACCAGCTCTCAAAGCTCTTAAAGACAGGCTCTTGRCTAAGAATGTGGCTG
a c c a g c t c t c a a a g c t c t t a a a g a c a g g c t c t t g | c t a a g a a t g t g g c t g
1 1 5 1  1 2 0 0
AAGAAATAGCTGA|AAGCTTT- GTGAATCTGTAGC- GGCTAGTCTCGTA-
a a g a a a t a g c t g a J a a g c t t t t g t g a a t c t g t a g c c g g c t a g t c t c g t a a
AAGAAATAGCTGARAAGCTTT- GTGAATCTGTAGC- GGCTAGTCTCGTA- 
AAGAAATAGCTGAJa AGCTTT- GTGAATCTGTAGC- GGCTAGTCTCGTA- 
1 2 0 1  1 2 5 0
g g a a a a a a a c t g g c t t c a t t c | c t a g a g | g t c | t c a a c a g t t c a g g c a g c
GGAAAAAAACTGGCTTCATTC|CTAGAG§GTCMTCAACAGTTCAGGCAGC 
GGAAAAAAACTGGCTTCATTC- CTAGAGGGTCNTCAACAGTTCAGGCAGC 
GGAAAAAAACTGGCTTCATTC|CTAGAG|GTCgTCAACAGTTCAGGCAGC 
1 2 5 1  1 3 0 0
a a t g g a a g a c g c a c t t g t t c | c a t t t t g a c t c c | a J | c | c t c t a t c g a t g
a a t g g a a g a c g c n c t t g t t c c c a t t t t g a c t c c | a H c | c t c t a t c g a t g
a a t g g a a g a c g c c c t t g t t c | c a t t t t g a c t c c | a § | c | c t c t a t c g a t g
AATGGAAGACGCMCTTGTTC|CATTTTGACTCCMAMMCKCTCTATCGATG 
1 3 0 1  1 3 5 0
TATTGAGGGATGTGCATGCTGCCA|[Gg§GCAAGGG|GGCCATATGT|§ATC 
TATTGAGGGATGTGCATGCTGCCA|G|GGCAAGGGGGGCCATATGTfATC
t a t t g a g g g a t g t g c a t g c t g c c a g g - | g c a a g g g | g g c c a t a t g t w a t c
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91G3 (1296)
83F5 (1345)
83G7 (1348)
91E9 (1342)
91G3 (1345)
83F5 (1394)
83G7 (1397)
91E9 (1392)
91G3 (1394)
83F5 (1444)
83G7 (1447)
91E9 (1442)
91G3 (1444)
83F5 (1493)
83G7 (1497)
91E9 (1492)
91G3 (1494)
83F5 (1542)
83G7 (1546)
91E9 (1542)
91G3 (1543)
83F5 (1592)
83G7 (1596)
91E9 (1592)
91G3 (1593)
83F5 (1642)
83G7 (1646)
91E9 (1642)
91G3 (1643)
83F5 (1692)
83G7 (1696)
91E9 (1692)
91G3 (1693)
83F5 (1742)
83G7 (1746)
91E9 (1742)
91G3 (1743)
83F5 (1792)
83G7 (1796)
91E9 (1792)
91G3 (1793)
83F5 (1842)
83G7 (1846)
91E9 (1842)
91G3 (1843)
83F5 (1892)
83G7 (1896)
91E9 (1892)
91G3 (1893)
83F5 (1942)
83G7 (1946)
91E9 (1942)
91G3 (1943)
83F5 (1992)
TATTGAGGGATGTGCATGCTGCCAjjG-||GCAAGGG1gGCCATATGT$ATC 
1351 1400
AC-ttttgttgg|gtaaatggagtcggraagtctaccattcttgctaaga 
AC-ttttgttggggtaaatggagtcgg§aagtctacca||tcttgctaaga 
acattttgttgg|gtaaatggagtcgg§aagtctaccaätcttgctaaga
AC-TTTTGTTGGGGTAAATGGAGTCGGgAAGTCTACCAATCTTGCTAAGA 
1401 1450
TAGCATACTGGCTTCAGCAGCACAATATCAGTGTTATGATGTCCGCTTGC 
TAGCATACTGGCTTCAGCAGCACAATATCAGTGTTATGATGfCCGCTTGC 
TAGCATACTGGCTTCAGCAGCACAATATCAGTGTTATGATG|CCGCTTGC
tagcatactggcttcagcagcacaatatcagtgttatgatg|ccgcttgc
1451 1500
GATACATTCAGATCAGGGGCAGT-GAACAGCTTCGGACTCATGCTCGTAG
gatacattcagatcaggggcagt|gaacagcttcggactcatgctcgtag
gatacattcagatcaggggcagt|gaacagcttcggactcatgctcgtag
gatacattcagatcaggggcagt|gaacagcttcggactcatgctcgtag
1501 1550
GCTCCAGATTCCTATATTTGAGAAAGGCTACGAAAAAGATCCT-GCTGTT 
GCTCCAGATTCCTATATTTGAGAAAGGCTACGAAAAAGATCCT-GCTGTT 
GCTCCAGATTCCTATATTTGAGAAAGGCTACGAAAAAGATCCTTGCTGTT 
GCTCCAGATTCCTATATTTGAGAAAGGCTACGAAAAAGATCCT-GCTGTT 
1551 1600
GTGGCAAAGGAAGCCATCCAAGAAGCfAGCCGAAACGGTTCTGACGTGGT 
GTGGCAAAGGAAGCCATCCAAGAAGCMAGCCGAAACGGTTCTGACGTGGT 
GTGGCAAAGGAAGCCATCCAAGAAGCfAGCCGAAACGGTTCTGACGTGGT 
GTGGCAAAGGAAGCCATCCAAGAAGCflAGCCGAAACGGTTCTGACGTGGT 
1601 1650
TCTTGTTGATACAGCTGGACGTATGCAGGACAACGAGCCATTGATGAGGG 
TCTTGTTGATACAGCTGGACGTATGCAGGACAACGAGCCATTGATGAGGG 
TCTTGTTGATACAGCTGGACGTATGCAGGACAACGAGCCATTGATGAGGG 
TCTTGTTGATACAGCTGGACGTATGCAGGACAACGAGCCATTGATGAGGG 
1651 1700
CCCTCTCAAAGCTCATATCCCTCAATAGTCCAGACCTAGTTCTGTTTGTT 
CCCTCTCAAAGCTCATATCCCTCAATAGTCCAGACCTAGTTCTGTTTGTT 
CCCTCTCAAAGCTCATATCCCTCAATAGTCCAGACCTAGTTCTGTTTGTT 
CCCTCTCAAAGCTCATATCCCTCAATAGTCCAGACCTAGTTCTGTTTGTT 
1701 1750
GGAGAAGCfCTGGTTGGCAATGATGCTGTAGATCAACTATCGAAGTTCAA 
GGAGAAGCCCTGGTTGGCAATGATGCTGTAGATCAACTATCGAAGTTCAA 
GGAGAAGCiCTGGTTGGCAATGATGCTGTAGATCAACTATCGAAGTTCAA 
GGAGAAGCfCTGGTTGGCAATGATGCTGTAGATCAACTATCGAAGTTCAA 
1751 1800
TCAGAAATTGGCAGATCTCTCAAACTCGCCTAGTTCCAGGGTGATTGATG 
TCAGAAATTGGCAGATCTCTCAAACTCGCCTAGTTCCAGGGTGATTGATG 
TCAGAAATTGGCAGATCTCTCAAACTCGCCTAGTTCCAGGGTGATTGATG 
TCAGAAATTGGCAGATCTCTCAAACTCGCCTAGTTCCAGGGTGATTGATG 
1801 1850
gaattgtgctc|caaagttcgattgt|ttgatgataaggttgg§gctgc|§
GAATTGTGCTCCCAAAGTTCGATTGTTTTGATGATAAGGTTGGGGCTGCC
gaattgtgctc|caaagttcgattgt|ttgatgataaggttgg§gctgc||
GAATTGTGCTC|CAAAGTTCGATTGT|TTGATGATAAGGTTGGiGCTGC§ 
1851 1900
CTTTCGATGGTGTATATgTCTGGiGCgCCAGTGATGTTTGTTGGTTGCGG 
CTTTCGATGGTGTATATTTCTGGGGCCCCAGTGATGTTTGTTGGTTGCGG
ctttcgatggtgtatat|tctgg§gc|ccagtgatgtttgttggttgcgg
ctttcgatggtgtatat|tctgg|gc|ccagtgatgtttgttggttgcgg
1901 1950
3CAGTCCTATgcjG§CTTGAAAAAGCTGAATGTCAAAACC§TTGTCgAG| 
CCAGTCCTATCCCGCCTTGAAAAAGCTGAATGTCAAAACCCTTGTCCAGC 
§CAGTCCTATj§C§G§CTTGAAAAAGCTGAATGTCAAAACC|TTGTCgAG§ 
|CAGTCCTATiciGicTTGAAAAAGCTGAATGTCAAAACCj|TTGTC§AG| 
1951 2000
CTCTCCTCAAGTAGAAGAAACTCCCCTCGTGGAAAACGTTCTGTCTAGAT 
CTCTCCTCAAGTAGAAGAAACTCCCCTCGTGGAAAACGTTCTGTCTAGAT 
CTCTCCTCAAGTAGAAGAAACTCCCCTCGTGGAAAACGTTCTGTCTAGAT 
CTCTCCTCAAGTAGAAGAAACTCCCCTCGTGGAAAACGTTCTGTCTAGAT 
2001 2050
t;|c||tgttaaagatttggctagtc8gg|ggaatagctatagattggtttc
144
83G7 (1996) THCHTGTTAAAGATTTGGCTAGTCCGGGGGAATAGCTATAGATTGGTTTC
91E9 (1992) t ä cISt g t t a a a g a t t t g g c t a g t c ^ g g |g g a a t a g c t a t a g a t t g g t t t c
91G3 (1993) T^ci|TGTTAAAGATTTGGCTAGTciGGiGGAATAGCTATAGATTGGTTTC
2051 2100
83F5 (2042) c t g g t | t t t t g c | c t t c t |t g a t t a a a a t t c 8g g a t a a t g t g t t t c | t t t
83G7 (2046) CTGGTTTTTTGCCCTTCTCTGATTAAAATTCCGGATAATGTGTTTCCTTT
91E9 (2042) CTGGTgTTTTGC$CTTCT|TGATTAAAATTC|GGATAATGTGTTTC|jjTTT
91G3 (2043) CTGGT§TTTTGcicTTCT|TGATTAAAATTcjGGATAATGTGTTTci§TTT
2101 2150
83F5 (2092) c|a g a t t |t t a a a g a t g a t g c t t t |t a t g t c t c c t t t |a a a a a a a a a a a a
83G7 (2096) CCAGATTTTTAAAGATGATGCTTTCTATGTCTCCTTTTAAAAAAAAAAAA
91E9 (2092) c||a g a t t |t t a a a g a t g a t g c t t t |t a t g t c t c c t t t § a a a a a a a a a a a a
91G3 (2093) c§a g a t t §t t a a a g a t g a t g c t t t |t a t g t c t c c t t t |a a a a a a a a a a a a
2151
83F5 (2142) AAAAAAAAAA
83G7 (2146) AAAAAAAAAA
91E9 (2142) AAAAAAAAAA
91G3 (2143) AAAAAAAAAA
Figure 4.12: Nucleotide alignment of the four signal recognition receptor like
proteins (83F5, 83G7, 91E9, 91G3) from the topi microarray experiments. The 
four contigs are homologous. The blue and white coloured nucleotides represent 
differences between the four sequences. These are possibly due to sequencing 
errors. Alignment undertaken using AlignX ' A component of VNTI Suite 8 
InforMax, Inc.
I Ajellomyces 
Arabidopsis
O. sativa
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Cons
Ajellomyces QMTLNDFDDTRSAQGYYNDQNDMDGAIPVR|ARARDRNSILSLGGGLVGRAKNMLGM
Arabidopsis -------- ------------------------ AQACFKQDHSQIGGPGFSRWYC----
O. sativa -------------------------- ----- -fAPASTETSTFSSAPGFTRAVRC----
P.somniferum
Ajellomyces KSPYSEMDLPLTETGARSAGVDTVGADDDGGSSSRLKEKKFSASDFKFGFGRRKIDP
Arabidopsis --------------NEPDSPEADSRh ^ ^ ^ ^ ^ ^ --------------------------
O. sativa --------------|GAGSSSSSSSSSDEGGaJ|--------------------------
P.somniferum
Ajellomyces STLGPRVILFNNSPANAANRYVDNHISTAKYNVFTFVPKFLFEQFSKYANLFFLFSA
Arabidopsis -YSDNYVRTTKYTLATFLPKSLFEQFRRVANFYFLVTG
0. sativa   YPGNAISTTKYTAASFVPKSLFEQFRRAANCFFLWA
P.somniferum
Cons
145
Aj ellomyces 
Arabidopsis
O. sativa
P. somniferum
ALQQIPNISPTNRYTTIAPLAWLLVSAIKELVGDWKRKTSDKSLNYSRAQVLKGS- 
VLAFTP-LAPYTASSAIVPLLFVTGATMVKEGVEDWRRQKQDNEVNNRKVKVHRGDG 
CVSFSP - LAPYRAVSVLLPLWWGAAMAKEAVEDWRRKQQDIEVNSRKVEVYDGTQ
Cons 1
Ajellomyces 
Arabidopsis
O. sativa
P. somniferum
TFEDTKWINVAVGDIVKVESEQPFPADLVLLASSEPEGLCYIETANLDGETNLKIKQ
SFDAKEWKTLSIGDIVKVEKNEFFPADLVLLSSSYEDAICYVETMNLDGETNLKVKQ
SFHQTEWKKLQVGDIVKVKKDEFFPADLVLLSSSYEDGICYVETMNLDGETNLKRKQ
Cons
Ajellomyces 
Arabidopsis
O. sativa
P. somniferum
AIPETADLVSPSQLGRLTGRIKSEQPNSSLYTYEATLTLQAGGGEKELALNPDQLLL
GLEVTSSLRDEFNFKGFEAFVKCEDPNANLYSFVGTMELKg--- JjkKYPLSPQQLLL
SLDVTAGLNEDHSFHTFKAFIQCEDPNEKLYSFLGTLHYNf--- QQYPLSPQQILL
Cons
Aj ellomyces 
Arabidopsis
O. sativa
P. somniferum
RGATLRNTPWIHGLWFTGHETKLMRNATATPIKRTAVERMVNLQILMLVGILLILS 
RDSKLRNTDFIFGAVIFTGHDTKVIQNSTDPPSKRSMIEKKMDKIIYLMFFMVITMA 
RDSKLRNTNQIYGIVIFTGHDTKVMQNAMEPPSKRSSVERRMDKIIYLLFVILFAIA
Cons
Aj ellomyces 
Arabidopsis
O. sativa
P. somniferum
LISSIGHLV-VRMKSADELIYL--------- YIGNVNAAQQFFSDIFTYWVLYSNL
FIGSVIFGVTTRDDLKDGVMKRWYLRPDSSSIFFDPKRAPVAAIYHFLTAVMLYSYF
sfgsvmfgirtraelsagnya^Vylrpdns™ yfdpnratlaaichfltslmlyvcl
Cons
Aj ellomyces 
Arabidopsis
O. sativa
P. somniferum
VPISLFVTIEIVKYYHAFLINSDLDIYYDKTDTSATCRTSSLVEELGQIEYIFSDKT
IPISLYVSIEIVKVLQSIFINQDIHMYYEEADKPARARTSNLNEELGQVDTILSDKT
VPISLYISIEIVKVLQSTFINQDQNMYCEESDKPARARTSNLNEELGQVHTILSDKT
Cons
Aj ellomyces 
Arabidopsis
O. sativa
P. somniferum
GTLTCNMMEFKQCSIGGLQYAEWSEDRRWD--------GDDSE-----------
GTLTCNSMEFIKCSVAGTAYGRGVTEVEMAMGRRKGGPLVFQSDENDIDMEYSKEAI 
GTLTCNSMEFLKCSIAGVAYGNRPIEVQMPYCJ--------|GIEEECVDIG-QKGAV
Cons
Ajellomyces 
Arabidopsis
O. sativa
P. somniferum
------- MGMYDFNQLVEHLTSHPTRTAIHHFLCLLATCHTVIPERKAEKPDVIKY
TEESTVKGFNFRDERIMNGNWVTETHADVIQKFFRLLAVCHTVIPEVD-EDTEKISY
KSVRPVKGFNFTDDRLMNGQWSKECHQDVIEMFFRVLAVCHTAIPVAD-RTSGGMSY
Cons
Aj ellomyces 
Arabidopsis
O. sativa
P. somniferum
QAASPDEGALVEGAVMMGYRFTNRRPKSV----- IISANGQEQEFELLAVCEFNST
EAESPDEAAFVIAARELGFEFFNRTQTTISVRELDLVSGKRVERLYKVLNVLEFNST
EAESPDEGALVAAARELGFEFYHRSQTSISVHEYDPVFGRKVDRTYKLLNTLEFSSA
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Cons
Ajellomyces 
Arabidopsis
O. sativa
P . somniferum
RKRMSTIFRCPDGKIRIYCKGADTVILERLHADNPTVD^F- -|*LQHLEEYASDGLRTL 
RKRMSVIVQEEDGKLLLLCKGADNVMFERLSK-NGREFEEETRDHVNEYADAGLRTL 
RKRMSVIVSTEEGRLFLFCKGADSVILERLSKDNSKACLTNTKCHIDEYSEAGLRTL
Cons
Ajellomyces
Arabidopsis
O. sativa i
P. somniferum
:lamrevpeeefsqwyqiydkaattatgnraeeldkrleiiekdffllgataiedkl
[LAYRELDEKEYKVFNERISEAKSSVSADRESLIEEVTEKIEKDLILLGATAVEDKL
^LAYRELTEDEYVAWNMEYSAAKNSVHNDHDVAVEKASENIEKDLVLLGATAVEDRL
Cons 1
Ajellomyces (
Arabidopsis
O. sativa
P. somniferum l
2DGVPDTIHTLQTAGIKVWVLTGDRQETAINIG.... -MSCKLISEDMALL
JNGVPDCIDKLAQAGIKIWVLTGDKMETAINIG---------- FACSLLRQDMKQI
2KGVPECIHKLAQAGIKIWILTGDKLETAVNIGLVPYVAYVPDNYACNLLRKGMEEV 
2SGVPECIDKLAQAGIKIWVLTGDKMETAINIG---------- YACSLLRQGMKQI
Cons *** • * ★ ★*★•*** • *  • * •
Ajellomyces
Arabidopsis
O. sativa
P. somniferum
[VNEES-------------- ALATKDNLSKKLQQVQSQAGS- -PDSETLALIIDGK
EINLETPEIQSLEKTGEKDVIAKASKENVLSQIINGKTQLKYSGG--NAFALIIDGK 
fTTLDNPGTNVPEEHNGESS-GMAPYEQIGRKLEDARRQILQK-GTSAPFALIIDGN 
EITLESPDVMAAEKTEDKIAIANVSRASILYQIDEGKAQLTSSAGSSDAFALIIDGK
Cons . . ........* T ******.
Ajellomyces 
Arabidopsis
O. sativa
P . somniferum
SLTYALEKDMEKIFLDIiAVMCKAVICCRVSPLQKALWKLQRH-LKALLIiAIGDGAN
SLAYALDDDIKHIFLELAVSCASVICCRSSPKQKALVTRLVKSGNGKTTLAIGDGAN
ALTHALMGGLKTAFLDLAVDCASVLCCRISPKQKALITRLVKNRIRKTTLAIGDGAN
SLAYALEDNLKHKFLFLAVGCASVICCRSSPKQKALVTRLVKAGTGKTTLAIGDGAN
Cons .JJ ** ★★★ ★ ****** ★ *r ★ ★ ★ *r • ̂ ★ • ********
Ajellomyces
Arabidopsis
O. sativa
P . somniferum
DVSMIQAAHVGVGISGVEGLQAARSADVAIAQFRFLRKLLLVHGAWSYQRISKVILY
DVGMLQEADIGVGISGVEGMQAVMSSDIAIAQFRYLERLLLVHGHWCYRRISTMICY
DVGMLQEADIGVGISGAEGMQAVMASDFAIAQFRFLERLLLVHGHWCYRRIAAMICY
DVGMLQEADIGVGISGVEGMQAVMSSDVAIAQFRFLERLLLVHGHWCYRRISAMVCY
Cons ** # * * * * # j * * * * * * # * * . * * # * .* ******.*# ******* * c * • ** • • • *
Ajellomyces
Arabidopsis
O. sativa
P . somniferum
SFYKNIALYMTQFWYSFQNSFSGQVIYESWTLSFYNVFFTVMPPFAMGIFDQFISAR
FFYKNITFGFTLFLYETYTTFSSTPAYNDWFLSLYNVFFSSLPVIALGVFDQDVSAR
FFFKNITFGFTLFWFEAHAMFSAQPGYNDWFISFYNVAFTSLPVIALGVFDKDVSSR
FFYKNVTFGVTLLFYEVYASFSATPAYNDWFMSFYNVFFTSLPALALGIFDQDVSAR
Cons *•**••* * • • ** * * * •*•*** * * * * .*.*.**• * * * *
Ajellomyces
Arabidopsis
O. sativa
P . somniferum
LLDRYPQLYQLGQKGVFFKMHSFWSWIGNGFYHSLIAYFEjSQAIFLWDLPEj ANGELA
YCLKFPLLYQEGVQNVLFSWRRILGWMFNGFYSAVIIFFLCKSSLQSQAFNHDGKTP
VCLEVPSLHQDGVNNLFFSWSRILSWMLNGVCCSIIIYFGALHAVLIQAVRQDGHVA
LCLKFPLLYQEGVQNVLFSWFRILGWMCNGICSATIIFFFCSTALEHQAFRKSGETV
Cons *  * . *  * j , j ; * ,  • .*:**. • ★ • * # • .*•
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A j e l l o m y c e s
A r a b i d o p s i s
O . s a t i v a
P . s o m n i fe r u m
GAGFSTEYEGIIPNLFQSLVFWLMAIVLPWCLVRDFAWKYIKRMYFPQAYHHVQEI
S -----TGAYKVFVEALAPSLSYWLITLFVWATLMPYFIYSALQMSFFPMYHGMIQWL
S  TSAYHVFWEACASSPLYWLSTLVIWTALIPYFLYKITQSLFCPQHCDQVQ- -
S -----TTAYQVFVEACAPAVSYWLITLFWPATLIPYFAFSAMRMRFFPRYHQMIQWI
A j  e l l o m y c e s
A r a b i d o p s i s
O. s a t i v a
P . s o m n i fe r u m
Cons
QKYNVQDYRPRMEQF - - QKAIRKVRQVQRNRKQR---------- GYAFSQADEGGQMRWNA j  e l l o m y c e s
iR SIR - PTTVGFTARLEAKKRSVRISEPASA r a b i d o p s i s
0 . s a t i v a
RAEGKAD-DPEYCQMIRQRSIR-PTYCRSHSTRRISKIVFGIILKSILVTGGNRSVNP . s o m n i fe r u m
A j  e l l o m y c e s
A r a b i d o p s i s
0 .  s a t i v a
P . s o m n i fe r u m IVFDFYLITPTVSERNCSFHVLKCLLANTEGEMPPTFVNFDSLLVGGHRFFFHLFFF
A j  e l l o m y c e s
A r a b i d o p s i s
O. s a t i v a
P . s o m n iferum LWLFSMYIFVLLKCNTWFHSDIELWLACNFYKFPFLVSLFENXPXLHFI !KMY
TRSRGRYGEMASSRPLDIA j  e l l o m y c e s
A r a b i d o p s i s
0 . s a t i v a
IENNTTKKKNYKWKKNLCPPTNKESKFTKVGGISPSVFANKHYFKTWNEQFLSETVGP . s o m n i fe r u m
Cons
A j  e l l o m y c e s
A r a b i d o p s i s
0 .  s a t i v a
P. s o m n i fe r u m VIRKSNTILTDRLPPVTRMLFKIIPKTILIARAAPXXSC
GREILGGTMYTCIVWWNLQMALAISYFTLIQHIVIWSSIWWYFFITVYGELPSRI
GFDILGVTMYTCWWTVNCQLALYISYFTWIQHFVIWGSILIWYTFLVIYGSFPPTI
GSDILGLTLYTCWWWNCQMALSISYFTLLQHIVIWGSMWWYLFLLVYGALPIRW
GHWFWGTALYTAVLATVLGKAALVTNIWTKYTFIAIPGSMIIRMGFLPVYGFSAPRI
Sequence homology is represented by the colour code-
BADAVG Go o d
Ajellomyces: putative calcium transporting ATPase [Ajellomyces capsulatus]. 
Accession number: AAF90186.
Figure 4.13: The translated alignment of the translated poppy clone 108H11 
with three ATPase type transporter proteins from the NCBI genbank database.
148
Arabidopsis: haloacid dehalogenase-like hydrolase family protein [Arabidopsis 
thaliana]. Accession number: NP_177038.
O. sativa: putative ATPase [Oryza sativa (japonica cultivar-group)]. Accession 
number: BAD05408
P. somniferum: Clone 108H11 from the topi microarray results.
T-COFFEE, Version_1.41 was used for the amino acid alignments (Notredame et 
a l 2000).
1 5 0
1 0 8 H 1 1 ( 1 ) CTCCAGTCTGGGGTACCAGAATGCATAGACAAACTCGCACAGGCTGGAAT
5 2 F 2 ( 1 ) CTCCAGTCTGGGGTACCAGAATGCATAGACAAACTCGCACAGGCTGGAAT
5 1 1 0 0
1 0 8 H 1 1 ( 5 1 ) AAAGATATGGGTTTTGACTGGGGATAAGATGGAGACTGCCATCAATATTG
5 2 F 2 ( 5 1 ) AAAGATATGGGTTTTGACTGGGGATAAGATGGAGACTGCCATCAATATTG
1 0 1 1 5 0
1 0 8 H 1 1 ( 1 0 1 ) G G TATG CATGCAGTTTGCTTAGGCAAGGAATGAAACAAATTATTATCACC
5 2 F 2 ( 1 0 1 ) G G TATG CATGCAGTTTGCTTAGGCAAGGAATGAAACAAATTATTATCACC
1 5 1 2 0 0
1 0 8 H 1 1 ( 1 5 1 ) TTGGAGTCACCTGATGTTATGGCAGCTGAGAAAACGGAGGACAAAATTGC
5 2 F 2 ( 1 5 1 ) TTGGAGTCACCTGATGTTATGGCAGCTGAGAAAACGGAGGACAAAATTGC
2 0 1 2 5 0
1 0 8 H 1 1 ( 2 0 1 ) AATTGCAAATGTATCAAGGGCAAGCATACTTTATCAAATAGATGAAGGGA
5 2 F 2 ( 2 0 1 ) AATTGCAAATGTATCAAGGGCAAGCATACTTTATCAAATAGATGAAGGGA
2 5 1 3 0 0
1 0 8 H 1 1 ( 2 5 1 ) AGGCACAGTTAACTTCTTCAGCCGGAAGCTCAGATGCATTTGCGTTGATC
5 2 F 2 ( 2 5 1 ) AGGCACAGTTAACTTCTTCAGCCGGAAGCTCAGATGCATTTGCGTTGATC
3 0 1 3 5 0
1 0 8 H 1 1 ( 3 0 1 ) ATTGATGGGAAGTCACTCGCGTATGCCCTTGAAGACAATTTGAAGCACAA
5 2 F 2 ( 3 0 1 ) ATTGATGGGAAGTCACTCGCGTATGCCCTTGAAGACAATTTGAAGCACAA
3 5 1 4 0 0
1 0 8 H 1 1 ( 3 5 1 ) G TTTCTATTCC TTG CAG TTG G CTG TG CATCCG TTATTTG TTG CCG CTCA T
5 2 F 2 ( 3 5 1 ) G TTTCTATTCC TTG CAG TTG G CTG TG CATCCG TTATTTG TTG CCG CTCA T
4 0 1 4 5 0
1 0 8 H 1 1 ( 4 0 1 ) CACCTAAACAGAAAGCACTTGTAACACGTCTGGTTAAAGCTGGAACAGGT
5 2 F 2 ( 4 0 1 ) CACCTAAACAGAAAGCACTTGTAACACGTCTGGTTAAAGCTGGAACAGGT
4 5 1 5 0 0
1 0 8 H 1 1 ( 4 5 1 ) AAAACAACATTAGCAATTGGAGACGGGGCCAACGATGTGGGTATGCTTCA
5 2 F 2 ( 4 5 1 ) AAAACAACATTAGCAATTGGAGACGGGGCCAACGATGTGGGTATGCTTCA
5 0 1 5 5 0
1 0 8 H 1 1 ( 5 0 1 ) AGAAGCAGATATTGGGGTCGGAATTAGCGGAGTTGAAGGAATGCAGGCAG
5 2 F 2 ( 5 0 1 ) AGAAGCAGATATTGGGGTCGGAATTAGCGGAGTTGAAGGAATGCAGGCAG
5 5 1 6 0 0
1 0 8 H 1 1 ( 5 5 1 ) TCATG TCAAGTG ATG TTG CAATTG CTCAG TTCCG ATTTTTG G AG CG TCTG
5 2 F 2 ( 5 5 1 ) TCATG TCAAGTG ATG TTG CAATTG CTCAG TTCCG ATTTTTG G AG CG TCTG
6 0 1 6 5 0
1 0 8 I I 1 1 ( 6 0 1 ) CTA CTTG TACATGGTCATTGGTGTTACAGAÄGAATATCAGCAATGGTATG
5 2 F 2 ( 6 0 1 ) CTA CTTG TACATGGTCATTGGTGTTACAGAAGAATATCAGCAATGGTATG
6 5 1 7 0 0
1 0 8 H 1 1 ( 6 5 1 ) C TA C TTC TTTTACAAG AA TG TTACATTCG G TG TCAC TCTG TTG TTCTACG
5 2 F 2 ( 6 5 1 ) C TA C TTC TTTTACAAG AA TG TTACATTCG G TG TCAC TCTG TTG TTCTACG
7 0 1 7 5 0
1 0 8 H 1 1 ( 7 0 1 ) AG G TG TATG CATCATTCTCTG CCACACCTG CCTATAACG ACTG G TTTATG
5 2 F 2 ( 7 0 1 ) AG G TG TATG CATCATTCTCTG CCACACCTG CCTATAACG ACTG G TTTATG
7 5 1 8 0 0
1 0 8 H 1 1 ( 7 5 1 ) TC A TTC TA TA A TG TTTTC TTC A C A TC A TTA C C TG C TC TTG C TC TTG G C A T
5 2 F 2 ( 7 5 1 ) TC A TTC TA TA A TG TTTTC TTC A C A TC A TTA C C TG C TC TTG C TC TTG G C A T
8 0 1 8 5 0
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1 0 8 H 1 1 ( 8 0 1 ) ATTTG ACCAAGACGTTTCCGCAAGGTTATGCCTCAAGTTCCCCCTACTGT
5 2 F 2 ( 8 0 1 ) ATTTG ACCAAGACGTTTCCGCAAGGTTATGCCTCAAGTTCCCCCTACTGT
8 5 1 9 0 0
1 0 8 H 1 1 ( 8 5 1 ) ACCAAGAAGGTGTGCAGAATGTCCTGTTCAGCTGGTTCAGGATACTCGGT
5 2 F 2 ( 8 5 1 ) ACCAAGAAGGTGTGCAGAATGTCCTGTTCAGCTGGTTCAGGATACTCGGT
9 0 1 9 5 0
1 0 8 H 1 1 ( 9 0 1 ) TG G ATG TG CAACGGTATCTGTAGTGCTACAATAATCTTTTTCTTCTGCTC
5 2 F 2 ( 9 0 1 ) TG G ATG TG CAACGGTATCTGTAGTGCTACAATAATCTTTTTCTTCTGCTC
9 5 1 1 0 0 0
1 0 8 H 1 1 ( 9 5 1 ) AACTGCATTAGAGCACCAGGCTTTCCGAAAGAGTGGCGAGACAGTTGGGT
5 2 F 2 ( 9 5 1 ) AACTGCATTAGAGCACCAGGCTTTCCGAAAGAGTGGCGAGACAGTTGGGT
1 0 0 1 1 0 5 0
1 0 8 H 1 1 ( 1 0 0 1 ) CTG ATATTCTTGG ACTAACCTTATACACTTG TG TCG TTTG G G TTG TAAAC
5 2 F 2 ( 1 0 0 1 ) CTG ATATTCTTGG ACTAACCTTATACACTTG TG TCG TTTG G G TTG TAAAC
1 0 5 1 1 1 0 0
1 0 8 H 1 1 ( 1 0 5 1 ) TG TCAG ATG G CG CTCTCAATCAG TTATTTCACACTTCTACAACATATAG T
5 2 F 2 ( 1 0 5 1 ) TG TCAG ATG G CG CTCTCAATCAG TTATTTCACACTTCTACAACATATAG T
1 1 0 1 1 1 5 0
1 0 8 H 1 1 ( 1 1 0 1 ) TATCTGGGGTAGTATGGTAGTGTGGTATCTATTCTTGTTGGTGTATGGCG
5 2 F 2 ( 1 1 0 1 ) TATCTGGGGTAGTATGGTAGTGTGGTATCTATTCTTGTTGGTGTATGGCG
1 1 5 1 1 2 0 0
1 0 8 H 1 1 ( 1 1 5 1 ) CCCTTCCTATAAGATGGTCGACAACCGCCTACCAAGTTTTTGTTGAGGCT
5 2 F 2 ( 1 1 5 1 ) CCCTTCCTATAAGATGGTCGACAACCGCCTACCAAGTTTTTGTTGAGGCT
1 2 0 1 1 2 5 0
1 0 8 H 1 1 ( 1 2 0 1 ) TG TG CACCTG CTG TTTCTTACTG G CTTATCACTCTTTTTG TTG TACCG G C
5 2 F 2 ( 1 2 0 1 ) TG TG CACCTG CTG TTTCTTACTG G CTTATCACTCTTTTTG TTG TACCG G C
1 2 5 1 1 3 0 0
1 0 8 H 1 1 ( 1 2 5 1 ) AACACTCATTCCATACTTTG CTTTCTCAG CTATGA GA ATG CG G TTTTTCC
5 2 F 2 ( 1 2 5 1 ) AACACTCATTCCATACTTTG CTTTCTCAG CTATGA GA ATG CG G TTTTTCC
1 3 0 1 1 3 5 0
1 0 8 H 1 1 ( 1 3 0 1 ) CTAGATATCATCAGATGATTCAGTGGATAAGAGCAGAAGGGAAAGCAGAT
5 2 F 2 ( 1 3 0 1 ) CTAGATATCATCAGATGATTCAGTGGATAAGAGCAGAAGGGAAAGCAGAT
1 3 5 1 1 4 0 0
1 0 8 H 1 1 ( 1 3 5 1 ) GATCCCGAATATTGCCAAATGATTAGGCAAAGATCCATCCGTCCCACATA
5 2 F 2 ( 1 3 5 1 ) G ATCCCG AATATTG CCAAATG ATTAG GCAAAG ATCCATCCG TCC-ACATA
1 4 0 1 1 4 5 0
1 Q 8 H 1 1 ( 1 4 0 1 ) CTGTAGGTCTCACAGCACGCGCAGAATCAGTTAAAAGATAGTCTTCGGAA
5 2 F 2 ( 1 4 0 0 ) CTGTAGGTCTCACAGCACGCGCAGAATCAGTTAAAAGATAGTCTTCGGAA
1 4 5 1 1 5 0 0
1 0 8 H 1 ( 1 4 5 1 ) TTATTTTAAAG AG CATTCTTG TCACTG G AG G TAATCG ATCAG TCAATATA
5 2 F 2 ( 1 4 5 0 ) TTATTTTAAAG AG CATTCTTG TCACTG G AG G TAATCG ATCAG TCAATATA
1 5 0 1 1 5 5 0
1 0 8 H 1 ( 1 5 0 1 ) G TG TTTG ATTTTTATCTTATAACACCAACAG TTTCAG AAAGG AATTG CTC
5 2 F 2 ( 1 5 0 0 ) G TG TTTG ATTTTTATCTTATAACACCAACAG TTTCAG AAAGG AATTG CTC
1 5 5 1 1 6 0 0
1 0 8 H 1 ( 1 5 5 1 ) ATTCCATGTCTTAAAATAGTGTTTATTGGCGAACACTGAAGGAGAAATGC
5 2 F 2 ( 1 5 5 0 ) ATTCCATGTCTTAAAATAGTGTTTATTGGCGAACACTGAAGGAGAAATGC
1 6 0 1 1 6 5 0
1 0 8 H 1 1 ( 1 6 0 1 ) CCCCAACTTTTG TAAATTTTG ATTCTTTG TTG G TCG G AG G G CATAGATTT
5 2 F 2 ( 1 6 0 0 ) CCCCAACTTTTG TAAATTTTG ATTCTTTG TTG G TCG G AG G G CATAGATTT
1 6 5 1 1 7 0 0
1 0 8 H 1 ( 1 6 5 1 ) TTTTTC C A T TTG T A G TTT TT C TTT TT G G T A G TA T TA TT C TC A A TG TA C A T
5 2 F 2 ( 1 6 5 0 ) TT TT TC C A T TTG TA G TTTTTC TTTTTG G TA G TA TC A TTC C C A A TG TA C A T
1 7 0 1 1 7 5 0
1 0 8 H 1 ( 1 7 0 1 ) TTTTGTATTATAACTAAAATG TAATA CAG TAG TG TTTC ACTCAG ACA TTG
5 2 F 2 ( 1 7 0 0 ) T T T --------------------------------------
1 7 5 1 1 8 0 0
1 0 8 H 1 ( 1 7 5 1 ) AG CTA TG G CTG TAAG CCTG TA ACTTCTACATG TTTCCG TTTTTAG TATCA
5 2 F 2 ( 1 7 0 3 )
1 8 0 1 1 8 5 0
1 0 8 H 1 ( 1 8 0 1 ) CTTTTTG A GTGAA A CAYTCCCGWA T T A C A T T T T A GTTA TAA TA CAAAAA T
5 2 F 2 ( 1 7 0 3 ) ----------------------------------- AGTTATAATACAAAAA T
1 8 5 1 1 9 0 0
1 0 8 H 1 ( 1 8 5 1 ) G TACATTGAGAATAATACTACCAAAAAGAAAAACTACAAATGGAAAAAAA
5 2 F 2 ( 1 7 2 0 ) GTACATTGAGAATAATACTACCAAAAAGAAAAACTACAAATGGAAAAAAA
1 9 0 1 1 9 5 0
1 0 8 H 1 ( 1 9 0 1 ) ATCTATGCCCTCCGACCAACAAAGAATCAAAATTTACAAAAGTTGGGGGC
5 2 F 2 ( 1 7 7 0 ) ATCTATGCCCTCCGACCAACAAAGAATCAAAATTTACAAAAGTTGGGGGC
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108H 1
52F 2
108H 1
52F 2
108H 1
52F 2
108H 1
52 F 2
1 9 5 1  2 0 0 0
(1 9 5 1 )  ATTTCTCCTTCAGTGTTCGCCAATAAACACTATTTTAAGACATGGAATGA 
( 1 8 2 0 )  ATTTCTCCTTCAGTGTTCGCCAATAAACACTATTTTAAGACATGGAATGA 
2 0 0 1  2 0 5 0
( 2 0 0 1 )  GCAATTCCTTTCTGAAACTGTTGGTGTTATAAGATAAAAATCAAACACTA 
( 1 8 7 0 )  GCAATTCCTTTCTGAAACTGTTGGTGTTATAAGATAAAAATCAAACACTA 
2 0 5 1  2 1 0 0
( 2 0 5 1 )  TATTGACTGATCGATTACCTCCAGTGACAAGAATGCTCTTTAAAATAATT 
( 1 9 2 0 )  TATTGACTGATCGATTACCTCCAGTGACAAGAATGCTCTTTAAAATAATT 
2 1 0 1  2 1 4 8
( 2 1 0 1 )  CCGAAGACTATCTTAATAGCTCGAGCTGCTCC-- CWGTARATCATGCC 
( 1 9 7 0 )  CCGAAGACTATCTTT- TAACTGATTCTGCGCGTGCTKGAGACCAATC-
Figure 4.14: The nucleotide alignment of the two cDNAs 52F2 and 108H11.
The two clones are almost identical (Identity 92.9%) except the cDNA clone
108H11 contains 130 extra nucleotides in the 3’ untranslated region (highlighted 
in green). This indicates that two this gene is encoded by at least two different
genes. The translated sequence alignment with flippase genes from other species 
shown in the previous Figure 4.17. Alignment obtained using AlignX* A
component of VNTI Suite 8 InforMax, Inc.
4.5 Germplasm with Altered Morphinan Alkaloid Yields
4.5.1 P. somniferum cv. Marianne
A total of five slides were used for the P. somniferum cv C052 versus P. 
somniferum cv. Marianne experiments. The microarray experiments included 3 
biological replicates and a technical replicate, dye swap, for two of the biological 
replicates. The analysis revealed a total of 460 clones, which were differentially 
expressed between the two cultivars (Figure 4.15).
Of the 460 differentially expressed genes 269 were more highly expressed in 
Marianne than in C052 using a cut-off expression ratio value of 2. The other 191 
genes were more highly expressed in the high morphine producing C052 
(Appendix 3). None of the control sequences printed on the array were 
differentially expressed between the two cultivars. Due to the large number of 
differentially expressed genes sequencing was not undertaken on the whole set. 
Rather the results were compared to the sets of differentially expressed genes 
with the other genotypes and mutants (see section 4.6).
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Figure 4.15: Graphical representation of the differentially expressed genes 
between P. somniferum cv. C052 and P. somniferum cv. Marianne. Using the 
differential ratio cut-off of 2 revealed a total of 460 genes [the green circles] were 
differentially expressed. 269 of these genes were more highly expressed in the 
Marianne cultivar than in the high morphine line C052. The remaining 191 genes 
were more highly expressed in the high morphine producing line C052. No 
control sequences were differentially expressed between the two cultivars.
4.5.2 P. somniferum Low Morphine Accumulating Mutant D205
Microarray experiments were undertaken using the procedures detailed in 
Chapter 2. Only two slides were used for experiments with mutant D205 and 
these were dye swaps of the one RNA preparation. To reduce the effect of 
biological differences the single biological sample for each mutant was prepared
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Figure 4.16: Graphical representation of the differentially expressed genes (red 
circles) between the low morphine-accumulating mutant, D205 and the parental 
control C052.
by pooling six independent mutant plants. A total of eighty-two cDNAs were 
differentially under-expressed in the mutant and only eight were over-expressed 
in the mutant compared to the control (Figure 4.16). For the full list of 
differentially expressed genes see Appendix 4. Due to the large number of clones 
found to be differential, sequencing of the entire set was not undertaken.
4.5.3 P. somniferum High Total Alkaloid Accumulating Mutant 
D242
Microarray experiments were undertaken using the procedures detailed in 
Chapter 2. Only two slides were used for experiments with mutant D242 and 
these were dye swaps of the one RNA preparation. To reduce the effect of
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Figure 4.17: Graphical representation of the differentially expressed genes (red 
circles) of the high thebaine and oripavine mutant, D242 compared to the parental 
control C052.
biological differences the single biological sample for each mutant was prepared 
by pooling six independent mutant plants. A total of eighty-six cDNAs were 
differentially under-expressed in the mutant and only fourteen were over-
expressed in the mutant compared to the control (Figure 4.17). For the full list of 
differentially expressed genes see Appendix 5. Due the large number of clones 
found to be differential, sequencing of the entire set was not undertaken.
4.5.4 P. somniferum Low Morphinan Alkaloid Mutant High 
Papaverine Accumulating Mutant D120
Microarray experiments were undertaken using the procedures detailed in 
Chapter 2. Only two slides were used for experiments with mutant D120 and
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Figure 4.18: Graphical representation of the differentially expressed genes (red 
circles) of the high papaverine-accumulating mutant, D120 compared to the 
parental control C052.
these were dye swaps of the one RNA preparation. To reduce the effect of 
biological differences the single biological sample for each mutant was prepared 
by pooling six independent mutant plants.
The microarray analysis revealed one hundred and four cDNAs to be under-
expressed and ninety-six were over-expressed in the mutant compared to the 
control parental phenotype C052 and the papaverine-accumulating mutant D120 
(Figure 4.18). For a full list of the differentially expressed genes see Appendix 6. 
Further analyses of this mutant may provide useful leads to the nature of 
regulatory control at the point of (^-coclaurine in the pathway.
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Further microarray experiments would obviously reduce the number of candidate 
genes, however resources were diverted to the next two subchapters rather than 
concentrating on the germplasm in this subchapter. While sequencing was not 
undertaken of these complete sets of differential genes, these uncharacterised 
differential sets were compared to each other and the differentials of the other 
experiments (section 4.6) in deciding on a set for sequencing and further analysis.
4.6 Comparisons Across The Experiments
As a further focus to the topi experiments the ten genes that were differentially 
expressed were then analysed for their differential expression across the other 
germplasm that were tested in this thesis (Table 4.7). This was undertaken to 
establish which genes of the set of ten were implicated as either affected by the 
morphinan pathway or involved in the pathway. The entire set of ten genes were 
also differentially expressed in: the other thebaine only accumulating mutant 
(F075); the low morphine and high papaverine accumulating mutant D120; the 
low morphine mutant D205; the high total morphinan accumulating mutant 
D242; and the E. californica germplasm. The only lines that these genes were 
not differentially expressed were in: the reticuline accumulating germplasm of the 
mutant E40/41; the Ir-cor reticuline accumulating transgenic and the low 
morphinan alkaloid accumulating P. somniferum cultivar Marianne.
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Table 4.7: The list of ten differential genes from the topi microarray and 
their respective differential expression values, if any, in the other 
microarray experiments undertaken in this thesis. The codeinone reductase 
RNAi experiment Ir-cor, Reticuline accumulating mutant (E40/41) and the 
low morphine P. somniferum cv Marianne are listed in the same column, as 
none of the genes from the topi experiment were differential.
Name
F075
(Thebaine)
E40/41
(R e ticu line ),
Ir-co r
(R e ticu line ), 
P .som n ife rum  
cv M arianne
D120 
(Low  M, 
h igh  
Pap)
D242
(H igh
M+C+T+O)
D205 
(Low  M)
E. ca lifo rn ica
116D7 5.1 nd 6.3 4.3 6.5 6.3
91G3 9.0 nd 14.1 8.7 5.9 6.3
27D12 10.2 nd 11.6 10.0 7.5 7.7
157C4 6.8 nd 6.8 5.4 5.5 9.1
91B6 6.2 nd 10.3 6.2 7.2 2.7
221C9 6.6 nd 7.6 5.3 3.6 4.6
54F9 5.8 nd 8.6 4.9 2.8 4.8
52F2 6.3 nd 7.2 6.8 4.8 6.3
151H8 8.8 nd 7.3 7.6 3.9 5.3
111C7 7.7 nd 8.8 7.7 6.4 7.1
D242 is high oripavine and thebaine. High total M (morphine)+C 
(codeine)+0 (oripavine)+T (thebaine).
D120 is the high (Pap) papaverine low morphine mutant.
D205 is the low morphine mutant.
Reticuline is the reticuline-accumulating mutant E40/41.
F075 is thebaine only accumulating mutant.
All values are indicative of reduced expression in the test sample compared
to the test sample (the wildtype control P. somniferum).
nd, represents the gene was not differential in this experiment.
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4.7 Summary
The use of microarrays has given more information regarding the expression 
profile and significance of the set of ten genes that were shown through an 
exhaustive set of microarray experiments to be differentially expressed in the 
topi mutant. Table 4.7 summarises the results of the expression ratios across each 
of the different mutants and species comparison experiments, excluding the 
codeinone reductase RNAi transgenic and P. somniferum cv. Marianne 
experiments, in which none of the ten genes were differential.
The experiments described in Chapter 4 have implicated a small number of genes 
to be associated with the pathway. The set of ten was arrived at after highly 
repeated experiments with topi mutation; furthermore their expression is 
consistently affected by other perturbations in the alkaloid pathway (Table 4.7).
It was not necessarily expected that the microarray analyses would reveal the 
mutated gene in the various studied mutation lines, and none of the differential 
genes can be considered a strong candidate as the causal gene for any of the 
mutations. However the consistently differential genes are implicated to be 
closely associated with the pathway, directly or indirectly. The strongest 
evidence of association is for the set of ten genes from the twelve topl- 
microarray experiments. In addition several other genes were differential with 
other mutants or transgenics that are possible candidates for alkaloid transport 
and control and warrant further consideration and experimentation.
The codeinone reductase RNAi transgenics have an almost identical alkaloid 
phenotype to the reticuline-accumulating mutant E40/41. The microarray results 
for these two genotypes however are quite different. None of the ten genes 
differentially expressed in topi are differential in the codeinone reductase RNAi 
transgenics.
Likewise none of the ten were significantly differentially expressed in the EMS 
generated reticuline-accumulating mutant, E40/41. However the two sets of 
differential genes for these two reticuline accumulating genotypes, a mutant and a 
knockout transgenic, are also quite different to each other.
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The blast results from the ten differentially expressed genes from the topi 
microarray experiments, does not suggest any as candidates for the demethylation 
of thebaine to neopinone. If the gene responsible for the demethylation reaction 
is a P450, as suggested by homology to the codeine and thebaine detoxifying 
protein in rat microsomes (Kodaira and Spector, 1994), it is possible that the 
P450 is one of the unknown genes from the array. P450 enzymes vary 
remarkably at both the nucleotide and amino acid level (reviewed in Chappie 
1998). If however none of the differential genes is the implicated demethylase, 
some of the possible explanations for failing to detect a convincing candidate for 
the demethylase reaction are:
• The cDNA responsible for the topi phenotype is of low abundance and 
was not printed on the array.
• An homologous gene (or genes) is expressed to such an extent that it 
masks the difference in expression of the mutated demethylase gene.
• The leaf material used for expression analysis is the wrong material and 
the gene is not expressed sufficiently in that tissue. Counter to this 
argument is the fact that morphine and codeine can be detected in leaf 
extracts. It is still unknown if the morphinan alkaloids are made in the 
leaf parenchyma cells and transported into the latex, however several 
genes have been shown to be expressed in leaf tissue (Kutchan and 
Dittrich 1995; Fachinni and De Luca 1994 and 1995b; Rosco et al., 1997; 
Pauli and Kutchn 1998; Unterlinner et al., 1999; Facchini and Park 2003; 
Ounaroon et al., 2003; Weid et al., 2004).
• The transcript levels of the demethylase gene(s) may remain unaffected in 
the mutant even though the mutation affects the catalytic activity, 
transport and/or translational modification process of the enzyme. Further 
to this post transcriptional control may be taking place affecting the level 
of translation and subsequently the level of enzyme activity. The 
transcript of the demethylase may still be produced at the same levels but 
the lifetime of the RNA may be altered again affecting the level of 
translated product but not necessarily the transcript levels seen on the
159
array. Similarly alternative splicing of the RNA could affect translation 
levels but not message levels.
Of course it also conceivable that topi does not directly affect the demethylation 
reaction, rather it is a structural change, which prevents the thebaine being 
delivered to the compartment where the demethylase is active. For example 
thebaine-accumulating vacuoles in the latex appears to be distinct from the 
morphine accumulating vacuoles in size and density (Pham and Roberts, 1991).
It is also possible that one or more of the topi ten differential genes is physically 
linked to the mutation responsible for the topi phenotype and its transcription is 
affected by the mutation. An argument against this hypothesis is that the same 
ten genes are also differentially expressed in all but one of the morphinan 
alkaloid mutants studied in this thesis and the low morphine P. somniferum cv 
Marianne. This suggests that these ten genes are not specifically causative of any 
of the mutations but are affected by the different perturbations to the alkaloid 
pathway. This chapter will investigate, where possible, each of the set of ten 
genes to establish a possible link with the alkaloid pathway. The analysis of 
these genes will include transcript analysis to further authenticate the set of ten 
genes as differentially expressed.
Some of the candidate genes have strong matches in the databases, which will 
allow some speculation of how they are associated with morphine biosynthesis 
and will guide future experimentation to confirm their roles. The initial analysis 
might involve comparing the genomic sequences of any of these differentially 
expressed genes from the mutant with the control to see if there are sequence 
variations in the structural enzyme. This initial comparison would not include 
possible differences in the promoter regions, which would require isolation of 
promoter sequences. A second stage of analysis of differential genes could be to 
knock out their activity in transgenic control plants; any effects on alkaloids 
would confirm the association with the pathway; a phenotype mimicking the 
original mutant would implicate the gene as the point of lesion in the original
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mutant. The ultimate confirmation that the gene was the point of lesion would be 
to “rescue” the wild type phenotype by expression of the gene in the mutant.
The ten differentially expressed topi genes will be briefly reviewed in the next 
chapter, and where possible within the time constraints of this PhD study, further 
experiments described to advance understanding of the potential association with 
the morphine pathway.
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Chapter 5
Further Characterisation Of The Genes Specific To The topi
Mutant
5.1 Introduction
The large quantity of secondary metabolites, their structural complexity and their use 
of nitrogen, an essential component of primary metabolism, are highley suggestive of 
an important role for secondary metabolites in the plant’s fitness and survival. The 
morphinan pathway is a case in point and recent evidence suggests that the 
morphinans are under intricate control and regulation (Bird et al., 2003; Weid et al., 
2004). Plant breeding programs have been responsible for large increases in 
morphinan alkaloid yields over recent decades, however even wild Papaver species 
have these complex products accumulating to high concentrations, suggesting they 
are contributing to fitness.
The P. somniferum morphinan alkaloid pathway is important not only because it 
produces such diverse and complex compounds more efficiently and in larger 
quantities than can be achieved via in vitro synthesis, but because of the insights it 
offers into how enzymes can perfonn such complicated reactions. The chemical 
reactions required to make these compounds, for example the reaction catalysed by 
the BBE enzyme, are so complex they defy in vitro mimicry.
Progress in unravelling the morphinan alkaloid pathway has been constrained by its 
restriction to a non-model species and by the limited availability of mutants in the 
pathway. Professor Zenk and co-workers have elucidated many of the enzymatic 
steps of the pathway from cell suspensions (Rueffer et al., 1981; 1983; Rueffer and 
Zenk, 1987; Stadler et al., 1988, Frenzel and Zenk, 1990; De-Eknamkul and Zenk,
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1990; De-Eknamkul and Zenk, 1992; Gerardy and Zenk, 1993a, b; Lenz and Zenk, 
1994; 1995a,c), and the laboratories of Professor Kutchan and Professor Facchini 
(Facchini and De Luca 1994; Pauli and Kutchan, 1998; Unterlinner et al., 1999; 
Ounaroon, et al., 2003) have isolated several structural genes. Understanding of the 
steps and structural genes of the pathway is slowly emerging, however almost 
nothing is known of its regulation and the transport of the various intermediates and 
the end products.
Early work has shown that the specialised vacuoles of the laticifers of the opium 
poppy are responsible for the storage of the various products and intermediates. 
However surprisingly there is some immunolocalisation results suggesting the 
enzymatic steps responsible for these products do not occur in these compartments 
(Bird et al., 2003; Weid et al., 2004). This would suggest that there are several 
levels of intermediate shuttling occurring via transport vesicles in and out of these 
vacuoles. Recently proteomics work has been published on the latex of P. 
somniferum revealing a snapshot of the proteins found in this specialised system 
(Decker et al., 2002). This work is substantial and offers a general insight into some 
of the proteins found in the latex. However many of the protein spots were not 
sequenced and for those that were, only short lengths of N-terminal sequencing were 
obtained. Furthermore there is a lack of annotated P. somniferum genes present in the 
database; consequently Decker et al., 2000 failed to give any functional assignment 
to many of the proteins.
Several mutants have been isolated at Tasmanian Alkaloids Pty Ltd. and one such 
mutant topi has been characterised using biochemical methods of analysis. Further 
characterisation of the transcriptome has been undertaken in this thesis using cDNA 
microarrays to reveal a set of ten differentially expressed genes that are all under-
expressed not only in the topi mutant but across several independent mutants 
compared to the control C052.
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This chapter will investigate, where possible, the roles of the seven genes with 
associated function and show further evidence to their involvement in the mutant 
topi phenotype. This will include: the further authentification of the microarray data 
using quantitative real time PCR analysis; analysis of the ten genes’ expression 
across root, stem and leaf tissue using reverse transcriptase PCR techniques; several 
of the genes with substantial associated function though blast searches will be further 
analysed; and finally an F3 population segregating for the topi phenotype will be 
analysed for the ten genes’ traits. This work will then be dicscussed as to its 
relevance and future directions proposed.
5.2 Quantitative Real Time PCR Analysis
Microarrays are beneficial in that they enable a large number of genes to be screened 
quickly. However a major drawback of cDNA spotted arrays is the chance of cross-
hybridisation of families of homologous expressed genes; since the cDNAs are long 
sequences there are more opportunities for segments of homology to be shared with 
various gene families. Cross-hybridisation can lead to the dilution of the real value 
for differential expression of a gene or can sometimes lead to the wrong cDNA being 
calculated as differentially expressed when in fact it is another differentially 
expressed gene that has reasonable sequence homology binding to the cDNA on the 
array. To confirm if the genes that are differentially expressed in the arrays are in 
fact the right genes semi-quantitative real time-PCR (qRT-PCR) analysis was 
undertaken. QRT-PCR enables specific primers to be used enabling the 
determination of expression of single genes if nucleotide differences can be obtained. 
This method is also more sensitive than PCR analysis and can allow the semi-
quantification of the expression of each of the cDNAs to authenticate the microarray 
results.
Quantitative real time PCR analysis was undertaken on the same tissue type as the 
microarray experiments using new biological material. The qRT-PCR data
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authenticated the microarray data (Table 5.1) showing the genes that could be tested 
were down regulated in the mutant topi compared to the control C052. Data could 
not be obtained for the gene 52F2. Several primer sets were designed and tested on 
RNA extracted from both the control and the mutant, but it was not possible to get a 
single band for qRT-PCR quantification. The presence of several bands suggests 
that there is possibly a gene family representing this clone with multiple isoforms in 
the poppy genome, several transcript variants or a combination of both situations 
making it difficult to get a single band using PCR primers until more sequence data 
is known of this gene or gene family.
The expression ratios for several of the genes however, differed between the 
microarray and the qRT-PC calculations. The specificity of the qRT-PCR primers 
enables targeting of a particular cDNA sequence whereas the cDNAs on the 
microarray are subject to hybridisation of a number of homologous sequences that 
may not be differential, reducing the differential expression ratio.
Five of the genes’ (116D7,91G3, 157C4, 91B6 and 151H8) qRT-PCR differential 
ratios were lower than the corresponding microarray ratios, and two of these five 
genes, 91B6 and 151H8, had differential ratios less than the arbitrary cut-off of two 
(Table 5.1). The possible reason for this is that the cDNA on the microarray is 
binding other homologous cDNAs, all of which are differentially expressed; the 
qRT-PCR primers may be more specific and detect only some of these differential 
homologues. Four of the genes, 27D12; 54F9; 221C9 and 111C7, had larger 
differential expression ratios (27D12: 7.5, 54F9: 6.7, 221C9: 69, and 111C7: 3.2) 
than the microarray ratios (27D12: 4.7, 54F9: 3.9, 221C9: 3.4, and 111C7: 2.9) 
(Table 5.1). The possible reason for this is that the qRT-PCR primers were designed 
to the specific cDNA which is affected by the topi mutation and that on the 
microarray the homologous transcripts are masking the differential effect. A study 
using a microarray containing synthetic gene fragments with decreasing sequence 
identities ranging from 100% to 60% revealed a cross hybridisation result between
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80-90% (Girke et al., 2000). One gene 221C9 had a 69-fold decrease in expression 
in the mutant topi compared to the wildtype C052.
The qRT-PCR analysis has strengthened the conclusion that at least seven of the ten 
genes are reproducibly differentially expressed in topi. This in turn has strengthened 
the impetus to find the link between these genes and the morphine pathway.
5.3 Reverse Transcriptase PCR
To further our understanding of the set of ten genes it was decided to analyse their 
spatial expression and determine if the genes are expressed where it is thought the 
alkaloids are predominantly synthesised.
To study spatial expression, reverse transcriptase PCR was used to compare the 
gene’s expression between the topi mutant and the control in leaf, root and stem 
tissue. This method was used in preference to qRT-PCR, as it was not possible to 
find a control gene for use in standardisation that remained unchanged across all 
three tissues types used. Primers designed to several P. somniferum genes were tried 
as qRT-PCR controls such as codeinone reductase, cyp80, BBE, TYDC, and the 3 
different Major Latex Proteins all of which were deemed to variable across the three 
tissue types and between the two genotypes to be used as successful controls. The 
study was undertaken on root, stem and leaf mRNA as this material is easily isolated 
and is thought to be the main areas of synthesis of alkaloids. The expression of these 
genes in latex would also be important information in determining the relationship of 
the expression of these genes and the accumulation of the morphinan alkaloids in the 
latex, however RNA extractions from the latex was difficult and only yielded 
degraded RNA.
The analysis of message levels was undertaken in leaf, root and stem tissue taken 
from the mutant topi and the control. RNA was extracted from new plants grown
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under the same conditions as the plants used for the microarray analysis (see sub 
Chapters 2.2 and 2.3) with the exception being material collected for the stem which 
was taken 4 days post petal drop (see Figure 1.7). Primer sets from the qRT-PCR 
were used and these worked for all of the ten genes except for two (52F2 and 91B6) 
that always gave multiple bands despite trying four different sets of primers for each 
gene and high annealing temperatures (62-65°C) for increased stringency. This 
suggests these two genes may belong to multi-gene families with different sized 
mRNA populations, or different RNA products, but with very similar sequence 
homology to the cDNA that was isolated from the microarray analysis.
The results of these experiments verified the qRT-PCR results for the leaf samples, 
however they also showed some differences between the expressions of these genes 
in the mutant topi compared to the control over the other tissue types (Figure 5.1). 
Not surprisingly the primers for 116D7 could not detect any message in the roots of 
either the mutant or the wild-type plant as this encodes a gene with a substantial hit 
to a chlorophyll a/b-binding protein. Expression of the other seven genes could be 
detected in stem and root tissue types.
The Rt-PCR experiments also give some information as to the level of expression of 
these genes across the various tissue types. The genomic controls yielded larger 
PCR products using the same primer combinations for several of the genes (91G3, 
27D12, 157C4 and 111C7) suggesting there is an intron or introns present between 
the sequence/s that the specific primer combinations yielded. The size difference 
between the RNA amplified products and the genomic material gives confidence in 
there being no contamination of genomic DNA in the RNA extractions.
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Figure 5.1: Reverse transcriptase PCR results of the eight differentially regulated 
genes from the topi mutant across leaf, stem and root transcript. The genomic 
control is also shown on the far right. This was obtained using C052 genomic DNA 
and the same primers used for the qRT-PCR reaction.
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Interestingly 3 genes, 54F9, 151H8 and 221C9 were differentially under expressed 
across all of the tissue types tested in the mutant topi compared to the control tissue 
samples. 221C9, which has homology to an aspartate aminotransferase, also had a 
large large decrease in expression in the mutant further authenticating the qRT-PCR 
and microarray data showing. The other two genes 54F9 andl51H8 have no 
substantial homology to any sequences in the NCBI database. 151H8 had a lower 
qRT-PCR value than the cut-off of 2 suggesting that the level of expression does not 
change substantially between the mutant topi and the control C052.
Two genes, 157C4 and 111C7, showed a large increase in expression in the topi 
mutant root over the control root expression (Figure 5.1 and Table 5.1) which has 
much lower levels of expression of either gene in the stem or leaf material. It is 
difficult to explain this situation except for the possibility of a feedback system. This 
could be explained by the mutation occurring in a positive regulator of expression of 
either or both the genes which is specifically expressed in the upper part of the plant 
(stem and leaf) and the plant is compensating by increasing transcript production in 
the roots with a different regulator which has been unaffected by the mutation.
Each of the genes, from the set of ten, with homology to known genes in the database 
will now be discussed as to their possible involvement in alkaloid biosynthesis.
5.4 Chlorophyll a/b Binding Protein 116D7
The cDNA (116D7) that has homology to a chlorophyll a/b binding protein seems to 
be differentially expressed in a number of mutations (Table 4.7) including the main 
focus of this thesis, the topi mutant. However this gene is not differentially under-
expressed in the reticuline-accumulating mutant. These results suggest that the 
altered expression of this gene is a pleiotropic affect when the alkaloid pathway is 
perturbed in a number of ways. It is also conceivable that this chlorophyll a/b gene is 
affected due to possible pleiotropic changes in energy supply or that this gene is in
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competition with another gene/s associated with the pathway. The gene 116D7 is 
only expressed in green tissue as confirmed by reverse transcriptase PCR expression 
data (Fig. 5.1 and Table 5.1) showed that it is only expressed in green tissue 
consistent with its presumed association with the photosynthetic machinery and its 
being under similar expression controls.
The chlorophyll a/b gene that 116D7 is closest to is that of the light-harvesting 
chlorophyll a/b binding protein Lhca2.1. The Lhca2 gene, to which Lhca2.1 is most 
similar, encodes one of the polypeptides of the light-harvesting complex of 
photosystem I. Lhca2.1 is thought to be too lowly expressed in Arabidopsis to have 
a role in the light-harvesting antennae and its function is still to be determined 
(Jansson 1999). Figure 5.2 illustrates the relatedness of the translated P. somniferum 
cDNA 116D7 to the Arabidopsis Lhca2.1 protein and to the rest of the Arabidopsis 
Lhca gene family. Another translated P. somniferum cDNA, 209F1, differentially 
expressed from the reticuline-accumulating mutants (E40/41) microarray, is also 
compared to the Arabidopsis Lhca proteins to show how divergent the P. somniferum 
proteins are fonn the Arabidopsis Lhca proteins.
A search of the literature did not reveal any direct links between photosynthesis and 
alkaloid production. The only possible link that can be attributed at this time would 
be the correlation that alkaloid genes and hence alkaloid synthesis (Facchini and 
Park, 2003) is increased due to stresses on the plant such as fungal attack and that 
photosynthesis is known to be down regulated in similar situations (Jung et al., 
2003). While both the alkaloid and photosynthetic pathways require nitrogen it is 
possible that the increase in alkaloids and nitrogen is offset by a reduction in 
photosynthesis. However the level of photosynthetic activity in molar terms far 
exceeds the level of alkaloid production in the plant making this simplistic link an 
unlikely explanation.
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116D7
Lhca2.1
Lhca2
Lhca5
Lhca6
Lhca3i1
209F1
Lhcal
Lhca4
Figure 5.2: Tree illustrating the relatedness of seven Arabidopsis thaliana 
chlorophyll light harvesting complex I (Lhca) protein sequences (Lhcal, Lhca2, 
Lhca2i, Lhca3i, Lhca4, Lhca5 and Lhca6). The sequence of 116D7 showed closest 
homology to the Lhca2i gene. The translated sequence of the 209F1 clone, shown 
here to reveal homology between the Papaver and Arabidopsis Lhca genes from the 
reticuline accumulating experiment (subchapter 4.4.2) was closest to the Lhcal gene. 
(Adapted from Jansson 1999) Phylogenetic and molecular evolutionary analyses 
were conducted using MEGA version 3.0 (Kumar et al., 2004). Numbers on 
branches are ClustalW scores for the two closest aligned protein sequences from 
each branch.
Arabidopsis Lhcal - NCBI Accesion Number M85150.
Arabidopsis Lhca2- NCBI Accesion Number AT3G61470.1.
Arabidopsis Lhca2.1- NCBI Accesion Number ATIG19150.1.
Arabidopsis Lhca3.1- NCBI Accesion Number U01103.
Arabidopsis Lhca4- NCBI Accesion Number X71878.
Arabidopsis Lhca5- NCBI Accesion Number AF134121.
Arabidopsis Lhca6- NCBI Accesion Number AF134130.
Papaver somniferum- 209F1 and 116D7 from this thesis.
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5.5 Aminotransferase like cDNA 221C9
Some attention has been given to 221C9, the amino transferase-like gene, because of 
the large difference in expression levels in the qRT-PCR results and all three tissue 
types in the RT-PCR data. The blast results revealed high homology to a gene with 
a known and characterised aminotransferase activity. The sequence has no similarity 
to cytochrome P450 enzymes and it seems very unlikely an aminotransferase could 
have been modified to catalyse the demethylation reaction of thebaine to neopinone.
GGTTTGCAAATCATCGGATGTGGCTAGCAGAGTTGAAAGTCAGCTGAAACTTGTTATCAG
GCCTATGTATTCAAATCCTCCCGTGCATGGCCCATCTATTGTGGCTACGGTCCTGAAAGA
TAGAGACTTGTACAATGAGTGGACTCTAGAGCTGAAAGCTATGGCTGACAGAATAATAA
GTATGCGTCAGCAACTATTTGATGCATTACGTGCAAGAGGTACACCAGGTGATTGGAGTC
ACATTATTAAACAAATTGGGATGTTTACTTTCACTGGTTTGAATAAAGAGCAAGTTGCTT
TCATGACTAGAGAATATCACATCTACATGACTTCTGATGGG>taaatgtctctatgcttacttgattacaattgc
aaggtcaatgctccttgattacaattgcaaggtcaatgctcaggatcaatatgggctattgttcagaatcccatgtcattttcatgggatatcattataagt
ctcctgtgctgcttgcatttcgtgtagatcctggaggaaacctatccaatattacagacaccggtttcctttaattttttttgttccttttctgaaacatgaattt
gtaaaggaattctcttgtcatgcaggagaattagcatggcgggttta<AGTTCAAGGACGGTGCCTCACCTTGCGGATG
CTATTAATGCTGCTGTGACCCGTATGGGTTGAGCAAAACTTGGTATCAAATTGTGTAGGA
TGCCTTTCGGAGGTTTGCTTTTTAATTTTATTTTTATTCTCTGTTGCAATAAAAAACAGCTC
AACAATTAGTGATGTAAGCTGCAGTTCCTAATTCGATTGAATCTCACGTGAGATATTTGC
CCCATCTTTTATAGAAATGAAACTTACTATGTGAGTTTTGTTTTTCCTTTTCTCTGGAAGTC
GAGGATTTTAATAGAGTGACTAACAAATGGACTCTTGTTGGAAAAAAAAAAAAAAAAAA
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
Figure 5.3: The nucleotide sequence for the P. somniferum cDNA 221C9. The blue 
sequence, enclosed by the symbols < >, is the region of the cDNA that does not align 
with any of the ESTs from the NCBI database.
Poppy cDNA 221C9 was found to be differentially under-expressed in microarray 
experiments comparing a number of other mutants to the controls; this was also true 
for the entire set of 10 topi differentially expressed genes (Table 4.7). However, 
the set of ten genes from the topi microarray experiments were not differentially 
expressed in either the Reticuline mutant or in the hairpin RNAi codeinone reductase
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GGTTTGCAAATCATCGGATGTGGCTAGCAGAGTTGAAAGTCAGCTGAAACTTGTTATCAG
GCCTATGTATTCAAATCCTCCCGTGCATGGCCCATCTATTGTGGCTACGGTCCTGAAAGA
TAGAGACTTGTACAATGAGTGGACTCTAGAGCTGAAAGCTATGGCTGACAGAATAATAA
GTATGCGTCAGCAACTATTTGATGCATTACGTGCAAGAGGTACACCAGGTGATTGGAGTC
ACATTATTAAACAAATTGGGATGTTTACTTTCACTGGTTTGAATAAAGAGCAAGTTGCTT
TCATGACTAGAGAATATCACATCTACATGACTTCTGATGGGAGTTCAAGGACGGTGCCTC
ACCTTGCGGATGCTATTAATGCTGCTGTGACCCGTATGGGTTGAGCAAAACTTGGTATCA
AATTGTGTAGGATGCCTTTCGGAGGTTTGCTTTTTAATTTTATTTTTATTCTCTGTTGCAAT
AAAAAACAGCTCAACAATTAGTGATGTAAGCTGCAGTTCCTAATTCGATTGAATCTCACG
TG AG AT ATTTGCCCC ATCTTTT AT AG A A ATG A AACTT ACT ATGTG AGTTTTGTTTTTCCTTT
TCTCTGGAAGTCGAGGATTTTAATAGAGTGACTAACAAATGGACTCTTGTTGGAAAAAAA
AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
Figure 5.4: The nucleotide sequence for Del 221C9. This is the nucleotide 
sequence from Figure 5.1 without the nucleotide sequence in blue that does not align 
to any of the ESTs from the NCBI database. The stop codon TGA is represented in 
red.
microarray experiments (Table 4.7). This suggests that the 221C9 cDNA (and the 
other nine topi differential genes) is associated with perturbations to the pathway in 
the later morphinan branch but not to perturbations resulting in accumulation of the 
earlier reticuline intermediate.
Blasting the poppy cDNA 221C9 against the NCBI EST database shows that the 
221C9 cDNA has an insertion that is not present in other ESTs that align to this 
gene. It seems likely that it is an unspliced intron present in cDNA 221C9. This 
insertion is shown in blue in the sequence in the Figure 5.3. Using this information a 
sequence was constructed without the novel inserted sequence (blue insertion) from 
Figure 5.3 and called Del_221C9 (Figure 5.4). The new nucleotide sequence 
translates into a longer protein by 20 amino acids (Figure 5.5), as the stop codon that 
occurred in the intron is no longer present to terminate translation.
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a) . Del 221C9 Translated - Longest ORF [Frame 2] 112 amino acids 
MYSNPPVHGPSIVATVLKDRDLYNEWTLELKAMADRIISMRQQLFDALRARGTPGDWSHIIK 
QIGMFTFTGLNKEQVAFMTREYHIYMTSDGSSRTVPHLADAINAAVTRMG
b) . Poppy 221C9 Translated - Longest ORF [Frame 2] 92 amino acids 
MYSNPPVHGPSIVATVFKDRDFYNEWTLEFKAMADRIISMRQQFFDAFRARGTPGDWSHIIK 
QIGMFTFTGFNKEQVAFMTREYHIYMTSDG
Figure 5.5: The translated open reading frames of the cDNA 221C9. a). Is the 
longest translated open reading frame of the Del_221C9 nucleotide sequence which 
shows the extra 20 amino acids in red that are not present in the translated 221C9 
sequence (b) that still contains the extra nucleotide sequence not found in the 
aligning ESTs in the database.
Alignment of the poppy cDNA 221C9 with homologues in the database revealed that 
the poppy clone contained an unspliced intron at the 3’ end (Figure 5.6). New 
primers (Figure 5.6) were designed to various regions of the cDNA for RT-PCR to 
check the qRT-PCR data. The results showed that the transcript intron seems to 
splice in the mutant but not in the control.
The 5’ forward primer of the original primer set (AGM180) used for the qRT-PCR 
was designed to the unspliced region in the 221C9 cDNA. The original cDNA clone 
221C9 was taken from the cDNA library generated from the control C052 plant and 
contains the unspliced intron. The mutant contains spliced versions of the transcript 
and it is the difference in the splicing of the intron that has caused this gene to appear 
to be differentially under-expressed; perhaps the presence of the intron in the 
transcript renders it more stable to degradation and therefore the microarrays will 
register the difference in the size of the transcript pool. It is possible that 221C9 
transcript in the control translates to a protein with no function compared to the
176
AGM265 (262 285)
I
AGM263(254 277)
Exon I
AGM261 (107-130) (1340) ' l l
t
Intion 
(341 310)
AG Ml 80 
(411431)
*
AGM264 
(498-521)
Exonll
(611-681)
AGM81
(647366)
AGM262 
(876 399)
3 ’ UTR 
(667-929)
I
I
Poly A tail
i
/
221C 9
995 bp
Figure 5.6: A diagrammatic representation of the cDNA 221C9, which shows the 
unspliced intron found in the control phenotype. The diagram also shows the 3’ 
untranslated region (3’ UTR), the two coding regions in red (Exon) and the Poly A 
tail of the cDNA. The blue arrows illustrate where each of the primers were 
designed to in the nucleotide sequence with the arrow showing the direction in which 
that primer amplified in for PCR. The primers AGM180 (5’ forward) and AGM 181 
(3’ reverse) were the original primers used for the qRT-PCR experiments that gave a 
69-fold difference in expression levels between the mutant topi and the control 
C052. AGM 180 is to the intron itself. Figure 5.7 shows the results obtained from 
the different combinations of each of the primers. The blue arrow representing each 
primer represents the DNA strand to which it binds and the arrow signifies the 
direction of amplification.
spliced version in topi plants. The non-spliced transcript may also translate to a 
protein with altered function. The altered splicing may not just be specific to this 
gene it may be occurring in other genes, one of which could be responsible for the 
alkaloid defect. This could also explain why so many protein changes are observed 
but not transcriptional changes.
Sequencing comparisons of the gene in genomic DNA of the mutant and control was 
undertaken, using primers to the 5' UTR region of the poppy aminotransferase
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221C9, to ascertain if there was an internal sequence mutation causing the splice- 
variant of 221C9 in the mutant. This experiment was unsuccessful; sequence from 
both genomic samples was of good quality for a few hundred base pairs from the 5’ 
end but then suddenly became undecipherable, suggesting that there are several 
polymorphic copies of the gene. Only by cloning each of the genes could this be 
resolved further.
More primers were designed to try to ascertain if a mutation lies between the mutant 
and control genes of 221C9. RT-PCR was conducted with various combinations of 
primers on RNA isolated from both the mutant topi and control to see if there were 
differences in the size of the products (Table 5.2) resulting from EMS-induced 
deletion. The resulting RT-PCR reactions using these primer combinations revealed 
some interesting results (Figure 5.7). Equal concentrations of RNA were used for 
the RT-PCR reactions and each reaction was run for 30 cycles to determine a 
difference in transcript levels. The first primer combination (Figure 5.7 number 1) of 
AGM180 and AGM181 was used as a control as these were the primers used for the 
verification of the of the microarrav data. This primer combination amplifies part of 
the intron and the second exon (Labelled Exonll in the Figure 5.6). The expected 
amplified bands are of 255 bp if the intron is present and no band is expected in the 
RT-PCR reaction of the RNA if the intron has been spliced. The expected non- 
excised band of 255 bp was seen in both the control and the topi mutant but to a 
much lesser extent. The genomic DNA showed that the 255 bp DNA fragment is 
present in both the mutant and control genomes. Another control reaction was with 
primers designed to the first open reading frame only (primers AGM261 and 
AGM263). As expected both the control and topi RT-PCR reactions produced a 170 
bp fragment. The genomic PCR revealed that there was more than just the 170 bp 
fragment present in both the control and mutant genotypes. It is possible that there is 
more than one gene coding for the aminotransferase 221C9 with different sized 
introns that are excised and not seen in the RT-PCR reactions. To test this theory the 
fragments would need to be cloned and sequenced and this sequence data compared
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Table 5.2: The primer combinations used to test for intron splicing of 221C9.
# Primer Primer Region Amplified Size expected Size Expected
5’ 3’ + Intron (bp) - Intron (bp)
1 AGM180 AGM181 Intron to Exonll 255 0
2 AGM180 AGM262 Intron to 3’ UTR 488 0
3 AGM180 AGM264 Internal to Intron 110 0
4 AGM261 AGM181 5’ExonI to Exonll 559 290
5 AGM261 AGM262 5’ ExonI to 3’ UTR 792 523
6 AGM261 AGM263 5’ ExonI 170 170
7 AGM261 AGM264 5 ’ ExonI to Intron 414 0
8 AGM265 AGM181 5’ ExonI to Exonll 404 135
Primer combinations used to test for differences between the topi and control 
aminotransferase 221C9 gene. Each primer pair was tested on RNA and genomic 
DNA extracted from the topi mutant and control plant. See Figure 5.6 for the 
position of each of the primers. The number (#) of the primer combination is given 
for reference for the resulting RT-PCR reactions (Figure 5.6). For primer sequences 
see Table 2.1.
to the aminotransferase 221C9 sequence. The second reaction undertaken (Figure 
5.7- 2) of the primers AGM180 and AGM262 were internal to the intron but this 
time to the 3’ untranslated region to detect if there are some different translational 
modifications. As can be seen in figure 5.7 there are three different bands in the 
control RT-PCR lane ranging in size from the expected 488 bp to about 250 bp and 
this range is also seen in the genomic samples for both the control and mutant 
phenotype suggesting that there are several copies of the same gene with different 
length regions between this primer pair or different splice sites 3’, especially as it 
means that the intron seq needs to be conserved. The topi RNA showed a reduced 
level of amplification of the same size band suggesting that there is a very low level 
of non-splicing of the intron taking place or another copy of the gene with the intron 
present and not spliced giving a lower level of transcript from which to amplify the 
product.
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The third reaction was undertaken using primers AGM180 and AGM262, which are 
both internal to the intron. The resulting 110 bp fragment could be seen in the 
control and again to a lesser extent in the mutant. Another band at around 700 bp 
could be seen amplifying in the control RT-PCR and in both the control and mutant 
genomic DNA PCR reactions. It is possible this is a primer artefact, however it is 
unusual that the band could not be seen in the topi mutant RT-PCR reaction 
suggesting that there may be another amplification product specific to this primer 
pair that is also downregulated in the mutant. Further work needs to be done on this 
however by sequencing the product and comparing the sequence to the 221C9 
sequence.
The next two sets of primers dealt with the 5’ end of the 221C9 sequence. Firstly 
two primers were designed to the 5’ end of the first open reading frame (ExonI in 
Figure 5.6). The first of the primers AGM261 was to a region of high homology 
across the aminotransferases in the database and the second 5’ primer AGM262 was 
to a less conserved region of the first open reading frame of the compared sequences 
of the aminotransferases in the database. Using the first primer to the more 
conserved region AGM261 no result could be obtained for reaction four with the 3’ 
primer AGM181, which was internal to the second open reading frame (Exonll in 
Figure 5.6). The size fragment expected from this reaction was 559 bp if the intron 
was not excised or 290 bp if it was. Both of these bands could only be seen in the 
topi genomic sample but not in the control or any of the RT-PCR reactions. Several 
other distinct bands could be seen in the topi genomic sample which again were not 
reciprocated in the control genomic or either of the RT-PCR reactions. It is possible 
that this was a bad primer combination. This reaction was repeated in reaction 8 
using the primer AGM262 to the less conserved region of the first open reading 
frame (ExonI in Figure 5.6) and the same 3’ primer as in reaction four. This time the 
expected result for the non-splicing event (404 bp fragment) could be seen in the 
control along with some splicing taking place as well, the 135 bp fragment. The topi 
mutant RT-PCR produced very little product of the unspliced form (404 bp in size)
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Figure 5.7: RT-PCR results of the 8 primer combinations used to test for any 
deletion mutations between the topi splicing-variant of the poppy aminotransferase 
221C9 and the non-splicing control version. The topi genomic DNA or RNA
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sample used for the RT-PCR or PCR respectively is represented by (/) and the 
control sample is represented by (C). RNA was used for the RT-PCR and genomic 
DNA for a PCR of the respective control or topi samples. The numbers 1-8 
represent the primer combinations used in each of the RT-PCR reactions. See Table 
5.2 for the list of primer combinations and the expected RT-PCR product sizes. The 
Promega 1 Kb marker is run on the left as a DNA ladder for approximate size 
determination.
and the major product was of the spliced version (135 bp). The genomic DNA 
amplified a single band of 404 bp showing that both genomes contain the unspliced 
intron.
1 2 3
1500 bp 
1000 bp
Figure 5.8: Cloning of the 5’end of 221C9 cDNA (Poppy aminotransferase) Using 
the 5’ primer SP6 to the vector containing the cDNA and 3’ primer (1) AGM181 
(647-666 bp) Extra 900 bp (not cloned), (2) AGM263 (254-277 bp) Extra 1200 bp 
(cloned) and (3) AGM264 (no product). See Figure 5.5 for primer positions. The 
sizes are listed on the gel for the 1000 bp and 1500 bp fragments of the DNA ladder 
(Promega 1 Kb DNA ladder) (left lane).
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Exonl (12-1310bp)
Intron (1311-1580bp)
Exonll (1581-1651 bp) 
3’ UTR (1652-1914bp) 
Poly A tail
(1968 bp)
Poppy Aminotransferase
Figure 5.9: The poppy aminotransferase gene. The diagram represents the cDNA 
221C9 from the topi microarray experiments along with an extra 1003 bp at the 5’ 
end of the gene found using the SP6 vector primer at the 5’ end of the inserted cDNA 
sequence and the internal 3’ reverse primer AGM263.
The last comparison that was made between the topi mutant and control 221C9 
transcripts was with a 5' primer (AGM261) to the first open reading frame (Exonl in 
Figure 5.6) and to either a 3’ primer (AGM264) internal to the intron (Reaction 7 in 
Figure 5.7) or a 3’ primer (AGM262) to the 3’ untranslated region intron (Reaction 5 
in Figure 5.7). The result for the primer set amplifying from within the intron 
(Reaction 7 Figure 5.7) showed a band running at a size of approximately 400 bp in 
both genotypes, which is the expected size for the product if the intron is not excised. 
The topi mutant also gave a band of the same size but the band was not as intense 
suggesting that there was less non-excised intron 221C9 transcript available for the 
RT-PCR reaction. The genomic PCR of both samples gave several bands including 
an approximate 400 bp fragment. Again this could be due to several copies of the 
aminotransferase with different sized introns being present or the aminotransferase 
genes could be close together on the same chromosome/s. The reaction that 
encompasses a fragment from the first open reading frame across the intron to the 3’ 
untranslated region of 221C9 (Reaction 5 in Figure 5.7) gave some interesting 
results. The control RT-PCR reaction gave a band the same size (500 bp) as 
expected for the topi mutant without the intron present. If the intron was not excised 
then there should be a 792 bp fragment, which isn’t seen. It is possible that the
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Figure 5.10: Alignment of the Poppy aminotransferase gene 221C9, including the 
cloned 5’ coding region, with other aminotransferases from the database. The colour 
code represents the quality of the alignment. BAD AVG GOOD 
Panicum miliaceum (proso millet) aspartate transaminase (EC 2.6.1.1) AAT2 -  proso 
millet. NCBI Accession number S53303.
Daucus carota (carrot) aspartate aminotransferase, cytoplasmic (Transaminase A). 
NCBI Accession number P28734.
Arabidopsis thaliana aspartate aminotransferase, chloroplast / transaminase A 
(ASP3) (YLS4). NCBI Accession number NP_ 196713.
Glycine max (soybean) aspartate transaminase (EC 2.6.1.1) AAT1 peroxisomal/ 
glyoxysomal precursor - soybean. NCBI Accession number T06136.
T-COFFEE, Version_1.41 was used for the amino acid alignments (Notredame et al.,
2000).
excised version of the cDNA was amplified in the PCR reaction preferentially over 
the larger fragment, or that there is another aminotransferase present that this primer 
combination can amplify but that previous combinations could not. The genomic 
PCR results using the same combination of primers gave different banding patterns 
between the control and the mutant. This again suggests that there are multiple 
copies of the gene with different sized introns or tandem repeats of the 
aminotransferase gene.
Using the reverse primers AGM181, AGM263 and AGM264 (See Figure 5.6) and 
the vector primer to the 5’ end of the cloned cDNA insert it was possible to amplify 
the 5’end of the aminotransferase gene from the control C052 cDNA library (Figures 
5.8 and 5.9). One fragment was cloned from the primer combination 5’ SP6 and 3’ 
AGM263 which was approximately 1400bp in length. Sequencing and BLAST x 
analysis showed that this fragment was longer than the coding region of
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aminotransferases in the database and therefore is giving some of the 5’ UTR region. 
Alignment of this sequence with the poppy cDNA 221C9 showed that the two 
sequences overlapped and the subsequent BLAST x analysis of the full contig 
revealed that the gene was in fact an aminotransferase. It aligned best to the Daucus 
(carrot) aspartate aminotransferase (Figure 5.10). There are 4 distinct 
aminotransferases in Arabidopsis with 3 different localisations; AAT2 is cytosolic, 
AAT1 is mitochondrial and AAT3 is chloroplastic. The Poppy aminotransferase 
falls between the plastid, mitochondrial and cytosolic AAT types and not to any 
particular one type. Without further analysis such as localisation studies it is difficult 
to classify the cDNA 221C9.
Several bands could be seen in these reactions that were in the control but not in the 
topi mutant (for example the 750 bp product seen in reaction 3) suggesting that there 
may be homologous regions outside the aminotransferase coding region and that the 
primer pairs are amplifying a larger construct. The first obvious step would be to 
undertake Southern analysis of the aminotransferase gene in the poppy to see if there 
are more copies than in A. thaliana and any possible gene duplication events.
The benzylisoquinoline alkaloid pathway requires this type of enzyme, still yet to be 
cloned, to perform the transaminase reaction on tyrosine to form 4- 
hydroxyphenylpyruvate. However 221C9 has highest homology to an aspartate 
aminotransferase rather than a tyrosine aminotransferase. As explained earlier, it is 
not feasible that an aminotransferase type enzyme could be directly involved in a 
demethylation reaction. Because of the splicing difference that has been uncovered in 
221C9, the most likely link between 221C9 and the topi mutation is that they are 
caused by two unrelated mutations in the topi germplasm. The F3 segregation data 
in chapter 5.11 reveals that this gene does segregate with the topi phenotype adding 
further evidence to the possibility of the mutation in the 221C9 gene being at least 
linked with the topi phenotype.
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5.6 Potential phospholipid-transporting ATPase cDNA 52F2
The transporter-like proteins represented by cDNA 52F2 are differentially under-
expressed in a number of the mutants of morphinan alkaloid biosynthesis examined 
in this thesis.
Morphinan alkaloids accumulate in latex vesicles within poppy laticifers and it is 
now generally accepted in the literature that laticifer ultrastructure and differentiation 
is related to morphinan accumulation. Several sequential enzymatic steps in alkaloid 
biosynthesis have been shown to occur in distinct cell types indicating that 
intercellular transport of intermediates occurs. Most of the information that is known 
comes from expression patterns and localisation studies performed on several of the 
alkaloids. Measurements of the alkaloids; morphine, codeine, thebaine, papaverine, 
and noscapine in latex showed that more than 90% of the alkaloid content was found 
in two different types of vacuoles (Fairbaim et al., 1974; Fairbaim and Steele, 1981; 
Homeyer and Roberts, 1984; Roberts et al., 1983; Roberts, 1987). One vacuole type 
was designated 900x g and the other 1 lOOx g due to their sedimentation properties. 
Of the two types of vacuoles the 900x g fraction of vacuoles seemed to contain the 
higher proportion of alkaloids and seemed to accumulate all of the aforementioned 
alkaloids measured except thebaine in the three weeks after petal opening (Pham and 
Roberts, 1991).
Two models for alkaloid transport in P. somniferum have been proposed:
1. The first, diffusion and ion trap mechanism, assumes lipophilic alkaloids can 
diffuse across the membranes and are trapped in the acidic vacuolar 
compartment by protonation and salt formation (Neumann et al., 1983;
Matile 1984; reviewed in Roberts et al., 1991). It has been shown in 
Chelidonium majus that chelidonic acid readily complexes alkaloids (Hauser 
and Wink, 1990) and possibly explains alkaloid accumulation against a 
concentration gradient as observed for sanguinarine and various other
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lipophilic alkaloids into latex vacuoles (Matile, 1976; Hauser and Wink,
1990) . In P. somniferum meconic acid is the major complexing agent found 
in the latex in high concentrations (Fairbaim and Williamson, 1978). High 
levels of sulphate and chloride were also found consistent with some form of 
ion trap mechanism for the major alkaloids of opium poppies (Pham and 
Roberts, 1991). There is however no direct evidence for an “ion trap” being 
responsible for the accumulation of morphinan alkaloids in latex vacuoles. 
Indeed morphine accumulates in opium poppy preferentially over several 
more basic alkaloids; this is inconsistent with ion trapping. An addition of 
ATP caused morphine uptake into the vacuoles to increase, however ATP 
inhibitors did not inhibit uptake (Roberts et al., 1991). These authors 
examined the uptake of various alkaloids and found no clear correlation with 
pK or lipophilicity. They proposed some sort of channel uptake mechanism 
with specificities to particular alkaloid molecules.
It is possible that the vacuoles in the latex may undertake this role. It is 
thought that the vacuoles of P. somniferum latex may be specialist vacuoles 
due to their size, resistance to external measures designed to reduce the A pH 
and capacity to sequester millimolar quantities of alkaloids (Roberts et al.,
1991) . Further to this the rapid and specific uptake of the major opium 
alkaloids has no absolute requirement for MgATP, is independent of 
temperature and does not show saturation kinetics (Homeyer and Roberts, 
1984).
2. The second model is based upon specific membrane bound alkaloid 
transporters. Other alkaloids have been shown to pass the tonoplast via a 
carrier mechanism. This is evident for o-reticuline, a charged species under 
cytosolic pH, and this mechanism appears to be stereo-selective for the S- 
rather than the R- enantiomer (Deus-Neumann and Zenk, 1986). This 
discrimination for the naturally occurring S-enantiomers has also been shown 
for the alkaloid S-scoulerine (Deus-Neumann and Zenk, 1986). Uptake is
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thought to occur by a H+ antiport mechanism such as for lupanine (Mende 
and Wink, 1987), S-reticuline, S-scoulerine (Deus-Neumann and Zenk,
1986), and l-(malonyl amino)-cyclopropane-l -carboxylic acid (Bouzayen et 
al., 1989). I-T- ATPase is a major vacuolar protein (Leigh and Walker, 1980; 
Sze, 1985; Bremberger et al., 1988) and along with pyrophosphatase (Leigh 
and Walker, 1980; Rea and Sanders, 1987; Bremberger et al., 1988) is 
responsible for tonoplast H+ concentration being greater than the cytoplasm 
(Thom and Komor, 1984; Sze, 1985; Rea and Sanders, 1987; Heidrich et al., 
1989; Taiz, 1992). This proton gradient has been shown to be utilized for a 
substrate- proton antiport transport mechanism (Lüttge et al., 1981; Hager 
and Hennsdorf, 1981; Thom and Komor, 1984, 1985; Briskin et al., 1985; 
Blumwald and Poole, 1985 a,b; Blumwald, 1987; Blackford et al., 1990;
Getz, 1991).
The phospholipid-transporting ATPases or flippases are known to transport lipids 
across membranes. They function by the substrate first partitioning into the 
cytoplasmic leaflet of the lipid bilayer from which it gains access to the transporter. 
The substrate is then 'flipped' by the transporter in an ATP-dependent manner to the 
opposite leaflet of the membrane and thence to the adjacent aqueous medium. MDR 
(multidrug resistance) transporters are also known to act in this way (van Helvoort et 
al., 1996) and the human MDR1 P-glycoprotein is a flippase of broad specificity that 
catalyses the transfer of phospholipids across the plasma membrane. Many 
molecules have been shown to be transported by flippases including the alkaloid 
vinblastine (Tamai and Safa 1991). While some flippases have been shown to be 
highly specific (van Helvoort et al., 1996), further detailed analysis of the flippases 
found in this study will be required to determine their specificity. These cDNAs 
could be representative of the ATP requiring transporters needed to shuttle alkaloids 
across the various compartments where they accumulate.
In order to test if these flippases are involved in alkaloid shuttling or some control 
process in morphinan synthesis it would be beneficial to use either antisense or
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RNAi gene silencing to respectively partially or totally knockout this gene.
Antisense technology may be more useful if this transporter is not specific in the 
transport of morphinans or associated compounds, as it would enable crucial cellular 
processes to continue. Overexpression studies of this gene would also yield 
invaluable insights into its function with the creation of still further phenotypes to 
study. Once it is known what compounds this flippase is specifically transporting 
studies could then be undertaken to ascertain how it performs this.
5.7 Signal recognition particle receptor-like protein cDNA 91G3
The signal recognition particle receptor-like proteins were also differentially under 
expressed in the mutant in each of the alkaloid mutants in comparison to their 
respective control phenotypes.
Signal recognition particle receptor (SRPR) proteins are necessary for efficient 
export of extra-cytoplasmic ER-targeted proteins. They are known to bind to the 
signal sequence when it emerges from the ribosomes; the signal recognition particle, 
which it binds to, consists of a 4.5S RNA molecule and protein Ffh. The protein has 
a two-domain structure: the G-domain binds GTP; the m-domain binds the RNA and 
also binds the peptide signal sequence. The Arabidopsis srpr-like proteins that align 
with the SRPR-like proteins found in these experiments have only been given 
function by homology. However these proteins are highly conserved across all 
classes of phyla due to their important roles in the transfer of the newly synthesised 
protein to its targeted membrane or compartment within the cell.
The SRPR like proteins found to be highly differentially downregulated in the 
mutant topi could be responsible for:
• the transfer of the CytP450 enzymes assumed to be responsible for the 
demethylation of thebaine, codeine and oripavine, to the endoplasmic
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reticulum and subsequently to the latex membranes or vacuoles where they 
act to synthesise codeine and morphine from thebaine; or 
• the targeting to the ER of a membrane transporter required to relocate 
alkaloids between cells or sub-cellular compartments.
The high conservation of SRPR-like proteins suggests RNAi induced silencing may 
have too many effects to be viable. Transgenic overexpression may prove the more 
revealing approach.
5.8 Phosphoenolpyruvate carboxykinase cDNA 157C4
PEPCK catalyses the decarboxylation of oxaloacetate to phosphoenolpyruvate 
(Figure 5.11). In C4 plants it is involved in CCE concentration, while in CAM plants 
it is involved in C4 acid decarboxylation. The exact role of PEPCK is unclear in C3 
plants though it appears to be involved in gluconeogenesis (the synthesis of glucose 
from non-carbohydrates) and may also be involved in amino acid synthesis. In plants 
that use the C4 photosynthetic pathway, PEPCK is characteristically expressed with 
several other photosynthetic enzymes to high levels in bundle sheath cells allowing 
concentration of CCE around Rubisco, and thus reduced photorespiration. C3 plants 
accumulate PEPCK enzyme in cells around the vascular system of petioles and stems 
where they are expressed to comparable levels to C4 plants (Hibberd & Quick,
2002).
PEPCK can be found in other tissues where its function is unclear. Examples 
include: in resin ducts, where it may be involved in plant defence; in developing 
seeds, with a possible role in metabolism of nitrogenous assimilates; and in 
cucumber phloem where it may be involved in amino acid metabolism (Chen et al., 
2004). So there is a potential role for PEPCK in the metabolism and/or conversion of 
amino acids in plants. It is possible that an affect on the morphinan alkaloid 
pathway, which is derived from the amino acid tyrosine, could cause a corresponding
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Figure 5.11: Illustration of the catalysis of oxaloacetate to phosphoenolpyruvate by 
phosphoenolpyruvate carboxykinase.
feedback on PEPCK if it is part of tyrosine metabolism. However this is considered a 
very unlikely association with topi.
5.9 Aldose 1- epimerase-like cDNA 111C7
The aldose 1-epimerase-like cDNA 111C7 has homology to a family of galactose 
mutarotase-like proteins. These proteins have been well characterised in bacteria, 
fungi and animals. They are thought to have a carbohydrate binding domain and act 
in the epimerisation of sugars, such as converting ß-D-galactose to a-D-galactose 
(Thoden et al., 2002). Expressed genes with homology to these mutarotase genes 
have been found in plants and have been shown to be glycoproteins localised to the 
nuclear rim (Heese-Peck, A., and Raikhel 1998). Enzymatic studies have been 
undertaken on purified extracts of plant material and have shown that the enzyme 
can catalyse a number of interconversions of sugars, particularly pentoses and 
hexoses related to D-glucose (Bailey, et al., 1967). The poppy cDNA 111C7 has 
homology to the sugar binding mutarotase domain of Arabidopsis genes in the 
database (Figure 5.12).
The domain of highest homology between the aldose epimerises is the sequence: 
EQGDAITFEGEVDKVYVSTPTKIAILDHEKKRTFVLRKDGLPDAVVWNPWD 
KKAKAMADFGDDEYKHMLCVEAAVVEKPITLKPGEEWKGRQELS. This is
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------- --------------- MATERHHFELAKGINGLDKIVLRESRGRSAEVY
MAAPPPSSPSPPPAAAAAATQQTQPHPQTPFYELVKGNSGIEKVLLRGTRGFSAEVY
MAAPAPAGAAASPSPKPQLPSPFAELVKTPSGLEKWLRGARNCCAEIY
LYGSHVTSWKNENGEELLHLSSKAIFKPPKPIRGGIPLCFPQFSNFGTLESHGFARN
LYGAQVTSWKNDHAEELLFVSSKAIFKPPKAIRGGIPICFPQFGTHGNLEQHGFARN
LYGGQVTSWKNDNGEELLFLSSKAIFKPPKAIRGGIPICLPQFGTHGNLEQHGFARN
RIWEVEANPPPLPLNSCSSAFVDLILRPTEDDLKIWPNNFEFRLRIALGTEGELTLT
RLWTIDDNPPPLPVNPAIKSFVDLILRPSDEDLKIWPHSFEFRLRVALGPNGDLSLT
RFWSIDNDPPPLPVNPAIKAFVDLILRPAEEDLKIWPHSFEFRLRVALGPSGDLSLT
SRIRNTNSDGKPFTFTFAYHTYFSVSDISEVRVEGLETLDYLDNLKDRERFTEQGDA
SRIRNTNTDGRSFSYTFAYHTYFSVSDISEVRVEGLETMDYLDNLKGKERFTEQGDA
SRIRNTNTDGRPFSYTFAYHTYFFVSDISEVRVEGLETMDYLDNLKAKERFTEQGDA
......................................... ..... PTRPEQGDA
*****
ITFESEVDKIYLSTPTKIAILDHEKKRTFVIRKDGLADAWWNPWDKKSKTISDLGD
IVFESEIDKVYLAAPSKIAIIDHEKKRTFVLTKEGLPDAWWNPWDKKAKAMQDFGD
IVFESEVDKVYLAAPSKIAIIDHEKKKTFWTKEGLPDAWWNPWDKKAKAMQDFGD
ITFEGEVDKVYVSTPTKIAILDHEKKRTFVLRKDGLPDAWWNPWDKKAKAMADFGD
*#**^*j**j* j • ^*********** • * • • * • * *
EDYKHMLCVEAAAIERPITLKPGEEWKGRLELSAVPSSYSSGQLDPKKVLE-----
GEYKHMLCVEPAAVEKPITLKPGEEWKGRLALSAVPSSYCSGQLDPLKVLQG----
AEYKNMLCVEPAAVEKPITLKPGEEWRGRIALSAVPSSYCSGQLDPLKVLHG----
DEYKHMLCVEAAWEKPITLKPGEEWKGRQELSAVPSSYCSGQLDPQRVLQTSRKIP
**.***** *.********** ******** ******
SFPVPYPVQCMSKFWNWNLTSEILAQWFSFFFFAGKGWGRIRQCRSFHINFFLLCF
FFFLISLWTIYYSTRQSLKGKYRFYKTRLKNLWPPVTDFFFFFVYNFSFFYSEHHRR
GIDIIWGSCESFGNPFSPTAMNDGYIFFFAMSNPSLIGDYYIYKNLFLLLQKKKKNK
Arabidopsis --
Oryza --
Buffelgrass --
Papaver KKK
Figure 5.12: Alignment of the P. somniferum from this thesis 111C7 with several 
aldose 1-epimerases from the database. The label Cons is the conserved sequence
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between the translated alignments. The colour code |BAD AVG GOOE| represents 
the quality of the alignment.
Arabidopsis thaliana aldose 1-epimerase family protein. NCBI Accession number 
NP 200543.
Oryza sativa (japonica cultivar-group) putative Aldose 1-epimerase. NCBI 
Accession number BAD05401.
Pennisetum ciliare (Buffelgrass). Possible apospory-associated protein c. NCBI 
Accession number Q40784.
T-COFFEE, Version l .41 was used for the amino acid alignments (Notredame et al.,
2000).
the mutarotase domain from the pFam database (Schultz et al., 1998). The P. 
somniferum cDNA 111C7 extends much further than any of the plant aldose 
epimerises in the database. It is possible that this is 3’ UTR or that the gene could 
have a different function.
5.10 cDNAs with no homology to genes in the database (27D12, 91B6, 54F9, 
and 151H8)
Several cDNAs revealed no homology to any sequences when blasted against the 
NCBI database. These three genes are also differentially under-expressed in several 
other alkaloid mutations, suggesting a general pleiotropic effect of various 
perturbations of the pathway. Further work testing the association of the expression 
of these genes with the inheritance of the topi phenotype is required.
Two of the genes, 91B6 and 151H8, without any homology to genes in the NCBI 
database, were under-expressed in the topi phenotype by the microarray analysis, 
however the qRT-PCR data showed that there was less than a two-fold difference in 
expression of both genes. It is possible that a mutated gene could have lost all 
function and yet its transcription is nearly unaffected. It is also possible that a very
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subtle drop in transcript level of a regulator could have much greater effects on the 
enzymes and pathway.
A further gene, 54F9, with no significant alignments in the database, showed an 
increased difference of expression between the topi mutant and the P. somniferum 
control in the qRTPCR data compared to the microarray data. This can be explained 
by the presence of a gene family or more than one gene with homologous regions 
that are binding to the cDNA spot on the array during the hybridisation process. If 
primers are designed to a region that is specific to the cDNA of interest (in this case 
54F9) it is possible to eliminate the other expressed genes with homologous regions.
With so few likely candidates it is definitely worth considering transgenic 
experiments to test 54F9, 91B6 andl51H8 in either or both of the following ways:
• Hairpin RNAi silencing of 54F9, 91B6 and 151H8 to see if the topi 
phenotype is recreated or morphine synthesis otherwise perturbed.
• Sense expression of 54F9, 91B6 and 151H8 in the topi mutant to see if the 
mutation is complemented.
5.11 F3 Segregating Population from topi x wild type cross
An F3 segregating population from a cross between topi and a wild type poppy was 
available from Tasmanian Alkaloids. It was considered likely that any causal 
association between the topi mutation and the set of ten differentially expressed 
genes would be evident as a co-segregation in the F3 population.
The material used for the topi experiments was derived from commercial lines that 
have undergone some breeding so as to eliminate any non topi phenotypic 
mutations, however the breeding was not extensive and there was still a possibility 
that there were secondary unrelated mutations in the topi germplasm. It was hoped 
that microarray experiments with the F3 segregating population would further 
shorten the list of genes of interest.
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RNA was extracted from eight F3 segregants that were shown to have the topi 
phenotype (thebaine and oripavine) and from four F3 segregants shown to have the 
morphine phenotype. The bulked segregant RNA was used for a microarray 
experiment. Plant phenotypes were determined by a combination of HPLC and TLC 
analysis as described in Chapter 2. 25 pg of RNA from each of the four plants of 
each phenotype were pooled, giving the 100 pg of RNA required for the microarray 
labelling reaction, for microarray analysis. A total of four slides were used for the 
F3 bulked segregant experiments, including two biological replicates and a technical 
replicate of each. Biological replicates consisted of pooling RNA from a different 
set of four F3 plants of either the thebaine or morphine phenotype (Figure 5.13). By 
pooling the RNA samples of the F3 progeny of the same phenotype it was expected 
to eliminate the variability in expression between individual plants and highlight 
those genes that were only directly related to the topi phenotype. Microarray results 
showed several genes that were differentially up or down regulated in the F3 topi 
phenotype plants compared with the F3 morphine phenotype plants (Figure 5.14).
Of the genes differentially expressed in the F3 bulked segregant microarray analysis 
only three (116D7, 221C9, and 151H8) of the set of ten genes from the earlier topi 
experiments were found to be differentially expressed and these three genes were 
below the differential cut-off value of 2 which has been applied in the earlier topi 
experiments (Table 5.3). 116D7 has its closest BLAST x hit to a putative 
chlorophyll a-b binding protein from A. thaliana. 221C9 has its closest match to an 
aspartate aminotransferase. Neither of these genes are likely candidates for the 
enzyme responsible for the demethylation of thebaine and oripavine. The third 
cDNA, 151H8, has no substantial hits in the database. Further work is needed to 
determine the nature of this gene and its interaction with morphine biosynthesis.
Given that the F3 bulked segregant microarray analysis was undertaken with limited 
replication, it is difficult to judge how much weight to give its conclusions relative to 
the highly replicated earlier topi analysis. Certainly it strengthens the argument for 
further attention to be paid to the overlapping three genes mentioned above. None of
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Figure 5.13: TLCs of the five segregating F3 populations (WF01-31-, WF01-29
WF01-27-, WF01-25-, WF01-23-) tested for the morphine or thebaine phenotype. 
Four thebaine and oripavine accumulating mutants were selected for the test sample 
on the microarray (WF01-31-5, WF01-29-1, WF01-25-8, WF01-23-5). Four of the 
F3 progeny segregating for the morphine control phenotype were selected for the 
reference sample (WF01-31-2, WF01-29-6, WF01-25-3, WF01-23-6). The alkaloid 
controls are run in the far left lane with morphine (M), codeine (C), oripavine (O) 
and thebaine (T). The topi parental phenotype is the second lane from the left (t)
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and the third lane is the morphine control parental phenotype (m). Lanes 1-8 
represent the different F3 individuals of each segregating F3 population.
the three genes has a hit to a gene resembling a gene with demethylase activity or a 
P450. It is thought that the gene responsible for this enzymatic demethylation of 
thebaine and oripavine is a P450 in animal tissues (Kodeira and Spector 1988). 
However the plant may have evolved an alternate O-demethylase that is responsible 
for the reaction and this may not be a cytochrome P450.
It is interesting to observe that one of the differential genes (101D1) in the F3 bulked 
segregant microarray experiment was a codeinone reductase cDNA which was more 
highly expressed in the mutant F3 lines than the control F3 lines (Table 5.3). This 
codeinone reductase from the cDNA library is very similar to the NCBI entries. It is 
known that codeinone reductase is a member of a large gene family with as many as 
twelve copies thought to be present in P. somniferum (Unterlinner et al., 1999) and 
101 Dl may be a different codeinone reductase than has yet been described. It is 
surprising that only one codeinone reductase clone appeared as differential, given the 
high homology between members of this multigene family.
Another interesting gene that was differentially expressed in this experiment was 
cDNA 2A2 (more highly expressed in the mutant), which has homology to a 
serine/threonine- protein kinase involved in brassinosteroid signal transduction. It is 
thought to be involved in the perception of systemin, a peptide hormone responsible 
for the systemic activation of defence genes in the leaves of wounded plants. It is 
also thought to regulate a signaling cascade involved in plant development (reviewed 
in Luan 2003). However, neither the codeinone reductase cDNA nor cDNA 2A2 
were differentially expressed in the original topi microarray experiments, suggesting 
that these genes are being differentially expressed as a result of factors other than the 
mutation responsible for the topi phenotype. These factors could be as a result of 
differences in the growing conditions, small differences in light due to placement of
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Figure 5.14: Graphical representation of the differentially expressed genes in the F3 
population segregating for the topi phenotype compared to the F3 population 
segregating for the morphine wildtype phenotype.
the pots in the glasshouse or even possible insect or microbe attack. C l3 is a 
genomic DNA sequence from Arabidopsis, which is a non-expressed genomic DNA 
sequence used as a negative control and printed several times on the microarray.
Only one of these replicate control spots was differential in the F3 experiment (Table 
5.3). There was apparently an expressed poppy sequence having enough homology 
to cross hybridize. The failure of the replicate spots to be differential suggests the 
appearance of Cl 3 is an undefined technical error. Several other differential genes in 
Table 5.3 did not have high enough homology to any sequences in the NCBI 
database and so remain without any known function. Also several cDNAs with good 
homology to photosynthetic enzymes appear as differential in the F3 experiment
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Table 5.3: Differentially expressed genes in the F3 segregating population for the 
topi phenotype._________________________________________________________
Name Expression
Ratio
Accession
Number
Description E-value
148A9 +2.6 - No Significant Hits -
84C9 +2.2 064452 N. paniculata. npcal Carbonic 
anhydrase, chloroplast precursor 
(Carbonate dehydratase) (ec 4.2.1.1).
4E-99
33H5 +1.8 AF389262 Dicentra eximia 26S ribosomal RNA 
gene, partial sequence.
1 E-l 30A
51C1 + 1.8 CB24 TO 
BAC
N. tabacum chlorophyll a-b binding 
protein 40, chloroplast precursor
1E-135
116D7t +1.7 ATU03395 A. thaliana psi type ii chlorophyll 
a/b-binding protein, putative.
6E-95
221C9| +1.7 AF419301 Securigera parviflora. Aspartate 
aminotransferase.
2E-54
151H81* + 1.6 - No Significant Hits -
91F8* -2.1 - No Significant Hits -
C13 -2.1 - Genomic repeat -
29A10 -2.1 - No Significant Hits -
101D 1 -2.1 Q9SQ69 P. somniferum NADPH-dependent 
codeinone reductase (ec 1.1.1.247)
IE -124
52H3 -2.1 AAD2787
7
Vigna radiata LHCII type III 
chlorophyll a/b binding protein
IE -123
133D7 -2.0 ATPA TO 
BAC
N. tabacum ATP synthase alpha 
chain (ec 3.6.3.14).
IE -169
103D8* -2.0 - No Significant Hits -
30F5 -2.0 - No Significant Hits -
2A2 -2.0 Q8LDB7 A. thaliana somatic embryogenesis 3E-55
_________________________________ receptor-like kinase, putative.___________
*Only 50% of the spots analyzed for the cDNAs 91F8 and 103D8 were reliable 
for statistical analysis. A + value represents the gene is downregulated in the F3 
plants with the topi phenotype. A -  value represents the gene is upregulated in 
the F3 plants with the topi phenotype, f  represents the three cDNAs that were 
significantly differentially under-expressed in the topi mutant microarray 
analysis that were also downregulated in the F3 experiment.
A All E-values are the best BLAST x hits except for 33H5 which is the best 
BLAST n value.
that were not differential in the original topi experiments, and are unlikely to have 
any direct functional link to morphine biosynthesis.
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5.12 Discussion & Conclusions
In summary this research has opened up a previously difficult area to study. Plant 
secondary metabolism is now recognised as a unique cross meshing of enzymes and 
products to give many useful products both to the plant (anthocyanins, plant defence 
compounds) and to man (morphine, codeine, caffeine, vinblastine). The 
Papaveraceae family is unique in its ability to accumulate morphine and P. 
somniferum is one of only a few members of this family to accumulate morphine to 
appreciable levels. The topi mutant has shown that intermediate morphinan alkaloids 
can accumulate in the plant to levels similar to that of the parent phenotype without 
any adverse affects on growth or maturity. The blockage in the pathway in topi 
seems to be at the enzymatic reaction following the synthesis of thebaine and 
oripavine in the bifurcated morphinan pathway. The microarray analysis, the first of 
its kind in any Papaver species, has revealed ten genes whose expression is affected 
in the topi mutant, and that may be involved in morphine biosynthesis indirectly; a 
number of those genes are novel, unknown in the GenBank database. The case for 
their interaction with the morphine pathway is strengthened by the fact that they are 
also differentially expressed in a number of other perturbations of the pathway. Their 
further study may add to our understanding of the regulation, enzymology and 
transport of the morphinan alkaloids.
This thesis has contributed to the understanding of morphinan alkaloid synthesis and 
accumulation in the ‘opium poppy’ Papaver somniferum. It describes the first 
molecular genetic analysis of the first stable mutations reported of morphine 
biosynthesis. What is believed to be a relatively simple mutation in a secondary 
metabolic pathway can have several other affects in what would have been thought 
to be unrelated metabolic areas. It is possible that several of these changes are 
attributable to indirect pleiotropic affects since they appear in several different 
alkaloid mutants. Further work is needed to address the nature of these associations.
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Specifically this thesis has succeeded in each of its aims: firstly a P. somniferum 
cDNA library has been produced and used for printing the first published poppy 
microarray; secondly, several new P. somniferum mutants have been characterised; 
thirdly these mutants (and other pathway-variant germplasm) have been further 
analysed for transcriptional changes using the poppy cDNA microarray; fourthly, the 
transcriptional changes have been analysed through sequencing and Blast x analysis 
with public domain databases; lastly, cross comparisons of experiments and further 
molecular analyses have foccused attention on a set of ten genes and particularly a 
set of three genes. The aims of this thesis have been met and directions for further 
research have been set.
5.13 Future Work
Since the morphinan alkaloid pathway is not present in any model genetic system, 
resources such as defined insertional mutations are not available. Fortunately a 
reasonably efficient transformation system has been developed and the best method 
of further study of candidate genes will be to produce transgenic P. somniferum 
plants. Two types of transgenics could be informative: those containing hairpin 
RNAi silencing constructs of each individual gene; and those with sense over-
expression constructs into various backgrounds including the various mutants. The 
possibility exists that RNAi transgenic plants may fail to give a phenotype because 
the genes may belong to functionally redundant families and where only some 
members are silenced by the chosen hairpin sequences. On the other hand the 
candidate gene may be functional in several other metabolic pathways, including 
primary metabolism, such that silencing could be lethal; in this case the only plants 
that might be regenerated would not be effectively silenced and show no phenotype. 
If a multigene family is suspected, such as the transporter-like proteins to which 
cDNA 52F2 belongs, it would be possible to isolate 5’ and or 3’ UTRs of several 
members of the family and create knockouts of each individual of the gene family
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separately and determine which member of the family is responsible or associated 
with the morphine pathway.
The set of three genes could possibly be homologues of other genes that are actually 
involved in the pathway. Microarray studies utilise the principal of nucleotide 
hybridisation and it is possible several different types of genes are cross hybridising 
to the cDNAs printed on the array. The hybridisation could involve gene families or 
classes of genes with specific regions of homology. The hybridisation procedure 
used was relatively stringent but it will not necessarily stop all permutations of cross 
hybridisation (Girke et al., 2000). This could explain why several of the qRT-PCR 
results were not consistent with the microarray results. This could also explain why 
the clone 116D7 was significant, even though it has a region of high homology to a 
chlorophyll a/b binding protein. There may be a sufficient region of homology 
between 116D7’s transcript and another gene’s transcript that is associated with the 
topi mutant phenotype.
There are several possible explanations for why the gene responsible for the mutation 
was not found using the microarray analyses.
1. The gene responsible for topi is not on the array. The cDNA library employed 
for the microarray showed very low redundancy, but there was still some 
redundancy. Estimates for the number of genes in the Arabidopsis genome 
range from 20 000 to 60 000 (Bevan et al., 1998). Therefore the P. somniferum 
17 000 cDNA array used in this study may have represented around 50-75% of 
the expressed genome. It is therefore possible that the gene responsible for topi 
is not represented on the array.
2. The topi mutation does not affect transcription. It is possible that the cDNA was 
present on the array, however the topi mutation does not affect transcription. 
Function may be lost due to a critical change in the coding region but the 
transcript level is unaltered. The mutant peptide may be altered in folding, active 
enzyme site or post-translational modification. A mutant enzyme may have 
altered signal peptides affecting localisation or anchoring which prevent access to
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its normal substrates. If the mutated topi gene encodes a morphinan regulator 
protein, it may be altered in DNA binding while leaving the transcript levels 
unchanged.
Using the arrays however has implicated several genes as having some role or 
association in alkaloid biosynthesis either indirectly or directly. A number of these 
warrant further study, such as the cDNAs associated with topi with no significant 
database homology. Further characterisation of these genes would involve isolating 
full-length clones and sequencing to firstly detennine if there are homologous clones 
in the database to give some clues as to their function. Secondly if no obvious 
function could be ascertained, it would then be important to create transgenic 
knockouts, either using antisense for a limited response or inverted repeat technology 
for a more severe affect. A recreation of a topi phenotype in a ‘knockout’ would 
confinn the causal relationship to the mutation. Thirdly, the topi phenotype could 
be complemented (repaired) with a full-length sense version of the gene or cDNA.
Further analysis using the microarravs could be undertaken using RNA isolated from 
the latex and the roots specifically since it has been shown that the ten genes do have 
different levels of expression in the roots and stem of the plants.
While the gene or genes responsible for the topi phenotype have not yet been 
identified from these experiments, the set of ten genes have yielded several important 
leads. In addition the three genes that were differentially down regulated, even in the 
F3 segregating population for the topi phenotype, 116D7, 221C9, 151H8, could be 
valuable as molecular markers for this economically important trait. Further work is 
required to detennine if one or more of these genes is sufficiently physically linked 
to the mutation and if a useful polymorphism can be found to facillitate marker- 
assisted breeding. A molecular marker map of P. somniferum is being constructed by 
Tasmanian Alkaloids; eventually it may be possible to clone the topi gene by map- 
based walking beginning with these three apparently linked genes.
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The genes isolated using the current microarray study are the first step in 
characterising the structural enzymes and illustrating the varying level of controls of 
the morphinan pathway. Other experiments to undertake would include further 
analysis of the differential proteins in the latex. By looking at 2D protein gels of 
segregating populations for the topi phenotype it would be possible to isolate 
proteins that are differential in the highly restricted morphine-accumulating tissue 
sampled in the latex. Analysis of the latex proteins assumes that the genes 
responsible for the phenotype are found here and that it is not a trafficking of 
intermediates and end products in and out of the laticifer system itself. The 
advantage of using this technique is that the latex fraction will be enriched for non-
photosynthetic proteins, which are unlikely to be involved in the direct synthesis of 
morphinans. By sequencing the differential proteins from the 2D gels the short 
protein sequences can be compared to the translations of the differentially expressed 
genes identified from the microarray experiments.
The morphine biosynthetic mutants and their global transcript analysis described in 
this thesis have advanced knowledge of the morphinan alkaloid pathway in P. 
somniferum. Much remains to be done before we comprehensively understand the 
regulatory controls, the nature of uncharacterised enzymatic steps, the missing gene 
sequences of structural enzymes, the various locations of biosynthesis, the trafficking 
of enzymes and intermediates, and the constraints on product accumulation.
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X. LN D J UJ UJ LTJ
cd Ti- 10 co in 1-rYT +̂- rp rŝ 3  sO 3 w - 7 ^
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Appendix 2
qRT-PCR results for the ten differential topi genes.
Appendix 2.1 -116D7 
Appendix 2.2 -91G3 
Appendix 2.3 -27D12 
Appendix 2.4 -157C4 
Appendix 2.5 -91B6 
Appendix 2.6 -54F9
Appendix 2.7 -No results could be obtained for 52F2. 
Appendix 2.8 -221C9 
Appendix 2.9 -151H8 
Appendix 2.10-111C7
Appendix 2.11 -Salutaridine acetyltransferase (Control)
Brief description of the four charts:
a) Illustrates the fluorescence of the PCR product versus the number of PCR cycles. 
Each sample was repeated in triplicate. cDNA samples consisted of 5 different 
concentrations. A water control or zero concentration, cDNA (control or topi) at 1 
ng/pL, cDNA (control or topi) at 5 ng/pL, cDNA (control or topi) at 10 ng/pL, and 
cDNA (control or topi) at 50 ng/pL.
b) . This graph illustrates the melting temperature of the product in each reaction. 
This parameter gives confidence in the product being amplified from the cDNA and 
not primer dimers or unspecified primer binding.
c) . Represents the point at which the qRT-PCR threshold crosses the amplification 
curve to give the Ct value (in order to calculate the concentration of the amplified 
product).
d). This is the standard curve obtained using the 5 different concentrations of each 
reaction and the Ct value as calculated automatically by the Rotorgene software 
(Version 5.0 Corbett Research Corbett Research: 1/14 Hilly St Mortlake NSW 2137 
Australia) in order to calculate the reaction efficiency of the PCR reaction (ie 
theoretically the number of samples should double for each cycle and the closer to 
one that this value is, represents a doubling of product at the designated Ct value). 
The R-value is the correlation coefficient (a number between 1 and -1), which 
represents how well a line of best fit describes a relationship between two variables. 
A value of 0 implies that the data does not fit this relationship. A value of 1 or -1 
does represent a good relationship between the two variables. Thus a good R-value 
is usually around 0.99 or -0.99.
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Appendix 2.1 116D7
Cycles
■ °  0 .1
Threshold
'60
Threshold
Cycles
R=0.99846 R *2=0.99692 Efficiency=0.97 
M -0.294 8=7.288
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Appendix 2.2 91G3
C  1.4
= ae
Cycles
Threshold
Cycles
R =0.89274 R"2=0.79698 Efficiency=0.81 
M—0.258 B-5.794
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Appendix 2.3 27D12
o  1 ?
Cycles
LL, 015
Threshold
Threshold
Cycles
d). 50
40
R =0.98300 R"2=0.96630 Efficiency=1.13 
M=-0.329 B =7.646
To
0 1 ' 1
|10"-1 |10"0 |10~1 |10"2 Concenliafion
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Appendix 2.4 157C4
Threshold
'60
Threshold
40 Cycles
R -0.99426 R ^ -O .98856 Efficiency-0.98 
M=-0.297 8=8.403
Concentration
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Appendix 2.5 91B6
Cycles
l -  0.1
Threshold
'60
'40 Cycles
R -0.98507 R~2=0.97036 Efficiency-1.46 
M= 0.392 B=13.001
Concentration
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Appendix 2.6 54F9
O  0 8
LL 0 6
Cycles
t  0 .1
T h r e s h o ld
'6 0
Cycles
R=0.99505 R "2=0.99013 Efficiency=1.31 
M = 0.363 B=8.691
Concentration
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Appendix 2.8 221C9
Cycles
276
Appendix 2.9 151H8
Cycles
Cycles
R =0.99697 RA2=0.99395 Efficiency=0 95 
M = 0.289 6=4.669
Concentration
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Appendix 2.10 111C7
Cycles
Cycles
R=0.99B87 R"2=0.99374 Efficiency=1.03 
M = 0.307 B=7.783
Concentralion10"  1
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Appendix 2.11 Salutaridine Acetyl Transferase
= 0  5
'40 Cycles
Threshold
'60
^  Cycles
R -0  99112 R~2-0.98231 EHiciency-0.91
M—0.281 B—6 052
10~-1 1 0 ^ 1 Concentration
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Appendix 3
The differentially expressed genes from the low morphinan cultivar P.somniferum 
cv. Marianne compared to the high morphine cultivar P. somniferum C052.
Clone
Name
M icroarray ratio 
down regulated 
in the low 
morphine P. 
som niferum  cv 
Marianne
Clone Name M icroarray ratio
upregulated in the low m orphine 
P. som niferum  cv M arianne
154A5 2.78 194E9 1.38
86G4 2.75 221G8 1.47
139D3 2.42 116F7 1.56
143A4 2.47 157G11 1.73
54G7 2.15 25D10 1.68
I54E4 2.74 25E11 1.39
21A7 2.70 83B1 1.74
144G8 2.61 162H7 1.48
83A3 2.59 152H6 1.74
115C7 2.39 13G6 1.57
146E5 2.38 189A9 1.48
158A8 2.21 178D6 1.74
57F5 1.95 158B10 1.47
210C5 2.19 105A10 1.55
149G4 1.97 48H4 1.48
93G12 2.50 105H7 1.48
82D6 2.47 143C6 1.72
12F3 2.15 63G12 1.68
121 A4 2.48 133H8 1.65
150B1 2.09 21A1 1.73
5D2 2.32 104B7 1.41
21E9 2.18 35B6 1.52
29H2 1.83 180E10 1.49
98E11 2.26 76E10 1.39
174D11 1.82 209G10 1.75
108B2 2.12 209C9 1.51
84 A9 2.39 157D3 1.40
23A10 2.58 16G12 1.45
194G12 2.01 138E12 1.48
33H3 1.98 110G2 1.49
22E7 1.95 209B12 1.40
183H10 1.99 199D8 1.49
19B8 1.94 110D8 1.49
280
179E7 1.90 140B7 1.49
175E5 1.89 10E8 1.77
20A7 2.53 53E5 1.50
145D12 1.72 196G8 1.40
112B10 1.90 85A11 1.46
151C1 1.89 14B12 1.59
99G8 1.89 218C9 1.41
133H10 1.87 202D4 1.57
105A3 1.89 60G4 1.58
111H8 1.86 90F1 1.60
24E1 1.83 30C1 1.51
20C4 1.84 48G10 1.58
59C6 2.30 108G3 1.46
183C8 1.98 29F10 1.43
193C9 1.85 196G3 1.50
180D9 2.17 133F11 1.51
36C12 1.82 206H6 1.51
25D3 2.00 132F2 1.51
84H6 1.83 162F5 1.72
110D7 2.33 67A3 1.52
193B8 1.82 80E3 1.52
191D9 2.31 174F6 1.42
202E5 2.30 29H1 1.42
14G8 1.79 179E10 1.54
83C2 2.22 175A7 1.43
77C5 1.80 162C10 1.67
206E2 2.28 54C12 1.43
79D8 1.77 23G7 1.43
146H5 1.77 87C9 1.74
115C5 1.78 14A4 1.82
223D1 2.24 81H3 1.48
27G5 1.75 15H10 1.54
133A5 1.76 209G8 1.57
103E12 1.76 152E4 1.54
76F5 1.74 185B5 1.70
221C9 1.73 117D8 1.44
146G5 1.73 133A2 1.49
139A8 1.89 46H2 1.55
174C1 2.18 144B11 1.55
213E3 1.63 201E7 1.45
60G8 1.72 147E5 1.47
218H9 1.58 30A3 1.49
114G12 1.87 38A7 1.82
20E7 2.00 78B11 1.66
99B10 2.14 83H7 1.54
281
37A8 1.86 158D3 1.56
40E12 1.68 95B7 1.50
34B1 2.12 98F2 1.53
46D3 1.56 136G9 1.56
151F2 2.03 136D2 1.56
202A7 2.11 81B5 1.69
38C5 1.68 27D12 1.56
88B4 1.68 1A6 1.64
145G4 1.68 52A5 1.45
17D9 1.68 12E5 1.56
154G6 1.68 139F8 1.48
58B10 1.83 117A4 1.59
192B7 1.82 139C9 1.59
150C1 2.09 110D10 1.59
221G3 2.09 218E7 1.67
78 A3 1.67 178F9 1.58
79A9 1.88 158H9 1.47
34D10 1.81 179D4 1.71
83C10 2.06 63F1 1.51
79B10 2.08 172F12 1.59
22H11 1.98 144E12 1.59
110A4 1.62 174F7 1.63
30F1 1.85 51E 1 1.74
111C7 1.67 10H5 1.60
71D3 2.07 112F1 1.48
184C1 1.70 43B3 1.68
206F8 2.06 194G3 1.50
112D11 2.03 105H5 1.60
169G12 1.79 63C9 1.61
52D6 1.70 143H12 1.77
133C8 2.04 142H3 1.78
98F3 1.66 46F9 1.50
16C4 2.04 2F8 1.66
5G1 1.52 23B10 1.50
78B8 1.78 156G2 1.50
23F8 1.64 175D7 1.50
160A8 1.65 46G12 1.72
4C4 2.01 218H5 1.65
143A3 2.01 195E6 1.63
155C7 1.65 158A11 1.55
2H3 2.01 206C2 1.66
83B9 1.63 46D6 1.65
7H12 1.59 98C12 1.52
52A12 2.00 113C5 1.66
4F5 1.99 175D1 1.66
282
112C1 1.63 3 2 A4 1.66
32F3 1.50 91F5 1.66
91F 10 1.75 117H4 1.60
27E3 1.97 82G7 1.65
23A3 1.55 19H11 1.65
24 A1 1.73 29F11 1.67
60H7 1.83 20A10 1.58
104H9 1.49 202H12 1.88
174G8 1.60 210A11 1.55
180C4 1.58 89F6 1.54
58D9 1.96 132F8 1.68
88D6 1.69 132F4 1.68
160H10 1.56 39F8 1.68
133G3 1.74 152D10 1.67
147C1 1.59 74A2 1.59
58H10 1.61 59A7 1.63
29E4 1.74 161B1 1.57
54F1 1.94 117G4 1.85
33A9 1.71 83F7 1.56
7G9 1.49 39A7 1.56
21E12 1.63 132G12 1.70
51E6 1.86 78G7 1.71
57B12 1.93 168A6 1.71
200E8 1.63 76F9 1.78
38A4 1.59 159B12 1.70
88E7 1.87 151F8 1.72
47C4 1.68 108B11 1.77
82A1 1.69 22D7 1.72
22G4 1.47 40E11 1.57
116F10 1.58 46C8 1.73
111A8 1.57 197E2 1.73
55H2 1.89 52B4 2.17
194E6 1.57 121H5 1.74
223E3 1.46 30G3 1.59
19A11 1.56 89F7 1.60
206E4 1.46 146A5 1.67
133H10 1.56 5 2 A4 1.77
109C9 1.62 135G5 1.70
14A6 1.88 1D6 1.64
137B9 1.64 16B3 1.66
58H4 1.55 136C12 1.70
100E11 1.56 67E6 1.63
108C2 1.56 224B5 1.79
209F1 1.61 147H1 1.72
210B12 1.74 193E12 1.84
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78C4 1.57 112H3 1.89
135C1 1.48 39D8 1.77
27G7 1.66 94D10 1.65
28E8 1.51 94D8 1.78
97A10 1.55 181C1 1.69
185F10 1.74 91F2 1.80
140G4 1.61 48B9 1.92
60D5 1.44 133F11 1.87
52F2 1.54 183F11 1.91
2 2 1 F3 1.48 20E6 1.77
27E4 1.44 97D11 1.78
11B3 1.58 103E6 1.85
140F1 1.44 30F3 2.14
146B9 1.85 21B4 2.04
79A11 1.55 200B9 1.94
96H2 1.70 147C5 1.85
82A7 1.44 224F3 1.95
5D5 1.53 99B9 2.11
108E2 1.75 18A10 2.00
180D2 1.64 71B1 1.97
186G4 1.83 90B12 2.27
34D11 1.61 180H4 3.54
29A3 1.52 180E1 4.95
224A10 1.82
28G4 1.82
31A8 1.56
194H3 1.82
117D11 1.46
155A3 1.63
151H3 1.51
89A5 1.51
85C12 1.48
82A9 1.52
84B9 1.50
84F8 1.55
179E6 1.80
21C4 1.65
146B1 1.79
121H3 1.51
63D11 1.51
4A9 1.79
190D5 1.59
112D12 1.74
37B4 1.41
88E8 1.59
284
209D 4 1.79
57H 11 1.78
7 8F 6 1.75
183B 10 1.51
35H 2 1.63
137C 3 1.51
2 6 G 7 1.50
3 4F 7 1.61
107C 12 1.49
84B 12 1.52
2 6 C 2 1.40
11F5 1.77
210F1 1.50
159C 8 1.49
17A 9 1.68
139E 6 1.76
108A11 1.49
162F 3 1.75
178D 5 1.57
210H 11 1.40
140F 4 1.49
162B 8 1.76
168H 6 1.64
109B11 1.42
27B 2 1.66
2 2 1 B4 1.75
133D 5 1.48
160C1 1.75
2 0 6 C 9 1.61
58H 7 1.49
25A11 1.39
137G 1 1.46
157C 4 1.57
102H 3 1.47
2 0 2 E 7 1.59
213A 4 1.41
139C 1 1.47
78D 10 1.39
186C 3 1.40
2 2 1 F9 1.56
57B1 1.39
121F 8 1.68
189D1 1.49
96D 3 1.47
2 1 3 G 9 1.47
285
4E2 1.73
27D12 1.73
26H10 1.47
2F6 1.43
135F8 1.65
210D9 1.50
63C1 1.42
151E6 1.72
144H8 1.44
104F10 1.46
83H6 1.72
286
Appendix 4
The differentially expressed genes from the low morphine accumulating P. 
somniferum mutant D205.
Clone
Name
Microarray ratio 
down regulated in the 
m utant D120
Clone Name M icroarray ratio 
up regulated in the 
m utant D120
27D12 7.52 94E4 2.01
28G4 7.25 81H8 2.03
91B6 7.20 76H3 2.03
116D7 6.48 86A12 2.03
111C7 6.36 225C5 2.15
91G3 5.86 199A8 2.20
71G5 5.69 29H11 2.24
156F9 5.64 137A3 2.29
157C4 5.50
108H11 5.45
33H5 5.42
52F2 4.82
83G7 4.70
C E12 4.42
153C2 4.39
112B7 4.32
151H8 3.94
20A7 3.62
221C9 3.57
91E9 3.40
83F5 3.34
145E11 3.15
46A6 3.03
148A9 2.98
194D4 2.96
54F9 2.80
33F11 2.78
147A12 2.59
139A8 2.52
209F3 2.49
102D3 2.43
186F8 2.43
16E8 2.43
137B7 2.39
137A5 2.36
287
196B12 2.34
40F6 2.34
144F10 2.33
18D8 2.31
90B 12 2.25
32D 4 2.24
209D 12 2.23
39G1 2.17
198D 10 2.16
121D 2 2.15
158G 12 2.15
25D 3 2.15
100C 6 2.15
29F4 2.14
83D11 2.14
51D 10 2.13
14C6 2.13
37F4 2.12
17A7 2.11
79B8 2.09
52C 5 2.09
27C 12 2.09
46F7 2.09
58B 3 2 .08
105D 7 2.08
43D 7 2.07
57E4 2.07
76C11 2.07
97F4 2.06
48F11 2.05
196E12 2.04
30B6 2.04
22D 6 2.04
79B7 2.04
7E1 2.04
98B6 2.03
19D4 2.03
60B2 2.03
82B7 2.03
102F3 2.02
55E11 2.02
25F7 2.02
159C 8 2.01
114D 3 2.01
2 0 F 6 2 .0 0
156 G 7 2 .0 0
149H 2 2 .0 0
289
Appendix 5
The differentially expressed genes from the high total alkaloid accumulating P. 
somniferum mutant D242.
Clone M icroarray ratio Clone Name M icroarray ratio
Name down regulated in the up regulated in the
m utant D242 m utant D242
27D12 9.98 18D11 2.02
91G3 8.68 38F9 2.03
111C7 7.66 77D6 2.06
151H8 7.64 15E9 2.06
52F2 6.84 26D12 2.07
91B6 6.24 57F3 2.09
108H11 6.10 18G11 2.11
71G5 5.74 193D12 2.12
156F9 5.65 77B10 2.12
157C4 5.38 108D11 2.19
221C9 5.32 98B10 2.29
91E9 5.19 86A12 2.66
28G4 5.12 209B8 2.72
54F9 4.92 25B4 2.77
186F8 4.60
147A12 4.57
116D7 4.34
153C2 4.28
33H5 4.21
11B6 4.15
83F5 4.02
83G7 3.91
112B7 3.90
144F10 3.27
148A9 2.94
83E5 2.87
162G6 2.69
189B10 2.65
137A7 2.57
15C7 2.56
20A7 2.55
81B12 2.53
145E11 2.53
198D10 2.49
191D7 2.49
117B11 2.48
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117D11 2.48
116G 4 2.45
202D1 2.44
5 1 D8 2.43
110D 4 2.42
169E12 2.38
160H 9 2.38
43A 12 2.38
75C 2 2.37
26B11 2.34
23A 10 2.32
194B5 2.32
33F11 2.31
8 3 A3 2.30
196B12 2.28
98C 6 2.27
12F3 2.26
30D 5 2.25
54E4 2.25
29E 10 2.22
39D 5 2.22
34 A 11 2.19
196H1 2.19
160B3 2.17
111F12 2.16
21A 7 2.15
132G1 2.15
146D 2 2.14
26A1 2.14
158B3 2.12
161D 7 2.12
139A8 2.11
111C 8 2.11
3D 10 2.11
36A7 2.10
87B5 2.10
30B11 2.09
117G 3 2.09
37F9 2.07
22E 7 2.06
121A4 2.06
18H8 2.05
169G 12 2.04
138D 10 2.04
19C9 2.04
10D7 2.02
194D4 2.02
63E8 2.01
106F8 2.01
93H2 2.00
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Appendix 6
The differentially expressed genes from the low morphinan and high papaverine 
accumulating P. somniferum mutant D120.
Clone
Name
M icroarray ratio 
down regulated in 
the m utant D120
Clone Name M icroarray ratio 
upregulated in the 
mutant D120
91G3 14.06 25H4 2.02
27D12 11.55 152F3 2.02
28G4 11.27 31C8 2.02
91B6 10.28 24F2 2.02
80F11 9.78 78F7 2.02
111C7 8.79 29E3 2.03
54F9 8.64 97H11 2.03
221C9 7.57 26D4 2.04
151H8 7.31 132D2 2.04
52F2 7.22 181 A3 2.04
91E9 6.94 115G4 2.04
83F5 6.92 2H2 2.05
157C4 6.76 160B6 2.06
83G7 6.60 110B8 2.06
116D7 6.27 159D4 2.06
83E5 4.63 186G12 2.06
153C2 4.51 157E12 2.07
112B7 4.51 71G2 2.07
198D10 4.46 213E7 2.09
108H11 4.01 159D10 2.09
63D4 3.93 25D4 2.09
C E12 3.65 77H11 2.09
18H8 3.43 38F5 2.10
3D10 3.25 88E4 2.10
63G12 2.92 15H5 2.10
196E10 2.83 140D2 2.11
104G9 2.73 199D3 2.11
150H6 2.70 201B4 2.12
30F11 2.65 46H4 2.13
132F8 2.65 156D7 2.13
132F4 2.59 29B4 2.14
116E12 2.57 38G4 2.14
89F7 2.55 16G7 2.15
34G11 2.49 78C8 2.15
206C2 2.47 162E8 2.16
95B7 2.46 88E5 2.16
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48D 12 2.45 5 1 F8 2.17
158H 9 2.44 161D11 2.17
103E6 2.44 38E5 2.18
155F3 2.44 2 2 1 H9 2.18
178C 2 2.41 200D 3 2.18
22D 7 2.41 27D1 2.23
151F8 2.39 94B4 2.23
147A12 2.38 159F3 2.23
89F6 2.36 74F7 2.26
76F9 2.33 83F8 2.27
175D1 2.32 46F1 2.28
218H11 2.31 11H8 2.29
21A1 2.27 26D 12 2.33
172F12 2.27 115D 12 2.33
117G 4 2.26 10B5 2.35
16B3 2 .25 57B7 2.38
190A7 2.24 140B1 2.38
157B9 2.24 116A12 2.38
116G 9 2.23 106F7 2.40
20E6 2.23 58A11 2.44
1D6 2.23 102B12 2.44
94D 10 2.22 15B2 2.47
74A2 2.22 59B8 2.47
206H 6 2.22 157A11 2.49
17G 5 2.22 175F5 2.51
19H11 2.22 29D 2 2.55
117D11 2.21 148E5 2.57
135G 5 2.21 105B7 2.58
133F11 2.20 87F9 2.60
179D 4 2.20 31B5 2.60
99B9 2.19 37H 2 2.60
30B9 2.19 143E3 2.63
113D 7 2.18 2 2 1 E4 2.64
97D11 2.17 121E 10 2.68
46H 2 2.15 146C4 2.70
39F8 2.14 26B 10 2.76
133F11 2.14 174F10 2.80
10H5 2.14 *38E8 2.81
102D 3 2.14 137A3 2.89
158F6 2.13 15E9 2.90
48H 4 2.13 192E10 2.96
151G 10 2.13 132A11 2.99
183F11 2.13 105H7 3.00
160B3 2.13 193D 12 3.00
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112H3 2.12 22E1 3.01
83F7 2.12 58A4 3.03
63C9 2.12 209H2 3.14
147H1 2.12 18D11 3.16
137G3 2.11 86A12 3.21
90B12 2.10 7A9 3.37
91F 1 2.10 76H3 3.43
39D8 2.09 77F10 3.52
53G10 2.09 71E4 3.54
37F9 2.09 39H6 3.65
162H7 2.09 25B4 3.94
111C8 2.08 152F12 4.04
174A1 2.08 18G11 4.07
51E1 2.06 209B8 4.18
153F8 2.06 29H11 4.26
12G11 2.05 38F9 4.53
53E5 2.03
80E3 2.03
29D1 2.01
46C8 2.01
105H5 2.01
79B5 2.00
15C7 2.00
30C1 2.00
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Appendix 7
Alignment of the 5 cDNAs that align to the 26S ribosomal RNA DNA.
« 33H 5 (1 )
« 1 5 6 F 9 (1 )
« 71G 5 (1 )
« 1 4 5 E 1 1 (1 )
« 4 6A6 (1 )
C o n s e n s u s (1 )
(2 )
« 33H 5 (1 )
« 1 5 6 F 9 (1 )
« 71G 5 (1 )
« 1 4 5 E 1 1 (1 )
« 4 6A6 (5 1 )
C o n s e n s u s (5 1 )
(5 2 )
« 33H 5 (1 )
« 1 5 6 F 9 (1 )
« 71G 5 (1 )
« 1 4 5 E 1 1 (1 )
« 4 6A6 (1 0 1 )
C o n s e n s u s (1 0 1 )
(1 0 2 )
« 33H 5 (1 )
« 1 5 6 F 9 (1 )
« 71G 5 (1 )
« 1 4 5 E 1 1 (1 )
« 46A 6 (1 5 1 )
C o n s e n s u s (1 5 1 )
(1 5 2 )
« 33H 5 (1 )
« 1 5 6 F 9 (1 )
« 71G 5 (1 )
« 1 4 5 E 1 1 (1 )
« 4 6A6 (2 0 1 )
C o n s e n s u s (2 0 1 )
( 2 0 2 )
« 3 3H5 (1 )
« 1 5 6 F 9 (1 )
« 7 1G5 (1 )
« 1 4 5 E 1 1 (1 )
« 4 6A6 (2 5 1 )
C o n s e n s u s (2 5 1 )
(2 5 2 )
« 33H 5 (1 )
« 1 5 6 F 9 (1 )
« 71G 5 (1 )
« 1 4 5 E 1 1 (1 )
« 46A 6 ( 3 0 1 )
C o n s e n s u s ( 3 0 1 )
(3 0 2 )
« 33H 5 (1 )
« 1 5 6 F 9 (1 )
« 71G 5 (1 )
« 1 4 5 E 1 1 (1 )
« 4 6A6 ( 3 5 1 )
C o n s e n s u s ( 3 5 1 )
( 3 5 2 )
i 50
TTTT TT TTT TT TTTTTA TTTTT TACGAAT CGGTGCGACATGGGGCTGAAT
T T T T TT T TT T T T TTTTATT TT T TACGAATCGGTGCGACATGGGGCT GAAT
51  1 0 0
CTCAGTGGATCGTGGCAGCAAGGCCACTCTGCCACTTACAATACCCCGTC
CTCAGTGGATCGTGGCAGCAAGGCCACTCTGCCACTTACAATACCCCGTC
1 0 1  1 5 0
GCGTATTTAAGTCGTCTGCAAAGGATTCTACCCGCCACCCGGTGGTAATA
GCGTATTTAAGTCGTCTGCAAAGGATTCTACCCGCCACCCGGTGGTAATA
1 5 1  2 0 0
GTAYTNTWAGGGCGGCCCGCGCAGCTCGTCCGCTGCGAGGGCTACGCCCA
GTANTNTNAGGGCGGCCCGCGCAGCTCGTCCGCTGCGAGGGCTACGCCCA
2 0 1  2 5 0
CGGCACGTGCCTCTGGGGACCCGAAGGTCCCTACTGCAGGTCGGCAATCG
CGGCACGTGCCTCTGGGGACCCGAAGGTCCCTACTGCAGGTCGGCAATCG
2 5 1  3 0 0
GGCGACGGGCGCATGTGCCGCTTCTTTAGCCTGGATTCTGACTTAGAGGC
GGCGACGGGCGCATGTGCCGCTTCTTTAGCCTGGATTCTGACTTAGAGGC
3 0 1  3 5 0
GTTCAGTCATAATCCTGCACACGGTAGCTTCGCGCCACTGGCTTTTCAAC
GTTCAGTCATAATCCTGCACACGGTAGCTTCGCGCCACTGGCTTTTCAAC
3 5 1  4 0 0
CAAGCGCGATGACCAATTGTGTGAATCAACGGTTCCTCTCGTACTAGGTT
CAAGCGCGATGACCAATTGTGTGAATCAACGGTTCCTCTCGTACTAGGTT
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401 450
« 33H5 
« 156F9 
« 71G5 
« 145E11 
« 4 6A6 
Consensus
« 33H5 
« 156F9 
« 71G5 
« 145E11 
« 4 6A6 
Consensus
« 3 3H5 
« 156F9 
« 71G5 
« 145E11 
« 4 6A6 
Consensus
« 33H5 
« 156F9 
« 71G5 
« 145E11 
« 4 6A6 
Consensus
« 33H5 
« 156F9 
« 71G5 
« 145E11 
« 4 6A6 
Consensus
« 33H5 
« 156F9 
« 71G5 
« 145E11 
« 4 6A6 
Consensus
« 33H5 
« 156F9 
« 71G5 
« 145E11 
« 4 6A6 
Consensus
« 33H5 
« 156F9 
« 71G5 
« 145E11 
« 4 6A6 
Consensus
« 33H5 
« 156F9 
« 71G5 
« 145E11 
« 4 6A6 
Consensus
(1 )
(1 )
(1 )
(1 )
(401)
(401)
(402)
(1 )
(1 )
(1)
(1)
(451)
(451)
(452)
(1 )
(1 )
(1 )
(37)
(501)
(501)
(502)
(1 )
(1 )
(1 )
(87)
(551)
(551)
(552)
(1)
(1 )
(1)
(137)
(601)
(601)
(602)
(1)
(1)
(1)
(187)
(651)
(651)
(652)
(1)
(1)
(1)
(237)
(701)
(701)
(702)
(1 )
(1)
(1)
(287)
(751)
(751)
(752)
(1)
(1 )
(1 )
(337)
(801)
(801)
GAATTACTATCGCGGCACTGTCATCAGTAGGGTAAAACTAACCTGTCTCA
GAATTACTATCGCGGCACTGTCATCAGTAGGGTAAAACTAACCTGTCTCA
451 500
GGCAG-TGGGGTTGGGGGGCGCAGC-ATATGCAGCT
CGACGGTCTAATCC--CAGCTCACGTT------C-C--CTAT-TG--G -T
CGACGGTCTAATCCGGCAGCTSRSGTTGGGGGGCGCAGCTATATGCAGCT
501 550
AGTTTACACATTATACACTTAAAAATTT-T -ATATTTACCTTAGAGCTTT 
GGGTGA-ACA- -AT-C-C- -AACACTTGGTGA-ATT--C-T--G--CTTC 
RGKTKACACATTATACACTTAAMAMTTKGTGATATTTACCTTAGAGCTTY
551 600
A - AATCTCTG - TAGGTAGTTTGTCC - A - ATT - ATGTCA - CACCACAGAAG
ACAAT--- GATAGGAAGA - - G - CCGACATCGAAGG - ATCA - - A - A - AAG
ACAAT CT CTGATAGGWAGWTTGTC CGACATYGAWGKCATCAC CACAGAAG
601 650
TAAGGTTC-CT-TCA-CAAA-GA-T -CC-CAAGCTAGCAGTTTTCCCAGT
CAACGT-CGCTATGAACGCTTGGCTGCCACAAGC CAGTTATCCCTGT
Y AASGTT CGCT AT S AA.CRMWTG TGCCACAAGCTAGCAGTTWTCCCWGT
651 700
CACG-A -CGTTGTAAAAC-GACGGCCAGTGCCTAGCTT-ATAATAC-GA-
G - -GTAACTTT-T--- CTGACA-CC--T-C-TAGCTTCA-AATTCCGAA
SACGTAACKTTGTAAAACTGACRGCCAGTGCCTAGCTTCATAATWCCGAA
701 750
-CTCACTATAGG G--A--CCACT-TTGTACAAGAAAGCTGGGTACGC
GGTC- -TAAAGGATCGATAGGCCACGCTT-T -CACG GTTCG-TATTC
G S TCACTAWAGGATCGATAGGCCAC KCTTGTACAMGAAAGYT S GGTAY KC
751 800
GTAAGCTTGGGCCCCTCGAGGGATACTCTAGAGCG-GCCG-- CCCTTTT
GTA--CT-GGAAA--TC-AG--A-A-TCAA-A -CGAGCTTTTACCCTTTT 
GTAAGCTTGGRMMCCTCGAGGGATACTCWAGAGCGAGCYKTTACCCTTTT
801 850
GTTCCACACGAGATTTCTGTTCTCGTTGAGCTCATCTTAGGACACCTGCG
GTTCCACACGAGATTTCTGTTCTCGTTGAGCTCATCTTAGGACACCTGCG
GTTCCACACGAGATTTCTGTTCTCGTTGAGCTCATCTTAGGACACCTGCG
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( 8 0 2 )
8 5 1 9 0 0
« 3 3 H 5 ( 1 )
« 1 5 6 F 9 ( 1 )
« 7 1 G 5 ( 1 )
« 1 4 5 E 1 1 ( 3 8 7 ) TTA TCTTTTA A CA G A TG TG CCG CCCCA G CCA A A CTCCCCA CCTG A CA A TG
« 4 6A 6 ( 8 5 1 ) TTA TCTTTTA A CA G A TG TG CCG CCCCA G CCA A A CTCCCCA CCTG A CA A TG
C o n s e n s u s ( 8 5 1 ) TTA TCTTTTA A CA G A TG TG CCG CCCCA G CCA A A CTCCCCA CCTG A CA A TG
( 8 5 2 )
9 0 1 9 5 0
« 3 3H 5 ( 1 )
« 1 5 6 F 9 ( 1 )
« 7 1 G 5 ( 1 )
« 1 4 5 E 1 1 ( 4 3 7 ) TCTTCCGCCCGGATCGGCATAGCAAGCTAGCCTTGGATCTAAAAAGAGGG
« 4 6A 6 ( 9 0 1 ) TCTTCCG CCCGGATCGGCATAGCAAGCTAGCCTTGGATCTAAAAAGAGGG
C o n s e n s u s ( 9 0 1 ) TCTTCCG CCCGGATCGGCATAGCAAGCTAGCCTTGGATCTAAAAAGAGGG
( 9 0 2 )
9 5 1 1 0 0 0
« 3 3 H 5 ( 1 )
« 1 5 6 F 9 ( 1 )
« 7 1 G 5 ( 1 )
« 1 4 5 E 1 1 ( 4 8 7 ) G CGA TG CCCCGCTTCCGCCTCACGGAATAAGTAAAATAACGTTAAAAGTA
« 4 6A 6 ( 9 5 1 ) GCGATGCCCCGCTYCCGCCTCM CGGAATAAGTAAAATAACGTTAAAAGTA
C o n s e n s u s ( 9 5 1 ) GCGATGCCCCGCTYCCGCCTCM CGGAATAAGTAAAATAACGTTAAAAGTA
( 9 5 2 )
1 0 0 1 1 0 5 0
« 3 3 H 5 ( 1 )
« 1 5 6 F 9 ( 1 )
« 7 1 G 5 ( 1 )
« 1 4 5 E 1 1 ( 5 3 7 ) G TG G TA TTTCA CCTTCG CCG CCA A A G A CG G - C TC C CA C TTA TC CTA CA C C
« 4 6A 6 ( 1 0 0 1 ) G TG G TA TTTCA CCTTCG CCG CCA A A G A A G G G CTCCCA CTTA TCCTA CA CC
C o n s e n s u s ( 1 0 0 1 ) G TG G TA TTTCA CCTTCG CCG CCA AA G A M G GG CTCCCACTTA TCCTA CA CC
( 1 0 0 2 )
1 0 5 1 1 1 0 0
« 3 3 H 5 ( 1 )
« 1 5 6 F 9 ( 1 )
« 7 1 G 5 ( 1 )
« 1 4 5 E 1 1 ( 5 8 7 ) T C T  CAAGT C A TTT CACAAAGT CGGACTAGAGT CAAGCT CAACAGGGTCTT
« 4 6A 6 ( 1 0 5 1 ) TCTCA A G TCA TTTCA CA A A G TCG G A CTA G AG TCA A G CTCA A CA G G G TCTT
C o n s e n s u s ( 1 0 5 1 ) TC TCA A G TCA TTTCA CA A A G TCG G A CTA G AG TCA A G CTCA A CA G G G TCTT
( 1 0 5 2 )
1 1 0 1 1 1 5 0
« 3 3 H 5 ( 1 )
« 1 5 6 F 9 ( 1 )
« 7 1 G 5 ( 1 )
« 1 4 5 E 1 1 ( 6 3 7 ) C TTTC C C C G C T G A TTC TG C C A A G C C C G T TC C C T TG G C TG TG G T TTC G C TG
« 4 6 A 6 ( 1 1 0 1 ) C TTTC CC C G CT G A TTC TG C C A A G C C C G T TC C C T TG G C TG TG G T TTC C C T G
C o n s e n s u s ( 1 1 0 1 ) C T T T C C C C G C T G A TTC TG C C A A G C C C G T TC C C T TG G C TG TG G T TTC SC TG
( 1 1 0 2 )
1 1 5 1 1 2 0 0
« 3 3 H 5 ( 1 )
« 1 5 6 F 9 ( 1 )
« 7 1 G 5 ( 1 )
« 1 4 5 E 1 1 ( 6 8 7 ) G A TA G TA G ACAGGGACAGTGGGAATCTCGATAATCCATTCATGCGCGTCA
« 4 6 A 6 ( 1 1 5 1 ) GATAGTAGACAGGGACAGDGGGAATCTCGTTAATCCATTCATGCGW GTCA
C o n s e n s u s ( 1 1 5 1 ) GATAGTAGACAGGGACAGDGGGAATCTCGW TAATCCATTCATGCGHGTCA
( 1 1 5 2 )
1 2 0 1 1 2 5 0
« 3 3 H 5 ( 1 )
« 1 5 6 F 9 ( 1 )
« 7 1 G 5 ( 1 )
« 1 4 5 E 1 1 ( 7 3 7 ) CTA A TTAGATGACGAGG- C A T T T G - G CTA CCTTA A G A G AG TCA TA GTTA C
« 4 6A 6 ( 1 2 0 1 ) CTA STTA G A TG A CG AG G A CA TTTG CG CTA CY TA A A G A G A GTCATA G TTA C
C o n s e n s u s ( 1 2 0 1 ) CTAVTTAGATGACGAGGACATTTGCGCTACYTW AAGAGAGTCATAGTTAC
( 1 2 0 2 )
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1251 1300
« 33H5 (1)
« 156F9 (1)
« 71G5 (1)
« 145E11 (787)
« 46A6 (1251)
Consensus (1251)
(1252)
« 33H5 (1)
« 156F9 (1)
« 71G5 (1)
« 145E11 (837)
« 4 6A6 (1301)
Consensus (1301)
(1302)
« 33H5 (1)
« 156F9 (1)
« 71G5 (1)
« 145E11 (887)
« 46A6 (1351)
Consensus (1351)
(1352)
« 3 3H5 (49)
« 156F9 (50)
« 71G5 (50)
« 145E11 (937)
« 4 6A6 (1401)
Consensus (1401)
(1402)
« 33H5 (99)
« 156F9 (100)
« 71G5 (100)
« 145E11 (987)
« 4 6A6 (1451)
Consensus (1451)
(1452)
« 33H5 (149)
« 156F9 (150)
« 71G5 (150)
« 145E11 (1037)
« 4 6A6 (1501)
Consensus (1501)
(1502)
« 33H5 (199)
« 156F9 (200)
« 71G5 (200)
« 145E11 (1087)
« 4 6A6 (1551)
Consensus (1551)
(1552)
33H5 (249)
« 156F9 (250)
« 71G5 (250)
« 145E11 (1137)
« 4 6A6 (1601)
Consensus (1601)
(1602)
« 33H5 (299)
« 156F9 (300)
« 71G5 (300)
« 145E11 (1187)
« 4 6A6 (1651)
Consensus (1651)
TCCC-GCC-GTTTACCCGCGCTTGGTTGAATTTCTTCACTTTGACATTCA 
TCCCCGCCCGTTTACCCGCGCTTGGTTGAATTTCTTCACTTTGACATTCA 
TCCCCGCCCGTTTACCCGCGCTTGGTTGAATTTCTTCACTTTGACATTCA
1301 1350
GAGCACTGGGCAGAAATCACATTGCGTTAGCATCCGCAGGGACCATCGCA
GAGCACTGGGCAGAAATCACATTGCGTTAGCATCCGCAGGGACCATCGCA
GAGCACTGGGCAGAAATCACATTGCGTTAGCATCCGCAGGGACCATCGCA
1351 1400
TTTTTTTTTTTTTTAATTAAACAGTCG _GATTGGCG _ TTGTCCGTAC- 
TTTTt tTTTTTTTTTAATTAAACAGTCG-GATTCCCC-TTGTCCGTAC- 
TTTTTTTTTTTTTTTAATTAAACAGTCG _ GAXTCCCCNTTGTCCGTAC _
ATGCTTTGTTTT---AATTAAACAGTCG-GATTCCCC-TTGTCCGTAC-
ATGCTTTGTTTT---AASTAAACAGTGGAGATTCCCC-TTGTCCGTACA
ATTTTTTTTTTTTTTTAATTAAACAGTCGNGATTCCCCNTTGTCCGTACN
1401 1450
CAGTTCTGAGTCGACTGTTCGACGCACGCGGAAGGCCCCGTGAGGAGCCG 
CAGTTCTGAGTCGACTGTTCGACGCACGCGGAAGGCCCCGTGAGGAGCCG 
CAGTTCTGAGTCGACTGTTCGACGCACGCGGAAGGCCCCGTGAGGAGCCG 
CAGTTCTGAGTCGACTGTTCGACGCACGCGGAAGGCCCCGTGAGGAGCCG 
CAGTTCTGAGTCGACTGTTCGACGCACGCGGAAGGCCCCGTGAGGAGCCG 
CAGTTCTGAGTCGACTGTTCGACGCACGCGGAAGGCCCCGTGAGGAGCCG
1451 1500
TTCCCAATCCGTCCCCCGGCCGGCACGCGACGACCCGCTCTCGCCGCGTG 
TTCCCAATCCGTCCCCCGGCCGGCACGCGACGACCCGCTCTCGCCGCGTG 
TTCCCAATCCGTCCCCCGGCCGGCACGCGACGACCCGCTCTCGCCGCGTG 
TTCCCAATCCGTCCCCCGGCCGGCACGCGACGACCCGCTCTCGCCGCGTG 
TTCCCAATCCGTCCCCCGGCGGGCACGWGACGACCCGCTCTCGCCGCGTG 
TTCCCAATCCGTCCCCCGGCCGGCACGCGACGACCCGCTCTCGCCGCGTG
1501 1550
AGCAGCTCGAGCAGT-TC-GCCGACAGCCGACGGGTTCGGGACTGGGACC 
AGCAGCTCGAGCAGT-TC-GCCGACAGCCGACGGGTTCGGGACTGGGACC 
AGCAGCTCGAGCAGT-TC-GCCGACAGCCGACGGGTTCGGGACTGGGACC 
AGCAGCTCGAGCAGT-TC-GCCGACAGCCGACGGGTTCGGGACTGGGACC 
AGCAGCTCGAGCA-WCTCC AGACAGCCGACGGGTTCGGGACTGGGACC 
AGCAGCTCGAGCAGTNTCNGCCGACAGCCGACGGGTTCGGGACTGGGACC
1551 1600
TCGTGCCCAGCCCTCAGAGCCAATCCTTTTCCCGAGGTTACGGATCCATT 
TCGTGCCCAGCCCTCAGAGCCAATCCTTTTCCCGAGGTTACGGATCCATT 
TCGTGCCCAGCCCTCAGAGCCAATCCTTTTCCCGAGGTTACGGATCCATT 
TCGTGCCCAGCCCTCAGAGCCAATCCTTTTCCCGAGGTTACGGATCCATT 
TCGTGCCCAGCCCTCAGAGCCAATCCTTTTCCCGAGGTTACGGATCCATT 
TCGTGCCCAGCCCTCAGAGCCAATCCTTTTCCCGAGGTTACGGATCCATT
1601 1650
TTG-CCGACTTCCCTTGCCTACATTGTTCCA-TCGACCAGAGGCTGTTCA 
TTGGCCGACTTCCCTTGCCTACATTGTTCCAATCG CAGAGGCTGTTCM 
TTG-CCGACTTCCCTTGCCTACATTGTTCCA-TCGACCAGAGGCTGTTCA 
TTG-CCGACTTCCCTTGCCTACATTGTTCCA-TCGACCAGAGGCTGTTCA 
TTG-CCGACTTCCCTTGCCTACATTGTTCCA-TCGACCAGAGGCTGTTCC 
TTGNCCGACTTCCCTTGCCTACATTGTTCCANTCGACCAGAGGCTGTTCA
1651 1700
CCTTGGA-GACCTGATGCGGTTATGAGTACGACCGGGCGTGGATGGCACT 
CCYTGGAAGACCTGATGCGGTTATGAGTACGACCGGGWGTGGATGGCACT 
CCTTGGA-GACCTGATGCGGTTATGAGTACGACCGGGCGTGGATGGCACT 
CCTTGGA-GACCTGATGCGGTTATGAGTACGACCGGGCGTGGATGGCACT 
CCTTGGA-GACCTGATGCGGTTATGAGTACGMCCGGGCGTGGAGGGCACT 
CCTTGGANGACCTGATGCGGTTATGAGTACGACCGGGCGTGGATGGCACT
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(1 6 5 2 )
« 3 3H5 (3 4 9 )
« 1 5 6 F 9 (3 5 0 )
« 71G5 (3 5 0 )
« 14 5 E 1 1 (1 2 3 7 )
« 4 6A6 (1 7 0 1 )
C o n s e n s u s (1 7 0 1 )
(1 7 0 2 )
« 33H5 (3 9 9 )
« 1 5 6 F 9 (4 0 0 )
« 71G5 (4 0 0 )
« 14 5 E 1 1 (1 2 8 7 )
« 4 6A6 (1 7 5 1 )
C o n s e n s u s (1 7 5 1 )
(1 7 5 2 )
« 33H5 (4 4 9 )
« 1 5 6 F 9 (4 5 0 )
« 71G5 (4 5 0 )
« 14 5 E 1 1 (1 3 3 7 )
« 4 6A6 (1 8 0 1 )
C o n s e n s u s (1 8 0 1 )
(1 8 0 2 )
« 3 3H5 (4 9 9 )
« 1 5 6 F 9 (5 0 0 )
« 71G5 (5 0 0 )
« 14 5 E 1 1 (1 3 8 7 )
« 4 6A6 (1 8 5 1 )
C o n s e n s u s (1 8 5 1 )
(1 8 5 2 )
« 3 3H5 (5 4 9 )
« 1 5 6 F 9 (5 5 0 )
« 71G5 (5 5 0 )
« 1 4 5 E 1 1 (1 4 3 7 )
« 4 6A6 ( • 1 8 6 1 )
C o n s e n s u s (1 9 0 1 )
(1 9 0 2 )
« 3 3H5 (5 9 9 )
« 1 5 6 F 9 (6 0 0 )
« 71G5 (6 0 0 )
« 14 5 E 1 1 (1 4 8 7 )
« 4 6A6 ( • 1 8 6 1 )
C o n s e n s u s (1 9 5 1 )
(1 9 5 2 )
« 3 3H5 (6 4 9 )
« 1 5 6 F 9 (6 5 0 )
« 71G5 (6 5 0 )
« 1 4 5 E 1 1 (1 5 3 7 )
« 4 6A6 ( • 1 8 6 1 )
C o n s e n s u s (2 0 0 1 )
(2 0 0 2 )
« 3 3H5 (6 9 9 )
« 1 5 6 F 9 (7 0 0 )
« 71G5 (7 0 0 )
« 14 5 E 1 1 (1 5 8 7 )
« 4 6A6 ( • 1 8 6 1 )
C o n s e n s u s (2 0 5 1 )
(2 0 5 2 )
1 7 0 1  1 7 5 0  
CGGTCCTCCGGATTTTCAAGGGCC- GCCGGGGGCGCACCGGACACCACGC 
CGGTCCTCCGGATTTTCAAGGGCCCGCCGGGGGCGCACCGGACACCACGW 
CGGTCCTCCGGATTTTCAAGGACC-GCGGGGGGCGCACCGGACACCACGG 
CGGTCCTCCGGATTTTCAAGGGCC- GCCGGGGGCGCACCGGACACCACGC 
CGGTCCTCCWWMTTTTCAARGGCC- CCCGGGGGCGCCCCGGACACCMCGC 
CGGTCCTCCGGATTTTCAAGGGCCNGCCGGGGGCGCACCGGACACCACGC
1 7 5 1  1 8 0 0  
GACGTGCGGT- GCTCTTCCGGCCGCTGGACCCTACCTCCGGCTGAACCGT 
GACGTGCGGT- GYTYTTCCGGCCGWTGGACCYTACCTCCGGCTGAACCGT 
GACGTGCGGT- GCTCTTCCGGCCGCTGGACCCTACCTCCGGCTGAACCGT 
GACGTGCGGT-GCTCTTCCGGCCGCTGGACCCTACCTCCGGCTGAACCGT 
GACGCGMGGTAGCTCTTCCGGCCGCTGGACCCTACCTCCGGCTGÄMCCGT 
GACGTGCGGTNGCTCTTCCGGCCGCTGGACCCTACCTCCGGCTGAACCGT
1 8 0 1  1 8 5 0  
TTCCAGGGTGGGCAGGCCGTTAAACAGAAAAGATAACTCTTTC- CGAGGC 
TTCCAGGGTGGGCAGGCCGTTAAMCAGAAAAGATAACTCTTTC-CGAGGC 
TTCCAGGGTGGGCAGGCCGTTAAACAGAAAAGATAACTCTTTC- CGAGGC 
TTCCAGGGTGGGCAGGCCGTTAAACAGAAAAGATAACTCTTTC-CGAGGC
TTCCAGGGTGGCCAG CG---------C -G --------GA----- CGCGTGGGCGA- - C
TTCCAGGGTGGGCAGGCCGTTAAACAGAAAAGATAACTCTTTCNCGAGGC
1 8 5 1  1 9 0 0  
CC- C - CG- CCGACGTCTCCGGACT- CCCTAACGTTGCCGTCA-GCCGCCA 
CC- C- CG-CCGACGTCTCCGGACTTCCCTAACGTTGCCGTCAAGCCGCCA 
CC- C- CG- CCGACGTCTCCGGACT- CCCTAACGTTGCCGTCA- GCCGCCA 
CC- C- CG- CCGACGTCTCCGGACT- CCCTAACGTTGCCGTCA-GCCGCCA 
CCACGCGTCCG
CCNCNCGNCCGACGTCTCCGGACTNCCCTAACGTTGCCGTCANGCCGCCA
1 9 0 1  1 9 5 0  
CGT- CCCGGTTCA-GGAATTTTAA- CCCGATT- CCCTTTCGAAGTTCGCG 
CGT-CCCGGTTCAAGGAATTTTAAACCCGATTTCCCTTTCGAAGTTCGCG 
CGT- CCCGGTTCA-GGAATTTTAA-CCCGATT- CCCTTTCGAAGTTCGCG 
CGTNCCCGGTTCA-GGAATTTTAA-CCCGATT-CCCTTTCGAAGTTCGCG
CGTNCCCGGTTCANGGAATTTTAANCCCGATTNCCCTTTCGAAGTTCGCG
1 9 5 1  2 0 0 0  
TGTTGCACGCTCTCTGACGGGCTTCCCCC-GTCTCTTAGGATCGACTAAC 
TGTTGCACGCTCTCTGACGGGCTTCCCCCCGTCTCTTAGGATCGACTAAC 
TGTTGCACGCTCTCTGACGGGCTTCCCCC-GTCTCTTAGGATCGACTAAC 
TGTTGCACGCTCTCTGACGGGCTTCCCCC- GTCTCTTAGGATCGACTAAC
TGTTGCACGCTCTCTGACGGGCTTCCCCCNGTCTCTTAGGATCGACTAAC
2 0 0 1  2 0 5 0  
CCATGTGCAAGTGCCGTTCACATGGAA-CCTTTCCCCTCTTCGGCCTTCA 
CCATGTGCAAGTGCCGTTCACATGGAAACCTTTCCCYTCTTCGGCCTTCA 
CCATGTGCAAGTGCCGTTCACATGGAA-CCTTTCCCCTCTTCGGCCTTCA 
CCATGTGCAAGTGCCGTTCACATGGAA-CCTTTCCCCTCTTCGGCCTTCA
CCATGTGCAAGTGCCGTTCACATGGAANCCTTTCCCCTCTTCGGCCTTCA
2 0 5 1  2 1 0 0  
AAGTTCTCATTTGAATATTTGCTACTACCACCAAGATCTGCACCGACGGA 
AAGTTCTCATTTGAATATTTGCTACTACCACCAAGATCTGCACCGACGGA 
AAGTTCTCATTTGAATATTTGCTACTACCACCAAGATCTGCACCGACGGA 
AAGTTCTCATTTGAATATTTGCTACTACCACCAAGATCTGCACCGACGGA
AAGTTCTCATTTGAATATTTGCTACTACCACCAAGATCTGCACCGACGGA
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2101 2150 
GGCTCCGCCCGGCCTCACGGCCTAGGTTTCGCAGCCACCGCCGCGCCCTC 
GGCTCCGCCCGGCCTCACGGCCTAG-TTTCGCAGCCACCGCCGCGCCCTC 
GGCTCCGCCCGGCCTCACGGCCTAGGTTTCGCAGCCACCGCCGCGCCCTC 
GGCTCCGCCCGGCCTCACGGCCTAGGTTTCGCAGCCACCGCCGCGCCCTC
GGCTCCGCCCGGCCTCACGGCCTAGGTTTCGCAGCCACCGCCGCGCCCTC
2151 2200 
CTACTCATCGGGG-CCTAACGATTGCCCCGACGGCCGGGTGTGGGTCGCG 
CTACTCATCGGGGGCCTAACGATTGCCCCRACGGCCGGGTGTGGGTCGCG 
CTACTCATCGGGG-CCTAACGATTGCCCCGACGGCCGGGTGTGGGTCGCG 
CTACTCATCGGGG-CCTAACGATTGCCCCGACGGCCGGGTGTGGGTCGCG
CTACTCATCGGGGNCCTAACGATTGCCCCGACGGCCGGGTGTGGGTCGCG
2201 2250 
CGCTTCAGCGCCATCCATTTT-CGGGGCTAGTTGATTCGGCAGGTGAGTT 
CGCTTCAGCGCCATCCATTTTTCGGGGCTAGTTGATTCGGCAGGKGAGTT 
CGCTTCAGCGCCATCCATTTT-CGGGGCTAGTTGATTCGGCAGGTGAGTT 
GGCTTCAGCGCCATCCATTTT-CGGGGCTAGTTGATTCGGCAGGTGAGTT
CGCTTCAGCGCCATCCATTTTNCGGGGCTAGTTGATTCGGCAGGTGAGTT
2251 2300 
GTTACACACTCCTTAGCGGATTTCGACTTCCATGACCACCG-TCCTGCTG 
GTTACMCACTCCTTA GGATTTCGACTTCMATGAMCACCGGTCCTGWTG 
GTTACACACTCCTTAGCGGATTTCGACTTCCATGACCACCG-TCCTGCTG 
GTTACACACTCCTTAGCGGATTTCGACTTCCATGACCACCG-TCCTGCTG
GTTACACACTCCTTAGCGGATTTCGACTTCCATGACCACCGNTCCTGCTG
2301 2350 
TCTTAATCGACCAACACCCTTTGTGGGTTCTAGGTTAGCGCGCAGTTGGG 
TCTTAATCGACMAACACCCTTTGTGGGTTCTARGTTA GCGCAGTTGGG 
TCTTAATCGACCAACACCCTTTGTGGGTTCTAGGTTAGCGCGCAGTTGGG 
TCTTAATCGACCAACACCCTTTGTGGGTTCTAGGTTAGCGCGCAGTTGGG
TCTTAATCGACCAACACCCTTTGTGGGTTCTAGGTTAGCGCGCAGTTGGG
2351 2400 
CACCGTAACCCGGCTTCCGGTTCATCCCGCAT-CGCCAGTTCTGCTTACC 
CACCGTAACCCGGCTTCCGGTTCATCCCGCATTCGCCAGTTCTGCTTACM 
CACCGTAACCCGGCTTCCGGTTCATCCCGCAT-CGCCAGTTCTGCTTACC 
CACCGTAACCCGGCTTCCGGTTCATCCCGCAT-CGCCAGTTCTGCTTACC
CACCGTAACCCGGCTTCCGGTTCATCCCGCATNCGCCAGTTCTGCTTACC
2401 2450 
AAAAATGGCCCACTTGGAGCTCTCGATTCCGTGGCGCGGCT-CATTGGAG 
AAAAATGGCCCACTTGGAGCTCTCGASTCCGKGGCGCGGCTTYSTTGGAG 
AAAAATGGCCCACTTGGAGCTCTCGATTCCGTGGCGCGGCT-CATTGGAG 
AAAAATGGCCCACTTGGAGCTCTCGATTCCGTGGCGCGGCT-CATTGGAG
AAAAATGGCCCACTTGGAGCTCTCGATTCCGTGGCGCGGCTNCATTGGAG
2451 2500 
CAGCCGCGCCGTCCTACCTATTTAAAGTTTGAGAATAGGTCGAGGGCGTT 
CAGCCGCGCCGTCCTACCTATTTAAAGTTTGAGAATAGGTCGAGGGCGTT 
CAGCCGCGCCGTCCTACCTATTTAAAGTTTGAGAATAGGTCGAGGGCGTT 
CAGCCGCGCCGTCCTACCTATTTAAAGTTTGAGAATAGGTCGAGGGCGTT
CAGCCGCGCCGTCCTACCTATTTAAAGTTTGAGAATAGGTCGAGGGCGTT
2501 2550 
GCGCCCCCGATGCCTCTAATCATTGGCTTTACCCGATAGAACTCGCCCGC 
GCGCCCCCGATGCCTCTAATCATTGGCTTTACCCGATAGAACTCGCCCGC 
GCGCCCCCGATGCCTCTAATCATTGGCTTTACCCGATAGAACTCGCCCGC 
GCGCCCCCGATGCCTCTAATCATNGGCTTTACCCGATAGAACTCGCCCGC
GCGCCCCCGATGCCTCTAATCATTGGCTTTACCCGATAGAACTCGCCCGC
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2 5 5 1  2 6 0 0
GGGCTCCAGCTATCCTGAGCCCACGCGTCCGCGGACGCGTGGG
GGGCTCCAGCTATCCTG
GGGCTCCAGCTATCCTGAGCCCACGCGTCCGCGGACGCGTGGG 
GGGCTCCAGCTATCCTGAGGGAAA- C T T C -G -G -A -G -G -G -- AACCAGC
GGGCTCCAGCTATCCTGAGCCCACGCGTCCGCGGACGCGTGGGAACCAGC
2 6 0 1  2 6 5 0
TACTAGACGGTTCGATTAGTCTTTCGCCCCTATACCCAAGTCAGACGAAC 
TACTAGACGGTTCGATTAGTCTTTCGCCCCTATACCCAAGTCAGACGAAC 
2 6 5 1  2 7 0 0
GATTTGCACGTCAGTATCGCTGCGAGCCTCCACCAGAGTTTCCTCTGGCT 
GATTTGCACGTCAGTATCGCTGCGAGCCTCCACCAGAGTTTCCTCTGGCT 
2 7 0 1  2 7 5 0
TCGCCCCGCTCAGGCATAGTTCACCATCTTTCGGGTCCCGACAGGTATGC 
TCGCCCCGCTCAGGCATAGTTCACCATCTTTCGGGTCCCGACAGGTATGC 
2 7 5 1  2 7 9 2
TNTCACTCGAACCCTTCACAGAAGATCTAGGTCGGTCGGCGG
TNTCACTCGAACCCTTCACAGAAGATCTAGGTCGGTCGGCGG
302
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brief communications
Morphine-pathway block in topi poppies
This op ium  poppy m utant provides chem ical precursors fo r non-addictive analgesics.
Codeine
Codeinone
L- tyrosine
Neopinone
Morphine
\  Morphinone
Salutaridine - -  ♦
i MCH,
Thebaine
Oripavine
Figure 1 An abbreviated biosynthesis pathway, leading from tyrosine to morphine and showing the two 
alternative routes from thebaine to morphine. (S)-reticuline is a major branchpoint precursor of a number 
of other alkaloids found in Papaver somniferum and in other plant species. The blocks in the pathway in 
the mutant top 1 are indicated by dotted lines through the enzymatic steps.
T "he opium poppy is a source of the phar- 
I maceuticals codeine, morphine and 
I their derived analgesics. Here we 
describe the initial characterization of the 
poppy mutant known as topi (for ‘thebaine 
oripavine poppy 1’), which accumulates the 
morphine and codeine precursors thebaine 
and oripavine and does not complete their 
biosynthesis into morphine and codeine. 
The original discovery of topi stimulated a 
re-engineering of the opioid industry in the 
island state of Tasmania, which grows over 
40% of the world’s licit opiates, in order to 
produce thebaine and oripavine efficiently 
from morphine-free poppy crops to provide 
precursors for highly effective analgesics and 
for treatment of opioid addiction.
The morphinan branch of the normal 
poppy pathway, from salutaridine to m or-
phine, involves two demethylation steps and 
proceeds by two alternative routes (Fig. I )1’2. 
Although the enzymatic synthesis of m or-
phine has been almost completely elucid-
ated3"5, knowledge about the genes involved 
in the morphinan branch, including their 
coordination and regulation, is sparse.
We treated seeds of a commercial poppy 
cultivar (Papaver somniferum) with a muta-
gen and then screened the progeny plants.
Control topi
_AA_
Figure 2 High-pressure liquid chromatography traces of alkaloid
profiles from the control parent poppy (upper) and the mutant topi 
(lower). The topi trace lacks codeine and morphine peaks. Inset, 
thin-layer chromatogram of latex from the control and the mutant 
topi (standards in third lane: T, thebaine; 0, oripavine; C, codeine; 
M, morphine). Thebaine and oripavine accumulate as the domi-
nant alkaloids in the mutant at the expense of morphine and 
codeine, which are evident in the parental phenotype.
The mutant topi 
was found to accu-
mulate thebaine 
and oripavine but 
not morphine or 
codeine (Fig. 2; for 
details of methods, 
see supplementary 
information). The 
segregation of 375 
F2 individuals was 
mendelian and was 
consistent with the 
involvement of a 
single gene.
The only visible 
phenotypic change 
in the mutant is 
that its latex is 
pigmented rather 
than the normal 
white. The latex 
colour change co-
segregates with the 
thebaine pheno-
type as a reliable visual marker. Feeding of 
radioactive intermediates (see supplemen-
tary information) confirmed that there is a 
block in both arms of the bifurcated pathway 
at thebaine and oripavine in topi. This block 
may be due to a defect in the enzyme the-
baine demethylase, which is likely to be 
responsible for the 6-O-demethylation of 
both thebaine and oripavine.
We developed a 17,000-gene poppy 
microarray and used it to explore global 
changes in gene expression in the mutant. Ten 
genes were identified as being significantly 
differentially underexpressed in topi, a result 
verified by quantitative real-time polymerase 
chain reaction; seven of the clones were highly 
homologous to known genes of other species 
(for details, see supplementary information). 
These include a component of the signal- 
recognition particle that mediates protein 
trafficking, a flippase ATP-dependent trans-
membrane transporter, and a homologue 
to ftsH protein, a transmembrane ATP- 
dependent metalloprotease. Three other 
clones encoded proteins with similarity 
to known enzymes: phosphoenolpyruvate 
carboxykinase, aspartate aminotransferase 
and aldose 1-epimerase.
A comparison of latex proteins revealed 
many obvious changes in topi in both the 
serum and membrane fractions (results not 
shown). It seems that the topi mutation 
triggers a series of changes in gene tran-
scripts, proteins and secondary products. 
None of the candidate genes from the 
microarray study has yet been proved to be
a demethylase or otherwise responsible for 
the topi phenotype. Although the apparently 
coordinated changes in these transcripts and 
proteins are not understood, a window is 
opening into the complex metabolic net-
work associated with the morphine pathway 
and new avenues for modifying the pathway 
are emerging.
There are several possible explanations 
for the topi mutation phenotype: the gene 
encoding the 6-O-demethylase that acts on 
thebaine and oripavine might be affected, as 
could a gene that regulates its function or 
expression (such as a transcriptional regula-
tor or a protein in a multiprotein complex). 
Alternatively, there may be an alteration in a 
structural or transport component that pre-
vents the substrates thebaine and oripavine 
from arriving at the subcellular com part-
ment where O-demethylation occurs6“8.
The topi mutant is not only contributing 
to the genetic dissection of the morphine 
pathway, it has been swiftly deployed for an 
agriculturally viable supply of thebaine and is 
a crop that carries little risk of diversion for 
illicit purposes. Its manufactured derivatives 
include oxycodone, buprenorphine, nalox-
one and naltrexone. Buprenorphine is a 
mixed agonist-antagonist and a potent anal-
gesic with a favourable side-effect profile. It is 
playing an expanding role in both severe pain 
control and in the treatment of addiction. 
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Ecology
Widespread colonization 
by polar hypoliths
I igh-latitude polar deserts are among 
K H  the most extreme environments on
I Earth. Here we describe a large and 
previously unappreciated habitat for photo-
synthetic life under opaque rocks in the 
Arctic and Antarctic polar deserts. This 
habitat is created by the periglacial move-
ment of the rocks, which allows some light 
to reach their underside. The productivity 
of this ecosystem is at least as great as that 
of above-ground biomass and potentially 
doubles previous productivity estimates for 
the polar desert ecozone.
The underside of rocks in climatically 
extreme deserts acts as a refugium for 
photosynthetic microorganisms (defined 
as ‘hypoliths’) and their community (the 
‘hypolithon’)1. Here, the organisms are pro-
tected from harsh ultraviolet radiation2 and 
wind scouring, and trapped moisture can 
provide them with a source of liquid water3 45. 
Colonization also usually requires the rocks 
to be sufficiently translucent to allow for the 
penetration of light — all hypoliths reported 
so far have been found under quartz, which 
is one of the most common translucent 
rocks4,5.
We examined 850 randomly selected 
opaque dolomitic rocks, without regard to 
the local patterns of periglacial rock sorting, 
on Cornwallis Island and Devon Island in the
Figure 1 Colonization by polar hypolithon. a, Hypolithic colonization is enhanced by 
rock sorting which, among other factors, increases light penetration to the underside 
of rocks, shown here at the edges of polygonal terrain (white lines indicate polygon 
edges), b, Opaque rocks are colonized on their underside by well defined bands of 
photosynthetic communities, seen  here on an excavated rock.
Canadian high Arctic. These are regions typ-
ical of extreme polar desert, where vegeta-
tion cover was measured to be 1.2% or less6. 
On Devon Island, 95% of rocks were found 
to be colonized, and on Cornwallis Island, 
94% were colonized. The photosynthetic 
organisms form a well defined green band 
on the underside of the rocks. The mean 
(±s.d.) band width of these communities 
was 3.1 ± 1.9 cm and 3.0 ± 1.6 cm on Devon 
Island and Cornwallis, respectively.
The Arctic hypoliths are dominated by 
cyanobacteria. Species found include 
Gloeocapsa cf. atrata Kützing, Gloeocapsa cf. 
punctata Nägeli, Gloeocapsa cf. kuetzin- 
giana Nägeli and Chroococcidiopsis-like 
cells; unicellular algal chlorophytes were 
also present7.
We investigated the colonization of well 
developed polygons, which are just one 
manifestation of a diversity of linear and cir-
cular featu res caused by the long-term action 
of periglacial processes8 *. In the Arctic, we 
found colonization on 68% of rocks within 
polygons, with a mean ( ± s.d.) band width 
of 0.7 ± 0.8 cm, where the rocks are sur-
rounded by fine soil sorted into their centres. 
At the edges, where the cracks around the 
rocks are larger, we found 100% colonization 
with a mean ( ± s.d.) band width of 
3.6± 1.4cm(Fig. 1).
We studied similar polygonal terrains at 
Mars Oasis on Alexander Island in the 
Antarctic Peninsula, a location where hypo-
lithic colonization occurs. The percentage 
colonization was 5% within polygons and 
100% on the edges of polygons, with mean 
(±s.d.) band widths of 0.7 ±0.1 and
2.1 ±0.3 cm, respectively. We 
propose that rock sorting by 
periglacial action, including 
that during freeze-thaw cycles, 
improves light penetration 
around the edges of rocks, one 
factor that might account for 
the widespread colonization of 
the underside of opaque rocks.
We estimated the productiv-
ity of the Arctic communities by 
monitoring the uptake of l4C- 
labelled sodium bicarbonate 
(for methods, see supplemen-
tary information). Assuming 
no carbon uptake from other 
sources, a conservative estimate 
of mean (±s.d.) productivity 
is about 0.8±0.3 g m -2 yr-1. 
Given that the estimated mean 
(±s.d.) productivity from 
plants, lichens and bryo- 
phytes on Devon Island is 
1.0±0.4 gm “2yr_1 (ref.6),the 
polar hypolithon may be just as 
important in sequestering car-
bon, at least doubling previous 
estimates of the productivity of 
the rocky polar desert.
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Corrigendum Does gut hormone P Y Y ^  decrease 
food intake in rodents?
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Supplementary Methods
Sequencing of Differentially-Expressed Genes
Primers to the vector at the 5’ and 3’ regions of the inserted cDNA were used to get sequence data of the 
differentially-expressed genes. Sequences were analysed on BioManager by ANGIS (http://www.angis.orjJ.au). 
against the NCBI database (GenBank main, SwissProt and SpTr EMBL databases).
2D protein Analysis.
Latex was collected into water from young green capsules of topi and C052, pooled from 8 plants and matched for 
developmental stage. Samples were separated into serum and 1000g pellet fractions. The serum proteins were 
acetone precipitated and dried. The 1000g pellet was washed, solubilised with 1% Triton XI00 and sonicated, 
acetone precipitated and dried. At the Australian Proteome Analysis Facility, lOOpg samples were separated first 
with isoelectric focusing pH 3-10 (87 kV hours), and then in the second dimension on 8-18% polyacrylamide 
gradients (3 h at 3mA, 14 h at 15 mA). Proteins were visualised with SYPRO Ruby fluorescent stain.
Real-Time Quantitative Reverse Transcriptase-Mediated PCR and Qualitative RT-PCR
Gene-specific primer sets were designed using the Primer3 software package (http://www-genome.wi.mit.edu/cui- 
bin/primer/primer3 www.cui) and made by Sigma (Sigma-Aldrich, Sydney, Australia). These primers were 
designed to have a Tm of 59-63 °C (with the optimal being =60 °C), yield a PCR product around 225-275 bp, GC
content from 40-60%, self-complementarity <4, and 3’ self-complementarity <3. Quantitative Real Time PCR (qRT-
12 . .
PCR) reactions were carried out as per . Ratio values were determined by comparing gene expression in C052 to
topi. RNA was extracted from de-veined leaf two days after petal drop. Three technical replicates of each sample 
were tested.
For Reverse transcriptase PCR analysis, RNA was isolated at two days post petal drop from the leaf, stem 
and roots. 20 ng of cDNA was used per PCR reaction using the primers (each at 6 pmoles) designed for qRT-PCR. 
Qiagen Hotstar Taq Polymerase mix was used in each 20 fiL reaction. An annealing temperature of 50° C was used 
in the PCR reaction. The number of cycles was adjusted to discern differences in expression levels. Two biological 
and two technical replicates were run for each sample and set of primers. RNA was quantified by comparison of the 
ribosomal loading on an RNA gel.
3C
Leaf Stem Root
116 d7 
91 g3
27 d!2
157 c4
54 f9 
221 c9
151 h8 
111 c7
Supplementary Figure 1: Gels of RT-PCR of the nine genes to compare transcript levels 
between the mutant top 1 and the control across leaf, stem and root. The RNA gel at the top 
shows the even loading of the RNA for the RT-PCRs
Supplementary Figure 2
Latex serum proteins Latex 1000g proteins
•  •  ■%
Supplementary Figure 2. Two dimensional protein separations using pH 3-10 isoelectric focussing, followed by 8- 
18%T polyacrylamide in the second dimension. Proteins were visualised with SYPRO ruby fluorescent stain.
A. lOOpg protein from the serum fraction of topi and C052
B. 100pg protein from the 1000g pellet fraction of topi and C052 
In each case some of the areas or difference are circled.
Supplementary Table 2
Microarray expression ratios of control verses mutant poppies and E.californica.
Clone
name A B C D E E .ca lifo rn ica
1 16d7 5.11 nd 6.27 4.34 6.48 6.25
91g3 8.97 nd 14.06 8.68 5.86 6.25
27d12 10.17 1 11.55 9.98 7.52 7.69
157c4 6.77 nd 6.76 5.38 5.5 9.09
91b6 6.2 1.1 10.28 6.24 7.2 2.70
221 c9 6.56 nd 7.57 5.32 3.57 4.54
54f9 5.84 nd 8.64 4.92 2.8 4.76
52f2 6.34 nd 7.22 6.84 4.82 6.25
151h8 8.81 nd 7.31 7.64 3.94 5.26
111 c7 7.69 0.94 8.79 7.66 6.36 7.14
Supplementary Table 2. Microarray expression ratios of control verses mutant poppies and E. californica. The 
values in the Table are the spatially normalised back-transformed data on the log (base 2) scale giving the expression 
ratio of the clones in the mutants or E. californica (see methods) compared to the control P. somniferum. A positive 
value reveals higher expression in the control (reference sample) than in the mutants or E. californica (test sample). 
A is a low morphine high thebaine mutant.
B is a reticuline accumulating and morphine free.
C is a mutant with high papaverine low morphine
D is a high oripavine and thebaine mutant, but also with morphine and codeine.
E is a low morphine mutant.
Supplementary Table 1. F2 segregation data for the topi phenotype
Cross ld Cross 2 Total
Morphine Phenotype
189 83 272
Thebaine Phenotype
81 22 103
Supplementary Table 1. The results of HPLC analysis of the latex of random F2 segregates from 2 independent 
crosses, both involving a homozygous mutant topi and a homozygous morphine accumulating parent line. It was 
sometimes possible to see a partial thebaine phenotype in heterozygotes because topi was incompletely dominant 
rather than recessive. However scoring heterozygotes was unreliable and not attempted in the data shown. 
a bTwo separate crosses between topi and normal morphine lines were made and advanced to F2.
As it was not always possible to distinguish heterozygotes from homozygous wild type, these two categories are 
combined for the analysis. Chi squared for equality of segregation ratio in the 2 crosses was 3.106, P between 5 and 
10%, therefore acceptable that they represent the same genetic ratio.
Chi squared for the totals against a 3:1 ratio with Yates’ correction, was 0.44 (P= 0.5068) and therefore conforms to 
a 3:1 ratio.
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s RNAi-mediated replacement of morphine with the
I nonnarcotic alkaloid reticuline in opium poppy
0 )
5 Robert S Allen1, Anthony G Millgate1, Julie A Chitty1, Jennifer Thisleton1, James A C Miller2, Anthony J Fist2, 
I  Wayne L Gerlach3 & Philip J Larkin1
,c
o We report on the silencing of codeinone reductase (COR) in the opium poppy, Papaver somniferum, using a chimeric 
« hairpin RNA construct designed to silence all members of the multigene COR family through RNA interference (RNAi).
3 After gene silencing, the precursor alkaloid (S)-reticuline— seven enzymatic steps upstream of codeinone— accumulated 
in transgenic plants at the expense of morphine, codeine, oripavine and thebaine. Methylated derivatives of reticuline 
also accumulated. Analysis verified loss of Cor gene transcript, appearance of 22-mer degradation products and reduction 
of enzyme activity. The surprising accumulation of (S)-reticuline suggests a feedback mechanism preventing intermediates 
from general benzylisoquinoline synthesis entering the morphine-specific branch. However transcript levels for seven 
other enzymes in the pathway, both before and after (S)-reticuline, were unaffected. This is the first report of gene 
silencing in transgenic opium poppy and of metabolic engineering to cause the high-yield accumulation of the 
nonnarcotic alkaloid reticuline.
Opium poppy is one o f the oldest cultivated plants, and its analgesic 
use can be traced to the beginnings o f civilization1,2. Opium, which is 
the dried latex o f poppy, contains alkaloids presumably involved in 
ecological defense, with codeine and morphine being two o f the most 
abundant3. In certain strains the morphinan intermediates oripavine4 
and thebaine5 also accumulate to similar levels. Presently, codeine and 
morphine remain two o f the most important and effective analgesics 
used in medicine worldwide. W ith five centers o f chirality, the 
©  structures o f morphinan alkaloids present a complexity that renders 
commercial synthesis uneconomic6 and cultivation o f poppy con- 
[gJ tinues to be the most effective means to produce opiate analgesics'.
Several other intermediates o f the morphine biosynthetic pathway 
have medicinal importance, particularly in the synthesis o f drugs 
derived from these compounds. Powerful analgesics, such as bupre- 
norphine and oxycodone8, are manufactured using thebaine as a 
substrate9.(R)- or (S)-reticuline, six and eight steps respectively before 
morphine, are potential substrates for the manufacture o f various 
compounds that have shown antimalarial10-13 or anticancer activ-
ities14,15. Reticuline itself stimulates hair growth16. These are examples 
o f morphine pathway intermediates that have attracted interest, and 
whose availability is limited. It would be advantageous to have 
cultivars capable o f accumulating desired alkaloids that normally 
exist only as transitory compounds. We demonstrate here for the 
first time that hairpin RNA silencing is an effective means to produce 
such modified poppies.
The enzymology o f the entire morphine pathway is largely eluci-
dated17,18 (Fig. I); cDNAs for six o f the enzymes involved in forming
(S)-reticuline from tyrosine have been cloned18-20, and two genes 
from the morphine-specific branch are now cloned21,22. A beginning 
has been made in determining the cellular location o f morphinan 
alkaloid biosynthesis23,24. Despite these important advances, virtually 
nothing is known of what regulates the accumulation o f morphine 
and its intermediates in poppy latex. We anticipate that perturbation 
o f specific enzymatic steps through gene silencing w ill provide 
information about pathway controls.
The cloning o f COR, the penultimate enzyme o f morphine bio-
synthesis, represents important progress21. Expression profiles ind i-
cated COR was a constitutive enzyme, and it was not induced with 
elicitor treatment or wounding, in contrast to other morphine 
biosynthetic genes such as salutaradinol acetyl transferase (SAT)19. 
We wanted to explore the regulatory and biochemical consequences o f 
silencing genes o f morphine biosynthesis; Cor was the most terminal 
gene available and was therefore chosen for this study.
The efficacy o f gene silencing in plants using inverted-repeat 
transgene constructs encoding hairpin RNA (hpRNA) has been 
demonstrated25-27. This technology permits one, some or all members 
o f a multigene family to be silenced by targeting sequences that are 
unique or shared.
COR is encoded by a multigene family21. We used RNAi to silence 
all members and show that silenced P. somniferum lines accumulate 
(S)-reticuline, which occurs seven enzymatic steps before COR. The 
implications o f this surprising result o f metabolic engineering 
are discussed together with new insights into morphinan alkaloid 
regulation. The capacity to engineer crops to accumulate specific
^SIRO Plant Industry, P0 Box 1600, Canberra, Australian Capital Territory 2601, Australia. 2Tasmanian Alkaloids Pty Ltd, PO Box 130, Westbury, Tasmania 7303, 
Australia. 3Johnson & Johnson Research Pty Ltd, Locked Bag 4555, Strawberry Hills, New South Wales 2012, Australia. Correspondence should be addressed to P.J.L. 
(philip.larkin@csiro.au).
Published online 14 November 2004; doi:10.1038/nbtl033
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Figure 1 A summary of the biosynthetic pathway leading to morphine, 
showing also the methylated derivatives of reticuline; enzymes indicated 
are those for which cDNAs have been previously cloned and that are 
investigated in this study. Enzyme abbreviations: 60MT, (/?,S)-norcoclaurine-
6- O-methyltransferase; CNMT, (S)-coclaurine /V-methyltransferase;
CYP80B1, (S)-A/-methylcoclaurine-3'-hydroxylase; 4'0MT, (S)-3'-hydroxy- 
A/-methylcoclaurine-4'-0-methyltransferase; 70MT, (R.S)-reticuline 7-0- 
methyltransferase; BBE, berberine bridge enzyme; SAT, salutaridinol
7- O-acetyltransferase.
intermediates of pharmaceutical significance may enable deployment 
of displacement poppy crops, which cannot readily be diverted to 
illicit uses.
RESULTS
A chimeric hpRNA construct targets the Cor gene family
An hpRNA binary vector was designed to silence all members of the 
Cor gene family. The family contains seven members, Cor1.1-1.6 
(AF108432-108437) and Cor2 (AF108438)21. Regions of cDNA from 
both Cor 1.1 and Cor2 were incorporated into an hpRNA-based vector 
driven by the S4S4 promoter from subterranean-clover stunt virus. 
The region chosen to target Corl.1-1.6 transcripts contained many
COR 1.1/2 hpRNA
Figure 2 The T-DNA from the transformation vector COR 1.1/2 hpRNA 
designed to produce hpRNA and initiate silencing of all members of the Cor 
family in P. somniferum. Shown are the left border (LB) and right border 
(RB), S4S4 promoter, Cor cDNA fragments, pyruvate orthophosphate 
dikinase (PdK) intron, malic enzyme (Mel) terminator and selectable marker 
n p tll gene (35S promoter and terminator).
22-bp sequences of 100% homology across all six genes. In addition a 
sequence specific for Cor2 was included to ensure silencing of this 
distinctive member of the family. The vector also contained the nptll 
gene with the 35S promoter (Fig. 2).
Analyses of the altered alkaloid profiles for hpRNA lines
Thin layer chromatography (TLC) of latex collected from transgenic T0 
lines transformed with the vector COR 1.1/2 hpRNA revealed a drastic 
alteration of the alkaloid profile (Fig. 3). All 18 transgenics consistently 
displayed a ‘reticuline’ phenotype, consisting of reticuline and its 
methylated derivatives codamine, laudanine and laudanosine. This 
was in stark contrast to the normal TLC pattern observed for 
nontransgenic controls, which consisted of morphine, codeine, 
oripavine and thebaine, with no detectable reticuline. Morphine 
was evident in most of the transgenics, although at substantially 
lower levels.
High-performance liquid chromatography (HPLC) and mass spec-
trometry (MS) analysis confirmed the identity of the alkaloids 
associated with the reticuline phenotype (Fig. 4) and enabled quanti-
fication of the various alkaloids (Fig. 5a). For example, transgenic 
lines 220-14-2, 215-25-lb, and 215-16-1 accumulated very little 
morphine, with over 98% of total alkaloid comprised of reticuline 
and its methylated derivatives, while families 220-2-1 and 220-13-2 
still accumulated morphine at up to 71% of total alkaloid. However, 
all transgenic lines consistently accumulated reticuline and its methy-
lated derivatives to at least 25% and up to 100% of total alkaloids. In 
contrast, neither the Tasmanian parental line C058-34 nor any of 
many commercial poppy cultivars examined, accumulate reticuline 
beyond 2% of total alkaloids.
Most of the 18 transgenics segregated in the T] generation in a 
manner consistent with a single transgenic locus and there was no 
obvious association between the amount of reticuline and the number 
of transgenic loci. For example 220-2-1 and 215-16-1 both had two or 
three transgenic loci, yet the first had the lowest level of reticuline 
(25%) and the second had the highest (100%). Conversely, 220-13-2 
and 215-25-lb both had a single transgenic locus, yet differed in 
reticuline content from second lowest (40%) to highest (100%). It was 
evident from the 18 independent primary transgenic lines that reticu-
line and its derivatives accumulate in direct proportion to the decrease 
in morphine (Fig. 5b, linear correlation, r2 =  0.9386).
To determine whether the reticuline, codamine, laudanine and 
laudanosine observed in the hpRNA transgenics were of the (R) or 
(S) form, the compounds were separated by HPLC from transgenic 
latex, fully methylated to laudanosine in vitro, and loaded onto chiral 
columns. Optically pure standards of (R)- and (S)-laudanosine were 
available. The reticuline and methylated derivatives present in the 
transgenic latex samples were predominantly of the (S)-isoform.
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Figure 3 Thin layer chromatography of poppy latex alkaloids. Two sets of 
standards are shown: stds 1 contains morphine (M), codeine (C), oripavine 
(0) and thebaine (T); stds 2 contains (S)-reticuline (R), codamine (Cd), 
laudanine (Ld) and laudanosine (Ls); latex from two C058-34 control 
poppies (control 1 and control 2); latex from three COR hpRNAT0 
transgenics (220-2-2, 215-16-1 , 215-251M .
COR enzyme activity is lower in COR hpRNA lines
Transgenic poppies carrying the COR hpRNA construct were analyzed 
for COR activity in leaf extracts. For the forward reaction, the loss of 
NADPH from the reaction mixture was measured to determine the 
specific activity of COR. The specific activity for the forward reaction, 
using codeinone and NADPH as substrates, was considerably lower 
compared to the control; control poppy leaf had activity of 439 ± 4 1  
pkat mg’ 1 protein, compared to 72 ±  51 pkat mg“ 1 protein for leaf 
extracts of transgenic plant 220-2-2. Measurement of the backward 
reaction using NADP+ and codeine as substrates showed the control 
plant had 62 pkat mg“ 1 protein and transgenic plant 215-14-2 had 
© zero activity.mCor message is diminished in Cor hpRNA transgenicsPoppy lines transformed with the COR hpRNA (hpCOR) were tested 
for the presence of Cor message, and a family of eight Tj segregants 
from a high reticuline-accumulating parent (220-2-2) was examined 
in detail. RT-PCR was initially used to distinguish transgenic Tj 
segregants by detection of nptll message (Fig. 6a). A multiplex RT- 
PCR assay was developed to detect both Cor and actin message 
simultaneously for this set of segregants. Although actin message 
was relatively uniform in all Tj segregants screened, Cor message was 
only visible for nontransgenic segregants (Fig. 6b). Using primers 
specific for Cor2 message, we showed that Cor2 transcript was also 
much lower in the transgenic segregants of 220-2-2 and other families 
(Supplementary Fig. 1 online). Northern blotting supported the 
multiplex RT-PCR analysis. The Tj segregants had equal amounts of 
RNA as evidenced by the ribosomal RNA bands; the Cor probe 
strongly hybridized with nontransgenic segregants (dark bands), but 
not with transgenic segregants (very faint bands) (Fig. 6c,d). RNA was 
separated electrophoretically, blotted to membrane and hybridized to 
detect the 22 mers generated by Dicer protein. Using a probe derived 
from the cDNAs in the silencing construct, 22-bp fragments corre-
sponding to Cor were detected in the transgenic silenced lines, but no 
22-mer fragments were detectable in nontransgenic segregants 
(Fig. 6e). TLC of latex collected from this segregating family
0.04
<  0.16
2 4 6 8 10 12 14 16 18 20
Minutes
Figure 4 HPLC chromatograms, (a) Control nontransgenic latex, (b) COR 
hpRNA transgenic latex. The identity of the major alkaloids was determined 
by comparison to retention time and spectra of standards. A nonalkaloid 
major peak is shown eluting at approximately 2 .3  min.
confirmed the correspondence between presence of the transgene; loss 
of COR transcript; appearance of 22-bp RNA degradation products; 
loss of morphine, codeine, oripavine and thebaine; and appearance of 
reticuline, codamine, laudanine and laudanosine (Fig. 6).
No transcriptional effect on other genes in the pathway
To shed further light on the nature of the altered pathway regulation 
occurring in the hpCOR plants, transcript levels of other pathway 
genes were examined, seven in all. Besides Cor, only one other gene of 
the morphine-specific branch after (S)-reticuline is cloned, salutar- 
idinol acetyl transferase (SAT)22. Relative to controls and nontrans-
genic segregants, Sat transcript was unaffected in the hpCOR 
transgenics (Supplementary Fig. 1 online).
Berberine bridge enzyme (BBE) initiates the alternative benzophe- 
nanthridine pathway, acting directly on (S)-reticuline, forming scou- 
lerine. The gene encoding BBE has been cloned28,29. RT-PCR 
demonstrated that transcript levels of BBE are not affected in 
hpCOR plants relative to controls and nontransgenic segregants 
(Supplementary Fig. 1 online).
(i?,S)-reticuline-7-0-methyltransferase (70MT) converts (S)- 
reticuline into laudanine; a cDNA has been cloned20. Because the 
reticuline-accumulating hpCOR plants also contain elevated levels of 
laudanine, codamine and laudanosine (Fig. 1), we were interested to 
see if there was upregulation of 70MT. RT-PCR demonstrated there 
was no feed-forward transcriptional activation of this step relative to 
controls (Supplementary Fig. 1 online).
We also used RT-PCR to examine the transcript levels of 
the four enzymatic steps before (S)-reticuline (Fig. 1). These 
cloned steps were norcoclaurine 6-O-methyltransferase (60M T)19,20, 
coclaurine-N-methyltransferase (CNMT)19, (S)-N-methylcoclaurine
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Figure 5 HPLC quantification of the alkaloid contents of 18 To hpRNA transgenics and a set of nine independent, nontransgenic control C058-34 
plants (cntls 1-9). (a) The reticuline (R) and codamine + laudanine + laudanosine (Cd +Ld +Ls) contents shown as a percentage of the total alkaloids, 
(b) The relationship between morphine (M) and benzyl tetrahydroisoquinolines (R+Ld+Cd+Ls) shown as a percentage of the total alkaloids in the 
18 T0 hpRNA transgenics.
3'-hydroxylase (CYP80B1)30 and 3'-hydroxyl-N-methylcoclaurine-4'- 
O-methyltransferase (4'OMT)19,20. Because the yield of reticuline 
in hpCOR plants was very high, it was anticipated that earlier steps 
in the pathway would be unaffected. RT-PCR of 60MT, CNMT, 
CYP80B1 and 4'OMT confirmed that transcript levels for these 
genes were the same as in controls and nontransgenic segregants 
(Supplementary Fig. 1 online).
Stable inheritance of the transgenic phenotype
T] individuals from 18 T0 parental lines were examined for segregation 
of the transgenes and reticuline phenotype. Segregation of the 
nptll gene was determined with 40-50 individuals for most lines 
and TLC confirmed the reticuline phenotype was stably inherited, 
and strictly correlated with the presence of nptll. As exemplified 
with the 220-2-2 family (Fig. 6f), the reticuline phenotype was 
also strictly correlated with the reduction of Cor gene transcript; 
(Cor message was uniformly diminished and reticuline levels 
were uniformly high. Most of these families segregated consistently 
with having either one or two transgenic loci. The alkaloids 
were quantified by HPLC in over 100 Tj individuals in a number 
of lines. Generally the highly silenced T0 lines with nearly 100% 
reticuline and methylated derivatives produced T t progeny in which 
all the transgenic segregants were also highly silenced with high 
reticuline yields.
DISCUSSION
Our results provide an example of an hpRNA-induced major mod-
ification of the morphine pathway in opium poppy. Silencing of COR 
has led to the accumulation of (S)-reticuline at the expense of 
morphine, codeine, thebaine and oripavine. Furthermore, the clear 
trade-off between reticuline and morphine observed in lines where 
COR is silenced opens new insights into the regulation of morphine 
synthesis. The eight-enzyme branch leading to morphine can be 
substantially downregulated in response to the loss of the penultimate 
enzyme, COR. Somehow the perturbation of morphinan processing is 
relayed back to the metabolic junction point at (S)-reticuline. This 
intermediate is shared with other alkaloid pathways in Papaver and 
other genera, responsible for berberine, benzophenanthridines, phtha- 
lide isoquinolines and benzyl isoquinolines. We believe this gene
silencing-induced feedback is the most dramatic example in second-
ary metabolism yet reported.
Screening of 18 primary transgenic (T0) lines by TLC and HPLC 
revealed a drastic and consistent alkaloid profile alteration, with 
(S)-reticuline and its methylated derivatives laudanine, laudanosine 
and codamine accumulating at up to 100% of total latex alkaloids. 
Screening of Tj individuals from all 18 T0 transgenics confirmed that 
this phenotype segregated with the transgene; all nontransgenic 
segregants displaying a normal phenotype. Northern analysis and 
RT-PCR verified that Cor message of both classes (1 and 2) was 
substantially reduced in all transgenics, and enzyme assays confirmed 
a dramatic drop in COR activity. Clearly the hpRNA construct was 
successful in greatly reducing COR expression and downregulating the 
entire morphine-specific pathway.
Two previous studies used antisense to suppress berberine bridge 
enzyme in cell and root cultures of Eschscholzia californica, a non- 
morphine-producing species31,32. Decreased levels of benzophenan-
thridines and an increase in tyrosine pools were observed. However, 
unlike the present study, no reticuline accumulated in the cell or root 
cultures. E. californica produces sanguinerine but no morphinan 
alkaloids; clearly the alkaloid metabolic options in E. californica cell 
and root cultures are different and the pathway is regulated quite 
differently in P. somniferum plants.
Although the full chain of events, which has led to the reticuline 
phenotype, cannot yet be elucidated, we suggest three processes that 
could be responsible for the result observed, (i) Buildup of the 
substrates codeinone and neopinone may trigger a negative feedback 
on one or more earlier enzymes or transport steps of the morphine 
branch, (ii) The substrate feedback may act to inhibit transcription of 
genes encoding earlier enzymes or transporters, (iii) Loss of COR 
enzyme from a larger interdependent enzyme complex may disable the 
other enzyme reactions normally associated with the complex. These 
three possibilities are considered in turn.
Negative feedback on morphinan alkaloid synthesis may occur 
directly on enzyme activity. The substrates codeinone and morphi- 
none may accumulate in the absence of COR and could directly 
inhibit the ability of reticuline oxidase to catalyze the oxidation of 
(S)-reticuline, which forms the 1,2-dehydroreticulinium ion as 
the entry point to the morphine pathway. The importance of
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Figure 6  Analysis of Ti family segregants derived from hpCOR parent 
220-2-2. (a) Nptll RT-PCR. (b) Multiplex RT-PCR of Cor message and actin 
message; bands corresponding to actin and Cor are labeled, (c) Ribosomal 
RNA. (d) Northern analysis of Cor. (e) Detection of 22-mer Cor fragments, 
(f) TLC analysis; stds 1 contains morphine (M), codeine (C), oripavine (0), 
thebaine (T). Stds 2 contains reticuline (R), codamine (Cd), laudanine (Ld) 
and laudanosine (Ls).
compartmentalization in alkaloid synthesis and accumulation has 
been indicated23,24,33, and the possibility exists that the feedback 
inhibition operates through a perturbation of the normal transport 
and storage architecture. For example (S)-reticuline may be unable to 
move to the appropriate subcellular compartment for processing into 
morphinan alkaloids. It has been shown previously that (S)-reticuline 
is preferentially transported into vacuoles compared to the (R)- 
isomer34. Salutaridine synthase is responsible for the synthesis of 
salutaridine from (R)-reticuline, a defining chemical step in morphine 
synthesis6. If the silencing of COR results in the feedback inhibition of 
salutaridine synthase, then the inability of (R)-reticuline to be seques-
tered may account for the observed accumulation of (S)-reticuline.
Alternatively the inhibition may act at the transcriptional level, 
for example, by codeinone or morphinone acting directly or indirectly 
to block transcription of the reticuline oxidase gene. We demonstrated 
that the transcript levels of 60MT, CNMT, CYP80B1, 4'OMT and 
Sat are all unaffected in the hpCOR plants. Furthermore, transcript 
levels for both enzymes that can act on (S)-reticuline to divert it 
from morphine synthesis, BBE and 70MT, are unaffected. These 
results confirm that there is no general impact on transcription in 
the early part of the pathway, nor on the chief alternative branch 
pathways from (S)-reticuline. The result with Sat message indicates
that the regulation leading to (S)-reticuline accumulation does 
not operate by coordinated transcriptional suppression of all the 
morphine branch genes.
However, it must be noted that the substrates codeinone and 
morphinone do not accumulate in wild-type or transgenic poppy 
and are undetectable by HPLC. Presumably these compounds have a 
fast turnover or are unable to be stored. If feedback inhibition by 
codeinone or morphinone is responsible for the reticuline phenotype, 
the pathway must be sensitive to small quantitative changes in these 
compounds. Further studies of feedback inhibition are hampered 
because the genes for reticuline oxidase and salutaridine synthase 
have not been cloned.
The third general hypothesis to explain the accumulation of 
(S)-reticuline concerns multienzyme complexes. In flavonoid bio-
synthesis in Arabidopsis thaliana, chalcone synthase, chalcone isomer- 
ase and dihydroflavonol-4-reductase are physically associated35. 
Similarly a multienzyme complex is implicated in polyamine 
synthesis36. It is postulated that such structures channel metabolites 
down a particular pathway, passing intermediates from one enzyme to 
the next. Such complexes, sometimes called metabolons, have been 
invoked to explain some features of O-methyltransferases in iso flavo-
noid biosynthesis37 and their involvement has been postulated in 
benzylisoquinoline synthesis38.
Two recent studies reported immunolocalization and in situ 
hybridization of alkaloid enzymes and transcripts in poppy23,24. 
These reports differed substantially on whether sieve elements were 
involved and on the location of COR. However, both implicated at 
least two cell types in morphine biosynthesis, laticifers and phloem 
parenchyma. If, as they indicated, there is spatial separation between 
accumulating products and enzymes, this greatly complicates a 
metabolon model. Morphine, codeine, oripavine, thebaine and, 
in the COR hpRNA transgenics, reticuline, all accumulate in the 
laticifei and yet most or all of the enzymes are in neighboring cells. 
Complex movement of intermediates is implicated between cell types 
and subcellular compartments. The present study has demonstrated 
that all tetrahydrobenzylisoquinoline synthetic enzymes upstream of 
(S)-reticuline formation are unaffected by the silencing of COR. 
However, physical associations between enzymes specific to the 
morphine branch of the pathway cannot yet be ruled out. Enzyme 
studies on hpCOR transgenics, or silencing of genes for other 
morphinan-specific enzymes may help resolve any interdependency 
between these enzymes.
Although the specific regulatory mechanisms responsible for the 
transgenic reticuline phenotype have not been resolved, the results 
presented here focus attention on (S)-reticuline as a central metabolite 
of importance in the regulation of morphine synthesis. Thebaine and 
oripavine can both accumulate to high levels in normal poppy; 
therefore, our initial expectation of silencing COR was to see the 
accumulation of these intermediates. The surprising accumulation of 
(S)-reticuline demonstrates that the highly specialized morphinan- 
alkaloid pathway can be coordinately regulated independently of the 
more general benzylisoquinoline pathway. Our results provide an 
example of the usefulness of hpRNA technology to dissect regulatory 
aspects of secondary metabolism. We have demonstrated the 
capability to concentrate novel alkaloids of potential commercial 
significance to levels comparable to the current high yields of 
morphine and codeine.
METHODS
Construction of Cor chimeric cDNA hpRNA silencing vector. pPLEX X002 
vector39,40 was digested with Clal, blunted with Pfu polymerase and treated
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with Calf Intestinal Alkaline Phosphatase. The cloning vector pBC KS+ 
containing the orthophosphate dikinase (PdK) intron was digested with Hindi 
and EcoRV to excise the intron. The intron fragment was ligated to the vector 
prepared above to produce pPLEX X002i. RT-PCR was then used to amplify a 
336-bp fragment of Cor 1.1 (GenBank accession no. AF108432) from poppy 
RNA (cultivar C058-34). This fragment included a BamHl site at the 5' end, 
derived from the forward primer, necessary for successive cloning steps. 
Primers used were (F) (5'-GGATCCCATCACTTCCAAGCTCTGGTGC 
GCTGATGCTCAC-3') and (reverse) (5'-GGGCTCATCTCCACTTGATTCACA 
ACTG-3')- The BamHl site is indicated in bold. This fragment corresponded to 
Cor 1.1 cDNA from nucleotide 246 through 575. The Cor 1.1 fragment was 
ligated into pGEM-T. A positive clone was designated pGEM-T/Corl.l. 
RT-PCR was used to amplify a 242-bp Cor2 (AF108438) fragment from total 
poppy RNA (cultivar C058-34). This fragment included Sadi and EcoRV sites at 
the 5'end derived from the forward primer, and a BamHl site at the 3' end derived 
from the reverse primer, necessary for successive cloning steps. Primers used 
were (F) (5'-TCCCCGCGGGATATCATGGACTCCGAGGTGCTGAACCAGAT 
TTCCCA-3') and (reverse) (5'-CGCGGATCCTTAATGGAGACAAAAGGAT 
CACCGGTTGACAC-3'). The incorporated restriction enzyme sites are indi-
cated in bold. This cDNA fragment corresponded to Cor2 cDNA from 
nucleotide 688 through 923. pGEM-T/Cor 1.1 (vector) was cut with Sadi 
and BamHl, and the Cor2 fragment was cut with SacII and BamHl and ligated 
to the vector. A positive clone was designated pGEM-T/ Corl.1/2. The vector 
pPLEX X002i was digested with Avdl and Hpal. pGEM-T/Corl.1/2 was 
digested with EcoRV and Spd. The Corl.1/2 insert was ligated to cut X002i. 
A clone was selected that contained the correct size fragment and this was 
designated pPLEX X002i/Cor 1.1/2 AS ami, which was digested with SnaBl and 
X/jo I. pGEM-T/Corl.1/2 was digested with EcoRV and Safi. The Corl.1/2 insert 
was ligated to cut the vector. A positive clone was identified and is designated 
COR 1.1/2 hpRNA.
Poppy hpCOR transformations. The construct COR 1.1/2 hpRNA was 
electroporated into Agrobacterium tumefaciens strain AGL1 (ref. 41) and a 
single colony was used to transform poppy cultivar C058-34 as previously 
described42. Paromomycin at 25 mg/1 was used as the selection agent.
Determination of transgenic status of T* progeny. Paromomycin leaf painting 
was used on young plants before rouging plants in pots to ensure both 
transgenic and nontransgenic segregants were grown for analysis. A solution 
of 2% paromomycin sulfate (Sigma) and 0.001% Tween 20 was applied with a 
cotton bud to the leaves. After 4-5 d, plants were scored as either tolerant or 
^susceptible on the basis of necrosis at the site of painting. The test was repeated 
land the transgenic status was confirmed by the expression of the selectable 
marker gene Nptll using RT-PCR (see below).
RT-PCR analysis of hpRNA lines. Within a day of anthesis of the main flower, 
young upper leaves were harvested and frozen using liquid nitrogen. RNA was 
extracted using a Qiagen RNAeasy plant mini-kit, with Qiagen Rnase-ffee 
Dnase treatment. For RT-PCR, primers were designed that corresponded to 
Cor 1.1-1.4 cDNAs. The primer binding regions chosen had identical sequences 
for all four functional isoforms. Forward (F) and reverse (R) primers were (F): 
(5'-GAGAGTAATGGTGTACCTATGATCACTCTCAGTTC-3') and (R): (5'-GG 
GCTCATCTCCACTTGATTCACAACTG-3'). Primers were also designed for 
the specific amplification of Cor 2 cDNA, (F): (5'- ATGGACTCCGAGGTGCT 
GAACCAGATTTCCCA-3') and (R): (5'-TTAATGGAGACAAAAGGATCAC 
CGGTTGACAC-3'). Primers used for nptll were: (F): (5'-GCACAACAGA 
CAATCGGCTGCTC-3') and (R): (5'- AGCACGAGGAAGCGGTCAGC-3').
Primers were designed as follows to amplify (S)-N-methylcoclaurine 
3'-hydroxylase (CYP80B1), salutaridinol acetyl transferase (SAT), berberine 
bridge enzyme (BBE), (R,S) norcoclaurine 6-O-methyltransferase (60M T ), 
(R,S) reticuline 7-O-methyltransferase (70M T ), (S)-coclaurine-N-methyltrans- 
ferase (CNMT) and (S)-3/-hydoxy-N-methylcoclaurine-4'-methyltransferase 
(4'OMT).
CYP80B1. (F): (5'-GAGATTCAAGTCCTAAAGGTTTGCCACCAGGTC-3') 
and (R): ('5-GTTTCATTACATTCAGACCACACAATAGAGTTCTCCAC-3');
SAT. (F): (5'-CCATTATCAATCCTGTTAAACAGTTAAACAC-3') and (R): 
(5'-GGATAAAAGTGAACTAGTGTTTTGGAAAGAGAACTC-3');
BBE. (F): (5'-GTACGAGGTGGTGATGTTAATGATAATCTCCTCTC-3') and 
(R): (5'-CACGACATTATCCGCAGCTAATCCGTACTTCCTC-3');
60M T  (F): (5,-GAGCTCAAATCATTCAATCATTCTTCTCATCAACAG-3') 
and (R): (5'-GAATCAACCATTGATTTCTCCCAGCCTCTC-3');
70M T  (F): (5'-CTGCAGAAGAAAGGTTGAAAGGGCAAGCTG-3') and 
(R): (5'-GATCCCAAATCTCACATCCATGAGCTCTCTC-3');
CNMT (F): (5'-TCTGTCTGAACTTCACTGGCAAGATCAATAGAC-3') and 
(R): (5,-TCTCCATATACAAATCCAGCATCGCTATCTCAG-3/);
4'OMT. (F): (5'-CCGGTGATATGTTCATGTCTGTTCCAAGTG-3') and (R):
(5'-GG AAATAGGG AACATCTCCTCAAGTG AAGATGAC-3').
Primers corresponding to Ratus norvegicus ß-actin were (F): (5'-GGAGAA 
GATTTGGCATCACACTTTCTACAATGAG-3') and (R): (5'-CTTCCTGATAT 
CCACAATCACACTTCATGATGG-3'). A Qiagen One-step RT-PCR kit was 
used for RT-PCR reactions. Reactions were performed as per the manu-
facturer’s instructions. Cycling conditions were as follows: 1 cycle of 50 °C 
for 30 min; 27 cycles of 94 °C for 45 s, 65 °C for 45 s, 72 °C for 1 min; 1 cycle of 
72 °C for 10 min. For the Nptll RT-PCR reaction 30 denaturation/annealing/ 
extension cycles were used. We combined 12 pi of each reaction with 3 pi of 
loading dye and ran it on a 1.3% agarose gel in Tris-acetate-EDTA running 
buffer stained with ethidium bromide. Gels were visualized using a Bio-Rad 
Gel-Doc system.
Northern analysis of transcripts. Denatured total RNA (15 pg) was run 
on 1.5% agarose gel containing formaldehyde and blotted for northern 
analysis. Hybridization was carried out at 65 °C in a SDS-phosphate 
buffer (0.5 M phosphate buffer pH 7.2, 7% SDS, 10 mM EDTA) using 
a ~570-bp cDNA fragment corresponding to Corl.1-1.4 generated by the 
same primers used for RT-PCR analysis. The fragment was labeled using 
a Ready-To-Go DNA labeling kit (Amersham Biosciences). Membranes 
were washed twice at 65 °C with 2x SSC, 0.1% SDS for 15 min, then once 
with 0.1 x SSC, 0.1% SDS. Blots were exposed on Kodak Biomax MS film 
with an intensifying screen at -70 °C for 12 h and developed with a Fuji CP 
1000 developer.
Detection of 22-mer fragments. Denatured total RNA in 12-pl volumes was 
run on a 15% acrylamide gel containing 1 x Tris/borate/EDTA, 7 M urea, 
2.6 mM ammonium persulfate, 3.3 M N,N,N'N'-tetramethyl-ethylenediamine. 
RNA was electroblotted to Hybond XL membrane. Prehybridization was carried 
out at 42 °C for 3 h in formamide buffer (0.125 mM sodium phosphate, 
250 mM NaCl2, 7% SDS, 50% formamide). A ~  550 bp PCR product was 
amplified from COR 1.1/2 hpRNA using the same primers (Cor2 F and Cor 1.1 
R) used for construction of the hpRNA binary. This fragment was labeled 
with 32P-dUTP using SP6 RNA polymerase to generate a riboprobe. The 
probe was then treated with carbonyl to create ~  50-bp fragments by adding 
300 pi of carbonate solution (80 mM NaHC03, 120 mM Na2C 0 3) to 
20 pi of the purified probe and incubating at 60 °C for 3 h. After incubation 
20 pi of 3M sodium acetate (pH 5) was added to the reaction and this was then 
added to the hybridization solution. Hybridization was carried out overnight at 
42 °C. The membrane was washed twice for 30 min in 2x SSC/0.2% SDS at 
42 °C and treated with 2 pg/ml RNase in 2x SSC. The membrane was exposed 
on Kodak Biomax MS film with an intensifying screen at -70 °C for 12 h and 
developed with a Fuji CP 1000 developer.
TLC analysis of T0 and Ti hpCOR plants. Small samples (50-100 pi) of 
latex were collected from cut green capsules on a spatula tip and suspended in 
200 pi of the latex extraction buffer (8.65 mM SDS, 200 mM NH4H2P 0 4, 
20% ethanol, pH 4.7). Samples were vortexed then centrifuged for 4 min at 
7,200g. We loaded 10 pi of supernatant onto the origin of Merck silica-gel-60 
plastic-backed plates. Standards were supplied by Tasmanian Alkaloids; 
morphine, oripavine, thebaine, codeine, codamine, laudanine, laudanosine 
and reticuline were dissolved in ethanol and NH3 (3:1) at 2-5 mg ml -1 
and 10 pi was loaded for TLC. The plates were developed with 40% toluene, 
40% acetone, 6% ethanol, 2% ammonia. Dragendorff reagent (25 mM 
Bi(N03)3, 0.8 M KI, 14% glacial acetic acid) was sprayed onto the plates to 
visualize the alkaloids.
Enzyme assays. We froze in liquid N2 3-g (fresh weight) stem or capsule tissue 
and ground it to powder in the presence of 300 mg insoluble polyclar
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(polyvinyl polypyrolidone). As the sample thawed, 10 m l o f buffer (100 m M  
Tris, 10% (vol/vol) glycerol, 1 m M  DTT) was added and mixed. Protease 
inhibitors were added to the buffer immediately before the extraction (0.1 m M  
PMSF, 1 pg/m l leupeptin, 1 pg/m l pepstatin, 1 pg/m l E64 (N-(fra«s-epoxy- 
succinyl)-L-leucine 4-guanidinobutylamide)). The m ixture was centrifuged at 
10,000g fo r 10 m in and the supernatant was used for assays. The protein 
concentration was determined using the Bradford method (Biorad protein 
assay reagent) and bovine serum albumin as standard.
We assayed the forward reaction, as described43. The assay buffer contained 
75 pM  codeinone, 150 pM NADPH, 100 m M  sodium phosphate buffer, 
pH 7.0, and 1 m M  DTT. Total protein per assay was 100 pg and assays were 
run for 60 m in at 37 °C. Controls included boiled extracts (15 m in boiling 
water bath) to inactivate the enzyme.
Reactions were stopped w ith  1 m l chloroform and 30 s o f vortexing. The 
lower chloroform phase containing both codeine and codeinone was removed. 
The absorption o f the aqueous phase was read at 340 nm to determine the rate 
o f oxidation o f NADPH.
The reverse reaction assay mixture comprised 0.4 m M  codeine, 0.6 m M  
NADP+, 200 m M  glycine/NaOH and 1 m M  DTT. 200 pg o f protein (200 pi) 
was used per assay together w ith  800 pi o f reaction m ix in a 2.5 m l tube. We 
used an equal volume o f boiled enzyme as a negative control. Reactions for 
both live and boiled extracts were performed in duplicate at 37 °C for 0, 5 and 
20 min. Reactions were stopped w ith 1 m l o f chloroform and 30 s o f vortexing. 
The chloroform phase (containing codeine and codeinone) was removed. The 
extraction was repeated w ith a further 1 m l chloroform extraction. The 
absorbance o f the aqueous phase was read at 340 nm to determine the rate 
o f formation o f NADPH.
HPLC and mass spectrometry o f hpCOR latex. Latex was collected 
from mature capsules and suspended in the latex extraction buffer used in 
the TLC analysis described above. Samples were run on an Alltech platinum 
C18 53 x 7 mm rocket column at a flow rate o f 1.5 m l/m in and analyzed 
using a Waters 2487 Dual wavelength detector and a M illennium  32 version 
3.05.01 data system w ith  UV detection o f peaks at 254 nm. Standards used 
were morphine, codeine, oripavine, salutaridine, reticuline, laudanine, 
thebaine, laudanosine, papaverine and noscapine. Chiral determinations 
were conducted by Alison Ung and Stephen Pyne at the University o f 
Wollongong. For chiral determination o f reticuline, laudanine and laudanosine, 
samples collected from  the HPLC system were methylated (in  the case o f 
reticuline and laudanine) to form laudanosine, before separating w ith  a normal 
phase Daicel chiral HPLC column (Chiral O D -H  25 cm (length) x  4.6 mm 
(internal diameter)), which used 5-pm particles o f silica gel. The flow rate 
was 1 m l/m in. Standards used were (S)-laudanosine and (R)-laudanosine 
’(Tasmanian Alkaloids).
Note to be added in proof: The enzyme referred to in this paper as reticuline 
oxidase has now been partially purified and should be called 1,2-dehydroreticuline 
synthase44.
Note: Supplementary information is available on the Nature Biotechnology website.
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Supplementary Figure 1 RT-PCR analysis of eight T, family segregants from hpCOR 
parent 220-2-2; these are the same individuals as shown in Figure 6. Top panel shows 
Nptll transgene expression. The other panels show the corresponding RT-PCR results for 
the same individuals for other genes from the benzlisoquinoline pathway multiplexed in 
each case with actin. Gene abbreviations: (^^-norcocalurine-ö-O-methyltransferase 
[60MT]; (S)-coclaurine N-methyltrasnferase [CNMT]; (^-^V-methylcoclaurine-S'- 
hydroxylase [CYP80B1]; 3'-hydoxy-0S)-/V-methylcoclaurine-4'-O-methyltransferase 
[4’OMT]; (/^Syreticuline 7-O-methyltransferase [70MT]; berberine bridge enzyme 
[BBE]; Salutaridinol 7-O-acetyltransferase [SAT]. The bottom panel shows the reduction 
in Cor2 transcript for the same individuals.
